concept_id	concept_synonym_name	language_concept_id
957770	Rhizopus infections	4180186
957771	1-(4-Bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea	4180186
957771	Urea, N-(4-bromo-5-(1-ethyl-1,2-dihydro-7-(methylamino)-2-oxo-1,6-naphthyridin-3-yl)-2-fluorophenyl)-N'-phenyl-	4180186
957772	naringenin 7-methyl ether	4180186
957774	basic blue 1	4180186
957774	C.I. 42025	4180186
957774	setoglaucine nitrate	4180186
957776	2-(alpha-thenoylthio)propionylglycine	4180186
957776	2-(alpha-theonyl)thiopropionylglycine	4180186
957776	Broncoplus	4180186
957776	N-(1-oxo-2-((2-thienylcarbonyl)thio)propyl)-glycine	4180186
957776	prostenoglycine	4180186
957776	stepronin lysine	4180186
957776	stepronin lysine salt	4180186
957776	stepronin monosodium salt	4180186
957776	stepronin sodium	4180186
957776	Tiase	4180186
957776	TS 5010680	4180186
957776	TS-5010680	4180186
957776	TTPG	4180186
957777	SIS block copolymer	4180186
957779	1,3,5-trichloroisocyanuric acid	4180186
957779	NSC 405124	4180186
957779	NSC-405124	4180186
957779	symclosene sodium	4180186
957779	trichloro-s-triazinetrione	4180186
957780	Penicillium marneffei infection	4180186
957780	P marneffei infection	4180186
957780	P. marneffei infection	4180186
957780	Talaromyces infection	4180186
957780	Talaromyces infections	4180186
957780	Talaromyces marneffei infection	4180186
957780	T marneffei infection	4180186
957780	T. marneffei infection	4180186
957781	99mTc-tilmanocept	4180186
957781	99mTc-DTPA-mannosyl-dextran	4180186
957781	(99m)Tc-tilmanocept	4180186
957781	Lymphoseek	4180186
957781	Tc-DTPA-mannosyl-dextran	4180186
957786	tinea manuum	4180186
957788	Aklief	4180186
957788	CD5789	4180186
957791	ONT-380	4180186
957791	tukysa	4180186
957791	N6-(4,4-Dimethyl-4,5-dihydrooxazol-2-yl)-N4-(3-methyl-4-((1,2,4)triazolo(1,5-a)pyridin-7-yloxy)phenyl)quinazoline-4,6-diamine	4180186
957791	irbinitinib	4180186
957791	N6-(4,5-dihydro-4,4-dmethyl-2-oxazolyl)-N4-(3-methyl-4-((1,2,4)triazolo(1,5-A)pyridin-7-Yloxy)phenyl)-4,6-quinazolinediamine	4180186
957792	1',2',5,7-tetrahydro-N-((3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)-3-piperidinyl)-2'-oxo-, (6S)- spiro(6H-cyclopenta(b)pyridine-6,3'-(3H)pyrrolo(2,3-b)pyridine)-3-carboxamide	4180186
957792	MK-1602	4180186
957792	ubrelvy	4180186
957793	(1aR,4S,4aS,7R,7aS,7bS)-1,1,4,7-tetramethyldecahydro-1H-cyclopropa(e)azulen-4-ol	4180186
958604	5 Methoxypsoralen	4180186
958604	5 Methoxy Psoralen	4180186
958604	5-Methoxy Psoralen	4180186
958604	Bergapten	4180186
958604	Pentaderm	4180186
958605	Abbreviated Injury Scales	4180186
958605	Injury Scale, Abbreviated	4180186
958605	Injury Scales, Abbreviated	4180186
958605	Scale, Abbreviated Injury	4180186
958605	Scales, Abbreviated Injury	4180186
958606	c7E3 Fab	4180186
958606	CentoRx	4180186
958606	Chimeric 7E3 Fab	4180186
958606	Clotinab	4180186
958606	Fab, Chimeric 7E3	4180186
958606	ReoPro	4180186
958611	Amevive	4180186
958611	LFA 3 IgG1 Fusion Protein	4180186
958611	LFA-3 IgG(1) Fusion Protein	4180186
958611	LFA-3 IgG1 Fusion Protein	4180186
958612	Polymannuronic Acid	4180186
958612	Poly(Mannuronic Acid)	4180186
958612	Polymannuronic Guluronic Acid	4180186
958612	Polymannuronic-Guluronic Acid	4180186
958613	9 cis Retinoic Acid	4180186
958613	9-cis-Retinoic Acid	4180186
958613	9cRA Compound	4180186
958613	BAL4079	4180186
958613	Panretin	4180186
958613	Toctino	4180186
958614	AlCl3	4180186
958614	Aluminum Chloride, Anhydrous	4180186
958614	Aluminum Chloride Hexahydrate	4180186
958614	Aluminum Trichloride	4180186
958614	Anhydrous Aluminum Chloride	4180186
958614	Drysol	4180186
958615	4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide	4180186
958615	Barnetil	4180186
958615	DAN 2163	4180186
958615	DAN-2163	4180186
958615	LIN 1418	4180186
958615	LIN-1418	4180186
958615	N-(Ethyl-1-pyrrolidinyl- 2-methyl)methoxy-2-ethylsulfonyl-5-benzamide	4180186
958615	Solian	4180186
958615	Sultopride	4180186
958615	Sultopride Hydrochloride	4180186
958618	Acute Physiology and Chronic Health Evaluation	4180186
958618	APACHE I	4180186
958618	APACHE II	4180186
958618	APACHE III	4180186
958619	(1-(3,5-bis(Trifluoromethyl)phenyl)ethoxy)-3-(fluoro)phenyl-4-(3-oxo-1,2,4-triazol-5-yl)methylmorpholine	4180186
958619	(2R)-(1R)-3,5-bis(Trifluoromethylphenyl)ethoxy)-(3S)-(4-fluoro)phenyl-4-(3-(5-oxo-1H,4H-1,2,4-triazole)methyl-morpholine	4180186
958619	3H-1,2,4-Triazol-3-one, 5-(((2R,3S)-2-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-morpholinyl)methyl)-2,4-dihydro-	4180186
958619	Emend	4180186
958619	L754030	4180186
958619	L 754030	4180186
958619	L 754,030	4180186
958619	L-754030	4180186
958619	L-754,030	4180186
958619	L754,030	4180186
958619	MK0517	4180186
958619	MK 0517	4180186
958619	MK-0517	4180186
958619	MK0869	4180186
958619	MK 0869	4180186
958619	MK-0869	4180186
958619	MK869	4180186
958619	MK 869	4180186
958619	MK-869	4180186
958621	3,12-Epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin, decahydro-10-methoxy-3,6,9-trimethyl-, (3R,5aS,6R,8aS,9R,10S,12R,12aR)-	4180186
958621	alpha Artemether	4180186
958621	alpha-Artemether	4180186
958621	Artemether, (3R-(3alpha,5abeta,6alpha,8abeta,9alpha,10beta,12beta,12aR*))-isomer	4180186
958621	Artemether, (3R-(3alpha,5abeta,6beta,8aalpha,9alpha,10beta,12beta,12aR*))-isomer	4180186
958621	Artemether, (3R-(3alpha,5abeta,6beta,8abeta,9alpha,10alpha,12beta,12aR*))-isomer	4180186
958621	Artenam	4180186
958621	beta Arthemeter	4180186
958621	beta-Arthemeter	4180186
958621	O Methyldihydroartemisinine	4180186
958621	O-Methyldihydroartemisinine	4180186
958623	(3R,5R)-7-(2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid	4180186
958623	Atorvastatin Calcium	4180186
958623	Atorvastatin Calcium Anhydrous	4180186
958623	Atorvastatin Calcium Hydrate	4180186
958623	Atorvastatin, Calcium Salt	4180186
958623	Atorvastatin Calcium Trihydrate	4180186
958623	CI981	4180186
958623	CI 981	4180186
958623	CI-981	4180186
958623	Lipitor	4180186
958623	Liptonorm	4180186
958625	CHI 621	4180186
958625	SDZ CHI 621	4180186
958625	Simulect	4180186
958626	PDGF-BB	4180186
958626	Platelet Derived Growth Factor BB	4180186
958626	Platelet-Derived Growth Factor BB	4180186
958626	Platelet Derived Growth Factor BB, Recombinant	4180186
958626	Platelet-Derived Growth Factor BB, Recombinant	4180186
958626	Recombinant Platelet Derived Growth Factor BB	4180186
958626	Recombinant Platelet-Derived Growth Factor BB	4180186
958626	Regranex	4180186
958626	rhPDGF-BB	4180186
958626	rPDGF-BB	4180186
958629	4-t-Butyl-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl)benzenesulfonamide	4180186
958629	Benzenesulfonamide, 4-(1,1-dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)(2,2'-bipyrimidin)-4-yl)-	4180186
958629	Bosentan Anhydrous	4180186
958629	Bosentan Monohydrate	4180186
958629	Ro 470203	4180186
958629	Ro 47 0203	4180186
958629	Ro 47-0203	4180186
958629	Ro-47-0203	4180186
958629	Tracleer	4180186
958630	1-((6-allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea	4180186
958630	1-Ethyl-2-(3'-dimethylaminopropyl)-3-(6'-allylergoline-8'-beta-carbonyl)urea diphosphate	4180186
958630	Cabaser	4180186
958630	Cabaseril	4180186
958630	Cabergoline Diphosphate	4180186
958630	Dostinex	4180186
958630	Ergoline-8-carboxamide, N-(3-(dimethylamino)propyl)-N-((ethylamino)carbonyl)-6-(2-propen-1-yl)-, (8beta)-	4180186
958630	FCE 21336	4180186
958630	FCE-21336	4180186
958630	Galastop	4180186
958632	1,3-Benzenediol, 2-(3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)-5-pentyl-, (1R-trans)-	4180186
958632	Epidiolex	4180186
958633	Hydrogen Peroxide, Urea	4180186
958633	Perhydrol Urea	4180186
958633	Urea, compd. with hydrogen peroxide (H2O2) (1:1)	4180186
958633	Urea Hydrogen Peroxide	4180186
958633	Urea Peroxide	4180186
958638	5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2Z)-2-(2-amino-4-thiazolyl)-2-(hydroxyimino)-1-oxoethyl)amino)-3-ethenyl-8-oxo-, (6R,7R)-	4180186
958638	7-(2 (2-Aminothiazol-4-yl)-2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4-carboxylic acid	4180186
958638	CI983	4180186
958638	CI 983	4180186
958638	CI-983	4180186
958638	FK482	4180186
958638	FK 482	4180186
958638	FK-482	4180186
958638	Omnicef	4180186
958638	PD 134393	4180186
958638	PD-134393	4180186
958642	1-Hexadecanaminium, N,N,N-trimethyl-	4180186
958642	1-Hexadecyltrimethylammonium Chloride	4180186
958642	Cetavlon	4180186
958642	Cetrimide	4180186
958642	Cetriminium	4180186
958642	Cetrimonium Bromide	4180186
958642	Cetrimonium Chloride	4180186
958642	Cetrimonium Hydroxide	4180186
958642	Cetrimonium Iodide	4180186
958642	Cetrimonium Methosulfate	4180186
958642	Cetrimonium Methyl Sulfate	4180186
958642	Cetrimonium Monosulfate	4180186
958642	Cetyltrimethylammonium Bromide	4180186
958642	Cetyltrimethylammonium Chloride	4180186
958642	CTAB	4180186
958642	CTAOH	4180186
958642	Hexadecyltrimethylammonium Bromide	4180186
958642	Hexadecyl Trimethyl Ammonium Bromide	4180186
958642	Hexadecyltrimethylammonium Octylsulfonate	4180186
958642	Hexadecyl(trimethyl)azanium	4180186
958642	HTAB Cpd	4180186
958642	Octylsulfonate, Hexadecyltrimethylammonium	4180186
958645	2(1H)-Quinolinone, 6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-	4180186
958645	6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone	4180186
958645	OPC 13013	4180186
958645	OPC-13013	4180186
958645	Pletal	4180186
958647	1H-1,5-Benzodiazepine-2,4(3H,5H)-dione, 7-chloro-1-methyl-5-phenyl-	4180186
958647	1-Phenyl-5-methyl-8-chloro-1,2,4,5- tetrahydro-2,4-diketo-3H-1,5-benzodiazepine	4180186
958647	Frisium	4180186
958647	HR 376	4180186
958647	LM2717	4180186
958647	LM 2717	4180186
958647	LM-2717	4180186
958647	Onfi	4180186
958647	Urbanyl	4180186
958649	Clopidogrel Besilate	4180186
958649	Clopidogrel Besylate	4180186
958649	Clopidogrel Bisulfate	4180186
958649	Clopidogrel Hydrochloride	4180186
958649	Clopidogrel Mepha	4180186
958649	Clopidogrel-Mepha	4180186
958649	Clopidogrel Napadisilate	4180186
958649	Clopidogrel Sandoz	4180186
958649	Clopidogrel, (+)(S)-isomer	4180186
958649	Iscover	4180186
958649	Methyl 2-(2-chlorophenyl)-2-(4,5,6,7-tetrahydrothieno(3,2-c)pyridin-5-yl)acetate	4180186
958649	PCR 4099	4180186
958649	PCR-4099	4180186
958649	Plavix	4180186
958649	SC 25989C	4180186
958649	SC 25990C	4180186
958649	SR 25989	4180186
958650	Closing Volumes	4180186
958650	Volume, Closing	4180186
958650	Volumes, Closing	4180186
958652	2-Pyridinamine, 3-((1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy)-5-(1-(4-piperidinyl)-1H-pyrazol-4-yl)-	4180186
958652	PF02341066	4180186
958652	PF 02341066	4180186
958652	PF-02341066	4180186
958652	PF2341066	4180186
958652	PF 2341066	4180186
958652	PF-2341066	4180186
958652	Xalkori	4180186
958653	Ro-24-7375	4180186
958653	Dacliximab	4180186
958653	Ro 247375	4180186
958653	Ro 24 7375	4180186
958653	Ro 24-7375	4180186
958653	Zenapax	4180186
958653	Zinbryta	4180186
958654	2' Deoxy 5 azacytidine	4180186
958654	2'-Deoxy-5-azacytidine	4180186
958654	5 Aza 2' deoxycytidine	4180186
958654	5-Aza-2'-deoxycytidine	4180186
958654	5AzadC	4180186
958654	5-AzadC	4180186
958654	5 Azadeoxycytidine	4180186
958654	5-Azadeoxycytidine	4180186
958654	5 Deoxyazacytidine	4180186
958654	5-Deoxyazacytidine	4180186
958654	AzadC Compound	4180186
958654	Compound, AzadC	4180186
958654	Dacogen	4180186
958654	Decitabine Mesylate	4180186
958654	Mesylate, Decitabine	4180186
958654	NSC127716	4180186
958654	NSC 127716	4180186
958654	NSC-127716	4180186
958659	Benzenepropanoic acid, beta-(((1,1-dimethylethoxy)carbonyl)amino)-alpha-hydroxy-, (2aR,4S,4aR,6R,9S,11S,12S,12aS,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,4a ,6,11-tetrahydroxy-8,12a,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester, (alphaR)-, hydrate (1:3)	4180186
958659	Docetaxel Anhydrous	4180186
958659	Docetaxel Hydrate	4180186
958659	Docetaxel Trihydrate	4180186
958659	Docetaxol	4180186
958659	N Debenzoyl N tert butoxycarbonyl 10 deacetyltaxol	4180186
958659	N-Debenzoyl-N-tert-butoxycarbonyl-10-deacetyltaxol	4180186
958659	NSC 628503	4180186
958659	RP56976	4180186
958659	RP 56976	4180186
958659	RP-56976	4180186
958659	Taxoltere Metro	4180186
958659	Taxotere	4180186
958660	1-Benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine hydrochloride	4180186
958660	1H-Inden-1-one, 2,3-dihydro-5,6-dimethoxy-2-((1-(phenylmethyl)-4-piperidinyl)methyl)-	4180186
958660	Aricept	4180186
958660	Donepezil Hydrochloride	4180186
958660	Donepezilium Oxalate Trihydrate	4180186
958660	E2020	4180186
958660	E 2020	4180186
958660	E-2020	4180186
958660	Eranz	4180186
958663	1 Phenyl 3 methyl 5 pyrazolone	4180186
958663	1-Phenyl-3-methyl-5-pyrazolone	4180186
958663	3H-pyrazol-3-one, 2,4-dihydro-5-methyl-2-phenyl-	4180186
958663	3 Methyl 1 phenyl 2 pyrazolin 5 one	4180186
958663	3-Methyl-1-phenyl-2-pyrazolin-5-one	4180186
958663	Edarabone	4180186
958663	MCI186	4180186
958663	MCI 186	4180186
958663	MCI-186	4180186
958663	Norantipyrine	4180186
958663	Norphenazone	4180186
958663	Phenylmethylpyrazolone	4180186
958663	Radicava	4180186
958665	3-Quinolinecarboxylic acid, 1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-	4180186
958665	Baytril	4180186
958665	Bay Vp 2674	4180186
958665	Bay-Vp-2674	4180186
958665	Endrofloxicin	4180186
958669	Oesophageal Squamous Cell Carcinoma	4180186
958672	Eucalyptus globulus Oil	4180186
958674	Expiratory Reserve Volumes	4180186
958674	Reserve Volume, Expiratory	4180186
958674	Reserve Volumes, Expiratory	4180186
958674	Volume, Expiratory Reserve	4180186
958674	Volumes, Expiratory Reserve	4180186
958678	Dificid	4180186
958678	Lipiarmycin	4180186
958678	Lipiarmycin A3	4180186
958678	Lipiarmycin A4	4180186
958678	Lipiarmycin B	4180186
958678	Lipiarmycin B3	4180186
958678	Lipiarmycin B4	4180186
958678	PAR101	4180186
958678	PAR 101	4180186
958678	PAR-101	4180186
958678	Tiacumicin B	4180186
958678	Tiacumicin C	4180186
958679	6-Heptenoic acid, 7-(3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-3,5-dihydroxy-, (3R,5S,6E)-	4180186
958679	7-(3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-3,5-dihydroxy-6-heptenoate	4180186
958679	Fluindostatin	4180186
958679	Fluvastatin Sodium	4180186
958679	Fluvastatin Sodium Salt	4180186
958679	Lescol	4180186
958679	XU62320	4180186
958679	XU 62320	4180186
958679	XU 62 320	4180186
958679	XU 62-320	4180186
958679	XU-62320	4180186
958680	4 Methylpyrazole	4180186
958680	4-Methylpyrazole	4180186
958680	4 Methylpyrazole Monohydrochloride	4180186
958680	4-Methylpyrazole Monohydrochloride	4180186
958680	Antizol	4180186
958682	Expiratory Forced Flow Rates	4180186
958682	Flow Rates, Expiratory Forced	4180186
958682	Flow Rates, Forced Expiratory	4180186
958683	Capacities, Timed Vital	4180186
958683	Capacity, Timed Vital	4180186
958683	Expiratory Volume, Forced	4180186
958683	Expiratory Volumes, Forced	4180186
958683	FEVt	4180186
958683	Forced Expiratory Volumes	4180186
958683	Forced Vital Capacity, Timed	4180186
958683	Timed Vital Capacities	4180186
958683	Timed Vital Capacity	4180186
958683	Vital Capacities, Timed	4180186
958683	Vital Capacity, Timed	4180186
958683	Volume, Forced Expiratory	4180186
958683	Volumes, Forced Expiratory	4180186
958686	1-(Aminomethyl)cyclohexaneacetic Acid	4180186
958686	ApoGabapentin	4180186
958686	Apo Gabapentin	4180186
958686	Apo-Gabapentin	4180186
958686	Convalis	4180186
958686	Gabapentin Hexal	4180186
958686	Gabapentin Ratiopharm	4180186
958686	Gabapentin-Ratiopharm	4180186
958686	Gabapentin Stada	4180186
958686	Neurontin	4180186
958686	NovoGabapentin	4180186
958686	Novo Gabapentin	4180186
958686	Novo-Gabapentin	4180186
958686	PMS-Gabapentin	4180186
958687	Analysis, Gait	4180186
958687	Gait Analyses	4180186
958688	1-cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid	4180186
958688	3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-	4180186
958688	AM 1155	4180186
958688	AM-1155	4180186
958688	BMS206584	4180186
958688	BMS 206584	4180186
958688	BMS-206584	4180186
958688	CG 5501	4180186
958688	Gatifloxacine	4180186
958688	Tequin	4180186
958688	Zymar	4180186
958690	1,8-Naphthyridine-3-carboxylic acid, 7-((4Z)-3-(aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-	4180186
958690	7-(3-aminomethyl-4-methoxyimino-pyrrolidine-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-(1,8)-naphthyridine-3-carboxylic acid	4180186
958690	Factive	4180186
958690	Gemifloxacin Mesylate	4180186
958690	LB20304	4180186
958690	LB 20304	4180186
958690	LB-20304	4180186
958690	SB265805	4180186
958690	SB 265805	4180186
958690	SB-265805	4180186
958692	Outcome Scale, Glasgow	4180186
958692	Scale, Glasgow Outcome	4180186
958694	Birth, Home	4180186
958694	Births, Home	4180186
958694	Childbirth at Home	4180186
958694	Childbirth, Home	4180186
958694	Childbirths at Home	4180186
958694	Childbirths, Home	4180186
958694	Home Birth	4180186
958694	Home Births	4180186
958697	1H-Imidazo(4,5-c)quinolin-4-amine, 1-(2-methylpropyl)-	4180186
958697	1-Isobutyl-1H-imidazo(4,5-c)quinolin-4-amine	4180186
958697	Aldara	4180186
958697	R837	4180186
958697	R 837	4180186
958697	R-837	4180186
958697	S 26308	4180186
958697	S-26308	4180186
958697	Zyclara	4180186
958702	SR47436	4180186
958702	1,3-Diazaspiro(4.4)non-1-en-4-one, 2-butyl-3-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-	4180186
958702	2-N-Butyl-3-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1,3-diazaspiro(4,4)non-1-en-4-one	4180186
958702	Aprovel	4180186
958702	Avapro	4180186
958702	BMS 186295	4180186
958702	BMS-186295	4180186
958702	Karvea	4180186
958702	SR 47436	4180186
958702	SR-47436	4180186
958703	(1,4'-Bipiperidine)-1'-carboxylic acid, (4S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinolin-9-yl ester	4180186
958703	7 Ethyl 10 hydroxycamptothecin	4180186
958703	7-Ethyl-10-hydroxycamptothecin	4180186
958703	Camptosar	4180186
958703	Camptothecin 11	4180186
958703	Camptothecin-11	4180186
958703	CPT11	4180186
958703	CPT 11	4180186
958703	CPT-11	4180186
958703	Irinotecan Hydrochloride	4180186
958703	Irrinotecan	4180186
958703	NK012 Compound	4180186
958703	SN 38	4180186
958703	SN-38	4180186
958703	SN3811	4180186
958703	SN 38 11	4180186
958703	SN-38-11	4180186
958705	Index, Karnofsky	4180186
958705	Karnofsky Index	4180186
958705	Karnofsky Performance Status Scale	4180186
958705	Karnofsky Scale	4180186
958705	Performance Status, Karnofsky	4180186
958705	Scale, Karnofsky	4180186
958705	Status, Karnofsky Performance	4180186
958710	GW282974X	4180186
958710	GW 282974X	4180186
958710	GW-282974X	4180186
958710	GW572016	4180186
958710	GW 572016	4180186
958710	GW-572016	4180186
958710	Lapatinib Ditosylate	4180186
958710	N-(3-chloro-4-(((3-fluorobenzyl)oxy)phenyl)-6-(5-(((2-methylsulfonyl)ethyl)amino)methyl) -2-furyl)-4-quinazolinamine	4180186
958710	Tykerb	4180186
958711	Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R)-3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoate	4180186
958711	PhXA34	4180186
958711	PHXA41	4180186
958711	Xalatan	4180186
958713	Euprotin	4180186
958713	Granocyte	4180186
958713	Lenograstim, Component 1	4180186
958713	Lenograstim, Component 2	4180186
958715	1-Pyrrolidineacetamide, alpha-ethyl-2-oxo-, (alphaS)-	4180186
958715	alpha ethyl 2 oxo 1 Pyrrolidineacetamide	4180186
958715	alpha-ethyl-2-oxo-1-Pyrrolidineacetamide	4180186
958715	Etiracetam	4180186
958715	Etiracetam, (R)-	4180186
958715	Etiracetam, R isomer	4180186
958715	Etiracetam, R-isomer	4180186
958715	Etiracetam, S isomer	4180186
958715	Etiracetam, S-isomer	4180186
958715	Keppra	4180186
958715	R-isomer Etiracetam	4180186
958715	S-isomer Etiracetam	4180186
958715	UCB6474	4180186
958715	UCB 6474	4180186
958715	UCB-6474	4180186
958715	Ucb L059	4180186
958715	Ucb-L059	4180186
958715	UcbL060	4180186
958715	Ucb L060	4180186
958715	Ucb-L060	4180186
958718	1-Methyl-4-(1-methylethenyl)cyclohexene	4180186
958718	4 Mentha 1,8 diene	4180186
958718	4-Mentha-1,8-diene	4180186
958718	(4R)-1-methyl-4-(1-methylethenyl)cyclohexene	4180186
958718	(4S)-1-methyl-4-isopropenylcyclohex-1-ene	4180186
958718	AISA 5203-L (+)Limonene	4180186
958718	Cyclohexene, 1-methyl-4-(1-methylethenyl)-, (4R)-	4180186
958718	Dipentene	4180186
958718	d Limonene	4180186
958718	d-Limonene	4180186
958718	(D)-Limonene	4180186
958718	(-)-Limonene	4180186
958718	(+)-Limonene	4180186
958718	Limonene, (+-)-	4180186
958718	Limonene, (+)-	4180186
958718	Limonene, (+-)-isomer	4180186
958718	Limonene, (R)-isomer	4180186
958718	Limonene, (S)-isomer	4180186
958718	(+)-(R)-4-isopropenyl-1-methylcyclohexene	4180186
958718	(R)-4-isopropenyl-1-methylcyclohexene	4180186
958718	(R)-(+)-Limonene	4180186
958719	9H-Fluorene-4-methanol, 2,7-dichloro-9-((4-chlorophenyl)methylene)-alpha-((dibutylamino)methyl)-, (Z)-	4180186
958719	Benflumetol	4180186
958719	Benflumetol, (-)-isomer	4180186
958719	Benflumetol, (+-)-isomer	4180186
958719	Benflumetol, (+)-isomer	4180186
958720	Compliance, Lung	4180186
958720	Compliances, Lung	4180186
958720	Lung Compliances	4180186
958722	Activity Score, Tegner	4180186
958722	Lysholm Knee Scale	4180186
958722	Lysholm Knee Scoring Scale	4180186
958722	Tegner Activity Level	4180186
958722	Tegner Activity Scale	4180186
958722	Tegner Activity Score	4180186
958723	4,4-Difluoro-N-((1S)-3-(exo-3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo(3.2.1)oct-8-yl)-1-phenylpropyl)cyclohexanecarboxamide	4180186
958723	Cyclohexanecarboxamide, 4,4-difluoro-N-((1S)-3-((3-exo)-3-(3-methyl-5-(1-methylethyl)-4H-1,2,4-triazol-4-yl)-8-azabicyclo(3.2.1)oct-8-yl)-1-phenylpropyl)-	4180186
958723	Selzentry	4180186
958723	UK427857	4180186
958723	UK 427857	4180186
958723	UK 427,857	4180186
958723	UK-427857	4180186
958723	UK-427,857	4180186
958723	UK427,857	4180186
958725	FEF 25 75 Percent	4180186
958725	25-75 Percent, FEF	4180186
958725	25-75 Percents, FEF	4180186
958725	FEF 25-75 Percent	4180186
958725	FEF 25-75 Percents	4180186
958725	Flow Rate, Maximal Midexpiratory	4180186
958725	Forced Expiratory Flow 025 075 Percent	4180186
958725	Forced Expiratory Flow 025-075 Percent	4180186
958725	MMFR	4180186
958725	Percent, FEF 25-75	4180186
958725	Percents, FEF 25-75	4180186
958727	Medical Record, Problem Oriented	4180186
958727	Medical Record, Problem-Oriented	4180186
958727	Medical Records, Problem Oriented	4180186
958727	Problem-Oriented Medical Record	4180186
958727	Problem Oriented Medical Records	4180186
958727	Problem-Oriented Medical Records	4180186
958727	Record, Problem Oriented Medical	4180186
958727	Record, Problem-Oriented Medical	4180186
958727	Records, Problem Oriented Medical	4180186
958727	Records, Problem-Oriented Medical	4180186
958728	1-Deoxy-1-(methylamino)glucitol antimonate(V)	4180186
958728	Glucantime	4180186
958728	N Methylglucamine Antimonate	4180186
958728	N-Methylglucamine Antimonate	4180186
958731	Banthine	4180186
958731	Ethanaminium, N,N-diethyl-N-methyl-2-((9H-xanthen-9-ylcarbonyl)oxy)-	4180186
958731	Methantheline Bromide	4180186
958731	Vagantin	4180186
958734	6 Azamianserin	4180186
958734	6-Azamianserin	4180186
958734	Esmirtazapine	4180186
958734	(N-Methyl-11C)mirtazapine	4180186
958734	Norset	4180186
958734	ORG3770	4180186
958734	ORG 3770	4180186
958734	ORG-3770	4180186
958734	Org 50081	4180186
958734	Remergil	4180186
958734	Remeron	4180186
958734	Rexer	4180186
958734	(S)-Mirtazapine	4180186
958734	Zispin	4180186
958736	2-(Benzhydrylsulfinyl)acetamide	4180186
958736	2-Benzhydrylsulfinylacetamide	4180186
958736	2 Benzhydrylsulfinylacetamide	4180186
958736	2-((Diphenylmethyl)sulfinyl)acetamide	4180186
958736	2-((R)-(Diphenylmethyl)sulfinyl)acetamide	4180186
958736	Alertec	4180186
958736	Armodafinil	4180186
958736	Benzhydrylsulfinylacetamide	4180186
958736	CRL 40476	4180186
958736	CRL-40476	4180186
958736	Modiodal	4180186
958736	Nuvigil	4180186
958736	Provigil	4180186
958736	R Modafinil	4180186
958736	R-Modafinil	4180186
958736	Sparlon	4180186
958737	1-Cyclopropyl--7-(2,8-diazabicyclo(4.3.0)non-8-yl)-6-fluoro-8-methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid	4180186
958737	Actira	4180186
958737	Avalox	4180186
958737	Avelox	4180186
958737	BAY128039	4180186
958737	BAY 128039	4180186
958737	BAY 12 8039	4180186
958737	BAY 12-8039	4180186
958737	BAY-128039	4180186
958737	BAY-12-8039	4180186
958737	Izilox	4180186
958737	Moxifloxacin Hydrochloride	4180186
958737	Octegra	4180186
958737	Proflox	4180186
958738	4-(6-Methoxy-2-naphthyl)-2-butanone	4180186
958738	ApoNabumetone	4180186
958738	Apo-Nabumetone	4180186
958738	Arthraxan	4180186
958738	BRL 14777	4180186
958738	Gen-Nabumetone	4180186
958738	Listran	4180186
958738	Mebutan	4180186
958738	Nabucox	4180186
958738	Nabumeton	4180186
958738	Relafen	4180186
958738	Relif	4180186
958738	Relifex	4180186
958738	Rhoxal nabumetone	4180186
958738	Rhoxal-nabumetone	4180186
958743	BMS936558	4180186
958743	BMS 936558	4180186
958743	BMS-936558	4180186
958743	MDX1106	4180186
958743	MDX 1106	4180186
958743	MDX-1106	4180186
958743	ONO4538	4180186
958743	ONO 4538	4180186
958743	ONO-4538	4180186
958743	Opdivo	4180186
958745	1-((3-Hexyl-4-oxo-2-oxetanyl)methyl)dodecyl-2-formamido-4-methylvalerate	4180186
958745	Alli	4180186
958745	L-Leucine, N-formyl-, 1-((3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl ester, (2S-(2alpha(R*),3beta))-	4180186
958745	Ro 18 0647	4180186
958745	Ro-18-0647	4180186
958745	Tetrahydrolipastatin	4180186
958745	Tetrahydrolipstatin	4180186
958745	THLP	4180186
958745	Xenical	4180186
958746	1,2 Diaminocyclohexane Platinum Oxalate	4180186
958746	1,2-Diaminocyclohexane Platinum Oxalate	4180186
958746	1,2-Diamminocyclohexane(trans-1)oxolatoplatinum(II)	4180186
958746	ACT078	4180186
958746	ACT 078	4180186
958746	ACT-078	4180186
958746	Cis-oxalato-(trans-l)-1,2-diaminocyclohexane-platinum(II)	4180186
958746	Eloxatin	4180186
958746	Eloxatine	4180186
958746	L-OHP Cpd	4180186
958746	Oxalato-(1,2-cyclohexanediamine)platinum II	4180186
958746	Oxaliplatine	4180186
958746	Oxaliplatin, (SP-4-2-(1R-trans))-isomer	4180186
958746	Oxaliplatin, (SP-4-2-(1S-trans))-isomer	4180186
958746	Oxaliplatin, (SP-4-3-(cis))-isomer	4180186
958746	Platinum(2+) ethanedioate (1R,2R)-1,2-cyclohexanediamine (1:1:1)	4180186
958746	Platinum(II)-1,2-cyclohexanediamine Oxalate	4180186
958748	10,11-Dihydro-10-oxo-5H-dibenz(b,f)azepine-5-carboxamide	4180186
958748	5H-Dibenz(b,f)azepine-5-carboxamide, 10,11-dihydro-10-oxo-	4180186
958748	GP 47680	4180186
958748	Timox	4180186
958748	Trileptal	4180186
958750	1 Hydroxy 3 aminopropane 1,1 diphosphonic acid	4180186
958750	1-Hydroxy-3-aminopropane-1,1-diphosphonic acid	4180186
958750	(3-Amino-1-hydroxypropylidene)-1,1-biphosphonate	4180186
958750	AHPrBP	4180186
958750	Amidronate	4180186
958750	Amino 1 hydroxypropane 1,1 diphosphonate	4180186
958750	Amino-1-hydroxypropane-1,1-diphosphonate	4180186
958750	Aminohydroxypropylidene Diphosphonate	4180186
958750	Aminopropanehydroxydiphosphonate	4180186
958750	Aredia	4180186
958750	Pamidronate Calcium	4180186
958750	Pamidronate Disodium	4180186
958750	Pamidronate Monosodium	4180186
958750	Pamidronic Acid	4180186
958757	5-(4-(2-(5-Ethyl-2-pyridyl)ethoxy)benzyl)-2,4-thiazolidinedione	4180186
958757	Actos	4180186
958757	AD4833	4180186
958757	AD 4833	4180186
958757	AD-4833	4180186
958757	Pioglitazone Hydrochloride	4180186
958757	U72107A	4180186
958757	U 72107A	4180186
958757	U-72107A	4180186
958757	U72,107A	4180186
958758	1,4 Diazacyclohexane	4180186
958758	1,4-Diazacyclohexane	4180186
958758	1,4 Piperazine	4180186
958758	1,4-Piperazine	4180186
958758	Piperazine Diacetate	4180186
958758	Piperazine Dihydrochloride	4180186
958758	Piperazine Hexahydrate	4180186
958758	Piperazine Hydrate	4180186
958758	Piperazine Hydrobromide	4180186
958758	Piperazine Hydrochloride	4180186
958758	Piperazine Monohydrochloride	4180186
958758	Piperazine Phosphate	4180186
958758	Piperazine Phosphate (1:1)	4180186
958758	Piperazine Phosphate Anhydrous	4180186
958758	Piperazine Salt	4180186
958758	Piperazine Sulfate	4180186
958758	Piperazine Tartrate	4180186
958758	Piperazine Tartrate (1:1), (R-(R*,R*))-isomer	4180186
958758	Piperazine Tartrate, (R-(R*,R*))-isomer	4180186
958758	Piperazinium Oleate	4180186
958758	Pripsen	4180186
958761	2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N6-propyl-, (S)-	4180186
958761	2-Amino-4,5,6,7-tetrahydro-6-propylaminobenzothiazole	4180186
958761	2 Amino 6 propylaminotetrahydrobenzothiazole	4180186
958761	2-Amino-6-propylaminotetrahydrobenzothiazole	4180186
958761	4,5,6,7-Tetrahydro-N6-propyl-2,6-benzothiazole-diamine	4180186
958761	6,7-Tetrahydro-N6-propyl-2,6-benzothiazolediamine dihydrochloride monohydrate	4180186
958761	Dexpramipexole	4180186
958761	KNS760704	4180186
958761	KNS 760704	4180186
958761	KNS-760704	4180186
958761	Mirapex	4180186
958761	Pramipexol	4180186
958761	Pramipexol Dihydrobromide, (+-)-isomer	4180186
958761	Pramipexol Dihydrochloride, (S)-isomer	4180186
958761	Pramipexole Dihydrochloride	4180186
958761	Pramipexole Dihydrochloride Anhydrous	4180186
958761	Pramipexole Hydrochloride Monohydrate	4180186
958761	Pramipexol, (+-)-isomer	4180186
958761	Pramipexol, (R)-isomer	4180186
958761	Sifrol	4180186
958761	SND 919	4180186
958761	SND-919	4180186
958761	SND919CL2x	4180186
958761	SND 919CL2x	4180186
958761	SND-919CL2x	4180186
958764	2-(2-((1-(Ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid	4180186
958764	3-Isoquinolinecarboxylic acid, 2-((2S)-2-(((1S)-1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-, (3S)-	4180186
958764	Accupril	4180186
958764	CI 906	4180186
958764	CI-906	4180186
958764	PD 1094522	4180186
958764	PD 109,452 2	4180186
958764	PD 109452 2	4180186
958764	PD 109452-2	4180186
958764	PD-109,452-2	4180186
958764	Quinapril Hydrochloride	4180186
958765	2-((2-Ethoxyphenoxy)benzyl)morpholine methanesulfonate	4180186
958765	Morpholine, 2-((R)-(2-ethoxyphenoxy)phenylmethyl)-, (2R)-	4180186
958765	Reboxetine Mesylate	4180186
958765	Vestra	4180186
958768	1,3-Benzenediol, 5-((E)-2-(4-hydroxyphenyl)ethenyl)-	4180186
958768	3,4',5-Stilbenetriol	4180186
958768	3,4',5-Trihydroxystilbene	4180186
958768	3,5,4'-Trihydroxystilbene	4180186
958768	cis Resveratrol	4180186
958768	cis-Resveratrol	4180186
958768	Resveratrol 3 sulfate	4180186
958768	Resveratrol-3-sulfate	4180186
958768	Resveratrol, (Z)-	4180186
958768	SRT501	4180186
958768	SRT 501	4180186
958768	SRT-501	4180186
958768	trans Resveratrol	4180186
958768	trans-Resveratrol	4180186
958768	trans Resveratrol 3 O sulfate	4180186
958768	trans-Resveratrol-3-O-sulfate	4180186
958769	2,7-(Epoxy(1,11,13)pentadecatrienoimino)furo(2'',3'':7',8')naphth(1',2':4,5)imidazo(1,2-a)pyridine-1,15(2H)-dione, 25-(acetyloxy)-5,6,21,23-tetrahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-, ( 2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-	4180186
958769	4-Deoxy-4'-methylpyrido(1',2'-1,2)imidazo(5,4C)rifamycin	4180186
958769	L105	4180186
958769	L 105	4180186
958769	L-105	4180186
958769	Redactiv	4180186
958769	Xifaxan	4180186
958770	2-(N-(Dicyclopropylmethyl)amino)oxazoline	4180186
958770	2-(N-(Dicyclopropylmethyl)amino)oxazoline Phosphate Salt	4180186
958770	2-Oxazolamine, N-(dicyclopropylmethyl)-4,5-dihydro-	4180186
958770	Hyperium	4180186
958770	Oxaminozoline	4180186
958770	Rilmenidine Phosphate	4180186
958770	S3341	4180186
958770	S 3341	4180186
958770	S-3341	4180186
958770	S33413	4180186
958770	S 3341 3	4180186
958770	S-3341-3	4180186
958772	1-(17-(Acetoyl)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)pyrrolidinium	4180186
958772	Androstane-3,17-diol, 2-(4-morpholinyl)-16-(1-(2-propen-1-yl)-1-pyrrolidiniumyl)-, 17-acetate, (2beta,3alpha,5alpha,16beta,17beta)-	4180186
958772	Esmeron	4180186
958772	Esmerone	4180186
958772	ORG9426	4180186
958772	ORG 9426	4180186
958772	ORG-9426	4180186
958772	Pyrrolidinium, 1-((2beta,3alpha,5alpha,16beta,17beta)-17-(acetyloxy)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)-, bromide	4180186
958772	Rocuronium Bromide	4180186
958772	Zemuron	4180186
958773	1 Propyl 2',6' pipecoloxylidide	4180186
958773	1-Propyl-2',6'-pipecoloxylidide	4180186
958773	2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-propyl-	4180186
958773	AL381	4180186
958773	AL 381	4180186
958773	AL-381	4180186
958773	LEA103	4180186
958773	LEA 103	4180186
958773	LEA-103	4180186
958773	Naropeine	4180186
958773	Naropin	4180186
958773	Ropivacaine Hydrochloride	4180186
958773	Ropivacaine Monohydrochloride	4180186
958773	Ropivacaine Monohydrochloride, (S)-isomer	4180186
958777	Impact Profile, Sickness	4180186
958777	Impact Profiles, Sickness	4180186
958777	Profile, Sickness Impact	4180186
958777	Profiles, Sickness Impact	4180186
958777	Sickness Impact Profiles	4180186
958781	2-Pyridinecarboxamide, 4-(4-((((4-chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-	4180186
958781	4-(4-(3-(4-Chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxylic acid methyamide-4-methylbenzenesulfonate	4180186
958781	BAY 439006	4180186
958781	BAY 43 9006	4180186
958781	BAY 43-9006	4180186
958781	BAY5459085	4180186
958781	BAY 5459085	4180186
958781	BAY 545 9085	4180186
958781	BAY 545-9085	4180186
958781	BAY-545-9085	4180186
958781	BAY 673472	4180186
958781	BAY-673472	4180186
958781	Nexavar	4180186
958781	Sorafenib N Oxide	4180186
958781	Sorafenib N-Oxide	4180186
958781	Sorafenib Tosylate	4180186
958783	Position, Standing	4180186
958783	Standing Positions	4180186
958785	4 aminobenzenesulfonamide	4180186
958785	4-aminobenzenesulfonamide	4180186
958785	Azol Polvo	4180186
958785	Benzenesulfonamide, 4-amino-	4180186
958785	Sulfanilamide Barium Salt	4180186
958785	Sulfanilamide Cadmium Salt	4180186
958785	Sulfanilamide Hydrochloride	4180186
958785	Sulfanilamide Lithium Salt	4180186
958785	Sulfanilamide Magnesium Salt	4180186
958785	Sulfanilamide Monohydrate	4180186
958785	Sulfanilamide Silver Salt	4180186
958785	Sulfanilamide Sodium	4180186
958785	Sulfanilamide Sodium Salt	4180186
958785	Sulfanilamide Strontium Salt	4180186
958785	Sulfanilamide Zinc Salt	4180186
958785	Sulphanilamide	4180186
958786	4-amino-N-2-thiazolyl Benzenesulfonamide	4180186
958786	Alphadol	4180186
958786	Benzenesulfonamide, 4 amino N 2 thiazolyl	4180186
958786	Benzenesulfonamide, 4-amino-N-2-thiazolyl	4180186
958786	N(1)-2-thiazolylsulfanilamide	4180186
958786	Norsulfazole	4180186
958786	Sulfathiazole, Monosodium Salt	4180186
958786	Sulfathiazole Sodium	4180186
958788	5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide	4180186
958788	5-((2R)-2-(2-(2-ethoxyphenoxy)ethylamino)propyl)-2-methoxy-benzenesulfonamide	4180186
958788	Flomax	4180186
958788	LY 253352	4180186
958788	LY-253352	4180186
958788	Tamsulosin Hydrochloride	4180186
958788	YM 617	4180186
958788	YM-617	4180186
958790	4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-, 4,4-dioxide, (2S,3S,5R)-	4180186
958790	Tazobactam Sodium	4180186
958790	YTR830	4180186
958790	YTR 830	4180186
958790	YTR-830	4180186
958790	YTR 830H	4180186
958796	Glipressin	4180186
958796	Glycylpressin	4180186
958796	Gly Gly Gly 8 Lys vasopressin	4180186
958796	Gly-Gly-Gly-8-Lys-vasopressin	4180186
958796	Glypressin	4180186
958796	N-(alpha)-glycyl-glycyl-glycyl-8-lysine vasopressin	4180186
958796	N-(N- (N-glycylglycyl)glycyl)-L-lysinevasopressin	4180186
958796	Remestyp	4180186
958796	Terlypressin	4180186
958796	TGLVP	4180186
958796	tri-Gly-8-Lys- Vasopressin	4180186
958796	Triglycyl-(8-lysine)vasopressin	4180186
958796	Triglycyl Lysine Vasopressin	4180186
958796	Triglycylvasopressin	4180186
958796	Vasopressin, tri-Gly-8-Lys-	4180186
958797	alpha1 Thymosin	4180186
958797	alpha1-Thymosin	4180186
958797	Thymosin alpha1	4180186
958797	Thymosin alpha(1)	4180186
958797	Zadaxin	4180186
958798	Cancer, Papillary Thyroid	4180186
958798	Cancers, Papillary Thyroid	4180186
958798	Carcinoma, Nonmedullary Thyroid	4180186
958798	Carcinoma, Papillary Thyroid	4180186
958798	Carcinomas, Nonmedullary Thyroid	4180186
958798	Carcinomas, Papillary Thyroid	4180186
958798	Familial Nonmedullary Thyroid Cancer	4180186
958798	Nonmedullary Thyroid Carcinoma	4180186
958798	Nonmedullary Thyroid Carcinomas	4180186
958798	Papillary Carcinoma Of Thyroid	4180186
958798	Papillary Thyroid Cancer	4180186
958798	Papillary Thyroid Cancers	4180186
958798	Papillary Thyroid Carcinoma	4180186
958798	Papillary Thyroid Carcinomas	4180186
958798	Thyroid Cancers, Papillary	4180186
958798	Thyroid Carcinoma, Nonmedullary	4180186
958798	Thyroid Carcinoma, Papillary	4180186
958798	Thyroid Carcinomas, Nonmedullary	4180186
958798	Thyroid Carcinomas, Papillary	4180186
958801	2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-9-((2-((1,1-dimethylethyl)amino)acetyl)amino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)-	4180186
958801	9-(tert-Butylglycylamido)minocycline	4180186
958801	GAR936	4180186
958801	GAR 936	4180186
958801	GAR-936	4180186
958801	TBG-MINO	4180186
958801	Tygacil	4180186
958803	Aggrastat	4180186
958803	Agrastat	4180186
958803	L 700462	4180186
958803	L 700,462	4180186
958803	L-700462	4180186
958803	L-700,462	4180186
958803	L700,462	4180186
958803	MK 383	4180186
958803	MK-383	4180186
958803	N-(Butylsulfonyl)-O-(4-(4-piperidyl)butyl)-L-tyrosine	4180186
958803	Tirofiban Hydrochloride	4180186
958803	Tirofiban Hydrochloride Monohydrate	4180186
958811	Diseases, Travel-Associated Infectious	4180186
958811	Diseases, Travel-Related	4180186
958811	Diseases, Travel-Related Infectious	4180186
958811	Disease, Travel-Associated Infectious	4180186
958811	Disease, Travel-Related	4180186
958811	Disease, Travel-Related Infectious	4180186
958811	Health Problems, Travel-Related	4180186
958811	Health Problem, Travel-Related	4180186
958811	Illnesses, Travel-Related	4180186
958811	Illness, Travel-Related	4180186
958811	Infections, Travel-Associated	4180186
958811	Infections, Travel-Related	4180186
958811	Infection, Travel-Associated	4180186
958811	Infection, Travel-Related	4180186
958811	Infectious Diseases, Travel-Associated	4180186
958811	Infectious Diseases, Travel-Related	4180186
958811	Infectious Disease, Travel-Associated	4180186
958811	Infectious Disease, Travel-Related	4180186
958811	Problems, Travel-Related Health	4180186
958811	Problem, Travel-Related Health	4180186
958811	Sicknesses, Travel	4180186
958811	Sicknesses, Travel-Related	4180186
958811	Sickness, Travel	4180186
958811	Sickness, Travel-Related	4180186
958811	Travel-Associated Infection	4180186
958811	Travel Associated Infections	4180186
958811	Travel-Associated Infections	4180186
958811	Travel-Associated Infectious Disease	4180186
958811	Travel Associated Infectious Diseases	4180186
958811	Travel-Associated Infectious Diseases	4180186
958811	Travel Related Disease	4180186
958811	Travel-Related Disease	4180186
958811	Travel-Related Diseases	4180186
958811	Travel-Related Health Problem	4180186
958811	Travel Related Health Problems	4180186
958811	Travel-Related Health Problems	4180186
958811	Travel Related Illness	4180186
958811	Travel-Related Illnesses	4180186
958811	Travel-Related Infection	4180186
958811	Travel Related Infections	4180186
958811	Travel-Related Infections	4180186
958811	Travel-Related Infectious Disease	4180186
958811	Travel Related Infectious Diseases	4180186
958811	Travel-Related Infectious Diseases	4180186
958811	Travel Related Sickness	4180186
958811	Travel-Related Sickness	4180186
958811	Travel-Related Sicknesses	4180186
958811	Travel Sickness	4180186
958811	Travel Sicknesses	4180186
958813	1H-Indole-3-carboxylic acid, 8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester, endo-	4180186
958813	(3 alpha-Tropanyl)-1H-indole-3-carboxylic Acid Ester	4180186
958813	ICS 205930	4180186
958813	ICS 205 930	4180186
958813	ICS 205-930	4180186
958813	ICS-205930	4180186
958813	ICS-205-930	4180186
958813	Indole 3 carboxylic Acid Tropine Ester	4180186
958813	Indole-3-carboxylic Acid Tropine Ester	4180186
958813	Navoban	4180186
958813	Tropisetron Hydrochloride	4180186
958814	Acyclovir, L valyl Ester	4180186
958814	2-((2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl L-valinate	4180186
958814	256U87	4180186
958814	Acyclovir, L-valyl Ester	4180186
958814	BW256U87	4180186
958814	D- Valacyclovir	4180186
958814	L Valylacyclovir	4180186
958814	L-Valylacyclovir	4180186
958814	L-valyl Ester Acyclovir	4180186
958814	Valaciclovir	4180186
958814	Valacyclovir, D-	4180186
958814	Valacyclovir, (D)-isomer	4180186
958814	Valacyclovir, (DL)-isomer	4180186
958814	Valacyclovir Hydrochloride	4180186
958814	Valacyclovir Hydrochloride, (DL)-isomer	4180186
958814	Valacyclovir, (L)-isomer	4180186
958814	Valacyclovir, X-Hydrochloride, (D)-isomer	4180186
958814	Valacyclovir, X-Hydrochloride, (DL)-isomer	4180186
958814	Valtrex	4180186
958818	18-Ethenyl-4,4a-dihydro-3,4-bis(methoxycarbonyl)-4a,8,14,19-tetramethyl-23H,25H-benzo(b)porphine-9,13-dipropanoic acid monomethyl ester	4180186
958818	Benzoporphyrin Derivative Monoacid Ring A	4180186
958818	BPD-MA	4180186
958818	BPD Verteporfin	4180186
958818	Verteporphin	4180186
958818	Visudyne	4180186
958819	(2S)-(((3-Hydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile	4180186
958819	Galvus	4180186
958819	NVP LAF237	4180186
958819	NVP-LAF237	4180186
958821	Analog Scales, Visual	4180186
958821	Analog Scale, Visual	4180186
958821	Scales, Visual Analog	4180186
958821	Scale, Visual Analog	4180186
958821	Visual Analog Scales	4180186
958823	1-(2-(2,4-Dimethylphenylsulfanyl)phenyl)piperazine	4180186
958823	Brintellix	4180186
958823	LuAA21004	4180186
958823	Lu AA21004	4180186
958823	Lu-AA21004	4180186
958823	Vortioxetine Hydrobromide	4180186
958825	Modified Wisconsin Card Sorting Test	4180186
958825	M-WCST	4180186
958827	Ambien	4180186
958827	Amsic	4180186
958827	Bikalm	4180186
958827	Dalparan	4180186
958827	Imidazo(1,2-a)pyridine-3-acetamide, N,N,6-trimethyl-2-(4-methylphenyl)-	4180186
958827	N,N,6-Trimethyl-2-(4-methylphenyl)imidazo(1,2a)pyridine-3-acetamide hemitartrate	4180186
958827	SL 80.0750	4180186
958827	SL 800750 23 N	4180186
958827	SL-800750-23-N	4180186
958827	Stilnoct	4180186
958827	Stilnox	4180186
958827	Zodormdura	4180186
958827	Zoldem	4180186
958827	Zolirin	4180186
958827	Zolpidem 1A Pharma	4180186
958827	Zolpidem AbZ	4180186
958827	Zolpidem Hemitartrate	4180186
958827	Zolpidem Tartrate	4180186
958827	Zolpi Lich	4180186
958827	Zolpi-Lich	4180186
958827	Zolpimist	4180186
958827	Zolpinox	4180186
958830	2-methylbenzenesulfonamide	4180186
958830	ortho-toluenesulphonamide	4180186
958830	o-toluenesulfonamide	4180186
958830	o-toluolsulfonamide	4180186
958830	OTS	4180186
958836	Spondylometaepiphyseal dysplasia, Anauxetic type	4180186
958836	Spondylometaepiphyseal dysplasia, Menger type	4180186
958842	Spastic paraplegia facial cutaneous lesions	4180186
958843	LY-3009104	4180186
958843	INCB-28050	4180186
958843	INCB-028050	4180186
958843	baricitinib phosphate salt	4180186
958843	baricitinib phosphate	4180186
958843	3-azetidineacetonitrile, 1-(ethylsulfonyl)-3-(4-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-1H-pyrazol-1-yl)-, phosphate (1:1)	4180186
958843	3-azetidineacetonitrile, 1-(ethylsulfonyl)-3-(4-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-1H-pyrazol-1-yl)-	4180186
958843	INCB028050	4180186
958843	LY3009104	4180186
958843	Olumiant	4180186
958848	Ankyrin-B Syndrome	4180186
958849	cardiotoxin 3, Naja naja atra	4180186
958849	cardiotoxin III, Taiwan cobra	4180186
958849	CTX-III, Taiwan cobra	4180186
958851	Mosaic trisomy 10	4180186
958851	Uniparental disomy of 10	4180186
958854	Chromosome 17 duplication	4180186
958854	Trisomy 17	4180186
958854	Trisomy 17 mosaicism	4180186
958855	Ring 6, Chromosome	4180186
958855	Ring chromosome 6 syndrome	4180186
958857	Trisomy 7 mosaicism	4180186
958857	Uniparental disomy of 7	4180186
958859	Trisomy 9 mosaic	4180186
958859	Trisomy 9 mosaicism	4180186
958859	Uniparental disomy of 9	4180186
958862	Familial benign copper deficiency	4180186
958862	Familial benign hypocupremia	4180186
958863	Charcot-Marie-Tooth disease with deafness and mental retardation	4180186
958863	Charcot-Marie-Tooth disease, X-linked recessive, 4	4180186
958863	NADMR	4180186
958863	NAMSD	4180186
958863	Neuropathy, Axonal Motor-Sensory, with Deafness and Mental Retardation	4180186
958864	Cantu Craniofaciofrontodigital Syndrome	4180186
958867	D-Glucitol, 1-deoxy-1-(methyl(1-oxodecyl)amino)-, stereoisomer	4180186
958867	MEGA-10	4180186
958870	Orilissa	4180186
958870	elagolix sodium	4180186
958870	R-(+)-4-(2-(5-(2-fluoro-3-methoxyphenyl)-3-(2-fluoro-6-(trifluoromethyl)benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl)-1-phenylethylamino)butyrate	4180186
958876	Aimovig	4180186
958876	Ajovy	4180186
958876	AMG 334	4180186
958876	Emgality	4180186
958876	erenumab-aooe	4180186
958876	fremanezumab-vfrm	4180186
958876	galcanezumab-gnlm	4180186
958878	Lactate Transporter Defect, Myopathy due to	4180186
958882	R935788 sodium hydrate	4180186
958882	R-935788 sodium hydrate	4180186
958882	R935788 sodium anhydrous	4180186
958882	R-935788 sodium anhydrous	4180186
958882	R935788 free acid	4180186
958882	R-935788 free acid	4180186
958882	R788 sodium hydrate	4180186
958882	R-788 sodium hydrate	4180186
958882	R788 sodium anhydrous	4180186
958882	R-788 sodium anhydrous	4180186
958882	R788 sodium	4180186
958882	R-788 sodium	4180186
958882	R788 free acid	4180186
958882	R-788 free acid	4180186
958882	fostamatinib disodium salt hexahydrate	4180186
958882	fostamatinib disodium hydrate	4180186
958882	fostamatinib disodium anhydrous	4180186
958882	fostamatinib disodium	4180186
958882	(6-((5-fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido(3,2-b)-1,4-oxazin-4-yl)methyl disodium phosphate hexahydrate	4180186
958882	2H-pyrido(3,2-b)-1,4-oxazin-3(4H)-one, 6-((5-fluoro-2-((3,4,5-trimethoxyphenyl)amino)-4-pyrimidinyl)amino)-2,2-dimethyl-4-((phosphonooxy)methyl)-, sodium salt (1:2)	4180186
958882	2H-pyrido(3,2-b)-1,4-oxazin-3(4H)-one, 6-((5-fluoro-2-((3,4,5-trimethoxyphenyl)amino)-4-pyrimidinyl)amino)-2,2-dimethyl-4-((phosphonooxy)methyl)-	4180186
958882	Tavalisse	4180186
958883	Cerebrooculofacial Lymphatic Syndrome	4180186
958883	Mental Retardation with Epilepsy and Characteristic Facies	4180186
958883	Pachygyria, Mental Retardation, Epilepsy, and Characteristic Facies	4180186
958886	Harpagophytum extract WS 1531	4180186
958886	harpagoside-B	4180186
958886	WS1531	4180186
958886	WS 1531	4180186
958887	cyclocaric acid A	4180186
958893	Ichthyosis congenita IV	4180186
958897	KLICK Syndrome	4180186
958898	Anesthetic-induced malignant hyperpyrexia in children	4180186
958898	King-Denborough Syndrome	4180186
958898	King syndrome	4180186
958900	Pachygyria, mental retardation and epilepsy	4180186
958900	Pachygyria with mental retardation and seizures	4180186
958901	Porcelain nails	4180186
958901	Hereditary white nails	4180186
958905	Spastic Paraplegia 21, Autosomal Recessive	4180186
958906	matrine, (5beta)-isomer	4180186
958906	sophoridine	4180186
958907	Mental Retardation, Epileptic Seizures, Hypogonadism and Hypogenitalism, Microcephaly, and Obesity	4180186
958907	X-linked MEHMO syndrome	4180186
958911	1-phenylethanol	4180186
958911	alpha-hydroxyethylbenzene	4180186
958911	alpha-methylbenzyl alcohol	4180186
958912	1-butyl-2-(hydroxylmethyl)piperidine-3,4,5-triol	4180186
958912	1-deoxygalactonojirimycin	4180186
958912	1-deoxy-galactonojirimycin	4180186
958912	1-deoxygalacto-nojirimycin	4180186
958912	AT1001 deoxyjirimycin	4180186
958912	Galafold	4180186
958912	GR181413A	4180186
958912	lucerastat	4180186
958912	migalastat HCl	4180186
958912	migalastat hydrochloride	4180186
958912	NB-DGJ	4180186
958912	N-butyldeoxygalactonojirimycin	4180186
958912	N-butyldeoxygalacto-nojirimycin	4180186
958913	AMG761	4180186
958913	AMG 761	4180186
958913	AMG-761	4180186
958913	KM8761	4180186
958913	KM-8761	4180186
958913	KW0761	4180186
958913	KW 0761	4180186
958913	KW-0761	4180186
958913	mogamulizumab-kpkc	4180186
958913	poteligeo	4180186
958916	Epiphyseal Dysplasia, Multiple, with Robin Phenotype	4180186
958920	Port-wine stain familial multiple	4180186
958927	Multicentric Osteolysis, Autosomal Dominant	4180186
958936	Novafil	4180186
958937	Polycystic Kidney Disease, Infantile Severe, With Tuberous Sclerosis	4180186
958937	Tuberous sclerosis-polycystic kidney disease contiguous gene syndrome	4180186
958939	diethyl N,N'-(((2-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)ethoxy)methyl)phosphonoyl)di-L-alaninate	4180186
958939	GS-9219	4180186
958939	VDC-1101	4180186
958945	Komuragaeri Disease	4180186
958945	Muscle spasms, intermittent with alopecia, diarrhea, and skeletal abnormalities	4180186
958945	Muscle Spasms, Intermittent, With Alopecia, Diarrhea, And Skeletal Abnormalities	4180186
958946	Cleft palate large ears small head	4180186
958946	Cleft palate, microcephaly, large ears, and short stature	4180186
958946	Say Barber Hobbs syndrome	4180186
958947	Craniodigital syndrome-mental retardation, Scott type	4180186
958947	Craniodigital syndrome with mental retardation	4180186
958947	Scott craniodigital syndrome with mental retardation	4180186
958951	Autosomal dominant spheroid body myopathy	4180186
958952	Spinal Muscular Atrophy, Congenital Benign, with Contractures	4180186
958953	Hereditary motor neuropathy, Jerash type	4180186
958953	Motor neuropathy, distal, Jerash type	4180186
958953	Neuronopathy, Distal Hereditary Motor, Jerash Type	4180186
958953	Neuropathy, distal hereditary motor, Jerash type	4180186
958953	Spinal Muscular Atrophy, Distal, Autosomal Recessive, 2	4180186
958955	SCA 11 Spinocerebellar Ataxia 11	4180186
958956	SCA12 Spinocerebellar Ataxia 12	4180186
958957	Autosomal dominant cerebellar ataxia with mental retardation	4180186
958957	Cerebellar ataxia, autosomal dominant with mental retardation	4180186
958957	SCA13 Spinocerebellar ataxia 13	4180186
958958	SCA14 Spinocerebellar ataxia 14	4180186
958960	SCA21 Spinocerebellar ataxia 21	4180186
958961	SCA23 Spinocerebellar ataxia 23	4180186
958963	SCA28 Spinocerebellar ataxia 28	4180186
958966	SCA31 Spinocerebellar Ataxia 31	4180186
958966	Spinocerebellar Ataxia, 16q22-Linked	4180186
958967	SCA8 Spinocerebellar ataxia 8	4180186
958968	Spondyloepimetaphyseal dysplasia with multiple dislocations, hall type	4180186
958968	Spondyloepimetaphyseal dysplasia with multiple dislocations, leptodactylic type	4180186
958970	Growth Hormone Deficiency with Wormian Bones, Cardiac Anomaly, and Brachycamptodactyly	4180186
958971	octanedioic acid	4180186
958971	suberic acid, cadmium (1:1) salt	4180186
958971	suberic acid, dipotassium salt	4180186
958971	suberic acid, disodium salt	4180186
958971	suberic acid, manganese (+2) (1:1) salt	4180186
958971	suberic acid, monosodium salt	4180186
958974	Cop 1 (polymer)	4180186
958974	copolymer I (synthetic peptide)	4180186
958974	GLAT copolymer	4180186
958974	L-Glutamic acid, polymer with L-alanine, L-lysine and L-tyrosine	4180186
958974	(L-tyrosine-L-glutamic acid)-poly(DL-alanine)-poly(L-lysine)	4180186
958974	multideterminant antigen (T,G)-A-L	4180186
958974	poly-L-(Tyr,Glu)-poly-DL-Ala-poly-L-Lys	4180186
958974	synthetic peptide copolymer I	4180186
958974	TGAL copolymer	4180186
958974	(Tyr-Tyr-Glu-Glu)-poly(DL-Ala)-poly(Lys)	4180186
958978	CTL019	4180186
958978	KYMRIAH	4180186
958979	2 (3-hydroxy-3,7,11,15-tetramethylhexadecyl)- 3,5,6-trimethyl-1,4-benzoquinone	4180186
958979	alpha-tocopherolquinone	4180186
958979	alpha-tocopherol quinone	4180186
958979	alpha-tocopheryl quinone	4180186
958979	alpha-tocoquinone	4180186
958979	delta-tocopherylquinone	4180186
958979	Eutrophyl	4180186
958979	gamma-tocopherylquinone	4180186
958979	tocopherolquinone	4180186
958979	tocopherylquinone, ((3R*,7R*,11R*)-(+-))-isomer	4180186
958979	vitamin E quinone	4180186
958981	HBr of trimethylamine	4180186
958981	HCl of trimethylamine	4180186
958981	HI of trimethylamine	4180186
958981	N,N-dimethylmethanamine	4180186
958983	Cerebro-facio-articular syndrome	4180186
958983	Cerebrofacioarticular syndrome	4180186
958983	Cerebro-facio-articular syndrome of Van Maldergem	4180186
958983	Van Maldergem syndrome	4180186
958987	vitamin MK 7	4180186
958987	menaquinone K7	4180186
958987	1,4-naphthalenedione, 2-(3,7,11,15,19,23,27-heptamethyl-2,6,10,14,18,22,26-octacosaheptaenyl)-3-methyl-, (all-E)-	4180186
958987	menaquinone-7	4180186
958987	vitamin K2(35)	4180186
958988	ADVIRC	4180186
958988	Autosomal dominant Vitreoretinochoroidopathy	4180186
958988	Microcornea, Rod-Cone Dystrophy, Cataract, And Posterior Staphyloma	4180186
958988	Vitreoretinochoroidopathy, Autosomal Dominant	4180186
958988	Vitreoretinochoroidopathy, Autosomal Dominant, With Nanophthalmos	4180186
958988	Vitreoretinochoroidopathy dominant	4180186
958988	Vitreoretinochoroidopathy With Microcornea, Glaucoma, And Cataract	4180186
958990	5,7-dihydroxy-8-methoxyflavone	4180186
958992	Familial short stature, developmental delay, pectus abnormalities, distinctive facies, and dysplastic nails	4180186
958992	Pectus excavatum, macrocephaly and dysplastic nails	4180186
979197	Acrocallosal Syndromes	4180186
979197	Hallux Duplication, Postaxial Polydactyly, and Absence of Corpus Callosum	4180186
979197	Syndrome, Acrocallosal	4180186
979197	Syndromes, Acrocallosal	4180186
979198	Actinomycetales Infection	4180186
979198	Actinomycete Infection	4180186
979198	Actinomycete Infections	4180186
979198	Infection, Actinomycetales	4180186
979198	Infection, Actinomycete	4180186
979198	Infections, Actinomycetales	4180186
979198	Infections, Actinomycete	4180186
979199	Alcohol-Induced Disorder	4180186
979199	Alcohol Induced Disorders	4180186
979200	Antibody Campath-1H, Monoclonal	4180186
979200	Campath	4180186
979200	Campath1G	4180186
979200	Campath 1G	4180186
979200	Campath 1 G	4180186
979200	Campath-1G	4180186
979200	Campath-1-G	4180186
979200	Campath1H	4180186
979200	Campath 1H	4180186
979200	Campath-1H	4180186
979200	Campath-1H, Monoclonal Antibody	4180186
979200	Campath 1M	4180186
979200	Campath-1M	4180186
979200	Lemtrada	4180186
979200	MabCambath	4180186
979200	Monoclonal Antibody Campath 1H	4180186
979200	Monoclonal Antibody Campath-1H	4180186
979202	Artificial Rupture of Membranes	4180186
979204	Ankyloglossia, Partial	4180186
979204	Ankyloglossias	4180186
979204	Ankyloglossias, Partial	4180186
979204	Partial Ankyloglossia	4180186
979204	Partial Ankyloglossias	4180186
979204	Tongue Tie	4180186
979204	Tongue Ties	4180186
979205	Anomalies, Anorectal	4180186
979205	Anomaly, Anorectal	4180186
979205	Anorectal Anomalies	4180186
979205	Anorectal Anomaly	4180186
979205	Anorectal Atresia	4180186
979205	Anorectal Atresias	4180186
979205	Anorectal Malformation	4180186
979205	Anorectal Stenoses	4180186
979205	Anorectal Stenosis	4180186
979205	Atresia, Anorectal	4180186
979205	Atresias, Anorectal	4180186
979205	Malformation, Anorectal	4180186
979205	Malformations, Anorectal	4180186
979205	Stenoses, Anorectal	4180186
979205	Stenosis, Anorectal	4180186
979206	ACL Injuries	4180186
979206	ACL Injury	4180186
979206	ACL Tear	4180186
979206	ACL Tears	4180186
979206	Anterior Cruciate Ligament Injury	4180186
979206	Anterior Cruciate Ligament Tear	4180186
979206	Anterior Cruciate Ligament Tears	4180186
979206	Injuries, ACL	4180186
979206	Injury, ACL	4180186
979206	Tear, ACL	4180186
979206	Tears, ACL	4180186
979208	Arthroplasties, Shoulder Replacement	4180186
979208	Arthroplasty, Shoulder Replacement	4180186
979208	Replacement Arthroplasties, Shoulder	4180186
979208	Replacement Arthroplasty, Shoulder	4180186
979208	Replacements, Total Shoulder	4180186
979208	Replacement, Total Shoulder	4180186
979208	Shoulder Replacement Arthroplasties	4180186
979208	Shoulder Replacement Arthroplasty	4180186
979208	Shoulder Replacements, Total	4180186
979208	Shoulder Replacement, Total	4180186
979208	Total Shoulder Replacement	4180186
979208	Total Shoulder Replacements	4180186
979209	Atrial Pressures	4180186
979209	Intra-atrial Pressure	4180186
979209	Intraatrial Pressure	4180186
979209	Intra-atrial Pressures	4180186
979209	Intraatrial Pressures	4180186
979209	Pressure, Atrial	4180186
979209	Pressure, Intraatrial	4180186
979209	Pressure, Intra-atrial	4180186
979209	Pressures, Atrial	4180186
979209	Pressures, Intraatrial	4180186
979209	Pressures, Intra-atrial	4180186
979210	Lactobacillus sporogenes	4180186
979213	Bankart Fractures	4180186
979213	Bankart Lesion	4180186
979213	Bankart Lesion, Bony	4180186
979213	Bankart Lesion, Osseous	4180186
979213	Bankart Lesions, Bony	4180186
979213	Bankart Lesions, Osseous	4180186
979213	Bankart Tears	4180186
979213	Bony Bankart Lesion	4180186
979213	Bony Bankart Lesions	4180186
979213	Fractures, Bankart	4180186
979213	Hill Sachs Lesion	4180186
979213	Hill-Sachs Lesion	4180186
979213	Hill Sachs Lesions	4180186
979213	Hill-Sachs Lesions	4180186
979213	Lesion, Bankart	4180186
979213	Lesion, Bony Bankart	4180186
979213	Lesion, Hill-Sachs	4180186
979213	Lesion, Osseous Bankart	4180186
979213	Lesions, Bankart	4180186
979213	Lesions, Bony Bankart	4180186
979213	Lesions, Hill-Sachs	4180186
979213	Lesions, Osseous Bankart	4180186
979213	Osseous Bankart Lesion	4180186
979213	Osseous Bankart Lesions	4180186
979213	Tears, Bankart	4180186
979214	Barium Enemas	4180186
979214	Enema, Barium	4180186
979215	3,4-Dihydro-2,5,8-trimethyl-2-(4,8,12- trimethyltridecyl)-2H-1-benzopyran-6-ol	4180186
979215	beta Tocopherol	4180186
979216	Bifidobacterium animalis subsp animalis	4180186
979216	Bifidobacterium animalis subsp lactis	4180186
979216	Bifidobacterium BB-12	4180186
979216	Bifidobacterium lactis	4180186
979219	ALCAPA	4180186
979219	ALCAPA Syndrome	4180186
979219	ALCAPA Syndromes	4180186
979219	Bland-White-Garland Syndrome	4180186
979219	Syndrome, ALCAPA	4180186
979219	Syndrome, Bland-White-Garland	4180186
979221	Brain Contusions	4180186
979221	Cerebellar Contusion	4180186
979221	Cerebellar Contusions	4180186
979221	Cerebral Contusion	4180186
979221	Cerebral Contusions	4180186
979221	Contusio Cerebri	4180186
979221	Contusion, Brain	4180186
979221	Contusion, Cerebellar	4180186
979221	Contusion, Cerebral	4180186
979221	Contusion, Cortical	4180186
979221	Contusions, Brain	4180186
979221	Contusions, Cerebellar	4180186
979221	Contusions, Cerebral	4180186
979221	Contusions, Cortical	4180186
979221	Cortical Contusion	4180186
979221	Cortical Contusions	4180186
979226	Bronchial Thermoplasties	4180186
979226	Thermoplasty, Bronchial	4180186
979228	B cepacia Infection	4180186
979228	B. cepacia Infection	4180186
979228	B cepacia Infections	4180186
979228	B. cepacia Infections	4180186
979228	Burkholderia cepacia Infection	4180186
979228	Burkholderia cepacia Infections	4180186
979228	Burkholderia cepacia Sepses	4180186
979228	Burkholderia cepacia Sepsis	4180186
979228	Burkholderia Infection	4180186
979228	Infection, B cepacia	4180186
979228	Infection, B. cepacia	4180186
979228	Infection, Burkholderia	4180186
979228	Infection, Burkholderia cepacia	4180186
979228	Infections, B cepacia	4180186
979228	Infections, Burkholderia	4180186
979228	Sepses, Burkholderia cepacia	4180186
979228	Sepsis, Burkholderia cepacia	4180186
979230	Canadian Oil	4180186
979230	Canola Oil	4180186
979230	LEAR Oil	4180186
979230	Low Erucic Acid Rapeseed Oil	4180186
979230	Oil, Canadian	4180186
979230	Oil, Canola	4180186
979230	Oil, LEAR	4180186
979230	Oil, Rapeseed	4180186
979231	Carcinoma, Oat Cell	4180186
979231	Carcinomas, Oat Cell	4180186
979231	Carcinomas, Small Cell	4180186
979231	Oat Cell Carcinoma	4180186
979231	Oat Cell Carcinomas	4180186
979231	Small Cell Carcinoma	4180186
979231	Small Cell Carcinomas	4180186
979232	Cardiac Conduction Defect	4180186
979232	Cardiac Conduction Defects	4180186
979232	Cardiac Conduction System Diseases	4180186
979232	Conduction Defect, Cardiac	4180186
979232	Defect, Cardiac Conduction	4180186
979233	Carotid Intima Media Thickness	4180186
979233	Intima-Media Thickness, Carotid	4180186
979234	Cellulites	4180186
979238	Oil, Coconut	4180186
979239	Cold Injuries	4180186
979239	Injuries, Cold	4180186
979239	Injury, Cold	4180186
979241	CAT Scan, Cone Beam	4180186
979241	CAT Scan, Cone-Beam	4180186
979241	CAT Scans, Cone-Beam	4180186
979241	Computed Tomography, Cone-Beam	4180186
979241	Computed Tomography, Volume	4180186
979241	Computed Tomography, Volumetric	4180186
979241	Computer-Assisted Tomography, Cone-Beam	4180186
979241	Computerized Tomography, Cone-Beam	4180186
979241	Cone-Beam CAT Scan	4180186
979241	Cone-Beam CAT Scans	4180186
979241	Cone Beam Computed Tomography	4180186
979241	Cone Beam Computer Assisted Tomography	4180186
979241	Cone-Beam Computer-Assisted Tomography	4180186
979241	Cone Beam Computerized Tomography	4180186
979241	Cone-Beam Computerized Tomography	4180186
979241	Cone Beam CT	4180186
979241	Cone-Beam CT	4180186
979241	Cone-Beam CT Scan	4180186
979241	Cone-Beam CT Scans	4180186
979241	CT, Cone-Beam	4180186
979241	CT Scan, Cone Beam	4180186
979241	CT Scan, Cone-Beam	4180186
979241	CT Scans, Cone-Beam	4180186
979241	CT, Volume	4180186
979241	CT, Volumetric	4180186
979241	Scan, Cone-Beam CAT	4180186
979241	Scan, Cone-Beam CT	4180186
979241	Scans, Cone-Beam CAT	4180186
979241	Scans, Cone-Beam CT	4180186
979241	Tomography, Cone Beam Computed	4180186
979241	Tomography, Cone-Beam Computed	4180186
979241	Tomography, Cone-Beam Computer-Assisted	4180186
979241	Tomography, Cone-Beam Computerized	4180186
979241	Tomography, Volume Computed	4180186
979241	Tomography, Volumetric Computed	4180186
979241	Volume Computed Tomography	4180186
979241	Volume CT	4180186
979241	Volumetric Computed Tomography	4180186
979241	Volumetric CT	4180186
979245	Ability, Creative	4180186
979245	Artistic Creativity	4180186
979245	Creative Abilities	4180186
979245	Creative Ability	4180186
979245	Creativeness	4180186
979245	Creative Thinking	4180186
979245	Creativity, Artistic	4180186
979245	Innovativeness	4180186
979245	Originality	4180186
979245	Thinking, Creative	4180186
979248	Cystogram	4180186
979248	Cystograms	4180186
979248	Cystographies	4180186
979252	Diet, High Protein	4180186
979252	Diets, High-Protein	4180186
979252	High Protein Diet	4180186
979252	High-Protein Diet	4180186
979252	High-Protein Diets	4180186
979253	Diverticular Bleeding	4180186
979253	Diverticular Bleedings	4180186
979253	Diverticular Disease	4180186
979254	Mismatch Repair	4180186
979254	Mismatch Repair, DNA	4180186
979254	Repair, DNA Mismatch	4180186
979254	Repair, Mismatch	4180186
979256	6,9-Dioxa-3,12-diazatetradecanedioic acid, 3,12-bis(carboxymethyl)-	4180186
979256	Acid, Egtazic	4180186
979256	EGATA	4180186
979256	EGTA	4180186
979256	EGTA, Tetrasodium	4180186
979256	Egtazic Acid Disodium Salt	4180186
979256	Egtazic Acid Potassium Salt	4180186
979256	Egtazic Acid Sodium Salt	4180186
979256	Ethylenebis(oxyethylenenitrile)tetraacetic Acid	4180186
979256	Ethylene Glycol Bis(2-aminoethyl ether)tetraacetic Acid	4180186
979256	Ethylene Glycol Tetraacetic Acid	4180186
979256	GEDTA	4180186
979256	Glycoletherdiamine-N,N,N',N'-tetraacetic Acid	4180186
979256	Magnesium EGTA	4180186
979256	Magnesium-EGTA	4180186
979256	Tetrasodium EGTA	4180186
979257	alpha Elastin	4180186
979257	alpha-Elastin	4180186
979257	Elastins	4180186
979257	kappa Elastin	4180186
979257	kappa-Elastin	4180186
979261	Extracorporeal High Intensity Focused Ultrasound Therapy	4180186
979261	Extracorporeal High-Intensity Focused Ultrasound Therapy	4180186
979261	Extracorporeal Shockwave Therapies	4180186
979261	Extracorporeal Shock Wave Therapy	4180186
979261	HIFU Therapies	4180186
979261	HIFU Therapy	4180186
979261	High Intensity Focused Ultrasound Therapy	4180186
979261	High-Intensity Focused Ultrasound Therapy	4180186
979261	Shock Wave Therapies	4180186
979261	Shockwave Therapies, Extracorporeal	4180186
979261	Shock Wave Therapy	4180186
979261	Shockwave Therapy, Extracorporeal	4180186
979261	Therapy, Extracorporeal Shockwave	4180186
979261	Therapy, HIFU	4180186
979261	Therapy, Shock Wave	4180186
979263	Adiposis Dolorosa Type III	4180186
979263	Dercum's Disease Type III	4180186
979263	Familial Multiple Lipoma	4180186
979263	Familial Multiple Lipomas	4180186
979263	Familial Multiple Lipomatoses	4180186
979263	Lipoma Dolorosa	4180186
979263	Lipomatoses, Familial Multiple	4180186
979263	Lipomatosis, Familial Multiple	4180186
979263	Multiple Lipoma, Familial	4180186
979263	Multiple Lipomas, Familial	4180186
979266	Ledderhose Disease	4180186
979266	Ledderhose's Disease	4180186
979266	Plantar Fibromatosis	4180186
979269	Fibrous Histiocytoma of Tendon Sheath	4180186
979269	Localized Giant Cell Tumor of the Tendon Sheath	4180186
979269	Localized Nodular Tenosynovitides	4180186
979269	Localized Nodular Tenosynovitis	4180186
979269	Localized Pigmented Villonodular Synovitis	4180186
979269	Nodular Tenosynovitides	4180186
979269	Nodular Tenosynovitides, Localized	4180186
979269	Nodular Tenosynovitis	4180186
979269	Nodular Tenosynovitis, Localized	4180186
979269	Tenosynovial Giant Cell Tumor	4180186
979269	Tenosynovitides, Localized Nodular	4180186
979269	Tenosynovitides, Nodular	4180186
979269	Tenosynovitis, Localized Nodular	4180186
979269	Tenosynovitis, Nodular	4180186
979275	Hyperekplexias	4180186
979276	Hypophysitides	4180186
979277	Dihydrochloride, Imidocarb	4180186
979277	Hydrochloride, Imidocarb	4180186
979277	Imidocarb Dihydrochloride	4180186
979277	Imidocarb Hydrochloride	4180186
979277	Urea, N,N'-bis(3-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-	4180186
979280	Factor, Multiplication-Stimulating	4180186
979280	IGF-2	4180186
979280	IGF-II	4180186
979280	Insulin Like Growth Factor II	4180186
979280	Insulin Like Somatomedin Peptide II	4180186
979280	Insulin-Like Somatomedin Peptide II	4180186
979280	Multiplication Stimulating Activity	4180186
979280	Multiplication-Stimulating Activity	4180186
979280	Multiplication Stimulating Factor	4180186
979280	Multiplication-Stimulating Factor	4180186
979280	Somatomedin A	4180186
979280	Somatomedin MSA	4180186
979281	Complication, Intraoperative	4180186
979281	Complication, Peroperative	4180186
979281	Complications, Intraoperative	4180186
979281	Complications, Peroperative	4180186
979281	Injuries, Surgical	4180186
979281	Injury, Surgical	4180186
979281	Intraoperative Complication	4180186
979281	Peroperative Complication	4180186
979281	Peroperative Complications	4180186
979281	Surgical Injuries	4180186
979281	Surgical Injury	4180186
979282	Disseminated Fungal Infection	4180186
979282	Disseminated Fungal Infections	4180186
979282	Fungal Infection, Disseminated	4180186
979282	Fungal Infection, Invasive	4180186
979282	Infection, Disseminated Fungal	4180186
979282	Infection, Invasive Fungal	4180186
979282	Invasive Fungal Infection	4180186
979282	Invasive Mycoses	4180186
979282	Mycoses, Invasive	4180186
979287	Langerhans Cell Sarcomas	4180186
979287	Sarcoma, Langerhans Cell	4180186
979287	Sarcomas, Langerhans Cell	4180186
979289	Adenopathies	4180186
979289	Adenopathy	4180186
979289	Lymphadenopathies	4180186
979291	Complete Mastoidectomies	4180186
979291	Complete Mastoidectomy	4180186
979291	Mastoidectomies	4180186
979291	Mastoidectomies, Complete	4180186
979291	Mastoidectomies, Modified Radical	4180186
979291	Mastoidectomies, Radical	4180186
979291	Mastoidectomy, Complete	4180186
979291	Mastoidectomy, Modified Radical	4180186
979291	Mastoidectomy, Radical	4180186
979291	Modified Radical Mastoidectomies	4180186
979291	Modified Radical Mastoidectomy	4180186
979291	Radical Mastoidectomies	4180186
979291	Radical Mastoidectomies, Modified	4180186
979291	Radical Mastoidectomy	4180186
979291	Radical Mastoidectomy, Modified	4180186
979292	Ileus, Meconium	4180186
979293	Celiac Artery Compression Syndrome	4180186
979293	Celiac Artery Stenosis from Compression by Median Arcuate Ligament of Diaphragm	4180186
979293	Celiac Trunk Compression Syndrome	4180186
979293	Dunbar Syndrome	4180186
979293	Syndrome, Dunbar	4180186
979297	Arthroscopic Meniscectomies	4180186
979297	Arthroscopic Meniscectomy	4180186
979297	Meniscal Resection	4180186
979297	Meniscal Resections	4180186
979297	Meniscectomies	4180186
979297	Meniscectomies, Arthroscopic	4180186
979297	Meniscectomy, Arthroscopic	4180186
979297	Resection, Meniscal	4180186
979298	Disease, Morton's	4180186
979298	Intermetatarsal Neuroma	4180186
979298	Intermetatarsal Neuromas	4180186
979298	Metatarsalgia, Morton's	4180186
979298	Morton Disease	4180186
979298	Morton Metatarsalgia	4180186
979298	Morton Neuralgia	4180186
979298	Morton's Disease	4180186
979298	Mortons Disease	4180186
979298	Morton's Metatarsalgia	4180186
979298	Mortons Metatarsalgia	4180186
979298	Morton's Neuralgia	4180186
979298	Mortons Neuralgia	4180186
979298	Morton's Neuroma	4180186
979298	Mortons Neuroma	4180186
979298	Neuralgia, Morton's	4180186
979298	Neuroma, Intermetatarsal	4180186
979298	Neuroma, Morton	4180186
979298	Neuroma, Morton's	4180186
979298	Neuromas, Intermetatarsal	4180186
979300	Blunt Cardiac Injuries	4180186
979300	Blunt Cardiac Injury	4180186
979300	Cardiac Contusion	4180186
979300	Cardiac Contusions	4180186
979300	Cardiac Injuries, Blunt	4180186
979300	Cardiac Injury, Blunt	4180186
979300	Contusio Cordis	4180186
979300	Contusion, Cardiac	4180186
979300	Contusion, Heart	4180186
979300	Contusion, Myocardial	4180186
979300	Contusions, Cardiac	4180186
979300	Contusions, Heart	4180186
979300	Contusions, Myocardial	4180186
979300	Cordis, Contusio	4180186
979300	Heart Contusion	4180186
979300	Heart Contusions	4180186
979300	Injuries, Blunt Cardiac	4180186
979300	Injury, Blunt Cardiac	4180186
979300	Myocardial Contusion	4180186
979301	Myotomies	4180186
979302	Early-Onset Sepses, Neonatal	4180186
979302	Early-Onset Sepsis, Neonatal	4180186
979302	Late-Onset Sepses, Neonatal	4180186
979302	Late-Onset Sepsis, Neonatal	4180186
979302	Neonatal Early-Onset Sepses	4180186
979302	Neonatal Early Onset Sepsis	4180186
979302	Neonatal Early-Onset Sepsis	4180186
979302	Neonatal Late-Onset Sepses	4180186
979302	Neonatal Late Onset Sepsis	4180186
979302	Neonatal Late-Onset Sepsis	4180186
979302	Neonatal Sepses	4180186
979302	Sepses, Neonatal	4180186
979302	Sepses, Neonatal Early-Onset	4180186
979302	Sepses, Neonatal Late-Onset	4180186
979302	Sepsis, Neonatal	4180186
979302	Sepsis, Neonatal Early-Onset	4180186
979302	Sepsis, Neonatal Late-Onset	4180186
979308	Norwalk Agent	4180186
979309	Nurse Midwife	4180186
979309	Nurse-Midwife	4180186
979309	Nurse-Midwives	4180186
979310	Fracture Open Reduction	4180186
979310	Fracture Open Reductions	4180186
979310	Fracture Reduction, Open	4180186
979310	Open Fracture Reductions	4180186
979310	Open Reduction, Fracture	4180186
979310	Open Reductions, Fracture	4180186
979310	Reduction, Fracture Open	4180186
979310	Reductions, Fracture Open	4180186
979311	Abuse, Opium	4180186
979311	Abuses, Opium	4180186
979311	Addiction, Opium	4180186
979311	Dependence, Opium	4180186
979311	Opium Abuse	4180186
979311	Opium Abuses	4180186
979311	Opium Addiction	4180186
979311	Opium Smoking	4180186
979311	Opium Use	4180186
979311	Opium Uses	4180186
979311	Smoking, Opium	4180186
979311	Use, Opium	4180186
979311	Uses, Opium	4180186
979312	Oil, Palm	4180186
979312	Palmolein	4180186
979315	Lymphoma, Plasmablastic	4180186
979315	Lymphomas, Plasmablastic	4180186
979315	Plasmablastic Diffuse Large B cell Lymphoma	4180186
979315	Plasmablastic Diffuse Large B-cell Lymphoma	4180186
979315	Plasmablastic Lymphomas	4180186
979315	Plasmablasts Diffuse Large B cell Lymphoma	4180186
979315	Plasmablasts Diffuse Large B-cell Lymphoma	4180186
979316	Necrotizing Pneumonia	4180186
979316	Necrotizing Pneumonias	4180186
979316	Pneumonias, Necrotizing	4180186
979317	CT PET	4180186
979317	CT PET Scan	4180186
979317	CT PET Scans	4180186
979317	CT Scan, PET	4180186
979317	CT Scans, PET	4180186
979317	PET-CT	4180186
979317	PET CT Scan	4180186
979317	PET-CT Scan	4180186
979317	PET CT Scans	4180186
979317	PET-CT Scans	4180186
979317	PET Scan, CT	4180186
979317	PET Scans, CT	4180186
979317	Positron Emission Tomography-Computed Tomography	4180186
979317	Scan, CT PET	4180186
979317	Scan, PET CT	4180186
979317	Scan, PET-CT	4180186
979317	Scans, CT PET	4180186
979317	Scans, PET CT	4180186
979317	Scans, PET-CT	4180186
979318	Aphasia, Progressive Nonfluent	4180186
979318	Aphasias, Progressive Nonfluent	4180186
979318	Nonfluent Aphasia, Progressive	4180186
979318	Nonfluent Aphasias, Progressive	4180186
979318	Non fluent Primary Progressive Aphasia	4180186
979318	Non-fluent Primary Progressive Aphasia	4180186
979318	PPA Syndrome	4180186
979318	PPA Syndromes	4180186
979318	Progressive Nonfluent Aphasia	4180186
979318	Progressive Nonfluent Aphasias	4180186
979318	Syndrome, PPA	4180186
979318	Syndromes, PPA	4180186
979319	Proliferation Therapies	4180186
979319	Proliferation Therapy	4180186
979319	Prolotherapies	4180186
979319	Therapies, Proliferation	4180186
979319	Therapy, Proliferation	4180186
979320	Mastectomies, Prophylactic	4180186
979320	Mastectomy, Prophylactic	4180186
979320	Prophylactic Mastectomies	4180186
979322	Fredet Ramstedt Operation	4180186
979322	Fredet-Ramstedt Operation	4180186
979322	Gastric Per oral Endoscopic Pyloromyotomy	4180186
979322	Gastric Per-oral Endoscopic Pyloromyotomy	4180186
979322	Gastric Peroral Endoscopic Pyloromyotomy	4180186
979322	G-POEM	4180186
979322	POEM Procedure	4180186
979322	POEM Procedures	4180186
979322	Pyloromyotomies	4180186
979322	Ramstedt Operation	4180186
979324	Nutcracker Phenomenon, Renal	4180186
979324	Nutcracker Phenomenons, Renal	4180186
979324	Nutcracker Syndrome, Renal	4180186
979324	Nutcracker Syndromes, Renal	4180186
979324	Phenomenon, Renal Nutcracker	4180186
979324	Phenomenons, Renal Nutcracker	4180186
979324	Renal Nutcracker Phenomenon	4180186
979324	Renal Nutcracker Phenomenons	4180186
979324	Renal Nutcracker Syndromes	4180186
979324	Renal Vein Entrapment Syndrome	4180186
979325	Resiliency, Psychological	4180186
979325	Psychological Resiliency	4180186
979325	Psychological Resilience	4180186
979326	Deoxymannose	4180186
979326	Mannose, 6-deoxy-	4180186
979326	Rhamnose, L Isomer	4180186
979326	Rhamnose, L-Isomer	4180186
979331	Cuff Injury, Rotator	4180186
979331	Glenoid Labral Tear	4180186
979331	Glenoid Labral Tears	4180186
979331	Injury, Rotator Cuff	4180186
979331	Labral Tear, Glenoid	4180186
979331	Labral Tears, Glenoid	4180186
979331	Rotator Cuff Injury	4180186
979331	Rotator Cuff Tear	4180186
979331	Rotator Cuff Tears	4180186
979331	Rotator Cuff Tendinitides	4180186
979331	Rotator Cuff Tendinitis	4180186
979331	Rotator Cuff Tendinoses	4180186
979331	Rotator Cuff Tendinosis	4180186
979331	Tear, Glenoid Labral	4180186
979331	Tear, Rotator Cuff	4180186
979331	Tears, Rotator Cuff	4180186
979331	Tendinitis, Rotator Cuff	4180186
979331	Tendinoses, Rotator Cuff	4180186
979331	Tendinosis, Rotator Cuff	4180186
979332	Arthropathy, Cuff Tear	4180186
979332	Cuff Tear Arthropathy	4180186
979332	Milwaukee Shoulder	4180186
979332	Milwaukee Shoulder Syndrome	4180186
979332	Shoulder, Milwaukee	4180186
979335	Salpingo-oophorectomies	4180186
979335	Salpingo oophorectomy	4180186
979336	Sclerotherapies	4180186
979341	Neuropathies, Small Fiber	4180186
979341	Neuropathies, Small Fibre	4180186
979341	Neuropathy, Small Fiber	4180186
979341	Neuropathy, Small Fibre	4180186
979341	Small Fiber Neuropathies	4180186
979341	Small Fibre Neuropathies	4180186
979341	Small Fibre Neuropathy	4180186
979341	Small Nerve Fiber Neuropathy	4180186
979342	Asymptomatic Multiple Myeloma	4180186
979342	Asymptomatic Multiple Myelomas	4180186
979342	Multiple Myeloma, Asymptomatic	4180186
979342	Multiple Myelomas, Asymptomatic	4180186
979342	Multiple Myeloma, Smoldering	4180186
979342	Myeloma, Smoldering	4180186
979342	Smoldering Multiple Myelomas	4180186
979342	Smoldering Myeloma	4180186
979342	Smoldering Myelomas	4180186
979345	Calculi, Staghorn	4180186
979345	Calculus, Staghorn	4180186
979345	Staghorn Calculus	4180186
979347	Pulmonary Vein Stenoses	4180186
979347	Pulmonary Vein Stenosis	4180186
979347	Stenoses, Pulmonary Vein	4180186
979347	Vein Stenoses, Pulmonary	4180186
979347	Vein Stenosis, Pulmonary	4180186
979348	Rehabilitation, Stroke	4180186
979350	SUNCT Syndromes	4180186
979350	Syndromes, SUNCT	4180186
979350	Syndrome, SUNCT	4180186
979351	Oil, Sunflower	4180186
979351	Oil, Sunflower Seed	4180186
979351	Seed Oil, Sunflower	4180186
979351	Sunflower Seed Oil	4180186
979352	Resection, Synovium	4180186
979352	Synovectomies	4180186
979352	Synovium Resection	4180186
979352	Synovium Resections	4180186
979353	Calcaneovarus, Talipes	4180186
979353	Calcaneus, Talipes	4180186
979353	Talipedes	4180186
979353	Talipes Calcaneovarus	4180186
979353	Talipes Calcaneus	4180186
979353	Talipes Varus	4180186
979353	Varus, Talipes	4180186
979354	Synostoses, Tarsal	4180186
979354	Synostosis, Tarsal	4180186
979354	Tarsal Coalitions	4180186
979354	Tarsal Synostoses	4180186
979354	Tarsal Synostosis	4180186
979355	Abnormal Spermatozoa	4180186
979355	Abnormal Spermatozoas	4180186
979355	Globozoospermia	4180186
979355	Globozoospermias	4180186
979355	Spermatozoa, Abnormal	4180186
979355	Spermatozoas, Abnormal	4180186
979355	Teratospermia	4180186
979355	Teratospermias	4180186
979355	Teratozoospermias	4180186
979358	Circulating Factor, Thymic	4180186
979358	Circulating Thymic Factor	4180186
979358	Facteur Thymique Serique	4180186
979358	Factor, Circulating Thymic	4180186
979358	Factor, Serum Thymic	4180186
979358	Factor, Thymic Circulating	4180186
979358	Factor, Thymic Serum	4180186
979358	Nonathymulin	4180186
979358	Serique, Facteur Thymique	4180186
979358	Serum Factor, Thymic	4180186
979358	Serum Thymic Factor	4180186
979358	Thymic Circulating Factor	4180186
979358	Thymic Factor, Serum	4180186
979358	Thymic Serum Factor	4180186
979358	Thymique Serique, Facteur	4180186
979358	Thymulin	4180186
979358	Thymuline	4180186
979360	Acute Lung Injury, Transfusion Related	4180186
979360	Acute Lung Injury, Transfusion-Related	4180186
979360	TRALI	4180186
979360	Transfusion Related Acute Lung Injury	4180186
979363	Undifferentiated Connective Tissue Disease	4180186
979364	Disomies, Uniparental	4180186
979364	Disomy, Uniparental	4180186
979364	Heterodisomies, Uniparental	4180186
979364	Heterodisomy, Uniparental	4180186
979364	Isodisomies, Uniparental	4180186
979364	Uniparental Disomies	4180186
979364	Uniparental Heterodisomies	4180186
979364	Uniparental Heterodisomy	4180186
979364	Uniparental Isodisomies	4180186
979364	Uniparental Isodisomy	4180186
979366	Buffalopox virus	4180186
979366	Buffalo Pox Virus	4180186
979366	Buffalopox viruses	4180186
979366	Buffalo Pox Viruses	4180186
979366	Poxvirus officinale	4180186
979366	Rabbitpox virus	4180186
979366	Rabbit Pox Virus	4180186
979366	Rabbitpox viruses	4180186
979366	Rabbit Pox Viruses	4180186
979366	Vaccinia viruses	4180186
979366	virus, Buffalopox	4180186
979366	Virus, Buffalo Pox	4180186
979366	Viruses, Buffalo Pox	4180186
979367	Congenital Varicella Syndrome	4180186
979368	Aortic Arch, Double	4180186
979368	Double Aortic Arch	4180186
979368	Right Aortic Arch Syndrome	4180186
979368	Right Aortic Arch with Left Ligamentum Arteriosum	4180186
979368	Vascular Rings	4180186
979370	Chloride, Vinyl	4180186
979370	Chloroethylene	4180186
979370	Ethene, chloro-	4180186
979371	Vulvectomies	4180186
979372	Proteins, Whey	4180186
979372	Protein, Whey	4180186
979372	Whey Protein	4180186
979373	1,10-phenanthroline hydrate	4180186
979373	1,10-phenanthroline hydrochoride	4180186
979373	1,10-phenanthroline monohydrochoride	4180186
979373	1,10-phenanthroline monoperchlorate	4180186
979373	1,10-phenanthroline, zinc salt	4180186
979373	5,6-dihydro-1,10-phenanthroline	4180186
979373	copper phenanthroline	4180186
979373	(OP)2Cu(I)	4180186
979373	O-PHE	4180186
979373	o-phenanthroline	4180186
979375	12-AS cpd	4180186
979375	4H-Furo(3,2-d)-1,3,2-dioxaphosphorin-7-ol, 6-(6-amino-8-azido-9H-purin-9-yl)tetrahydro-2-hydroxy-, 2-oxide, (4aR,6R,7R,7aS)-	4180186
979376	12-ketostearate	4180186
979379	1-monoarachidonic glyceride	4180186
979379	2-arachidonyl glyceride	4180186
979379	5,8,11,14-Eicosatetraenoic acid, 2,3-dihydroxypropyl ester, (all-Z)-	4180186
979379	glycerylarachidonate	4180186
979379	glyceryl arachidonate	4180186
979379	glyceryl monoarachidonate	4180186
979380	N-methylhydantoin	4180186
979381	1-hydroxynaphthalene	4180186
979381	1-naphthol, 1-(14)C-labeled	4180186
979381	1-naphthol, 2-(13)C-labeled	4180186
979381	1-naphthol, ion(1+)	4180186
979381	1-naphthol, lithium salt	4180186
979381	1-naphthol, potassium salt	4180186
979381	1-naphthol, sodium salt	4180186
979381	alpha-naphthol	4180186
979382	2-(2',4'-diaminophenoxy)ethanol dihydrochloride	4180186
979382	2-(2',4'-diaminophenoxy)ethanol sulfate	4180186
979382	2-(2',4'-diaminophenoxy)ethanol sulfate (1:1)	4180186
979382	2,4-diaminophenoxyethanol	4180186
979385	2,3-EPA	4180186
979385	glycidyl acrylate	4180186
979386	2,6-dimethylhept-5-en-1-al	4180186
979386	2,6-DMH	4180186
979386	dimethyl heptenal	4180186
979387	di-tert-butyl-methylphenol	4180186
979389	2-bromobutane, ion(1+)	4180186
979389	2-bromobutane, (+-)-isomer	4180186
979389	2-bromobutane, (R)-isomer	4180186
979389	2-bromobutane, (S)-isomer	4180186
979392	2-ketogluconate, (D)-isomer	4180186
979392	2-ketogluconate, (D)-isomer, monopotassium salt	4180186
979392	2-ketogluconate, monosodium salt	4180186
979392	2-ketogluconic acid	4180186
979392	2-oxogluconate	4180186
979393	simeton	4180186
979394	4-((2-hydroxy-1-naphthalenyl)azo)benzenesulfonic acid monosodium salt	4180186
979394	Acid Orange 7	4180186
979394	AO-7 dye	4180186
979394	beta-naphthol orange	4180186
979394	C.I. Acid Orange	4180186
979394	C.I. Acid Orange 7	4180186
979394	D&C orange no. 4	4180186
979394	DC orange no. 4	4180186
979394	orange 4	4180186
979394	Orange II	4180186
979394	Tropaeolin	4180186
979396	rhodinol	4180186
979397	3-cresol, calcium salt(1:2)	4180186
979397	3-cresol, sodium salt	4180186
979397	3-methylphenol	4180186
979397	m-cresol	4180186
979397	metacresol	4180186
979397	meta-cresol	4180186
979402	4-chloro-3,5-dimethylphenol sulfonate	4180186
979404	4-tert-nonylphenol	4180186
979404	para-nonylphenol	4180186
979405	HPABH4A	4180186
979405	Hyperphenylalaninemia, BH4-Deficient, Type A	4180186
979405	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency	4180186
979405	Hyperphenylalaninemia, Tetrahydrobiopterin-Deficient, Due To PTS Deficiency	4180186
979405	PTS Deficiency	4180186
979405	PTPS deficiency	4180186
979407	Aase-Smith Syndrome I	4180186
979407	Hydrocephalus cleft palate joint contractures	4180186
979407	Joint contractures with other abnormalities	4180186
979408	BA058	4180186
979408	tymlos	4180186
979411	Abruzzo-Erickson Syndrome	4180186
979411	Charge-Like Syndrome, X-Linked	4180186
979411	CHARGE like syndrome, X linked	4180186
979413	Pseudoprogeria Syndrome	4180186
979414	ACP-196	4180186
979414	Calquence	4180186
979418	Glaucoma, Juvenile, With Unusual Upper Lip And Dental Roots	4180186
979418	Juvenile glaucoma with unusual upper lip and dental roots	4180186
979418	Molar Roots, Pyramidal, With Juvenile Glaucoma And Unusual Upper Lip	4180186
979418	Pyramidal molars, glaucoma, abnormal upper lip	4180186
979421	Acrofacial Dysostosis, Catania Type	4180186
979421	Opitz Mollica Sorge syndrome	4180186
979423	Acrofacial Dysostosis Syndrome Of Rodriguez	4180186
979423	Rodriguez lethal acrofacial dysostosis syndrome	4180186
979424	Acro fronto facio nasal dysostosis	4180186
979424	Acrofrontofacionasal Dysostosis 1	4180186
979424	Cleft lip-palate with frontonasal dysostosis and postaxial polysyndactyly	4180186
979424	Polysyndactyly, postaxial, frontonasal dysostosis, and cleft lip-palate	4180186
979425	Thick lips and oral mucosa	4180186
979427	Acromesomelic dwarfism Maroteux type	4180186
979429	Syndactyly, preaxial polydactyly, and sternal deformity	4180186
979435	Fasps	4180186
979436	Stimmler Syndrome	4180186
979438	Albinism-Deafness Syndrome	4180186
979440	Nonspecific mental retardation associated with retinitis pigmentosa	4180186
979440	X-linked mental handicap-retinitis pigmentosa syndrome	4180186
979446	ATR-16 Syndrome	4180186
979446	Hemoglobin H-Related Mental Retardation	4180186
979446	Mental Retardation with Hemoglobin H	4180186
979448	Alveolar hydatid disease	4180186
979448	Alveolococcosis	4180186
979448	Echinococcus Multilocularis Infection	4180186
979448	Multilocular echinococcosis	4180186
979450	Hypocalcified-hypoplastic enamel, onycholysis with subungual hyperkeratosis, and hypohidrosis	4180186
979451	(3-aminopropyl)triethoxysilane	4180186
979451	(3-aminopropyl)triethoxy silane	4180186
979451	3-aminopropyltriethoxysilane	4180186
979451	3-aminopropyl triethoxysilane	4180186
979451	3-(triethoxysilyl)propylamine	4180186
979451	aminopropyltriethoxysilane	4180186
979451	(aminopropyl)triethoxysilane	4180186
979451	aminopropyl triethoxysilane	4180186
979451	APTES cpd	4180186
979451	gamma-aminopropylsilane	4180186
979451	(gamma-aminopropyl)triethoxysilane	4180186
979451	gamma-aminopropyltriethoxysilane	4180186
979451	gamma-triethoxysilylpropylamine	4180186
979451	propylamine, 3-(triethoxysilyl)-	4180186
979452	Epilepsy Syndrome, Infantile-Onset Symptomatic	4180186
979452	GM3 Synthase Deficiency	4180186
979456	Anonychia and absence-hypoplasia of distal phalanges	4180186
979456	Cooks syndrome	4180186
979458	Anophthalmia, Clinical, With Mild Facial Dysmorphism And Variable Malformations Of The Lung, Heart, And Diaphragm	4180186
979458	Anophthalmia-Microphthalmia And Pulmonary Hypoplasia	4180186
979458	Matthew Wood syndrome	4180186
979458	Matthew-Wood syndrome	4180186
979458	MCOPS9	4180186
979458	Microphthalmia, Syndromic 9	4180186
979458	Pulmonary agenesis, Microphthalmia, and Diaphragmatic defect	4180186
979458	Spear Syndrome	4180186
979460	1,1,1,2,3,3,3-heptafluoropropane	4180186
979460	2H-heptafluoropropane	4180186
979460	2-hydroheptafluoropropane	4180186
979460	HFA 227	4180186
979460	HFA-227	4180186
979460	hydrofluoroalkane	4180186
979461	ARN-509	4180186
979461	Erleada	4180186
979463	Oculoectodermal Syndrome	4180186
979464	galactoarabinan	4180186
979465	Bosma arhinia microphthalmia syndrome	4180186
979466	Cerebro-oculo-hepato-renal syndrome	4180186
979466	Chorioretinal coloboma with cerebellar vermis aplasia	4180186
979466	Coloboma, Chorioretinal, With Cerebellar Vermis Aplasia	4180186
979466	Dekaban Arima syndrome	4180186
979466	Dekaban-Arima Syndrome	4180186
979466	Joubert syndrome with bilateral chorioretinal coloboma	4180186
979469	Arthrogryposis, Distal, Type Iid	4180186
979469	Arthrogryposis With Severe Scoliosis	4180186
979472	AMC, distal, X-linked	4180186
979472	Amcx1	4180186
979472	Arthrogryposis, X-Linked, Type I	4180186
979472	Smax2	4180186
979472	Spinal Muscular Atrophy, Infantile X-Linked	4180186
979472	Spinal Muscular Atrophy, X-Linked 2	4180186
979472	Spinal Muscular Atrophy, X-Linked Lethal Infantile	4180186
979472	Xlsma	4180186
979476	ENB-0040	4180186
979476	Strensiq	4180186
979478	anti-PDL1	4180186
979478	immunoglobulin G1, anti-(human CD antigen CD274) (human monoclonal MDPL3280a heavy chain), disulfide with human monoclonal MDPL3280a kappa-chain, dimer	4180186
979478	MPDL3280A	4180186
979478	MPDL-3280A	4180186
979478	RG7446	4180186
979478	RG-7446	4180186
979478	Tecentriq	4180186
979480	Papular Atrichia	4180186
979482	Familial Adenomatous Polyposis, Attenuated	4180186
979484	Microcephaly Primary Hereditary	4180186
979484	Primary Autosomal Recessive Microcephaly	4180186
979484	True Microcephaly	4180186
979485	bavencio	4180186
979485	MSB0010682	4180186
979485	MSB-0010682	4180186
979485	MSB0010718C	4180186
979485	MSB-0010718C	4180186
979486	2-((6-chloro-3-pyridazinyl)thio)-N,N-diethylacetamide	4180186
979486	6-chlorpyridazin-(3-ylthio)diethylacetamide	4180186
979486	azintamide	4180186
979486	oragallin	4180186
979489	Microcephaly intracranial calcification	4180186
979496	Beemer lethal malformation syndrome	4180186
979498	Giant urachal cyst	4180186
979498	Infected urachal cyst	4180186
979498	Inflamed urachal cyst	4180186
979501	6,6-dimethyl-2-methylene-bicyclo(3.1.1)heptane	4180186
979501	terbenthene	4180186
979501	terebenthene	4180186
979504	MBL-CDB1	4180186
979504	MDX-1388	4180186
979504	MK-6072	4180186
979504	Zinplava	4180186
979505	GS-9883 sodium	4180186
979505	GS-9883-01 sodium	4180186
979505	GS-9883-01	4180186
979505	bictegravir sodium	4180186
979505	GS-9883	4180186
979506	Biemond syndrome type 2	4180186
979508	HMC Syndrome	4180186
979508	Hypertelorism microtia facial clefting syndrome	4180186
979508	Hypertelorism, Microtia, Facial Clefting Syndrome	4180186
979509	Blepharocheilodontic syndrome	4180186
979509	Clefting, ectropion, and conical teeth	4180186
979509	Elschnig syndrome	4180186
979509	Lagophthalmia with bilateral cleft lip and palate	4180186
979510	Bohring-Opitz syndrome	4180186
979510	C-like syndrome	4180186
979510	Opitz trigonocephaly-like syndrome	4180186
979512	Polysyndactyly with Cardiac Malformation	4180186
979513	Bork syndrome	4180186
979513	Uncombable hair, retinal pigmentary dystrophy, dental anomalies, and brachydactyly	4180186
979522	Brachydactyly Ballard type	4180186
979522	Brachydactyly, Ballard Type	4180186
979522	Brachydactyly, combined B and E types	4180186
979522	Pitt Williams brachydactyly	4180186
979522	Pitt-Williams Brachydactyly	4180186
979523	Bilginturan syndrome	4180186
979523	Brachydactyly type E with short stature and hypertension	4180186
979523	Brachydactyly, Type E, With Short Stature And Hypertension	4180186
979523	Hypertension With Brachydactyly	4180186
979524	Brachydactyly Temtamy type	4180186
979524	Brachydactyly, type A4	4180186
979524	Brachymesophalangy II And V	4180186
979524	Temtamy type brachydactyly	4180186
979525	Anodontia-Hypotrichosis Syndrome	4180186
979525	Oculoosteocutaneous Syndrome	4180186
979527	Bresek Syndrome	4180186
979527	Bresheck Syndrome	4180186
979528	Branchial Arch Syndrome, X-Linked	4180186
979528	Mandibulofacial Dysostosis, Toriello Type	4180186
979531	1-pyrrolidineacetamide, alpha-ethyl-2-oxo-4-propyl-, (alphaS,4R)-	4180186
979531	2-(2-oxo-4-propylpyrrolidin-1-yl)butanamide	4180186
979531	(2S)-2-((4R)-2-oxo-4-propylpyrrolidin-1-yl)butanamide	4180186
979531	Briviact	4180186
979531	UCB34714	4180186
979531	UCB 34714	4180186
979531	UCB-34714	4180186
979532	AMG 827	4180186
979532	AMG-827	4180186
979532	KHK4827	4180186
979532	KHK-4827	4180186
979532	Siliq	4180186
979538	Cataract, Hypertrichosis, Mental Retardation syndrome	4180186
979540	Short foot-brachydactyly of toes, camptodactyly , brachydactyly	4180186
979541	Camptodactyly Syndrome, Guadalajara, Type I	4180186
979541	Facio-thoraco-skeletal syndrome	4180186
979541	Faciothoracoskeletal Syndrome	4180186
979541	Guadalajara camptodactyly syndrome	4180186
979541	Guadalajara camptodactyly syndrome type 1	4180186
979542	Guadalajara camptodactyly syndrome type 2	4180186
979542	Camptodactyly Syndrome, Guadalajara, Type II	4180186
979544	Primary gonadal failure, short stature, mitral valve prolapse, and mental retardation	4180186
979546	Squamous Cell Carcinoma, Head And Neck	4180186
979546	Squamous cell carcinoma of the head and neck	4180186
979547	Pfeiffer cardiocranial syndrome	4180186
979547	Pfeiffer Singer Zschiesche syndrome	4180186
979547	Pfeiffer syndrome 2	4180186
979547	Pfeiffer-type cardiocranial syndrome	4180186
979550	Paraganglioma and Gastric Stromal Sarcoma	4180186
979550	Paraganglioma and Gastrointestinal Stromal Tumor	4180186
979552	Carrington's Disease	4180186
979552	Carrington's pulmonary eosinophilia	4180186
979552	Chronic eosinophilic pneumonia (CEP)	4180186
979552	Chronic idiopathic eosinophilic pneumonia	4180186
979552	Eosinophilic idiopathic chronic pneumopathy	4180186
979553	5-isopropyl-2-methylphenol	4180186
979554	Cardiomyopathy and cataract	4180186
979554	Sengers syndrome	4180186
979556	Catel-Manzke Syndrome	4180186
979556	Hyperphalangy-clinodactyly of index finger with Pierre Robin syndrome	4180186
979556	Index Finger Anomaly With Pierre Robin Syndrome	4180186
979556	Palatodigital syndrome, Catel-Manzke type	4180186
979556	Pierre Robin syndrome with hyperphalangy and clinodactyly	4180186
979559	Cerebellar Ataxia and Ectodermal Dysplasia	4180186
979559	Ectodermal dysplasia and cerebellar ataxia	4180186
979560	CEDNIK syndrome	4180186
979564	APN311	4180186
979564	APN-311	4180186
979564	ch14.18	4180186
979564	CH-14.18	4180186
979564	ch14.18 monoclonal antibody	4180186
979564	CH-14.18-UTC	4180186
979564	CH14.18-UTC	4180186
979564	dinutuximab beta	4180186
979564	MAb ch14.18	4180186
979564	monoclonal antibody ch14.18	4180186
979564	unituxin	4180186
979567	HMSNID	4180186
979567	Charcot-Marie-Tooth disease, demyelinating, Type 1D	4180186
979567	Charcot-Marie-Tooth Neuropathy, Type 1D	4180186
979567	CMT1D	4180186
979567	Hereditary motor and sensory neuropathy 1D	4180186
979567	HMSN1D	4180186
979567	HMSN 1D	4180186
979569	Charcot-Marie-Tooth disease, demyelinating, Type 1F	4180186
979569	Charcot-Marie-Tooth Neuropathy, Type 1f	4180186
979569	CMT1f	4180186
979569	CMT 1F	4180186
979571	Charcot-Marie-Tooth Disease, Axonal, Autosomal Recessive, B1	4180186
979571	Charcot-Marie-Tooth disease, axonal, Type 2B1	4180186
979571	Charcot-Marie-Tooth disease, neuronal, Type 2B1	4180186
979571	Charcot-Marie-Tooth Neuropathy, Type 2b1	4180186
979571	CMT2B1	4180186
979573	Charcot-Marie-Tooth disease, axonal, Type 2H	4180186
979573	Charcot-Marie-Tooth disease, axonal, with pyramidal features, autosomal recessive	4180186
979573	Charcot-Marie-Tooth Neuropathy, Axonal, With Pyramidal Features, Autosomal Recessive	4180186
979573	Cmt2h	4180186
979574	Charcot-Marie-Tooth disease, axonal, autosomal recessive, Type 2K	4180186
979574	Charcot-Marie-Tooth disease, axonal, Type 2K	4180186
979574	Charcot-Marie-Tooth Neuropathy, Axonal, Type 2k	4180186
979574	Cmt2k	4180186
979574	CMT 2K	4180186
979577	Charcot-Marie-Tooth Disease, With Focally Folded Myelin Sheaths, Autosomal Recessive, Type 4B2	4180186
979577	Charcot-Marie-Tooth Neuropathy, Type 4B2	4180186
979577	CMT4B2	4180186
979578	Charcot-Marie-Tooth Disease, Demyelinating, Autosomal Recessive, Type 4c	4180186
979578	Charcot-Marie-Tooth Neuropathy, Type 4c	4180186
979578	Cmt4c	4180186
979578	CMT 4C	4180186
979579	Charcot-Marie-Tooth Disease, Autosomal Recessive, Type 4H	4180186
979579	Charcot-Marie-Tooth Disease, Demyelinating, Autosomal Recessive, Type 4H	4180186
979579	Charcot-Marie-Tooth Neuropathy, Type 4H	4180186
979580	Charcot-Marie-Tooth Disease, Autosomal Recessive, Type 4j	4180186
979581	Deafness, femoral epiphyseal dysplasia, short stature and developmental delay	4180186
979581	Growth retardation, deafness, femoral epiphyseal dysplasia, and lacrimal duct obstruction	4180186
979584	Choreoathetosis, Kinesigenic, with Episodic Ataxia And Spasticity	4180186
979584	Choreoathetosis, Paroxysmal, with Episodic Ataxia	4180186
979584	Dystonia 9	4180186
979585	CRAPB Chorioretinal atrophy progressive bifocal	4180186
979585	PBCRA Progressive bifocal chorioretinal atrophy	4180186
979585	Progressive bifocal chorioretinal atrophy	4180186
979586	Boucher-Neuhauser Syndrome	4180186
979587	Choroido-cerebral calcification syndrome with retardation	4180186
979587	Choroid Plexus Calcification and Mental Retardation	4180186
979588	51Cr radioisotope	4180186
979588	Cr-51 radioisotope	4180186
979594	Microduplication 3q29 Syndrome	4180186
979596	Deletion 8p23 1	4180186
979596	Monosomy 8p23 1	4180186
979597	Partial trisomy 8	4180186
979597	Trisomy Partial 8	4180186
979602	Cleido rhizomelic syndrome	4180186
979602	Rhizomelic shortness with clavicular defect	4180186
979602	Wallis Zieff Goldblatt syndrome	4180186
979605	Cochleosaccular Degeneration	4180186
979605	Cochleosaccular Degeneration of the Inner Ear with Progressive Cataracts	4180186
979607	Amides, coco, N,N-bis(hydroxyethyl)	4180186
979607	cocoamide DEA	4180186
979607	coco diethanolamide	4180186
979609	Coenzyme Q Deficiency	4180186
979609	Coq10 Deficiency, Primary	4180186
979609	CoQ Deficiency	4180186
979609	Ubiquinone Deficiency	4180186
979611	Amegakaryocytic Thrombocytopenia, Congenital	4180186
979613	Congenital Disorder of Glycosylation, Type IE	4180186
979614	Congenital Disorder of Glycosylation, Type IF	4180186
979615	Congenital Disorder of Glycosylation, Type IH	4180186
979618	Congenital Disorder of Glycosylation, Type IL	4180186
979624	CDG2F	4180186
979624	CDGIIF	4180186
979624	CDG IIF	4180186
979625	CDG2H	4180186
979625	CDGIIH	4180186
979625	CDG IIIH	4180186
979627	Cloves Syndrome	4180186
979627	Clove Syndrome	4180186
979627	Congenital Lipomatous Overgrowth, Vascular Malformations, Epidermal Nevi, and Skeletal-Spinal Abnormalities	4180186
979630	essential oil, Coriandrum sativum	4180186
979632	Congenital corneal dystrophy, progressive sensorineural deafness	4180186
979632	Corneal dystrophy and sensorineural deafness	4180186
979632	Harboyan syndrome	4180186
979633	Endothelial Corneal Dystrophy, X-Linked	4180186
979635	Posterior Amorphous Corneal Dystrophy	4180186
979636	Subepithelial Mucinous Corneal Dystrophy	4180186
979639	2,3-dihydrobenzofuran	4180186
979641	Cleft lip-palate, agenesis of clavicles and cervical vertebrae, and talipes equinovarus	4180186
979642	Craniofrontonasal dysostosis	4180186
979642	Craniofrontonasal syndrome	4180186
979643	Boyadjiev-Jabs Syndrome	4180186
979655	Hypoparathyroidism Lymphedema syndrome	4180186
979655	Hypoparathyroidism-Lymphedema Syndrome	4180186
979655	Lymphedema hypoparathyroidism syndrome	4180186
979655	Lymphedema-Hypoparathyroidism Syndrome	4180186
979656	Hydrocephalus, tall stature, joint laxity, and kyphoscoliosis	4180186
979657	Dandy-Walker malformation with postaxial polydactyly	4180186
979657	Dwm With Postaxial Polydactyly	4180186
979662	Bilateral sensorineural hearing loss, enamel hypoplasia and nail defects	4180186
979662	Hearing Loss, Sensorineural, With Enamel Hypoplasia And Nail Defects	4180186
979662	Heimler syndrome	4180186
979662	Sensorineural hearing loss, enamel hypoplasia, and nail abnormalities	4180186
979666	1-(6-amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-7-(3-hydroxyazetidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid	4180186
979666	3-quinolinecarboxylic acid, 1-(6-amino-3,5-difluoro-2-pyridinyl)-8-chloro-6-fluoro-1,4-dihydro-7-(3-hydroxy-1-azetidinyl)-4-oxo-	4180186
979666	ABT492	4180186
979666	ABT 492	4180186
979666	ABT-492	4180186
979666	Baxdela	4180186
979666	RX-3341	4180186
979670	Bilateral corneal dermoids	4180186
979670	Corneal dermoids and short stature	4180186
979670	Guizar-Vazquez Luengas-Munoz syndrome	4180186
979671	Austedo	4180186
979672	Autoimmune Lymphoproliferative Disease without Fas Mutations	4180186
979672	Autoimmune lymphoproliferative syndrome without FAS mutations	4180186
979672	Dianzani Autoimmune Lymphoproliferative Disease	4180186
979672	Dianzani form of autoimmune lymphoproliferative disease	4180186
979673	Vertebral Ossification, Defect in, with Nephrogenic Rests	4180186
979675	Enteric Anendocrinosis	4180186
979680	Brachydactyly due to Absence of Distal Phalanges	4180186
979680	Deafness, Onychodystrophy, Osteodystrophy, And Mental Retardation Syndrome	4180186
979680	DOOR Syndrome	4180186
979680	Eronen Syndrome	4180186
979681	4,4'-(2-pyridinylmethylene)bisphenol	4180186
979681	bis(p-hydroxyphenyl)pyridyl-2-methane	4180186
979681	DDPM	4180186
979681	deacetylbisacodyl	4180186
979681	desacetylbisacodyl	4180186
979681	desacetyl-bisacodyl	4180186
979682	di-isopropylamine dichloroacetate	4180186
979682	diisopropylammonium dichloroacetate	4180186
979682	diisopropylammonium dichloroethanoate	4180186
979682	DIPA	4180186
979682	dipromonium	4180186
979684	dimethylamine, conjugate acid	4180186
979684	dimethylamine hydrochloride	4180186
979684	dimethylamine monosulfate	4180186
979684	dimethylamine nitrate	4180186
979684	dimethylamine perchlorate	4180186
979684	dimethylamine phosphate (3:1)	4180186
979684	dimethylamine sulfate	4180186
979684	dimethylamine sulfate (1:1)	4180186
979684	dimethylammonium chloride	4180186
979684	dimethylammonium formate	4180186
979687	DMGDH Deficiency	4180186
979687	DMGDHD	4180186
979688	N,N-dimethyl-N-octadecyl(3-aminopropyl)trimethoxysilyl chloride	4180186
979690	Arthrogryposis, distal, type 2b	4180186
979690	Arthrogryposis multiplex congenita, distal, type 2b	4180186
979690	Arthrogryposis Multiplex Congenita, Distal, Type II, with Craniofacial Abnormalities	4180186
979690	Arthrogryposis multiplex congenita type 2B	4180186
979690	Freeman-Sheldon Syndrome Variant	4180186
979690	Sheldon-Hall syndrome	4180186
979694	1-dodecanaminium, N,N,N-trimethyl-, bromide	4180186
979694	ammonium, dodecyltrimethyl-,bromide	4180186
979694	ammonium, dodecyltrimethyl-, chloride	4180186
979694	C12QAC	4180186
979694	C12TAC	4180186
979694	C(12)TAC	4180186
979694	dodecyltrimethylammonium bromide	4180186
979694	dodecyl trimethyl ammonium chloride	4180186
979694	dodecyl trimethylammonium chloride	4180186
979694	dodecyltrimethylammonium chloride	4180186
979694	dodecyltrimethylammonium chromate (2:1)	4180186
979694	dodecyltrimethylammonium ethyl sulfate	4180186
979694	dodecyltrimethylammonium hydroxide	4180186
979694	dodecyltrimethylammonium iodide	4180186
979694	dodecyltrimethylammonium maleate (2:1)	4180186
979694	dodecyltrimethylammonium methyl sulfate salt	4180186
979694	dodecyltrimethylammonium perchlorate	4180186
979694	dodecyltrimethylammonium sulfate (2:1)	4180186
979694	dodecyltrimethylammonium sulfide (2:1)	4180186
979694	dodecyltrimethylammonium thiomolybdate salt hydrate	4180186
979694	DoTAC compound	4180186
979694	DTMACl cpd	4180186
979694	laurtrimonium	4180186
979694	laurtrimonium bromide	4180186
979694	laurtrimonium chloride	4180186
979694	lauryltrimethylammonium bromide	4180186
979694	lauryl trimethyl ammonium chloride	4180186
979694	lauryltrimethylammonium chloride	4180186
979694	monolauryltrimethylammonium chloride	4180186
979694	n-dodecyl triethylammonium bromide	4180186
979694	n-dodecyltrimethylammonium	4180186
979694	n-dodecyltrimethylammonium chloride	4180186
979694	N,N,N-trimethyl-1-dodecanaminium	4180186
979694	N,N,N-trimethyl-1-dodecanaminium chloride	4180186
979697	Imfinzi	4180186
979697	MEDI4736	4180186
979697	MEDI-4736	4180186
979707	Galactosyltransferase 1 deficiency	4180186
979707	Galactosyltransferase I Deficiency	4180186
979707	Progeroid variant of Ehlers-Danlos syndrome	4180186
979707	Proteodermatan sulfate, defective biosynthesis of	4180186
979707	Xylosylprotein 4-beta-galactosyltransferase deficiency	4180186
979708	Bone Modeling Defect of Hands and Feet	4180186
979709	Melanolysosomal neurocutaneous syndrome	4180186
979709	Neuroectodermal melanolysosomal disease	4180186
979709	Neuro-ectodermal melanolysosomal syndrome	4180186
979711	BMS-901608	4180186
979711	Empliciti	4180186
979711	HuLuc63	4180186
979711	PDL063	4180186
979711	PDL-063	4180186
979713	endomorphin-2	4180186
979713	l-phenylalaninamide, l-tyrosyl-l-prolyl-l-phenylalanyl-	4180186
979713	l-tyrosyl-l-prolyl-l-phenylalanyl-l-phenylalaninamide	4180186
979713	l-tyrosyl-l-prolyl-l-phenylalanyl-l-phenylalaninamide, (-)-	4180186
979713	tetrapeptide-15	4180186
979713	tyrosyl-prolyl-phenylalanyl-phenylalaninamide	4180186
979713	Tyr-Pro-Phe-Phe-NH2	4180186
979717	Autosomal recessive multiple epiphyseal dysplasia	4180186
979717	Multiple epiphyseal dysplasia 4	4180186
979717	Multiple epiphyseal dysplasia, autosomal recessive	4180186
979717	Multiple epiphyseal dysplasia with bilayered patellae	4180186
979717	Multiple epiphyseal dysplasia with clubfoot	4180186
979717	Multiple epiphyseal dysplasia with double-layered patella	4180186
979718	Ataxia, Episodic, With Vertigo And Tinnitus	4180186
979726	AVI-4658	4180186
979726	Exondys 51	4180186
979727	acrylic acid ethyl ester	4180186
979728	Encephalopathy, ethylmalonic	4180186
979728	Encephalopathy, Petechiae, and Ethylmalonic Aciduria	4180186
979728	Epema Syndrome	4180186
979728	Syndrome of encephalopathy, petechiae, and ethylmalonic aciduria	4180186
979737	Familial renal carcinoma	4180186
979741	FBZ-SO	4180186
979742	ferrous sulfide, mackinawite	4180186
979742	ferrous sulfide, trolite	4180186
979742	iron sulfide	4180186
979742	iron sulfide (FeS)	4180186
979742	mackinawite	4180186
979744	Du Pan syndrome	4180186
979745	Syndactyly type I with microcephaly and mental retardation	4180186
979745	Syndactyly, Type I, With Microcephaly And Mental Retardation	4180186
979746	Brachycephaly, deafness, cataract and mental retardation	4180186
979746	Brachycephaly, Deafness, Cataract, Microstomia, And Mental Retardation	4180186
979747	Mental retardation with spastic paraplegia and palmoplantar hyperkeratosis	4180186
979749	(18F)GE-148	4180186
979749	1-amino-3-fluorocyclobutane-1-carboxylic acid	4180186
979749	(1R,3R)-1-amino-3(18F)fluorocyclobutane-1-carboxylic acid	4180186
979749	anti-(18F)FACBC	4180186
979749	Axumin	4180186
979749	cyclobutanecarboxylic acid, 1-amino-3-(fluoro-18F)-, trans-	4180186
979749	F(18)1-amino-3-fluorocyclobutane-1-carboxylic acid	4180186
979749	F(18)-FACBC	4180186
979749	F-FACBC	4180186
979749	fluciclovine (18F)	4180186
979749	fluciclovine F 18	4180186
979749	GE-148 (18F)	4180186
979749	GE-148 F-18	4180186
979749	NMK 36	4180186
979749	NMK-36	4180186
979749	NMK36 cpd	4180186
979751	Isolated follicle-stimulating hormone (FSH) deficiency	4180186
979751	Isolated FSH deficiency	4180186
979755	Fronto-facio-nasal dysostosis	4180186
979755	Frontofacionasal Dysostosis	4180186
979755	Frontofacionasal Dysplasia	4180186
979759	Macular Dystrophy, Hemorrhagic	4180186
979760	67Ga radioisotope	4180186
979760	Ga-67 radioisotope	4180186
979761	Galloway-Mowat Syndrome	4180186
979761	Galloway syndrome	4180186
979761	Microcephaly, hiatal hernia and nephrotic syndrome	4180186
979761	Microcephaly, Hiatus Hernia, And Nephrotic Syndrome	4180186
979761	Microcephaly nephrosis syndrome	4180186
979761	Nephrosis-Microcephaly Syndrome	4180186
979761	Nephrosis neuronal dysmigration syndrome	4180186
979761	Nephrosis-Neuronal Dysmigration Syndrome	4180186
979762	Hydrocephalus with associated malformations	4180186
979763	gellan	4180186
979763	gellan gum (low acyl)	4180186
979763	Gelrite	4180186
979764	Glaucoma, Ectopia, Microspherophakia, Stiff joints, Short stature syndrome	4180186
979765	Camera Lituania Cohen syndrome	4180186
979765	Holoprosencephaly craniosynostosis	4180186
979765	Holoprosencephaly, Semilobar, With Craniosynostosis	4180186
979765	Semilobar holoprosencephaly and primary craniosynostosis	4180186
979769	Glomangiomas, Multiple	4180186
979769	Glomus Tumors, Multiple	4180186
979769	Glomuvenous malformations	4180186
979769	Venous Malformations With Glomus Cells	4180186
979769	VMGLOM	4180186
979773	copper glycyl-histidyl-lysine	4180186
979773	copper(II)GHK	4180186
979773	GHK-Cu	4180186
979773	glycylhistidyllysine	4180186
979773	glycyl-histidyl-lysine monoacetate	4180186
979773	Gly-His-Lys	4180186
979773	Iamin	4180186
979773	N(2)-(N-glycyl-L- histidyl)-L-lysine	4180186
979774	gliphosate	4180186
979774	glyphosate, calcium salt	4180186
979774	glyphosate, calcium salt (1:1)	4180186
979774	glyphosate, copper (2+) salt	4180186
979774	glyphosate, dilithium salt	4180186
979774	glyphosate, disodium salt	4180186
979774	glyphosate hydrochloride (2:1)	4180186
979774	glyphosate, magnesium salt	4180186
979774	glyphosate, magnesium salt (2:1)	4180186
979774	glyphosate, monoammonium salt	4180186
979774	glyphosate, monopotassium salt	4180186
979774	glyphosate, monosodium salt	4180186
979774	glyphosate, sodium salt	4180186
979774	glyphosate, zinc salt	4180186
979774	Kalach 360 SL	4180186
979774	N-(phosphonomethyl)glycine	4180186
979774	Roundup	4180186
979774	yerbimat	4180186
979776	GLH Syndrome	4180186
979776	Cerebellotrigeminal dermal dysplasia	4180186
979776	Cerebellotrigeminal-dermal dysplasia	4180186
979776	Gomez-Lopez-Hernandez Syndrome	4180186
979778	GMS Syndrome	4180186
979782	Deafness, Nerve Type, with Mesenteric Diverticula of Small Bowel and Progressive Sensory Neuropathy	4180186
979782	Groll-Hirschowitz Syndrome	4180186
979784	Ala-beta-Nal-Ala-Trp-Phe-Lys-NH2	4180186
979784	alanyl-(2-naphthyl)alanyl-alanyl-tryptophyl-phenylalanyl-lysinamide	4180186
979784	D-alanyl-3-(2-naphthyl)-D-alanyl-L-alanyl-L-tryptophyl-D-phenylalanyl-L-lysinamide	4180186
979784	GHRP-2	4180186
979784	KP 102	4180186
979784	KP-102	4180186
979784	pralmorelin	4180186
979785	Gurrieri syndrome	4180186
979785	Skeletal dysplasia epilepsy short stature	4180186
979787	Microcephaly-Faciocardioskeletal Syndrome	4180186
979788	Calderon Gonzalez-Cantu syndrome	4180186
979788	Kinky hair, photosensitivity, broken eyebrows and eyelashes, and nonprogressive mental retardation	4180186
979793	Distinctive craniofacial features with Pterygia and mental retardation	4180186
979793	Haspeslagh syndrome	4180186
979793	Mental retardation with pterygia, shortness and distinct facial appearance	4180186
979793	Pterygia, Mental Retardation, And Distinctive Craniofacial Features	4180186
979797	Bencze Syndrome	4180186
979801	Ehlers-Danlos syndrome with progeroid facies and mild mental retardation	4180186
979801	Hernández Aguirre-Negrete syndrome	4180186
979802	Osteoporosis and Oculocutaneous Hypopigmentation Syndrome	4180186
979802	Osteoporosis oculocutaneous hypopigmentation syndrome	4180186
979805	1,1,1-trimethyl-N-(trimethylsilyl)silanamine	4180186
979805	hexamethyldisilazane	4180186
979805	hexamethylsilazane, aluminum salt	4180186
979805	hexamethylsilazane, beryllium salt	4180186
979805	hexamethylsilazane, cadmium salt	4180186
979805	hexamethylsilazane, cerium (+3) salt	4180186
979805	hexamethylsilazane, chromium (3+) salt	4180186
979805	hexamethylsilazane, cobalt (2+) salt	4180186
979805	hexamethylsilazane, europium (3+) salt	4180186
979805	hexamethylsilazane, gadolinium (3+) salt	4180186
979805	hexamethylsilazane, gallium salt	4180186
979805	hexamethylsilazane, germanium (2+) salt	4180186
979805	hexamethylsilazane, holmium (3+) salt	4180186
979805	hexamethylsilazane, indium (3+) salt	4180186
979805	hexamethylsilazane, iron (3+) salt	4180186
979805	hexamethylsilazane, lanthanum (3+) salt	4180186
979805	hexamethylsilazane, lead (2+) salt	4180186
979805	hexamethylsilazane, lithium salt	4180186
979805	hexamethylsilazane, lutetium (3+) salt	4180186
979805	hexamethylsilazane, magnesium salt	4180186
979805	hexamethylsilazane, manganese (2+) salt	4180186
979805	hexamethylsilazane, mercury (2+) salt	4180186
979805	hexamethylsilazane, neodymium (3+) salt	4180186
979805	hexamethylsilazane, potassium salt	4180186
979805	hexamethylsilazane, praseodymium (3+) salt	4180186
979805	hexamethylsilazane, samarium (3+) salt	4180186
979805	hexamethylsilazane, scandium (3+) salt	4180186
979805	hexamethylsilazane, silanamine-(15)N-labeled	4180186
979805	hexamethylsilazane, sodium salt	4180186
979805	hexamethylsilazane, thallium (3+) salt	4180186
979805	hexamethylsilazane, tin (2+) salt	4180186
979805	hexamethylsilazane, titanium (3+) salt	4180186
979805	hexamethylsilazane, uranium (3+) (3:1) salt	4180186
979805	hexamethylsilazane, vanadium (3+) salt	4180186
979805	hexamethylsilazane, ytterbium (3+) salt	4180186
979805	hexamethylsilazane, yttrium (3+) salt	4180186
979805	hexamethylsilazane, zinc salt	4180186
979805	N-lithiohexamethyldisilazane	4180186
979805	sodium hexamethyldisilazide	4180186
979806	Beukes Familial Hip Dysplasia	4180186
979806	Osteoarthropathy, Premature Degenerative, of Hip	4180186
979808	Hunter-McAlpine craniosynostosis	4180186
979808	Hunter-McAlpine craniosynostosis syndrome	4180186
979812	Okamoto Syndrome	4180186
979814	Congenital stiff person syndrome	4180186
979814	Exagerrated startle reflex	4180186
979814	Familial startle disease	4180186
979814	Kok disease	4180186
979814	Stiff baby syndrome	4180186
979818	Melanosis Universalis Hereditaria	4180186
979819	Anterior cervical hypertrichosis	4180186
979819	Hairy throat	4180186
979819	Hairy throat syndrome	4180186
979821	Hypertryptophanemia	4180186
979824	Hypoparathyroidism, Familial Isolated	4180186
979825	Cystinuria with Mitochondrial Disease	4180186
979825	Homozygous 2p21 Deletion Syndrome	4180186
979828	Hypotrichosis, Spanish Type	4180186
979830	Ichthyosis-Cheek-Eyebrow Syndrome	4180186
979830	Sidransky Feinstein Goodman syndrome	4180186
979832	Ichthyosis-Sclerosing Cholangitis Syndrome	4180186
979832	ILVASC	4180186
979832	Neonatal Ichthyosis-Sclerosing Cholangitis Syndrome	4180186
979832	Nisch Syndrome	4180186
979833	ADABI-FAB	4180186
979833	BI655075	4180186
979833	BI 655075	4180186
979833	BI-655075	4180186
979833	Praxbind	4180186
979834	111In radioisotope	4180186
979834	In-111 radioisotope	4180186
979835	Convulsions, infantile, with paroxysmal choreoathetosis, familial	4180186
979835	ICCA Infantile convulsions and choreoathetosis	4180186
979836	Infantile-Onset Spinocerebellar Ataxia	4180186
979836	OHAHA Syndrome	4180186
979836	Ophthalmoplegia, hypotonia, ataxia, hypacusis, and athetosis	4180186
979836	Spinocerebellar ataxia infantile with sensory neuropathy	4180186
979836	Spinocerebellar Ataxia, Infantile, with Sensory Neuropathy	4180186
979838	CMC-544	4180186
979838	CMC544	4180186
979839	(1A-21A),(1B-29B)-insulin (human), 29B-(N6-(N-(15-carboxy-1- oxopentadecyl)-L-gamma- glutamyl)-L-lysine)-	4180186
979839	degludec	4180186
979841	123I radioisotope	4180186
979841	I-123 radioisotope	4180186
979843	131I radioisotope	4180186
979843	I-131 radioisotope	4180186
979844	BAL8557	4180186
979844	BAL 8557	4180186
979844	BAL-8557	4180186
979844	Cresemba	4180186
979844	isavuconazonium sulfate	4180186
979844	1-((2R,3R)-3-(4-(4-cyanophenyl)-1,3-thiazol-2-yl)-2-(2,5-difluorophenyl)-2-hydroxybutyl)-4-((1RS)-1-((methyl(3-((((methylamino)acetyl)oxy)methyl)pyridin-2-yl)carbamoyl)oxy)ethyl)-1H-1,2,4-triazol-4-ium monosulfate	4180186
979844	4-(2-((2R,3R)-3-(2,5-difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)butan-2-yl)-1,3-thiazol-4-yl)benzonitrile	4180186
979844	AK-1820	4180186
979844	AK1820	4180186
979844	BAL 4815	4180186
979844	BAL-4815	4180186
979844	BAL4815	4180186
979844	BAL-8557-002	4180186
979844	BAL8557-002	4180186
979846	2-hydroxybenzoic acid, 3-methylbutyl ester	4180186
979848	1-isopropyl-3-methyl-5-pyrazolyldimethylcarbamate	4180186
979848	dimethylcarbamic acid 3-methyl-1-(1-methylethyl)- 1H-pyrazol-5-yl ester	4180186
979849	N-acetyl-l-aspartyl-l-glutamate	4180186
979849	NAAGA	4180186
979849	NAAGA magnesium salt	4180186
979849	NAAGA sodium salt	4180186
979849	Naaxia	4180186
979849	N-acetyl-1-aspartylglutamic acid	4180186
979849	N-acetyl-1-aspartylglutamic acid, (L)-isomer ion	4180186
979849	N-acetyl-1-aspartylglutamic acid, magnesium salt	4180186
979849	N-acetyl-1-Asp-Glu	4180186
979849	N-acetylaspartylglutamate	4180186
979849	N-acetyl-aspartyl-glutamate	4180186
979849	N-acetyl-aspartyl-glutamic acid	4180186
979849	N-acetyl-L-alpha-aspartylglutamic acid	4180186
979849	N-(N-acetyl-l-alpha-aspartyl)-l-glutamic acid	4180186
979849	ZY15106	4180186
979849	ZY 15106	4180186
979849	ZY-15106	4180186
979849	Zy15109	4180186
979849	Zy 15109	4180186
979849	Zy-15109	4180186
979850	MLN9708	4180186
979850	MLN 9708	4180186
979850	MLN-9708	4180186
979850	Ninlaro	4180186
979851	LY2439821	4180186
979851	LY-2439821	4180186
979851	Taltz	4180186
979852	Aphalangy of the hands and feet, hemivertebrae, and visceral malformations	4180186
979852	Aphalangy with Hemivertebrae	4180186
979853	AADH syndrome	4180186
979853	Alopecia anosmia deafness hypogonadism syndrome	4180186
979853	Alopecia-Anosmia-Deafness-Hypogonadism Syndrome	4180186
979853	Johnson-Mcmillin syndrome	4180186
979854	Arthrogryposis with Hyperkeratosis	4180186
979854	Joint contractures, hyperkeratosis, and severe hypoplasia of the posterior columns	4180186
979858	Mesomelic dysplasia, Kantaputra type	4180186
979858	Mesomelic dysplasia, Thai type	4180186
979858	Mesomelic dysplasia with ankle, carpal, and tarsal synostosis	4180186
979859	Acrocraniofacial dysostosis	4180186
979863	Agonadism dextrocardia diaphragmatic hernia	4180186
979863	Agonadism with multiple internal malformations	4180186
979863	PAGOD syndrome	4180186
979865	Buschke Fischer Brauer syndrome	4180186
979865	Keratoderma, palmoplantar punctate type 1	4180186
979865	Keratoderma, Palmoplantar, Punctate Type I	4180186
979865	Keratodermia palmoplantaris papulosa, Buschke-Fischer-Brauer type	4180186
979865	Type I punctate palmoplantar keratoderma	4180186
979868	9q34.3 Deletion Syndrome	4180186
979868	9q34.3 Microdeletion Syndrome	4180186
979868	9q Subtelomeric Deletion Syndrome	4180186
979868	9q- Syndrome	4180186
979868	Chromosome 9q34.3 Deletion Syndrome	4180186
979869	Arachnodactyly, abnormal ossification and mental retardation	4180186
979869	Syndrome of arachnodactyly, disturbance of cranial ossification, protruding eyes, feeding difficulties, and mental retardation	4180186
979870	Krasnow Qazi Yermakov syndrome	4180186
979873	D-glucose, O-beta-D-galactopyranosyl-(1->4)-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1->3)-O-beta-D-galactopyranosyl-(1->4)-	4180186
979873	lacto-N-tetraose	4180186
979873	LNnT	4180186
979873	N-neotetraose	4180186
979874	Arthrogryposis, ectodermal dysplasia, cleft lip palate and developmental delay	4180186
979874	Congenital contractures, ectodermal dysplasia, cleft lip-palate, and developmental impairment	4180186
979875	Branchial dysplasia, clubfoot, inguinal hernia, and biliary atresia	4180186
979877	Laryngeal and ocular granulation in indian children	4180186
979877	Laryngoonychocutaneous Syndrome	4180186
979877	Logic syndrome	4180186
979880	Fibula And Ulna, Duplication Of, With Absence Of Tibia And Radius	4180186
979880	Fibula ulna duplication tibia radius absence	4180186
979880	Laurin Sandrow syndrome	4180186
979880	Laurin-Sandrow Syndrome, Segmental	4180186
979880	Mirror hands and feet with nasal defects	4180186
979880	Mirror-Image Polydactyly	4180186
979880	Sandrow syndrome	4180186
979880	Tetramelic mirror-image polydactyly	4180186
979883	west indian lemongrass oil	4180186
979884	((5-bromo-4-(4-cyclopropyl-1-naphthyl)-4H-1,2,4-triazol-3-yl)sulfanyl)acetic acid	4180186
979884	RDEA594	4180186
979884	Zurampic	4180186
979890	Ataxia, Delayed Dentition, and Hypomyelination	4180186
979890	Leukodystrophy, Hypomyelinating, 7	4180186
979890	Leukoencephalopathy, Hypomyelinating, with Ataxia and Delayed Dentition	4180186
979892	LTC4 Synthase Deficiency	4180186
979893	(2S)-2-(((2-(benzofuran-6-ylcarbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinolin-6- yl)carbonyl)amino)-3-(3-(methylsulfonyl)phenyl)propanoic acid	4180186
979893	lifitegrast ophthalmic solution	4180186
979893	L-phenylalanine, n-((2-(6-benzofuranylcarbonyl)-5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl)carbonyl)-3-(methylsulfonyl)-	4180186
979893	SAR 1118	4180186
979893	SAR-1118	4180186
979893	SHP606	4180186
979893	SHP-606	4180186
979893	Xiidra	4180186
979895	acid green 5	4180186
979895	C.I. 42095	4180186
979895	food green 2	4180186
979897	limonene-1,2-epoxide, (1R-(1alpha,4beta,6alpha))-isomer	4180186
979897	limonene-1,2-epoxide, (1S-(1alpha,4alpha,6alpha))-isomer	4180186
979897	limonene-1,2-epoxide, cis-isomer	4180186
979897	limonene-1,2-epoxide, cis-(+)-isomer	4180186
979897	limonene-1,2-epoxide, trans-isomer	4180186
979897	limonene-1,2-epoxide, trans-(+)-isomer	4180186
979897	limonene-1,2-oxide	4180186
979897	limonene oxide	4180186
979897	limoxide	4180186
979899	linalyl acetate, (+-)-isomer	4180186
979899	linalyl acetate, (R)-isomer	4180186
979899	linalyl acetate, (S)-isomer	4180186
979900	Hydranencephaly and Abnormal Genitalia	4180186
979900	Lissencephaly, X-Linked, with Ambiguous Genitalia	4180186
979906	Irons-Bianchi Syndrome	4180186
979906	Lymphedema, Atrial Septal Defect, And Characteristic Facies	4180186
979907	Caudal appendage, short terminal phalanges, deafness, cryptorchidism and mental retardation	4180186
979909	1-acyl-sn-glycerol-3-phosphate	4180186
979909	1-oleoyl-lyso-phosphatidic acid	4180186
979909	1-oleoyl-lysophosphatidic acid	4180186
979909	1-O-oleyllysophosphatidic acid	4180186
979909	9-octadecenoic acid (9Z)-, 2-hydroxy-3-(phosphonooxy)propyl ester	4180186
979909	LPA (lysophosphatidic acid)	4180186
979909	monooleylphosphatidate	4180186
979909	monooleylphosphatidic acid	4180186
979909	monooleylphosphatidic acid, (R)-isomer	4180186
979909	monooleylphosphatidic acid, sodium salt, (R)-isomer	4180186
979913	Retinal degeneration, nanophthalmos, glaucoma	4180186
979913	Retinal Degeneration with Nanophthalmos, Cystic Macular Degeneration, and Angle Closure Glaucoma	4180186
979915	Macrophagic myofasciitis, childhood	4180186
979916	Congenital hypomelanotic and hypermelanotic macules	4180186
979916	Hereditary congenital hypopigmented and hyperpigmented macules	4180186
979916	Macules, Hereditary Congenital Hypopigmented and Hyperpigmented	4180186
979916	Westerhof Beemer Cormane syndrome	4180186
979919	Mangifera indica bark	4180186
979919	Vimang	4180186
979919	mango extract	4180186
979922	Cataract, mental retardation, hypogonadism	4180186
979922	Cataract-Mental Retardation-Hypogonadism	4180186
979925	Binder syndrome	4180186
979927	Cleft lip, cleft palate, characteristic facies, intestinal malrotation, and lethal congenital heart disease	4180186
979927	Cleft Lip-Palate with Characteristic Facies, Intestinal Malrotation, and Lethal Congenital Heart Disease	4180186
979928	Meacham Syndrome	4180186
979930	ADMCKD1	4180186
979930	MCKD1 Medullary cystic kidney disease 1	4180186
979930	Medullary cystic kidney disease, autosomal dominant	4180186
979930	Polycystic kidneys, medullary type	4180186
979933	Fifteen dorsal vertebrae and rib pairs	4180186
979935	Mutchinick Syndrome	4180186
979937	Christian Syndrome	4180186
979938	Smith Fineman Myers syndrome	4180186
979939	Belgian type mental retardation syndrome	4180186
979946	Hypoplasia of Ulna and Fibula	4180186
979946	Mesomelic dwarfism of hypoplastic ulna and fibula type	4180186
979946	Reinhardt-Pfeiffer mesomelic dysplasia	4180186
979946	Reinhardt-Pfeiffer mesomelic skeletal dysplasia	4180186
979946	Reinhardt Pfeiffer syndrome	4180186
979946	Ulna And Fibula, Hypoplasia Of	4180186
979947	Mesomelic Dysplasia with Absent Fibulas and Triangular Tibias	4180186
979958	Kawashima tsuji syndrome	4180186
979958	Microcephaly-Deafness Syndrome	4180186
979958	Syndrome of microcephaly, deafness-malformed ears, mental retardation and peculiar facies	4180186
979959	Dwarfism, micromelic, with cone epiphyses, metaphyseal dysplasia, and vertebral segmentation defects	4180186
979959	Micromelic dwarfism with cone epiphyses, metaphyseal dysplasia, and vertebral segmentation defects	4180186
979959	Spondyloepimetaphyseal dysplasia, micromelic	4180186
979960	Linear skin defects with multiple congenital anomalies 1	4180186
979960	MCOPS7	4180186
979960	Microphthalmia, dermal aplasia, and sclerocornea	4180186
979960	Microphthalmia with linear skin defects	4180186
979960	Microphthalmia with Linear Skin Defects Syndrome	4180186
979960	Microphthalmia with Linear Skin Lesions Syndrome	4180186
979960	Midas Syndrome	4180186
979960	Syndromic Microphthalmia-7	4180186
979962	isomintlactone	4180186
979963	Mitochondrial DNA Depletion Syndrome 1	4180186
979963	Mitochondrial DNA Depletion Syndrome 8A	4180186
979963	Mitochondrial Dna Depletion Syndrome, Encephalomyopathic Form, With Renal Tubulopathy, Autosomal Recessive	4180186
979963	Mitochondrial Myopathy with Sensorimotor Polyneuropathy, Ophthalmoplegia, and Pseudo-Obstruction	4180186
979963	Mitochondrial Neurogastrointestinal Encephalopathy Disease	4180186
979963	Mitochondrial Neurogastrointestinal Encephalopathy Syndrome, Rrm2b-Related	4180186
979963	MNGIE Disease	4180186
979963	Mngie, Rrm2b-Related	4180186
979963	MNGIE Syndrome	4180186
979963	Mngie Without Leukoencephalopathy	4180186
979963	Myoneurogastrointestinal encephalopathy syndrome	4180186
979963	Oculogastrointestinal Muscular Dystrophy	4180186
979963	POLIP Syndrome	4180186
979963	Polyneuropathy, ophthalmoplegia, leukoencephalopathy, and intestinal pseudoobstruction	4180186
979963	Polyneuropathy, Ophthalmoplegia, Leukoencephalopathy, and Intestinal Pseudo-Obstruction	4180186
979963	Thymidine Phosphorylase Deficiency	4180186
979964	Choroidal atrophy alopecia	4180186
979964	Regional choroidal atrophy and alopecia	4180186
979968	Bedouin spastic ataxia syndrome	4180186
979973	Leukemia, Transient	4180186
979973	Transient Abnormal Myelopoiesis	4180186
979975	Mitochondrial myopathy and sideroblastic anemia	4180186
979975	MLASA	4180186
979979	Acrofrontofacionasal Dysostosis 2	4180186
979979	Acrofrontofacionasal dysostosis, severe	4180186
979979	Acrofrontofacionasal Dysostosis with Genitourinary Anomalies	4180186
979979	Hypertelorism, Hypospadias, and Polysyndactyly Syndrome	4180186
979979	Hypertelorism hypospadias polysyndactyly syndrome	4180186
979979	Naguib syndrome	4180186
979980	Cardiogenital syndrome	4180186
979980	Genital Anomaly With Cardiomyopathy	4180186
979982	S-297995	4180186
979982	Symproic	4180186
979982	17-(cyclopropylmethyl)-6,7-didehydro-4,5alpha-epoxy-3,6,14-trihydroxy-N-(2-(3-phenyl- 1,2,4-oxadiazol-5-yl)propan-2-yl)morphinan-7-carboxamide	4180186
979985	naphthoquine phosphate	4180186
979992	Nephroblastomatosis, Fetal Ascites, Macrosomia, And Wilms Tumor	4180186
979992	Perlman Syndrome	4180186
979992	Renal hamartomas, nephroblastomatosis, and fetal gigantism	4180186
979994	Cerebral palsy-hypotonic seizures-megalcornea syndrome	4180186
979994	Megalocornea-macrocephaly-mental and motor retardation (MMMM) syndrome	4180186
979994	Megalocornea mental retardation syndrome	4180186
979994	Megalocornea-Mental Retardation Syndrome	4180186
979994	MMR syndrome	4180186
979994	Seizures-hypotonic cerebral palsy-megalocornea-mental retardation syndrome	4180186
979996	Neurofibromatosis with Noonan phenotype	4180186
979996	Noonan neurofibromatosis syndrome	4180186
979996	Noonan-Neurofibromatosis Syndrome	4180186
979998	Charcot-Marie-Tooth Disease, Demyelinating, Autosomal Recessive, Type 4d	4180186
979998	Charcot-Marie-Tooth Disease, Type 4D	4180186
979998	Charcot-Marie-Tooth Neuropathy, Type 4d	4180186
979998	CMT4D	4180186
979998	Hereditary motor and sensory neuropathy, LOM type	4180186
979998	HMSN4D	4180186
979998	HMSNL	4180186
979999	HEREDITARY MOTOR AND SENSORY NEUROPATHY, PROXIMAL TYPE	4180186
979999	HMSNO	4180186
979999	HMSNP	4180186
980000	Charcot-Marie-Tooth disease, autosomal recessive, type 4g	4180186
980000	Charcot-Marie-Tooth disease, type 4g	4180186
980000	Charcot-Marie-Tooth Neuropathy, Type 4g	4180186
980000	Cmt4g	4180186
980000	Hereditary motor and sensory neuropathy, Russe type	4180186
980000	HMSNR	4180186
980006	2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide	4180186
980006	MK4827	4180186
980006	MK 4827	4180186
980006	MK-4827	4180186
980006	niraparib hydrochloride	4180186
980006	Zejula	4180186
980010	noggin protein, human	4180186
980010	noggin protein, mouse	4180186
980010	noggin protein, rat	4180186
980010	noggin protein, Xenopus	4180186
980010	NOG protein, human	4180186
980010	Nog protein, mouse	4180186
980010	Nog protein, rat	4180186
980010	nog protein, Xenopus	4180186
980011	N-nonylphenol (mixed isomers)	4180186
980011	nonylphenol barium	4180186
980011	nonylphenol potassium	4180186
980011	nonylphenol sodium	4180186
980011	nonylphenol strontium	4180186
980011	Phenol, nonyl-	4180186
980014	ASO-10-27	4180186
980014	ISIS 396443	4180186
980014	ISIS-SMNRx	4180186
980014	ISIS-SMN(Rx)	4180186
980014	SPINRAZA	4180186
980015	1-vinyl-2-pyrrolidone	4180186
980015	N-vinylpyrrolidone	4180186
980015	N- vinyl pyrrolidone	4180186
980016	6alpha-ethyl-3alpha,7alpha-dihydroxy-5beta-cholan-24-oic acid	4180186
980016	6alpha-ethyl-chenodeoxycholic acid	4180186
980016	6ECDCA	4180186
980016	6-ECDCA	4180186
980016	6-ethyl-3,7-dihydroxycholan-24-oic acid	4180186
980016	6-ethyl chenodeoxycholic acid	4180186
980016	6-ethylchenodeoxycholic acid	4180186
980016	cholan-24-oic acid, 6-ethyl-3,7-dihydroxy-, (3alpha,5beta,6alpha,7alpha)-	4180186
980016	DSP1747	4180186
980016	DSP-1747	4180186
980016	INT747	4180186
980016	INT 747	4180186
980016	INT-747	4180186
980016	Ocaliva	4180186
980018	Ocrevus	4180186
980018	PR070769	4180186
980018	PR 070769	4180186
980018	PR-070769	4180186
980018	R1594	4180186
980018	R 1594	4180186
980018	R-1594	4180186
980018	RG-1594	4180186
980020	ethylhexyl triazone	4180186
980021	Arthrogryposis, Distal, Type 5	4180186
980021	Arthrogryposis, Distal, Type IIb	4180186
980021	Arthrogryposis with oculomotor limitation and electroretinal abnormalities	4180186
980022	Instituto Venezolano de Investigaciones Cientificas syndrome	4180186
980022	Radial ray defects, hearing impairment, external ophthalmoplegia, and thrombocytopenia	4180186
980023	Oculopalatocerebral Dwarfism	4180186
980027	IMC-3G3	4180186
980027	Lartruvo	4180186
980029	Postaxial Polydactyly and Mental Retardation	4180186
980030	Pontocerebellar hypoplasia, type 5	4180186
980030	Pontocerebellar Hypoplasia Type 5	4180186
980032	Omodysplasia, Generalized Form	4180186
980032	Omodysplasia 1	4180186
980032	Omodysplasia, Autosomal Recessive	4180186
980032	Omodysplasia autosomal recessive form	4180186
980032	Omodysplasia generalized form	4180186
980032	Omodysplasia (Maroteaux)	4180186
980033	Cleft palate-omphalocele syndrome, lethal	4180186
980033	Lethal omphalocele-cleft palate syndrome	4180186
980033	Omphalocele-Cleft Palate Syndrome, Lethal	4180186
980035	Trigonocephaly syndrome	4180186
980038	Oral-facial-digital syndrome 5	4180186
980038	Oral-Facial-Digital Syndrome, Type V	4180186
980038	Orofaciodigital syndrome, Thurston type	4180186
980038	Orofaciodigital syndrome V	4180186
980038	Polydactyly, Postaxial, With Median Cleft Of Upper Lip	4180186
980038	Thurston syndrome	4180186
980039	Varadi-Papp Syndrome	4180186
980039	OFD6	4180186
980039	OFDS VI	4180186
980039	Oral-facial-digital syndrome, type 6	4180186
980039	Oral-Facial-Digital Syndrome, Type VI	4180186
980039	Orofaciodigital Syndrome VI	4180186
980039	Polydactyly, Cleft Lip-Palate or Lingual Lump, and Psychomotor Retardation	4180186
980039	Varadi Papp syndrome	4180186
980039	Varadi Syndrome	4180186
980042	Tagrisso	4180186
980044	Gnathodiaphyseal Dysplasia	4180186
980044	Gnathodiaphyseal Sclerosis	4180186
980044	Levin syndrome 2	4180186
980044	Osteogenesis imperfecta with unusual skeletal lesions	4180186
980046	1,4,5,6-tetrahydro-2-(3-hydroxy styryl)-1-methylpyrimidine	4180186
980046	CP 14,445	4180186
980046	CP-14,445	4180186
980046	oxantel monohydrochloride, (E)-isomer	4180186
980046	oxantel tartrate	4180186
980046	oxantel tartrate (1:1), (R-(R*,R*))-isomer	4180186
980048	Epiphyseal stippling with osteoclastic hyperplasia	4180186
980048	Pacman syndrome	4180186
980052	Parastremmatic dysplasia	4180186
980053	Catlin Marks	4180186
980053	Cranium Bifidum, Hereditary	4180186
980053	Cranium Bifidum Occultum	4180186
980053	Enlarged Parietal Foramina	4180186
980053	Foramina Parietalia Permagna	4180186
980053	Parietal Foramina, Symmetric	4180186
980055	Basal ganglia disorder with mental retardation	4180186
980055	Basal Ganglion Disorder With Mental Retardation	4180186
980055	Laxova Brown Hogan syndrome	4180186
980055	Parkinsonism, Early-Onset, With Mental Retardation	4180186
980055	Waisman syndrome	4180186
980055	X-linked recessive basal ganglia disorder with mental retardation	4180186
980058	Patterson Stevenson Fontaine syndrome	4180186
980058	Patterson-Stevenson-Fontaine Syndrome	4180186
980058	Polydactyly of Triphalangeal Thumb	4180186
980058	Polydactyly, Preaxial II	4180186
980058	Split-foot deformity with ectrodactyly and mandibulofacial dysostosis	4180186
980058	Split-Foot Deformity With Mandibulofacial Dysostosis	4180186
980058	TPT and PSD syndrome	4180186
980058	Triphalangeal Thumb-Polydactyly Syndrome	4180186
980058	Triphalangeal thumb polysyndactyly syndrome	4180186
980058	Triphalangeal Thumb-Polysyndactyly Syndrome	4180186
980058	Triphalangeal Thumb with Polysyndactyly	4180186
980061	Kosenow Syndrome	4180186
980061	Scapuloiliac Dysostosis	4180186
980066	Congenital alopecia, psychomotor retardation, convulsions	4180186
980066	Neuroectodermosis with alopecia or hypotrichosis	4180186
980067	Pseudoneonatal adrenoleukodystrophy	4180186
980067	Straight-chain ACYL-COA oxidase deficiency	4180186
980075	Gout, PRPS-Related	4180186
980076	32P radioisotope	4180186
980076	P-32 radioisotope	4180186
980079	1-(1-methylpropoxycarbonyl)-2-(2-hydroxyethyl)piperidine	4180186
980079	2-(2-hydroxyethyl)-1-piperidinecarboxylic acid 1-methylpropyl ester	4180186
980079	Bayrepel	4180186
980079	icaridin	4180186
980079	KBR 3023	4180186
980079	Saltidin	4180186
980079	sec-butyl 2-(2-hydroxyethyl)piperidine-1-carboxylate	4180186
980084	Thumb ankylosis with mental retardation	4180186
980085	Hyde Forster Mccarthy Berry syndrome	4180186
980085	Mental retardation, plagiocephaly, brachycephaly, prominent forehead, and coarse facial features	4180186
980085	Mental retardation, X-linked Hyde-Forster type	4180186
980085	Mental retardation, X-linked, Hyde-Forster type	4180186
980085	Mental retardation, X-linked, with craniofacial dysmorphism	4180186
980086	FPDAML	4180186
980086	FPDMM	4180186
980086	Platelet Disorder, Aspirin-Like	4180186
980086	Thrombocytopenia, Familial, with Propensity to Acute Myelogenous Leukemia	4180186
980089	Baquacil	4180186
980089	cosmocil	4180186
980089	Lavasept	4180186
980089	PHMB polymer	4180186
980089	polihexanide hydrochloride	4180186
980089	polyhexamethylenbiguanid	4180186
980089	polyhexamethylenbiguanide	4180186
980089	polyhexamethylen-biguanide	4180186
980089	poly(hexamethylene biguanide)	4180186
980089	polyhexamethylene biguanide	4180186
980089	poly(hexamethylenebiguanide) hydrochloride	4180186
980089	polyhexamethylene biguanide hydrochloride	4180186
980089	polyhexanide	4180186
980089	Poly(iminocarbonimidoyliminocarbonimidoylimino-1,6-hexanediyl)	4180186
980089	poly(iminocarbonimidoyliminocarbonimidoylimino-1,6-hexanediyl) hydrochloride	4180186
980089	Vantocil	4180186
980089	Vantocil IB of Vantocil	4180186
980091	Index Finger Polydactyly	4180186
980092	Adult Polyglucosan Body Disease	4180186
980094	TEINS glucan	4180186
980094	beta-D-glucan (1-3)	4180186
980094	beta-1,3-D-polyglucose	4180186
980094	beta-1,3-D-glucan	4180186
980094	(1,3)-beta-D-glucan	4180186
980094	beta-D-glucan, (1-3)-	4180186
980094	krestin	4180186
980094	protein-bound polysaccharide extract, Trametes versicolor	4180186
980094	PSK extract, Trametes versicolor	4180186
980097	Cerebellar Atrophy With Progressive Microcephaly	4180186
980097	Pch With Optic Atrophy	4180186
980098	Encephalopathy, Fatal Infantile, With Mitochondrial Respiratory Chain Defects	4180186
980099	Aslan Multiple Pterygium Syndrome	4180186
980099	Bartsocas-Papas Syndrome	4180186
980099	Multiple Pterygium Syndrome, Aslan Type	4180186
980099	Pterygium, Popliteal, Lethal Type	4180186
980103	PHAVER syndrome	4180186
980103	Vertebral, radial, congenital heart, and ear defects	4180186
980105	Autosomal dominant preaxial deficiency, postaxial polydactyly, and hypospadias	4180186
980105	Guttmacher syndrome	4180186
980105	Preaxial Deficiency, Postaxial Polydactyly, And Hypospadias	4180186
980109	Acro-dermato-ungual-lacrimal-tooth syndrome	4180186
980109	ADULT syndrome	4180186
980109	Pigment anomaly ectrodactyly hypodontia	4180186
980110	Hereditary prostate cancer	4180186
980110	Prostate Cancer, Hereditary, 1	4180186
980112	Php1c	4180186
980112	Php Ic	4180186
980112	Pseudohypoparathyroidism, Type Ic	4180186
980115	pumice sulfate	4180186
980121	Aasa Dehydrogenase Deficiency	4180186
980121	Epilepsy, Pyridoxine-Dependent	4180186
980121	Pyridoxine dependency	4180186
980121	Pyridoxine dependency with seizures	4180186
980121	Pyridoxine-Dependent Seizures	4180186
980121	Vitamin B6-Dependent Seizures	4180186
980122	Dysharmonic skeletal maturation muscular fibre disproportion	4180186
980122	Puertorican infant hypotonia syndrome	4180186
980122	Puerto Rican Infant Hypotonia Syndrome	4180186
980123	1,4-benzoquinone	4180186
980123	2,5-cyclohexadiene-1,4-dione	4180186
980123	benzoquinone	4180186
980123	NSC36324	4180186
980123	NSC-36324	4180186
980123	para-benzoquinone	4180186
980123	p-benzoquinone	4180186
980124	Radial hypoplasia, triphalangeal thumbs, hypospadias, and maxillary diastema	4180186
980124	Radial hypoplasia triphalangeal thumbs hypospadias maxillary diastema	4180186
980124	Schmitt Gillenwater Kelly syndrome	4180186
980129	Renal Dysplasia-Limb Defects Syndrome	4180186
980129	Renal dysplasia, mesomelia, and radiohumeral fusion	4180186
980129	Ulbright Hodes syndrome	4180186
980130	CEP38072	4180186
980130	CEP-38072	4180186
980130	Cinqair	4180186
980130	DCP835	4180186
980130	DCP 835	4180186
980130	DCP-835	4180186
980130	SCH55700	4180186
980130	SCH 55700	4180186
980130	SCH-55700	4180186
980132	Severe combined immunodeficiency with hypereosinophilia	4180186
980138	Retinitis pigmentosa, HYpopituitarism, Nephronophthisis, and mild Skeletal dysplasia	4180186
980138	Retinitis pigmentosa syndrome	4180186
980139	Kisqali	4180186
980139	LEE011	4180186
980140	Ataxia-deafness-retardation syndrome with ketoaciduria	4180186
980140	Familial ataxia-hypogonadism syndrome	4180186
980140	Ketoaciduria-mental deficiency syndrome	4180186
980140	Ketoaciduria With Mental Deficiency And Other Features	4180186
980142	Hypoplasia of the right ventricle	4180186
980142	Isolated hypoplasia of the right ventricle	4180186
980142	Isolated right ventricular hypoplasia	4180186
980142	Right ventricular hypoplasia	4180186
980142	Right Ventricular Hypoplasia, Isolated	4180186
980143	Bilateral, annular limbal dermoids with corneal and conjunctival extension	4180186
980143	Ring dermoid syndrome	4180186
980148	Kousseff syndrome	4180186
980149	2-(4-(3-fluorobenzyloxy)benzylamino)propionamide	4180186
980149	fbap methanesulfonate	4180186
980149	FCE 26743	4180186
980149	FCE-26743	4180186
980149	FCE 28073	4180186
980149	FCE-28073	4180186
980149	NW-1015	4180186
980149	PNU 151774E	4180186
980149	PNU-151774E	4180186
980149	(S)-2-((4-(3-fluorobenzoxy)benzyl)amino)propanamide	4180186
980149	safinamide methanesulfonate	4180186
980149	Xadago	4180186
980151	153Sm radioisotope	4180186
980151	Sm-153 radioisotope	4180186
980153	Kevzara	4180186
980153	REGN88	4180186
980153	REGN-88	4180186
980153	SAR153191	4180186
980153	SAR-153191	4180186
980157	Triphalangeal thumbs and dislocation of patella	4180186
980158	Trigonocephaly, short stature and developmental delay	4180186
980158	Trigonocephaly, short stature, and retarded psychomotor development	4180186
980158	Trigonocephaly with Short Stature and Developmental Delay	4180186
980161	Cataracts, sensorineural deafness, hypogonadism, hypertrichosis and short stature	4180186
980163	Immunoosseous dysplasia Schimke type	4180186
980163	Immunoosseous Dysplasia, Schimke Type	4180186
980163	Schimke Immuno-Osseous Dysplasia	4180186
980166	Early balding, patella luxation, acromicria and hypogonadism	4180186
980166	Early Balding, Patella Luxation, Acromicria, And Hypogonadism	4180186
980167	Neurilemmomatosis, congenital cutaneous	4180186
980167	Schwannomatosis 1	4180186
980169	Kanuma	4180186
980171	Autosomal Recessive Infantile Parkinsonism	4180186
980171	Dopa-Responsive Dystonia, Autosomal Recessive	4180186
980171	DOPA responsive dystonia, autosomal recessive	4180186
980171	Dystonia, Dopa-Responsive, Autosomal Recessive	4180186
980171	Dystonia, DOPA responsive, autosomal recessive	4180186
980171	Dystonia, Dopa-Responsive, With Or Without Hyperphenylalaninemia, Autosomal Recessive	4180186
980171	Parkinsonism, infantile, autosomal recessive	4180186
980171	Th-Deficient Drd	4180186
980171	Tyrosine Hydroxylase Deficiency	4180186
980172	2-(4-((5,6-diphenylpyrazin-2-yl)(isopropyl)amino)butoxy)-N-(methylsulfonyl)acetamide	4180186
980172	ACT293987	4180186
980172	ACT 293987	4180186
980172	ACT-293987	4180186
980172	NS-304	4180186
980172	Uptravi	4180186
980180	Brachydactyly-distal symphalangism syndrome	4180186
980184	monosodium metasilicate	4180186
980184	silicic acid (H2SiO3) , disodium salt	4180186
980184	sodium metasilicate nonahydrate	4180186
980187	Abdallat Davis Farrage syndrome	4180186
980187	Abdallat syndrome	4180186
980187	Lison syndrome	4180186
980187	Spastic Paraparesis, Vitiligo, Premature Graying, Characteristic Facies	4180186
980187	Spastic paraplegia and pigmentary abnormalities	4180186
980187	Spastic paraplegia, vitiligo, premature graying and characteristic facies	4180186
980187	Spastic Paraplegia With Pigmentary Abnormalities	4180186
980189	HDL4 Huntington Disease-Like 4	4180186
980189	Huntington Disease-Like 4	4180186
980189	SCA17 Spinocerebellar Ataxia 17	4180186
980196	Ataxia-dementia syndrome, X-linked	4180186
980196	Spinocerebellar Ataxia, X-Linked 4	4180186
980197	Splenogonadal fusion limb defects syndrome	4180186
980197	Splenogonadal Fusion Limb Defect Syndrome	4180186
980197	Splenogonadal Fusion with Limb Defects and Micrognathia	4180186
980200	Karsch-Neugebauer syndrome	4180186
980200	Nystagmus-Split Hand Syndrome	4180186
980200	Split hand nystagmus syndrome	4180186
980200	Split-Hand With Congenital Nystagmus, Fundal Changes, And Cataracts	4180186
980201	Casamassima-Morton-Nance Syndrome	4180186
980203	SEMD, Missouri Type	4180186
980204	SEMD, Pakistani Type	4180186
980206	Fantasy Island Syndrome	4180186
980206	SED-BDS	4180186
980206	Tattoo Dysplasia	4180186
980208	Brachyolmia, Toledo type	4180186
980208	Brachyolmia Type 1, Toledo Type	4180186
980208	Paps-Chondroitin Sulfate Sulfotransferase Deficiency	4180186
980208	SED, Chondroitin Sulfate Type	4180186
980208	Spondyloepiphyseal dysplasia, chondroitin sulfate type	4180186
980208	Toledo type brachyolmia	4180186
980209	Spondylometaphyseal Dysplasia, Schmidt Type	4180186
980209	Spondylometaphyseal Dysplasia With Severe Genu Valgum	4180186
980211	1-octadecanamine, hydrochloride	4180186
980211	1-octadecanamine, hydrochloride (1:1)	4180186
980211	1-octadecylamine	4180186
980211	octadecylamine	4180186
980211	octadecylamine hydrochloride	4180186
980211	octadecyl ammonium chloride	4180186
980211	stearamine	4180186
980211	stearyl amine	4180186
980211	stearylamine hydrochloride	4180186
980211	stearylammonium chloride	4180186
980220	89Sr radioisotope	4180186
980220	Sr-89 radioisotope	4180186
980227	Syndactyly, Type II	4180186
980227	Synpolydactyly	4180186
980227	Synpolydactyly 1	4180186
980228	Familial syndactyly type 3	4180186
980228	Ring and little finger syndactyly	4180186
980228	Syndactyly of fingers four and five	4180186
980228	Syndactyly Of Fingers IV and V	4180186
980228	Syndactyly of the ring and little finger	4180186
980228	Syndactyly, Type III	4180186
980229	Haas Type Syndactyly	4180186
980229	Polysyndactyly, Haas Type	4180186
980232	beef tallow	4180186
980233	Pierre Robin syndrome with congenital heart malformation and clubfoot	4180186
980233	Talipes Equinovarus, Atrial Septal Defect, Robin Sequence, and Persistence of Left Superior Vena Cava	4180186
980234	Congenital alopecia and nail dystrophy associated with severe functional T-cell immunodeficiency	4180186
980234	Pignata Guarino syndrome	4180186
980234	T-Cell Immunodeficiency, Congenital Alopecia, And Nail Dystrophy	4180186
980236	Al Awadi Teebi Farag syndrome	4180186
980236	Profound limb deficiency, thoracic dystrophy, unusual facies, and normal intelligence	4180186
980240	LX1606	4180186
980240	telotristat etiprate	4180186
980241	LX1032	4180186
980241	Xermelo	4180186
980244	Frank Ter Haar syndrome	4180186
980244	Frank-Ter Haar Syndrome	4180186
980244	Megalocornea, multiple skeletal anomalies, and developmental delay	4180186
980244	Borrone dermatocardioskeletal syndrome	4180186
980244	Borrone Di Rocco Crovato syndrome	4180186
980251	PRN1	4180186
980251	PTCPRN	4180186
980256	ecteinascidin 743	4180186
980256	ET 743	4180186
980256	ET-743	4180186
980256	NSC 684766	4180186
980256	Yondelis	4180186
980262	Triphalangeal thumb and brachy-ectrodactyly syndrome	4180186
980262	Triphalangeal thumb and brachyectrodactyly syndrome	4180186
980262	Triphalangeal Thumbs with Brachyectrodactyly	4180186
980264	Radioulnar Synostosis with Microcephaly, Short Stature, Scoliosis, and Mental Retardation	4180186
980265	Dobrin syndrome	4180186
980265	TINU syndrome	4180186
980265	Tubulointerstitial nephritis and uveitis syndrome	4180186
980265	Tubulointerstitial Nephritis with Uveitis	4180186
980269	Familial dyschondroplasia	4180186
980269	Perthes-like hip disease, enchondromata, and ecchondromata	4180186
980273	GS-5816	4180186
980278	Mutilating Keratoderma with Ichthyosis	4180186
980278	Vohwinkel Syndrome with Ichthyosis	4180186
980285	Distal myopathy, Swedish type	4180186
980286	Familial spastic paraparesis and deafness	4180186
980286	Spastic Paraparesis and Deafness	4180186
980287	Hereditary whispering dysphonia	4180186
980289	Miles-Carpenter x-linked mental retardation syndrome	4180186
980289	Mental Retardation, X-Linked, with Congenital Contractures and Low Fingertip Arches	4180186
980289	Mental retardation, X-linked, syndromic 4	4180186
980289	Apraxia, oculomotor, with congenital contractures and muscle atrophy	4180186
980289	Contractures of feet, muscle atrophy, and oculomotor apraxia	4180186
980289	Wieacker Wolff syndrome	4180186
980289	Wieacker-Wolff Syndrome	4180186
980290	Microcephaly cardiomyopathy	4180186
980290	Microcephaly-Cardiomyopathy	4180186
980290	Microcephaly-cardiomyopathy syndrome	4180186
980290	Microcephaly with cardiomyopathy	4180186
980290	Microcephaly with mental retardation and dilated cardiomyopathy	4180186
980290	Severe microcephaly and self-limiting dilated cardiomyopathy	4180186
980290	Severe microcephaly with mental retardation and dilated cardiomyopathy	4180186
980293	Congenital suprabulbar paresis	4180186
980293	Suprabulbar paresis congenital	4180186
980293	Suprabulbar Paresis, Congenital	4180186
980293	Worster-Drought Syndrome	4180186
980297	Warburg Thomsen syndrome	4180186
980297	Yemenite (Warburg) deaf-blind hypopigmentation syndrome	4180186
980303	zinc iodide, (65)Zn-labeled	4180186
1001480	Durat; H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1001480	快速动眼期睡眠持续时间:时间:时间点:^患者:定量型	4182948
1001481	4-hydroxy-2-oxoglutarate aldolase 1; Blood; C10orf65; DHDPS2; DHDPSL; dihydrodipicolinate synthase-like, mitochondrial; dihydrodipicolinate synthetase homolog 2; Document; Finding; Findings; full gene sequencing; Full Mut Anl; high-throughput sequencing; HTS; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1001481	HOGA1 Full Mut Anl Bld/T Seq	4180186
1001481	HOGA1 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
1001482	Ab Ao Holodias flow reversal DOP	4180186
1001482	Ab Ao; Abd; Abdo; Abdomen; AO; Aortic; Bld flow; CARD.US; Cardiology; DOP; DUPLEX; Dynamic; Echography; Finding; Findings; Holodias flow reversal; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sonogram; Sonograph; Sonography; ULS; Ultrasound	4180186
1001482	血流逆转.全舒张期:发现:时间点:主动脉.腹腔段:序数型:超声.多普勒	4182948
1001483	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Coccidiodes; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; San Joaquin Valley fever; species; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; spp; SUDS; Valley fever	4180186
1001483	Coccidioides IgG CSF IA-aCnc	4180186
1001483	球孢子菌属单个未知种 抗体.IgG:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
1001486	LV Max atrial contract strain rate 3D US	4180186
1001486	3D US; Arbitrary rate; CARD.US; Cardiac; Cardiology; Echography; Hrt; Hrt ventr; L; Largest; LT; LV; Max atrial contract strain rate; Max strain rate; Maximal; Maximum; Peak; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ventricular	4180186
1001486	心房收缩应变速率.最大值:任意型速率:时间点:心脏.心室.左侧:定量型:超声.3D	4182948
1001487	Finding; Findings; Gestation; Gestations; Gravida; Ordinal; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
1001490	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1001492	H+P; H+P.HX; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1001492	焦虑严重程度:印象:时间点:^患者:序数型	4182948
1001493	C4 NeF SerPl Ql	4180186
1001493	C4 NeF; C4NEF; Complement.C4 Nephritic; Fac; Fact; HEMATOLOGY/CELL COUNTS; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1001493	补体 C4.肾病型:存在情况或阈值:时间点:血清/血浆:序数型	4182948
1001494	4 weeks; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1001496	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1001497	Act/Nor; Alpha-2 integrin chain; Antigen, CD49b; Blood; CD49b Antigen; CD49b Antigens; CELL MARKERS; Control; Dynamic; FC; Glycoprotein Ia, Platelet; GPIa; Pl; Platelet Glycoprotein Ia; Platelets; Platelt; Plt; Plt CD49b; Plt CD49b Act/Nor; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Thrombocyte; Thrombocytes; VLA-2 alpha chain; WB; Whole blood	4180186
1001497	Plt CD49b Act/Nor Bld FC	4180186
1001497	血小板 CD49b 实际的/正常的:相对比率:时间点:全血:定量型:流式细胞测量术	4182948
1001499	Cnt; Count; Number; QNT; Quan; Quant; Quantitative; Survey; SURVEY.CSSRS	4180186
1001500	B miyamotoi IgM SerPl IA-aCnc	4180186
1001500	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B miyamotoi; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin M; Immunoglobulin M; MEIA; Microbiology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; TBRF; Tick Borne Diseases; tick-borne relapsing fever	4180186
1001500	宫本疏螺旋体 抗体.IgM:任意型浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
1001501	3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
1001502	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; F. necrophorum; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1001502	F. necrophorum DNA Bld Pos Ql NAA+probe	4180186
1001502	坏死梭杆菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:探针法.基因扩增.靶向	4182948
1001503	Osmolality 1h p Vaso SerPl	4180186
1001503	1 hour; 1.0Hr; 1h p Vaso; 60 min; 60 minutes; 60M; 60min; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; Osmo; Osmol; Osmolality; osmolarity; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; VP	4180186
1001503	渗透压^在给予剂量后叶加压素之后1小时:渗透压:时间点:血清/血浆:定量型	4182948
1001504	Psychosine CSF-sCnc	4180186
1001504	1-beta-D-galactosphingosine; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Galactosylsphingosine; Globoid Cell Leukodystrophies; Globoid Cell Leukodystrophy; Krabbe disease; Leukodystrophy, Krabbe; Level; Point in time; PSY; QNT; Quan; Quant; Quantitative; Random; Sphingosine galactoside; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
1001504	神经鞘氨醇半乳糖苷:物质的量浓度:时间点:脑脊液:定量型	4182948
1001505	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1001506	Fac; Fact; Finding; Findings; H+P; H+P.HX; Nominal; P prime; Point in time; Random	4180186
1001506	自杀风险因素:发现:时间点:^患者:名义型	4182948
1001507	PA Rist 15 ug/mL PRP	4180186
1001507	Agg; Aggr; COAGULATION; mcg; PA; PA Rist; Pl; Platelet rich plasma; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RIPA; RlACnc; Thrombocyte; Thrombocytes	4180186
1001507	血小板聚集.瑞斯托菌素诱导型^15 微克/毫升:相对任意型浓度:时间点:富血小板血浆:定量型	4182948
1001514	1q Del; Chromosom; Chromosomes; Del; Deletions; Fluorescent in situ hybridization; Molecular pathology; MOLPATH; MOLPATH.DELDUP; Number ratio; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
1001514	1p/1q Chrom Del Tiss FISH	4180186
1001514	1号染色体短臂 缺失/1q 染色体 缺失:计数型比率:时间点:组织与涂片:定量型:FISH	4182948
1001516	A phagocyt + E chaff IgG + IgM Pnl Ser	4180186
1001516	A phagocyt + E chaff IgG + IgM Pnl; E chaff IgG+IgM Pnl; E chaffeensis; E equi; E phagocytophila; Ehrlichia equi; Ehrlichia phagocytophila; HGE; HME; Human granulocytic ehrlichiosis; Human monocytic ehrlichiosis; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Serum; SR	4180186
1001516	嗜吞噬球无形体与查菲埃立克体抗体.IgG 与 IgM 组套:-:时间点:血清:-	4182948
1001520	3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide; Addiction; C16H22Cl2N2O; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Doxylam; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Synthetic opioid; UA; UR; Urn	4180186
1001520	AH-7921 Ur Cfm-mCnc	4180186
1001520	AH-7921:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1001521	Proteus sp DNA Bld Pos Ql NAA+probe	4180186
1001521	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; species; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1001521	变形杆菌属单个未知种 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:探针法.基因扩增.靶向	4182948
1001522	NASH + fibrosis Pnl SerPl	4180186
1001522	Chemistry; NASH + fibrosis Pnl; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1001522	非酒精性脂肪变性肝炎与肝纤维化组套:-:时间点:血清/血浆:-	4182948
1001525	3rd; 3rd finger; Arm; Bone dev stage; EXT; Finger.3rd; Finger.3rd.prox phlnx; Imaging; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; RADIOLOGY; Random; Scale; UE; Up; Xray; X-ray	4180186
1001525	XR Finger.3rd.prox phlnx Bone dev stage	4180186
1001525	骨骼发育阶段:评分:时间点:上肢>手指.第三.近节指骨:定量型:X射线摄影术	4182948
1001526	Bld Grp Ag Pnl RBC	4180186
1001526	Ag; Bld Grp Ag Pnl; BLOOD BANK; Erythrocytes; Pan; PANEL.BLOODBANK; Panl; Pnl; Point in time; Random; Red blood cells; Red blood corpusles	4180186
1001526	血型抗原组套:-:时间点:红细胞:-	4182948
1001527	4-Chloro-N-(1-(4-nitrophenethyl)piperidin-2-ylidene)benzenesulfonamide; 4-chloro-N-[1-(2-phenylethyl)-2-piperidinylidene]-benzenesulfonamide; Addiction; C19H20ClN3O4S; C19H21ClN2O2S; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Synthetic opioid; UA; UR; Urn	4180186
1001527	Nor-W-18+Nor-W-15 Ur Cfm-mCnc	4180186
1001527	Nor-W-18+Nor-W-15:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1001528	Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Study report; Visit note	4180186
1001528	Immunology Diag study note	4180186
1001528	诊断性检查记录:发现:时间点:{环境}:文档型:免疫学	4182948
1001531	Visits to ED in last 6Mo	4180186
1001531	Cnt; Count; ED visits; H+P; H+P.HX; Number; P prime; Past; QNT; Quan; Quant; Quantitative; Visits to ED in last 6Mo	4180186
1001531	在过去的6个月当中的急诊科就诊:数量(计数):6个月:^患者:定量型	4182948
1001532	Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Study report; Visit note	4180186
1001532	Pharmacogenomics Diag study note	4180186
1001532	诊断性检查记录:发现:时间点:{环境}:文档型:药物基因组学	4182948
1001535	LV EF A2C SP A-L	4180186
1001535	2D US; A2C SP A-L; Calculated; CARD.US; Cardiac; Cardiology; Echography; EF; Frac; Fract; Fractionation; Fractions; Hrt; Hrt ventr; L; LT; LV; LVEF; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular; Volfr; Volume fraction	4180186
1001535	射血分数:体积分数:时间点:心脏.心室.左侧:定量型:超声.2D.A2C+单平面面积-长度计算法	4182948
1001536	Centers for Medicare and Medicaid Assessment; Disch; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1001539	Variant drug resist effect Nar	4180186
1001539	Blood; Drugs; Finding; Findings; Genetics; Genomic; Molecular pathology; MOLPATH; Narrative; Point in time; Random; Report; Resist; Resistanc; Resistant; Resistent; Tissue; Tissue, unspecified; Variant drug resist effect; WB; Whole blood; Whole blood or Tissue	4180186
1001539	遗传变异对耐药性的影响:发现:时间点:全血/组织:叙述型	4182948
1001540	4 weeks; Finding; Findings; Job; Last; Occupation; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1001541	DRUG/TOXICOLOGY; Drugs; Gluc; Glucouronide; Normison; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Restoril; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
1001541	Temazepam glucuronide Ur Ql Scn	4180186
1001541	葡萄糖苷酸替马西泮:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
1001542	Centers for Medicare and Medicaid Assessment; Hx; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Patient Hx; Pnl; Point in time; Random; Survey	4180186
1001547	1 hour; 1.0Hr; 1h p carb; 60 min; 60 minutes; 60M; 60min; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; p carb; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction	4180186
1001547	Breath methane 1h p carb	4180186
1001547	甲烷/已呼出的气体^在给予剂量碳水化合物之后1小时:体积分数:时间点:呼出的气体:定量型	4182948
1001550	ANTIBIOTIC SUSCEPTIBILITIES; Bact; Bacterial rpsL drug res mut; Drugs; Identity or presence; Islt; Islt/Spm; Isol; Molecular genetics; Mut; Mutations; Nominal; PCR; Point in time; Random; Resist; Resistanc; Resistant; Resistent; Spec	4180186
1001550	Bacterial rpsL drug res mut Islt/Spm	4180186
1001550	细菌 rpsL 基因耐药性突变:存在与否或特征标识:时间点:分离株/标本:名义型:分子遗传学类实验室方法	4182948
1001554	Psych Diag study note	4180186
1001554	Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Study report; Visit note	4180186
1001554	诊断性检查记录:发现:时间点:{环境}:文档型:心理学	4182948
1001555	Platelet glycoprotein Pnl Bld FC	4180186
1001555	Blood; CELL MARKERS; Dynamic; FC; gG; Glycoprot; Glycoproteins; GP; Pan; PANEL.CELLMARK; Panl; Pl; Plat Gp; Platelet glycoprotein Pnl; Platelet GP disorder; Platelets; Platelt; Plt; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
1001555	血小板糖蛋白疾病组套:-:时间点:全血:定量型:流式细胞测量术	4182948
1001561	Bld flow; CARD.US; Cardiology; DOP; DUPLEX; Dynamic; Echography; Finding; Findings; Hep v; Hep vein; Hepar; Liver; Liver vein; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sonogram; Sonograph; Sonography; Sys flow reversal; ULS; Ultrasound; Ven; Venous	4180186
1001561	Hep v Sys flow reversal DOP	4180186
1001561	血流逆转.收缩期:发现:时间点:肝静脉:序数型:超声.多普勒	4182948
1001563	Muts/Mb Tumor	4180186
1001563	Cancer; Mb; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutation; Muts; Muts/Mb; Number ratio; Point in time; QNT; Quan; Quant; Quantitative; Random; TMB; Tumor mutation burden; Tumor mutational load; tumors; tumour; tumours	4180186
1001563	突变/兆碱基:计数型比率:时间点:肿瘤:定量型	4182948
1001567	Antigen; Antigens; Bronchial alveolar lavage; Bronchoalveolar lavage; Coccidiodes; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; Mass concentration; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; San Joaquin Valley fever; species; spp; SUDS; Valley fever	4180186
1001567	Coccidioides Ag BAL IA-mCnc	4180186
1001567	球孢子菌属单个未知种 抗原:质量浓度:时间点:支气管肺泡灌洗液:定量型:免疫测定法	4182948
1001568	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Chemistry; gamma-4-Androstenedione; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
1001568	Androst Amn-sCnc	4180186
1001568	雄烯二酮:物质的量浓度:时间点:羊水:定量型	4182948
1001569	After; Antigen; Antigens; BLOOD BANK; Erythrocytes; K Ag^p transf rx; KEL1; Kell Blood Group System; Ordinal; p transf; p transf rx; Point in time; PR; PST; QL; Qual; Qualitative; Random; React; Red blood cells; Red blood corpusles; Rxn; Screen; Transf React; Tx	4180186
1001569	K Ag p transf rx RBC Ql	4180186
1001569	K 抗原^在输血反应之后:存在情况或阈值:时间点:红细胞:序数型	4182948
1001570	XR Skull to Coccyx 2V or 3V	4180186
1001570	多重视图 双重 or 三重:发现:时间点:头部>颅骨 & 颈部>脊椎.颈段 & 胸部>脊椎.胸段 & 腹部>脊椎.腰段 & 盆腔>骶骨+尾骨:文档型:X射线摄影术	4182948
1001570	2V; 2V or 3V; 2VW; Abd; Abdo; Abdomen+; Abdominal; Brain; C/sp; C+T+L+Sacrum; C+T+L-spine; C+T-spine; Cerv; Cranial; Cranium; C-spine; C-spine to Coccyx; CXR; Document; Dorsal spine; Films; Finding; Findings; Head; II; III; Imaging; Intracranial; L/sp; L-spine; L-spine+Sacrum; L-spine+Sacrum+Coccyx; Lumbar; Lumbo; Lumbosacral; Pelvic; Pelvis+L-spine; Plain Films; Point in time; Radiology; Random; Skull; Skull to Coccyx; Spinal; Spinal Cord; T Spine+Ab; T+L-Spine; Th/sp; Thorax; T-spine; View; VWS; Xray; X-ray	4180186
1001571	3-Me-fentanyl; Addiction; C23H30N2O; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; III; Illicit; Level; Mass concentration; Mefentanyl; Me-fentanyl; N-[3-methyl-1-(2-phenylethyl)piperidin-4-yl]-N-phenylpropanamide; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Synthetic opioid; UA; UR; Urn	4180186
1001571	3-Me-fentanyl Ur Cfm-mCnc	4180186
1001571	3-甲基芬太尼:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1001573	11DC; Chemistry; Compound S; Cortexolone; Cortodoxone; Deoxycortisol; Desoxycortisol; Level; Metopirone; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; Substance concentration	4180186
1001573	11DC Sal-sCnc	4180186
1001573	11-脱氧皮质醇:物质的量浓度:时间点:唾液:定量型	4182948
1001574	C18 ceramide/C24 ceramide Plas-sRto	4180186
1001574	C18 Cer; C18 ceramide; C24 ceramide; Chemistry; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio	4180186
1001574	N-硬脂酰基神经鞘氨醇/N-二十四烷酰基神经鞘氨醇:物质的量比率:时间点:血浆:定量型	4182948
1001576	ADMIN; Ident; Identifier; Nominal; Point in time; Random	4180186
1001576	Funeral service licensee ID Facility	4180186
1001576	丧葬服务持照方标识符:标识符:时间点:设施:名义型	4182948
1001577	German turnip IgE Qn	4180186
1001577	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Brassica caulorapa; Brassica oleracea var caulorapa; German turnip; Immune globulin E; Immunoglobulin E; Kohlrabi; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1001577	苤蓝 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
1001580	Document; Finding; Findings; Fluorescent in situ hybridization; Molecular pathology; MOLPATH; Point in time; Random; Rearr; Rearrangement; SSXT; Synovial sarcoma translocation, chromosome 18; Synovial sarcoma, translocated to X chromosome; SYT; Tissue; Tissue, unspecified	4180186
1001580	SS18 gene Rear Tiss FISH	4180186
1001580	SS18 基因重排:发现:时间点:组织与涂片:文档型:FISH	4182948
1001582	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Compx; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; E cloac comp; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1001582	E cloac comp DNA Bld Pos Ql NAA+probe	4180186
1001582	阴沟肠杆菌复合菌群 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:探针法.基因扩增.靶向	4182948
1001584	Hepta-CP3 24h Ur-sRate	4180186
1001584	1 day; 24 hours; 24HR; 3; Chemistry; Hepacarboxyporph; Heptacarbox; Heptacarboxyl porphyrin; Heptacarboxylate porphyrin; Heptacarboxylporphyrins; Heptacarboxyporph; Heptacarboxyporphyrin; Hepta-CP; Hepta-CP3; Heptaporphyrin; Hexacarboxyl porphyrin; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn	4180186
1001584	七羧基卟啉 III:物质的量速率:24小时:尿液:定量型	4182948
1001588	Erysipelothrix sp Tiss Ql ImStn	4180186
1001588	IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; species; spp; St; Stains; Stn; Tissue; Tissue, unspecified	4180186
1001588	丹毒丝菌属单个未知种:存在情况或阈值:时间点:组织与涂片:序数型:免疫染色法	4182948
1001590	Carb chal Pnl ExG	4180186
1001590	Breath; Carb chal Pnl; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; Pan; PANEL.CHALLENGE; Panl; Pnl; Point in time; Random	4180186
1001590	碳水化合物刺激组套:-:时间点:呼出的气体:-	4182948
1001591	Breath methane 2h p carb	4180186
1001591	120 min; 120 minutes; 120min; 2 hours; 2h p carb; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; p carb; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction	4180186
1001591	甲烷/已呼出的气体^在给予剂量碳水化合物之后2小时:体积分数:时间点:呼出的气体:定量型	4182948
1001592	1st metacarpal; Arm; Bone dev stage; EXT; First finger; Imaging; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; RADIOLOGY; Random; Scale; Thumb.distl phlnx; UE; Up; Xray; X-ray	4180186
1001592	XR Thumb.distl phlnx Bone dev stage	4180186
1001592	骨骼发育阶段:评分:时间点:上肢>拇指.远节指骨:定量型:X射线摄影术	4182948
1001593	ABS; Aby; Alfa; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; GFAP; GFAP alpha; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; Ordinal; Pituitary glycoproteins; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Stroke; TBI (Traumatic Brain Injury); Traumatic Brain Injuries	4180186
1001593	GFAP alpha IgG Ser Ql CBA IFA	4180186
1001593	神经胶质纤维酸性蛋白.alpha 亚单位 抗体.IgG:存在情况或阈值:时间点:血清:序数型:CBA IFA	4182948
1001595	PA Epineph 10 umol/L PRP	4180186
1001595	Adrenalin; Adrenaline; Adreneline; Agg; Aggr; COAGULATION; E; Epi; Epin; Epinep; Epineph; Epinphrine; Eppi; Left; Levo; PA; PA Epineph; Pl; Platelet rich plasma; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RlACnc; Thrombocyte; Thrombocytes	4180186
1001595	血小板聚集.肾上腺素诱导型^10 微摩尔/升:相对任意型浓度:时间点:富血小板血浆:定量型	4182948
1001597	1 month; 1 month (30 days); 30 days; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Spec; Survey; SURVEY.CSSRS	4180186
1001598	7-amino flunitrazepam; 7Aminoflunitrazepam; DRUG/TOXICOLOGY; Drugs; Flunitrazepam metabolite; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
1001598	7Aminoflunitrazepam Ur Ql Scn	4180186
1001598	7-氨基氟硝安定:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
1001601	Cryptoc Ag Titr Ur IA.rapid	4180186
1001601	Antigen; Antigens; Crypt; Crypto; Cryptococcal; Cryptococcosis; Cryptococcosus; Dilution factor; Dilution Factor (Titer); EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Microbiology; Point in time; Random; SmQn; species; spp; SUDS; Titer; Titered; Titre; Ttr; UA; UR; Urn	4180186
1001601	隐球菌属单个未知种 抗原:滴定度:时间点:尿液:定量型:免疫测定法.快速	4182948
1001604	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; Idiopathic Membranous Nephropathy; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombospondin Type-1 Domain-Containing 7A; Thrombospondin Type-1 Domain-Containing 7A Antibodies IgG; THSD7A; THSD7A Ab; THSD7A Ab.IgG; Time Resolved Fluorescence; TRF	4180186
1001604	THSD7A IgG SerPl Ql IF	4180186
1001604	I 型血小板反应蛋白 7A 域 抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:免疫荧光法	4182948
1001609	Antigen; Antigens; BLOOD BANK; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells cord; Rh Blood Group System; Screen	4180186
1001609	E Ag RBCCo Ql	4180186
1001609	E 抗原:存在情况或阈值:时间点:脐带血红细胞:序数型	4182948
1001611	Fam Med Phone Note	4180186
1001611	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Fam Med; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1001611	记录:发现:时间点:电话就医:文档型:家庭医学	4182948
1001612	DOP LE aa+vv-Bl	4180186
1001612	Bil; Bilat; Both; Document; DOP; DUPLEX; Echography; EXT; Extr-Bl; Finding; Findings; Imaging; LE; LE aa+vv-Bl; LE vv; LE-Bl; Leg; Low; Point in time; Radiology; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound	4180186
1001612	多层:发现:时间点:下肢.双侧>下肢动脉类+下肢静脉类:文档型:超声.多普勒	4182948
1001623	Breath H2 pre carb	4180186
1001623	Before; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; H2; Hyd; Percent; Point in time; pre carb; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction	4180186
1001623	氢/已呼出的气体^在给予剂量碳水化合物之前:体积分数:时间点:呼出的气体:定量型	4182948
1001625	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bact; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; GP bact; GP Bact DNA; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; Pos; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1001625	GP bact DNA Bld Pos Ql NAA+probe	4180186
1001625	革兰氏阳性细菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:探针法.基因扩增.靶向	4182948
1001626	PhenX - CBC protocol	4180186
1001626	Pan; Panel; PANEL.PHENX; Panl; PhenX - CBC protocol; Pnl; Point in time; Random	4180186
1001626	PhenX - 全血细胞计数方案 220501:-:时间点:^患者:-:PhenX	4182948
1001631	Finding; Findings; Gestation; Gestations; Gravida; Occupation; Ordinal; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH; Work	4180186
1001635	E. aerog+amn+gergo DNA Bld Pos Ql NAA+pr	4180186
1001635	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; E aerogenes; E. aerog+amnig+gergo; Enterobacter non-cloacae complex; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1001635	产气肠杆菌+河生肠杆菌+日沟维肠杆菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:探针法.基因扩增.靶向	4182948
1001636	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; E coli; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o002; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1001636	E coli DNA Bld Pos Ql NAA+probe	4180186
1001636	大肠埃希菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:探针法.基因扩增.靶向	4182948
1001637	Nighttime awaken	4180186
1001637	Awakened during night; Cnt; Count; H+P; H+P.HX; Number; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Woke up during the night	4180186
1001637	夜间觉醒:数量(计数):时间点:^患者:定量型	4182948
1001638	3 months; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS; Tx	4180186
1001640	CHEMISTRY.CHALLENGE TESTING; Pan; PANEL.CHALLENGE; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UA; UR; Ur+SerPl; Urn; Water deprivation Pnl	4180186
1001640	Water deprivation Pnl Ur+SerPl	4180186
1001640	限制饮水刺激组套:-:时间点:尿液+血清/血浆:-	4182948
1001641	Benz; Benzodiaz; Benzodiazepine; Benzodiazepines Pnl; DRUG/TOXICOLOGY; Drugs; Ordinal; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
1001641	Benzodiazepines Pnl Ur Scn	4180186
1001641	苯二氮类组套:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
1001643	3 months; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS	4180186
1001644	2D US; A4C SP A-L; Calculated; CARD.US; Cardiac; Cardiology; CO; Echography; Flow; Hrt; Hrt ventr; L; LT; LV; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular; Volume rate; vRate	4180186
1001644	LV Output A4C SP A-L	4180186
1001644	心输出量:体积速率:时间点:心脏.心室.左侧:定量型:超声.2D.A4C+单平面面积-长度计算法	4182948
1001645	Finding; Findings; H+P; H+P.HX; Nominal; P prime; Point in time; Random	4180186
1001645	感觉不适的原因:发现:时间点:^患者:名义型	4182948
1001646	Chr 19 polysomy Tiss Ql FISH	4180186
1001646	Chr 19 polysomy; Chromosom; Chromosomes; Fluorescent in situ hybridization; Molecular pathology; MOLPATH; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified	4180186
1001646	染色体 19 多体性:存在情况或阈值:时间点:组织与涂片:序数型:FISH	4182948
1001649	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.CSSRS	4180186
1001652	XR Skull to Coccyx GE 6V	4180186
1001652	多重视图 GE 六重:发现:时间点:头部>颅骨 & 颈部>脊椎.颈段 & 胸部>脊椎.胸段 & 腹部>脊椎.腰段 & 盆腔>骶骨+尾骨:文档型:X射线摄影术	4182948
1001652	Abd; Abdo; Abdomen+; Abdominal; Brain; C/sp; C+T+L+Sacrum; C+T+L-spine; C+T-spine; Cerv; Cranial; Cranium; C-spine; C-spine to Coccyx; CXR; Document; Dorsal spine; Films; Finding; Findings; GE 6V; Head; Imaging; Intracranial; L/sp; L-spine; L-spine+Sacrum; L-spine+Sacrum+Coccyx; Lumbar; Lumbo; Lumbosacral; Pelvic; Pelvis+L-spine; Plain Films; Point in time; Radiology; Random; Skull; Skull to Coccyx; Spinal; Spinal Cord; T Spine+Ab; T+L-Spine; Th/sp; Thorax; T-spine; View; VWS; Xray; X-ray	4180186
1001653	1 hour; 1.0Hr; 1h p Vaso; 60 min; 60 minutes; 60M; 60min; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; CR; Crea; Creat; Level; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; VP	4180186
1001653	Creat 1h p Vaso SerPl-mCnc	4180186
1001653	肌酐^在给予剂量后叶加压素之后1小时:质量浓度:时间点:血清/血浆:定量型	4182948
1001655	4 weeks; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; SDOH; Survey; SURVEY.GNHLTH	4180186
1001656	Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS; Typ	4180186
1001657	Lurasidone SerPl-mCnc	4180186
1001657	DRUG/TOXICOLOGY; Drugs; Latuda; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1001657	鲁拉西酮:质量浓度:时间点:血清/血浆:定量型	4182948
1001658	1 hour; 1.0Hr; 1h p Vaso; 60 min; 60 minutes; 60M; 60min; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; k; K+; Level; p dose; Pl; Plasma; Plsm; Point in time; Potass; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; VP	4180186
1001658	Potassium 1h p Vaso SerPl-sCnc	4180186
1001658	钾^在给予剂量后叶加压素之后1小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
1001659	1 month; 1 month (30 days); 30 days; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS	4180186
1001662	Antigen; Antigens; BLOOD BANK; Erythrocytes; Fy3; Fy3 Ag; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen	4180186
1001662	Fy3 Ag RBC Ql	4180186
1001662	Fy3 抗原:存在情况或阈值:时间点:红细胞:序数型	4182948
1001663	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
1001665	Antigen; Antigens; BLOOD BANK; D Var Ag; Dextro; Erythrocytes; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen	4180186
1001665	D Var Ag RBC Ql	4180186
1001665	D 变异型 抗原:存在情况或阈值:时间点:红细胞:序数型	4182948
1001667	Finding; Findings; H+P; H+P.HX; Levels; Levl; LV; LVL; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen; Sx	4180186
1001667	症状困扰程度:发现:时间点:^患者:序数型	4182948
1001668	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
1001669	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CAP; Donr; EBV; EBV capsid Ab; EBV VCA; EIA; ELFA; ELISA; Enzyme immunoassay; Epstn; HHV-4; human herpesvirus 4; IAA; Immune globulin G; Immunoglobulin G; MEIA; Microbiology; Mono; Mononucleosis; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; VCA; Viral capsid	4180186
1001669	EBV VCA IgG Ser Donr Ql IA	4180186
1001669	Epstein Barr 病毒衣壳 抗体.IgG:存在情况或阈值:时间点:血清^供体:序数型:免疫测定法	4182948
1001670	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; APPV; Atyp; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Pork; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Reactive; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; Swine; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
1001670	APPV RNA Ct Spec Qn NAA+probe	4180186
1001670	猪非典型性瘟病毒 RNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
1001672	3D US; CARD.US; Cardiac; Cardiology; Echography; Hrt; Hrt ventr; L; Largest; Length Ratio; LT; LV; Max area strain; Max strain; Maximal; Maximum; Peak; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ventricular	4180186
1001672	LV Max area strain 3D US	4180186
1001672	面积应变.最大值:长度比率:时间点:心脏.心室.左侧:定量型:超声.3D	4182948
1001673	F tular IgG+IgM Ser-Imp	4180186
1001673	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; F tular; F tularensis; F. tularensis IgG + IgM; IgG+IgM; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Microbiology; Nominal; Point in time; Random; Serum; SR; Tularemia	4180186
1001673	土拉弗朗西斯菌 抗体.IgG 与 IgM:印象:时间点:血清:名义型	4182948
1001677	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey; SURVEY.GNHLTH	4180186
1001686	HCO3 2h p Vaso SerPl-sCnc	4180186
1001686	120 min; 120 minutes; 120min; 2 hours; 2h p Vaso; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; BIC; bicar; Bicarb; CHEMISTRY.CHALLENGE TESTING; HCO3; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SBC; SBIC; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; VP	4180186
1001686	碳酸氢盐^在给予剂量后叶加压素之后2小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
1001687	C24:1 ceramide Plas-sCnc	4180186
1001687	C24:1 ceramide; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
1001687	N-神经酰基神经鞘氨醇:物质的量浓度:时间点:血浆:定量型	4182948
1001689	Finding; Findings; H+P; H+P.HX; Nominal; P prime; Point in time; Random	4180186
1001689	最为烦恼的关注事项:发现:时间点:^患者:名义型	4182948
1001690	ABO + Rh p HSCT Bld	4180186
1001690	ABO + Rh; ABO group and Rh type; ABO+Rh Gp; ABO+Rh Gp^p stem trnsplt; After; Blood; BLOOD BANK; D phenotyping; D typing; Nominal; p HSCT; Point in time; PST; Random; Rh phenotyping; Rh typing; Typ; WB; Whole blood	4180186
1001690	ABO与Rh血型^在造血干细胞移植之后:类型:时间点:全血:名义型	4182948
1001693	XR Skull to Coccyx 4V or 5V	4180186
1001693	多重视图 四重 or 五重:发现:时间点:头部>颅骨 & 颈部>脊椎.颈段 & 胸部>脊椎.胸段 & 腹部>脊椎.腰段 & 盆腔>骶骨+尾骨:文档型:X射线摄影术	4182948
1001693	4V; 4V or 5V; 4VW; Abd; Abdo; Abdomen+; Abdominal; Brain; C/sp; C+T+L+Sacrum; C+T+L-spine; C+T-spine; Cerv; Cranial; Cranium; C-spine; C-spine to Coccyx; CXR; Document; Dorsal spine; Films; Finding; Findings; Head; Imaging; Intracranial; L/sp; L-spine; L-spine+Sacrum; L-spine+Sacrum+Coccyx; Lumbar; Lumbo; Lumbosacral; Pelvic; Pelvis+L-spine; Plain Films; Point in time; Radiology; Random; Skull; Skull to Coccyx; Spinal; Spinal Cord; T Spine+Ab; T+L-Spine; Th/sp; Thorax; T-spine; View; VWS; Xray; X-ray	4180186
1001694	Blastomyces Ag SerPl IA-mCnc	4180186
1001694	Antigen; Antigens; Blasto; Blastomycosis; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; Mass concentration; MEIA; Microbiology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; species; spp; SR; SUDS	4180186
1001694	芽生菌属单个未知种 抗原:质量浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
1001695	Au sup(b) Ag RBC Ql	4180186
1001695	A little u super little b; Antigen; Antigens; Au sup(b); Au^b Ag; Auberger; BLOOD BANK; Erythrocytes; LU19; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen	4180186
1001695	Au^b 抗原:存在情况或阈值:时间点:红细胞:序数型	4182948
1001696	2D US; Calc; Calculation; CARD.US; Cardiac; Cardiology; Echography; ES vol; Hrt; Hrt ventr; L; LT; LV; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular; Vol; Volume	4180186
1001696	LV ES vol Biplane area-length	4180186
1001696	心脏收缩末期容积:体积型属性:时间点:心脏.心室.左侧:定量型:超声.2D+双平面面积-长度计算法	4182948
1001697	4-Fluorobutyrfentanyl; 4-Fluorobutyrylfentanyl; Addiction; C23H29FN2O; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; N-(4-fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]butanamide; para-Fluorobutyrylfentanyl; p-Fluorobutyrfentanyl; p-Fluorobutyryl fentanyl; p-Fluorobutyrylfentanyl; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Synthetic opioid; UA; UR; Urn	4180186
1001697	4-Fluorobutyrylfentanyl Ur Cfm-mCnc	4180186
1001697	4-氟丁酰基芬太尼:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1001698	Finding; Findings; Levels; Levl; LV; LVL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.CSSRS	4180186
1001699	15M p carb; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; p carb; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction	4180186
1001699	Breath methane 15M p carb	4180186
1001699	甲烷/已呼出的气体^在给予剂量碳水化合物之后15分钟:体积分数:时间点:呼出的气体:定量型	4182948
1001708	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey	4180186
1001709	MDM2 copy num/nucleus EntNum Tiss FISH	4180186
1001709	Entitic; Entitic number; Fluorescent in situ hybridization; MDM2 copy num; Molecular pathology; MOLPATH; No; Num; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
1001709	MDM2 基因拷贝数/核:实体数量:时间点:组织与涂片:定量型:FISH	4182948
1001712	bod; Bodies; Finding; Findings; Gestation; Gestations; Gravida; Ordinal; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH; Wt	4180186
1001714	GALNS Ur-cCnc	4180186
1001714	Catalytic Concentration; Chemistry; Chondroitin sulfatase; Chondroitinase; Galactose-6-sulfate sulfatase; GalN6S; GALNS; Morquio disease, type A; MPS VI A; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
1001714	N-乙酰半乳糖胺-6-硫酸酯酶:催化浓度:时间点:尿液:定量型	4182948
1001716	XR Finger.5th.mid phlnx Bone dev stage	4180186
1001716	5th; 5th finger; Arm; Bone dev stage; EXT; Finger.5th; Finger.5th.mid phlnx; Imaging; little finger; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; RADIOLOGY; Random; Scale; UE; Up; Xray; X-ray	4180186
1001716	骨骼发育阶段:评分:时间点:上肢>手指.第五.中节指骨:定量型:X射线摄影术	4182948
1001717	Finding; Findings; H+P; H+P.HX; Nominal; Nonverb pain ind; P prime; Point in time; Random	4180186
1001717	Nonverb pain ind	4180186
1001717	非言语型疼痛指标:发现:时间点:^患者:名义型	4182948
1001719	4 weeks; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Survey; SURVEY.GNHLTH	4180186
1001721	C Ag p HSCT RBC Ql	4180186
1001721	After; Antigen; Antigens; BLOOD BANK; C Ag^p stem trnsplt; Erythrocytes; Ordinal; p HSCT; Point in time; PR; PST; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Rh; Rh Blood Group System; Screen	4180186
1001721	C 抗原^在造血干细胞移植之后:存在情况或阈值:时间点:红细胞:序数型	4182948
1001725	H+P; H+P.HX; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen; Subs; SUD severity	4180186
1001725	SUD severity	4180186
1001725	物质使用障碍严重程度:印象:时间点:^患者:序数型	4182948
1001726	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1001728	2 days; 2D; 48 hours; 48HR; Acd; Acids; Bile acid.total; Bile salt; Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; QNT; Quan; Quant; Quantitative; sRate; Stl; Stool = Fecal; Substance Rate	4180186
1001728	Bile Ac 48h Stl-sRate	4180186
1001728	胆汁酸:物质的量速率:48小时:大便:定量型	4182948
1001729	Arm; Bone dev stage; Carpal bone; Carpal bones; Carpal bones and joint; EXT; Imaging; Navicular (wrist); Plain Films; Point in time; QNT; Quan; Quant; Quantitative; RADIOLOGY; Random; Scale; UE; Up; Upper extremity joint; Xray; X-ray	4180186
1001729	XR Scaphoid Bone dev stage	4180186
1001729	骨骼发育阶段:评分:时间点:上肢>腕部.手舟骨:定量型:X射线摄影术	4182948
1001730	Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS	4180186
1001731	?Tm; CLIN; dur walking; Energy/time; Power; QNT; Quan; Quant; Quantitative	4180186
1001731	Calories burned dur walking ?Tm	4180186
1001731	已消耗的热量^在步行的过程中:功率:XXX:^患者:定量型	4182948
1001733	Iothalamate SerPl-mCnc	4180186
1001733	Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1001733	碘酞酸盐:质量浓度:时间点:血清/血浆:定量型	4182948
1001735	B fragilis DNA Bld Pos Ql NAA+probe	4180186
1001735	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B fragilis; B fragilis DNA; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1001735	脆弱类杆菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:探针法.基因扩增.靶向	4182948
1001739	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1001740	CARDIO-PULM; EXCZ; Flow; Heart beat; O2; O2 consumption; O2 consumption/HR; peak W exer; Point in time; Post; Postdose; Post-dose; PULMONARY; Pulse; QNT; Quan; Quant; Quantitative; Random; tO2; Volume rate; vRate; W exercise	4180186
1001740	Peak oxygen pulse	4180186
1001740	氧消耗/心率^运动过程中的峰值:体积速率:时间点:^患者:定量型	4182948
1001741	Addiction; C24H26N2O2; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Furanyl fentanyl; GCMS; Illicit; Level; Mass concentration; N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Synthetic opioid; UA; UR; Urn	4180186
1001741	Furanylfentanyl Ur Cfm-mCnc	4180186
1001741	呋喃基芬太尼:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1001744	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Special Txs, procedures and programs; Survey; Tx; Tx, px, programs discharge; Txs	4180186
1001749	Chives IgE Qn	4180186
1001749	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Chives; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1001749	细香葱 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
1001753	7-amino clonazepam; 7Aminoclonazepam; Addiction; Clonazepam metabolite; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
1001753	7Aminoclonazepam Ur Ql Scn	4180186
1001753	7-氨基氯硝安定:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
1001756	C burnet; C burnet Ph1; C burnet Ph2; C burnetii; Coxiella burnetii phase I; Coxiella burnetii phase II; Coxiella burnettii; i; II; Immune globulin G; Immunoglobulin G; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Q fev; Q fever; Qfever; R rickettsi; R rickettsii; R. rickettsii + C. burnetti 1 + 2 IgG Pnl; Random; Ricket; Rickettsial; RMSF; Rocky mountain spotted fever; Serum; Spotted fever; SR	4180186
1001756	R. rickettsii + C. burnetii 1 2 IgG Pnl	4180186
1001756	立氏立克次体及贝氏柯克斯体 1 相与 2 相抗体.IgG 组套:-:时间点:血清:-	4182948
1001761	Monotypic PC DNA index Mar FC-Rto	4180186
1001761	BM; BON; Bone marrow; Deoxyribonucleic acid; DI; DNA score; Dynamic; FC; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Molecular pathology; MOLPATH; Monotypic PC DNA index; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto	4180186
1001761	单型浆细胞 DNA 指数:比率:时间点:骨髓:定量型:流式细胞测量术	4182948
1001765	Admin info; Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1001766	CE Ag RBC Ql	4180186
1001766	Antigen; Antigens; BLOOD BANK; Erythrocytes; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen	4180186
1001766	CE 抗原:存在情况或阈值:时间点:红细胞:序数型	4182948
1001767	blaOXA-23+48-like genes Islt/Spm Ql	4180186
1001767	Bact; blaOXA-24+48-like; CPR; Islt; Islt/Spm; Isol; Microbiology; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec	4180186
1001767	细菌碳青霉烯类耐药 blaOXA-23-样基因+blaOXA-48-样基因:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
1001768	Bile acid pnl Stl	4180186
1001768	2 days; 2D; 48 hours; 48HR; Acd; Acids; Bile acid pnl; Bile acid.total; Bile salt; Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Pan; PANEL.CHEMISTRY; Panl; Pnl; Stl; Stool = Fecal	4180186
1001768	胆汁酸组套:-:48小时:大便:-	4182948
1001770	Bld vel; CARD.US; Cardiology; DOP; DUPLEX; Echography; Length; Point in time; QNT; Quan; Quant; Quantitative; Random; Regurg bld vel VTI; Sonogram; Sonograph; Sonography; TV; TVI; ULS; Ultrasound; Vel; VTI	4180186
1001770	TV Regurg bld vel VTI DOP	4180186
1001770	反流血流速度-时间积分:长度:时间点:三尖瓣:定量型:超声.多普勒	4182948
1001773	Finding; Findings; Gases; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey	4180186
1001778	1 hour; 1.0Hr; 1h p Vaso; 60 min; 60 minutes; 60M; 60min; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; Level; Na; Na+; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; VP	4180186
1001778	Sodium 1h p Vaso SerPl-sCnc	4180186
1001778	钠^在给予剂量后叶加压素之后1小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
1001782	Art; Bld flow; CARD.US; Cardiology; Dia flow reversal; Dias; Diast; Diastoli; DOP; DUPLEX; Dynamic; Echography; Finding; Findings; MPA; Ordinal; PA; Point in time; QL; Qual; Qualitative; Random; Screen; Sonogram; Sonograph; Sonography; ULS; Ultrasound	4180186
1001782	MPA Dia flow reversal DOP	4180186
1001782	血流逆转.舒张期:发现:时间点:肺动脉.主干:序数型:超声.多普勒	4182948
1001787	Bacterial fabG1 drug res mut Islt/Spm	4180186
1001787	ANTIBIOTIC SUSCEPTIBILITIES; Bact; Bacterial fabG1 drug res mut; Drugs; Identity or presence; Islt; Islt/Spm; Isol; Molecular genetics; Mut; Mutations; Nominal; PCR; Point in time; Random; Resist; Resistanc; Resistant; Resistent; Spec	4180186
1001787	细菌 fabG1 基因耐药性突变:存在与否或特征标识:时间点:分离株/标本:名义型:分子遗传学类实验室方法	4182948
1001789	1-beta-D-galactosphingosine; Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Galactosylsphingosine; Globoid Cell Leukodystrophies; Globoid Cell Leukodystrophy; Krabbe disease; Leukodystrophy, Krabbe; Level; Point in time; PSY; QNT; Quan; Quant; Quantitative; Random; Sphingosine galactoside; Substance concentration; WB; Whole blood	4180186
1001789	Psychosine DBS-sCnc	4180186
1001789	神经鞘氨醇半乳糖苷:物质的量浓度:时间点:全血.斑点:定量型	4182948
1001791	5NT; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; cN1A; cN-1A; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; Inclusion body myositis; Inclusion Body Myositis, Sporadic; MEIA; Mup44; NT; NT5C1A; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
1001791	cN-1A IgG SerPl Ql IA	4180186
1001791	胞质-5'-核苷酸酶 1A 抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:免疫测定法	4182948
1001794	BRAF p.V600 mutations Plas.cfDNA	4180186
1001794	BRAF p.V600 mutations; B-Raf proto-oncogene, serine/threonine kinase; BRAF1; B-RAF1; Identity or presence; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutation; Muts; Nominal; NS7; P prime; PCR; Pl; Plasma; Plsm; Point in time; RAFB1; Random; v-raf	4180186
1001794	BRAF 基因.p.Val600 突变:存在与否或特征标识:时间点:血浆.cfDNA:名义型:分子遗传学类实验室方法	4182948
1001796	BLOOD BANK; Pan; PANEL.BLOODBANK; Panl; Pnl; Point in time; Random; React; Rxn; Transf React; Transf React Pnl; Tx	4180186
1001796	Transf React Pnl	4180186
1001796	输血反应组套:-:时间点:^患者:-	4182948
1001798	MV Regurg bld vel VTI DOP	4180186
1001798	Bld vel; CARD.US; Cardiology; DOP; DUPLEX; Echography; Length; MV; Point in time; QNT; Quan; Quant; Quantitative; Random; Regurg bld vel VTI; Sonogram; Sonograph; Sonography; TVI; ULS; Ultrasound; Vel; VTI	4180186
1001798	反流血流速度-时间积分:长度:时间点:二尖瓣:定量型:超声.多普勒	4182948
1001799	Finding; Findings; H+P; H+P.HX; Nominal; P prime; Point in time; Random	4180186
1001799	自杀意念:发现:时间点:^患者:名义型	4182948
1001802	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EA; EA-D; EBV; EBV EA; EBV EA-D; EIA; ELFA; ELISA; Enzyme immunoassay; Epstn; HHV-4; human herpesvirus 4; IAA; Immune globulin A; Immunoglobulin A; MEIA; Microbiology; Mono; Mononucleosis; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
1001802	EBV EA-D IgA SerPl IA-aCnc	4180186
1001802	Epstein Barr 病毒早期扩散型 抗体.IgA:任意型浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
1001803	1 day; 24 hours; 24HR; Chemistry; Hexacarbox; Hexacarboxyl porphyrin; Hexacarboxylic acid porphyrin I; Hexacarboxylporphyrins; Hexacarboxyporphy; Hexacarboxyporphyrin; Hexacarboxyporphyrin I; Hexa-CP; Hexa-CP I; Hexaporphyrin; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn	4180186
1001803	Hexa-CP I 24h Ur-sRate	4180186
1001803	六羧基卟啉 I:物质的量速率:24小时:尿液:定量型	4182948
1001804	Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS	4180186
1001805	H+P; H+P.HX; Nominal; P prime; Point in time; Random; Typ	4180186
1001805	Pain cat	4180186
1001805	疼痛类别:类型:时间点:^患者:名义型	4182948
1001807	Document; Finding; Findings; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; NTRK1+NTRK2+NTRK3; NTRK1+NTRK2+NTRK3 rearr; PCR; Point in time; Random; Rearr; Rearrangement; Tissue; Tissue, unspecified	4180186
1001807	NTRK1+NTRK2+NTRK3 rearr Tiss	4180186
1001807	NTRK1 基因 & NTRK2 基因 & NTRK3 基因重排:发现:时间点:组织与涂片:文档型:分子遗传学类实验室方法	4182948
1001809	Diff Lg B-cell Lymph.ABC Tiss	4180186
1001809	弥漫性大B细胞淋巴瘤细胞.活化B细胞亚型:似然性:时间点:组织与涂片:定量型	4182948
1001809	ABC; Activ; B Cell; B-ALL; B-cell acute lymphoblastic leukemia; BCELLS; BLYM; Diff Lg B-cell lymph; Diff Lg B-cell Lymph.ABC; DLBCL; GCB; Lg B-cell lymph; PATHOLOGY; Point in time; QNT; Quan; Quant; Quantitative; Random; Risk; Tissue; Tissue, unspecified	4180186
1001810	Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Study report; Visit note	4180186
1001810	Trauma Diag study note	4180186
1001810	诊断性检查记录:发现:时间点:{环境}:文档型:创伤专业	4182948
1001811	DOC.ONT; Document; Finding; Findings; Point in time; Psychiatric; Random	4180186
1001811	Psychiatric Letter	4180186
1001811	信函:发现:时间点:{环境}:文档型:精神病学	4182948
1001812	Navigator Plan of care note	4180186
1001812	Care plan; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Treatment plan; Visit note	4180186
1001812	医疗服务计划记录:发现:时间点:{环境}:文档型:医疗保健服务导航员	4182948
1001813	(V exp/min)/CO2 prod w exercise; (Vol.exp/ min)/CO2 prod; Carbonic anhydride; CARDIO-PULM; CO2; CO2 production; End tidal volume; EXCZ; Minute ventilation; Minute volume; Point in time; PULMONARY; QNT; Quan; Quant; Quantitative; Random; Total ventilation; Vet; Vol; Vol exp; Vol.exp/M; Volume ratio	4180186
1001813	VE/VCO2 slope dur exercise	4180186
1001813	体积.每分钟呼出/二氧化碳产生^采用运动:体积比率:时间点:^患者:定量型	4182948
1001814	Hepta-CP I 24h Ur-sRate	4180186
1001814	1 day; 24 hours; 24HR; Chemistry; Hepacarboxyporph; Heptacarbox; Heptacarboxyl porphyrin; Heptacarboxylate porphyrin; Heptacarboxylporphyrins; Heptacarboxyporph; Heptacarboxyporphyrin; Hepta-CP; Hepta-CP I; Heptaporphyrin; Heptaporphyrine I; Hexacarboxyl porphyrin; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn	4180186
1001814	七羧基卟啉 I:物质的量速率:24小时:尿液:定量型	4182948
1001819	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Mass Content; Mec; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Tramal; Ultram	4180186
1001819	traMADol Mec Cfm-mCnt	4180186
1001819	曲马多:质量含量:时间点:胎便:定量型:毒理学确认试验	4182948
1001821	Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS; Tx	4180186
1001822	2D US; A4C MOD; Calculated; CARD.US; Cardiac; Cardiac output/Heart beat; Cardiology; Echography; Hrt; Hrt ventr; L; LT; LV; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; SV; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular; Vol; Volume	4180186
1001822	LV SV A4C MOD	4180186
1001822	心搏量:体积型属性:时间点:心脏.心室.左侧:定量型:超声.2D.A4C+圆盘单平面计算法	4182948
1001823	mGluR1 IgG Titr Ser IF	4180186
1001823	代谢型谷氨酸受体 1 抗体.IgG:滴定度:时间点:血清:定量型:免疫荧光法	4182948
1001823	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; c707; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; Glu; Glutamic acid; i; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; mGluR1; mGluR1 Ab; mGluR1 IgG; Point in time; Random; Rec; Recept; Receptors; Recp; Recptr; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
1001825	HEDIS 2020 BMI; HEDIS 2020 BMI prctl; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
1001825	HEDIS 2020 BMI prctl	4180186
1001825	HEDIS 2020 取值集合 - 体质指数百分位数:-:时间点:^患者:-	4182948
1001829	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1001831	Chemistry; Level; Mass concentration; Omnipaque; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1001831	Iohexol SerPl-mCnc	4180186
1001831	碘海醇:质量浓度:时间点:血清/血浆:定量型	4182948
1001832	Micro Detect Tm; Microbiology; Microorganisms; Org; Organism; Organisms; QNT; Quan; Quant; Quantitative; Spec	4180186
1001832	Micro Detect Tm Spec	4180186
1001832	检出微生物生长所需的时间:时间:*:标本:定量型	4182948
1001833	EBV DNA Bld NAA+probe-aCnc	4180186
1001833	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Arbitrary concentration; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; EBV; Epstn; HHV-4; human herpesvirus 4; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Mono; Mononucleosis; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load; WB; Whole blood	4180186
1001833	Epstein Barr 病毒 DNA:任意型浓度:时间点:全血:定量型:探针法.基因扩增.靶向	4182948
1001835	1 month; 1 month (30 days); 30 days; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS; Typ	4180186
1001836	Bacterial embB drug res mut Islt/Spm	4180186
1001836	ANTIBIOTIC SUSCEPTIBILITIES; Bact; Bacterial embB drug res mut; Drugs; Identity or presence; Islt; Islt/Spm; Isol; Molecular genetics; Mut; Mutations; Nominal; PCR; Point in time; Random; Resist; Resistanc; Resistant; Resistent; Spec	4180186
1001836	细菌 embB 基因耐药性突变:存在与否或特征标识:时间点:分离株/标本:名义型:分子遗传学类实验室方法	4182948
1001838	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; TCDCA	4180186
1001838	TCDCA SerPl-sCnc	4180186
1001838	牛磺鹅去氧胆酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
1001839	ABS; Aby; Alfa; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; GFAP; GFAP alpha; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; Ordinal; Pituitary glycoproteins; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Stroke; TBI (Traumatic Brain Injury); Traumatic Brain Injuries	4180186
1001839	GFAP alpha IgG CSF Ql CBA IFA	4180186
1001839	神经胶质纤维酸性蛋白.alpha 亚单位 抗体.IgG:存在情况或阈值:时间点:脑脊液:序数型:CBA IFA	4182948
1001841	Bipolar screen report	4180186
1001841	Asympt; Asymptomatic; Bipolar screen report; DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random; Scn	4180186
1001841	双相障碍筛查报告:发现:时间点:^患者:文档型	4182948
1001846	HTR2A c.614-2211T>C Geno Bld/T	4180186
1001846	5-HT-2A; 5-hydroxytryptamine receptor 2A gene; Blood; HTR2A c.614-2211T&gt;C; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Nominal; PCR; Point in time; Random; rs7997012; serotonin receptor 2A gene; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1001846	HTR2A 基因.c.614-2211T>C:基因型:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
1001850	MCS+consult note	4180186
1001850	Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; MCS+consult note; notes; Point in time; Random; Visit note	4180186
1001850	机械循环支持+会诊记录:发现:时间点:{环境}:文档型:{角色}	4182948
1001853	Pulm v Bld vel.S2 wave DOP.PW	4180186
1001853	Bld flow; Bld flow vel; Bld flow.velocity; Bld vel.S2 wave; CARD.US; Cardiology; DOP; DOP.PW; DUPLEX; Dynamic; Echography; Point in time; Pulm v; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Vel; Velocity; Ven; Venous	4180186
1001853	血流速度.S2 波:速度:时间点:肺静脉:定量型:超声.多普勒.PW	4182948
1001855	LV ED vol Biplane area-length	4180186
1001855	2D US; Calc; Calculation; CARD.US; Cardiac; Cardiology; Dias; Diast; Diastoli; Echography; ED vol; Hrt; Hrt ventr; L; LT; LV; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular; Vol; Volume	4180186
1001855	心脏舒张末期容积:体积型属性:时间点:心脏.心室.左侧:定量型:超声.2D+双平面面积-长度计算法	4182948
1001856	Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1001856	自杀计划:发现:时间点:^患者:序数型	4182948
1001858	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; F. nucleatum; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1001858	F. nucleatum DNA Bld Pos Ql NAA+probe	4180186
1001858	核梭杆菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:探针法.基因扩增.靶向	4182948
1001860	2 days; 2D; 48 hours; 48HR; Acd; Acids; Bile acid.total; Bile salt; Bowel movement; CDCA; CDCA+CA; CDCAe; Chemistry; Chenodeoxycholic acid; Cholic acid; Faecal; Faeces; Fecal; Feces; Percent; QNT; Quan; Quant; Quantitative; Stl; Stool = Fecal; Substance Fraction; Tot; Totl	4180186
1001860	CDCA+CA 48h SFr Stl	4180186
1001860	鹅去氧胆酸+胆酸/胆汁酸.总计:物质的量分数:48小时:大便:定量型	4182948
1001861	Finding; Findings; Gestation; Gestations; Gravida; New born; Ordinal; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
1001862	RA ES vol A4C	4180186
1001862	2D US; Atrial; CARD.US; Cardiac; Cardiology; Echography; ES vol; Hrt; Point in time; QNT; Quan; Quant; Quantitative; R; RA; Random; RT; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ultrasound - 2-dimensional; Vol; Volume	4180186
1001862	心脏收缩末期容积:体积型属性:时间点:心脏.心房.右侧:定量型:超声.2D.A4C	4182948
1001865	Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Study report; Visit note	4180186
1001865	Nephrology Diag study note	4180186
1001865	诊断性检查记录:发现:时间点:{环境}:文档型:肾病学	4182948
1001866	1 month; 1 month (30 days); 30 days; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS	4180186
1001869	?Tm; CLIN; Energy/time; Power; QNT; Quan; Quant; Quantitative	4180186
1001869	Calories burned playing a sport ?Tm	4180186
1001869	已消耗的热量^在参加体育运动时:功率:XXX:^患者:定量型	4182948
1001872	2-chloro-N-[[1-(dimethylamino)cyclohexyl]methyl]-benzamide; Addiction; C16H23ClN2O; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Synthetic opioid; UA; UR; Urn	4180186
1001872	AH-8533 Ur Cfm-mCnc	4180186
1001872	AH-8533:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1001875	ANTIBIOTIC SUSCEPTIBILITIES; Bact; Bacterial gidB drug res mut; Drugs; Identity or presence; Islt; Islt/Spm; Isol; Molecular genetics; Mut; Mutations; Nominal; PCR; Point in time; Random; Resist; Resistanc; Resistant; Resistent; Spec	4180186
1001875	Bacterial gidB drug res mut Islt/Spm	4180186
1001875	细菌 gidB 基因耐药性突变:存在与否或特征标识:时间点:分离株/标本:名义型:分子遗传学类实验室方法	4182948
1001877	3 months; Cnt; Count; Number; QNT; Quan; Quant; Quantitative; Survey; SURVEY.CSSRS	4180186
1001880	Clarity Fld	4180186
1001880	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; Nominal; Point in time; Random; SPEC; Typ	4180186
1001880	透明度:类型:时间点:体液:名义型	4182948
1001883	3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
1001885	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cauliflower; Cooked cauliflower; f291; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf291; Serum; SR	4180186
1001885	Cooked cauliflower IgE Qn	4180186
1001885	经过烹调的花椰菜 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
1001888	Finding; Findings; Gestation; Gestations; Gravida; Ordinal; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
1001889	Calories burned dur aerobic activity ?Tm	4180186
1001889	?Tm; Activ; Actvty; CLIN; dur aerobic activity; Energy/time; Movements; Power; QNT; Quan; Quant; Quantitative	4180186
1001889	已消耗的热量^在有氧活动的过程中:功率:XXX:^患者:定量型	4182948
1001895	Alepam; Chlordiazepoxide metabolite; Diazepam metabolite; DRUG/TOXICOLOGY; Drugs; Gluc; Glucouronide; Ordinal; Point in time; PR; Prazepam metabolite; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Serax; Temazepam metabolite; UA; UR; Urn	4180186
1001895	Oxazepam glucuronide Ur Ql Scn	4180186
1001895	葡萄糖苷酸奥沙西泮:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
1001897	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1001901	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; species; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1001901	Serratia sp DNA Bld Pos Ql NAA+probe	4180186
1001901	沙雷菌属单个未知种 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:探针法.基因扩增.靶向	4182948
1001904	Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH; Tot; Totl	4180186
1001905	Antigen; Antigens; BLOOD BANK; e; E Ag^infant; Erythrocytes; infant; little e Ag^infant; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Rh Blood Group System; Screen	4180186
1001905	little e Ag infant RBC Ql	4180186
1001905	e 抗原^婴儿期期间:存在情况或阈值:时间点:红细胞:序数型	4182948
1001913	ETG + EtS Pnl Ur	4180186
1001913	DRUG/TOXICOLOGY; Drugs; EtG; ETG + EtS Pnl; ETG EtS; Ethanol metabolite; ethyl hydrogen sulfate; EtS; Gluc; Glucouronide; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; SO4; SO4-2; Sulf; Sulfovinate; Sulfovinic acid; UA; UR; Urn	4180186
1001913	硫酸乙酯与乙基葡萄糖醛酸苷组套:-:时间点:尿液:-	4182948
1001914	Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.CSSRS	4180186
1001915	FLUAV NP gene Islt-Seq	4180186
1001915	Avian influenza; Bird flu; FLUA; FLUAV; FLUAV NP gene; FLUV; Fowl plague; high-throughput sequencing; HTS; Influ; Influenza A; Influenza A virus; Islt; Isol; Microbiology; Next generation sequencing; NGS; Nominal; Point in time; Random	4180186
1001915	流感病毒 A NP 基因:序列:时间点:分离株:名义型:序列测定	4182948
1001916	THSD7A IgG Titr SerPl CBA IFA	4180186
1001916	I 型血小板反应蛋白 7A 域 抗体.IgG:滴定度:时间点:血清/血浆:定量型:CBA IFA	4182948
1001916	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); Idiopathic Membranous Nephropathy; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; Pl; Plasma; Plsm; Point in time; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Thrombospondin Type-1 Domain-Containing 7A; Thrombospondin Type-1 Domain-Containing 7A Antibodies IgG; THSD7A; THSD7A Ab; THSD7A Ab.IgG; Titer; Titered; Titre; Ttr	4180186
1001919	XR Metacarpal.3rd Bone dev stage	4180186
1001919	3rd; Arm; Bone dev stage; EXT; Imaging; Metacarpal.3rd; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; RADIOLOGY; Random; Scale; UE; Up; Upper extremity; Xray; X-ray	4180186
1001919	骨骼发育阶段:评分:时间点:上肢>手.掌骨.第三:定量型:X射线摄影术	4182948
1001920	Arteriogram; c; Contr; Contra; Contrst; D fist^W c+G p tran ang + trn p stnt; Dialy; Document; Films; Finding; Findings; Fis^W c IA & prc trns ang + stent plc; Fistulogram; Fluor; Fluoro; Fluoroscopy; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Perc; Point in time; PTA; RADIOLOGY; Random; RFA; Spec; To be specified in another part of the message; Unspecified; Vesl; Vessels.XXX; View; Vs dial fist^W c IA & Perc trans angio; Vs dial fistula^W cont IA; Vs for dial fistula; VWS; W c IA & Perc Trans Angio; W c IA + PTA + stent place; W contr IA; WC	4180186
1001920	RFA dial fist W c IA + PTA + stent place	4180186
1001920	针对透析瘘管的多重视图^采用动脉注射对比剂 & 旨在经皮腔内血管成形术 + 经导管置入支架的引导:发现:时间点:XXX>血管类:文档型:放射荧光透视法.血管造影术	4182948
1001921	Chemistry; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Ordinal; Pl; Plasma; Plsm; Point in time; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1001921	Liver steatosis interp SerPl-Imp	4180186
1001921	肝脂肪变性解释:印象:时间点:血清/血浆:序数型	4182948
1001923	Arterial Stenosis; Finding; Findings; Gestation; Gestations; Gravida; Ordinal; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH; Sx	4180186
1001924	CHIKV IgG SerPl Ql	4180186
1001924	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CHIKV; Immune globulin G; Immunoglobulin G; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1001924	基孔肯亚病毒 抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型	4182948
1001926	Addiction; BU; BUP; Bupe; Buprenex; buprenorphine HCI; Buprex; Butrans; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Finobrin; Illicit; Norspan; Ordinal; Point in time; PotentialForAbuse; PR; Prefin; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Suboxone; Subutex; Temgesic; UA; UR; Urn	4180186
1001926	Buprenorphine Ur Ql Scn	4180186
1001926	丁丙诺啡:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
1001928	Antigen; Antigens; CELL MARKERS; Dynamic; Entitic; Entitic number; FC; Fc gamma receptor I; Fc gamma RI; FC gammaRI; FCR I; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1001928	CD64 Ag EntNum Neut FC	4180186
1001928	CD64 抗原:实体数量:时间点:嗜中性粒细胞:定量型:流式细胞测量术	4182948
1001931	Assoc; Bone age assess TW2 panel; Imaging; Pan; PANEL.RADIOLOGY; Panl; Pnl; Point in time; Radiology; Random	4180186
1001931	Bone age assess TW2 panel	4180186
1001931	骨龄评估 - Tanner-Whitehouse 法相关观察组套:-:时间点:^患者:-	4182948
1001934	Hexa-CPr3 24h Ur-sRate	4180186
1001934	1 day; 24 hours; 24HR; 3; Chemistry; Hexacarbox; Hexacarboxyl porphyrin; Hexacarboxylporphyrins; Hexacarboxyporphy; Hexacarboxyporphyrin; Hexa-CP; Hexa-CPr3; Hexaporphyrin; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn	4180186
1001934	六羧基卟啉 III:物质的量速率:24小时:尿液:定量型	4182948
1001936	Antithrombin III; AT3; AT3D; ATIII; Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; high-throughput sequencing; HTS; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Serpin C1; Serpin peptidase inhibitor, clade C (antithrombin), member 1; THPH7; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1001936	SERPINC1 gene Full Mut Anl Bld/T Seq	4180186
1001936	SERPINC1 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
1001938	Plt CD41 Act/Nor Bld FC	4180186
1001938	Act/Nor; alpha IIb integrin chain; Blood; CD41 Antigen; CELL MARKERS; Control; Dynamic; FC; Glycoprotein IIB; Glycoprotein IIb, Membrane; GPIIb; integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41); Membrane Glycoprotein IIb; Pl; Plasma Membrane Glycoprotein IIb; Platelet membrane glycoprotein Iib; Platelets; Platelt; Plt; Plt CD41; Plt.CD41 Act/Nor; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
1001938	血小板 CD41 实际的/正常的:相对比率:时间点:全血:定量型:流式细胞测量术	4182948
1001940	Finding; Findings; Gestation; Gestations; Gravida; Ordinal; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
1001942	4 weeks; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1001945	Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; SDOH; Survey	4180186
1001947	1 day; 24 hours; 24HR; Chemistry; Pentacarboxyl porphyrin; Pentacarboxyporhyrin; Penta-CP; Penta-CPI; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn	4180186
1001947	Penta-CPI 24h Ur-sRate	4180186
1001947	五羧基卟啉 I:物质的量速率:24小时:尿液:定量型	4182948
1001949	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1001950	Assessment; Centers for Medicare and Medicaid Assessment; Eval; H&P; History and physical; Hosp; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1001951	H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale	4180186
1001951	焦虑症评分:评分:时间点:^患者:定量型	4182948
1001952	Nighttime awake duration	4180186
1001952	夜间觉醒持续时间:时间:时间点:^患者:定量型	4182948
1001952	Awake dur; Awakened during night; Durat; H+P; H+P.HX; Nighttime awake duration; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Woke up during the night	4180186
1001954	Tamoxifen metab pattern SerPl-Imp	4180186
1001954	DRUG/TOXICOLOGY; Drugs; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Metabolite; Metb; Nolvadex; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tamoxifen metab pattern	4180186
1001954	他莫西芬代谢产物模式:印象:时间点:血清/血浆:名义型	4182948
1001959	Guanidinoacetate DBS-sCnc	4180186
1001959	Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; GAA; glycocyamine; guanidinoacetic acid; guanidoacetic acid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood	4180186
1001959	胍基乙酸:物质的量浓度:时间点:全血.斑点:定量型	4182948
1001960	SC5b9 SerPl IA-mCnc	4180186
1001960	Comp; Complement SC5 B-9; Complement soluble C5b-9; Complmt; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; Mass concentration; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SC5b9; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; Terminal complement complex; TTC	4180186
1001960	补体 Sc5b-9:质量浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
1001964	PM+R Diag study note	4180186
1001964	Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; PM+R; Point in time; Random; Study report; Visit note	4180186
1001964	诊断性检查记录:发现:时间点:{环境}:文档型:物理医学与康复学	4182948
1001966	11Ketotestost; Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1001966	11Ketotestost SerPl-mCnc	4180186
1001966	11-酮睾酮:质量浓度:时间点:血清/血浆:定量型	4182948
1001967	4 weeks; Finding; Findings; Last; Ordinal; Pos; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1001970	BM; BON; Bone marrow; Leukemia; MAR; Marrow (bone); MGUS; minimal angle of resolution; Minimum angle of resolution; Molecular genetics; Molecular pathology; MOLPATH; Mono PC ID + risk Pnl; Monoclonal; Monoclonal gammopathy of uncertain significance; Multiple myeloma; Myeloproliferative Disorder; Pan; Panel.molpath; Panl; PCR; Plasma cell myeloma; Pnl; Point in time; Random	4180186
1001970	Mono PC ID + risk Pnl Mar	4180186
1001970	单型浆细胞鉴别与风险分层组套:-:时间点:骨髓:-:分子遗传学类实验室方法	4182948
1001971	Emesis count 24h nRate	4180186
1001971	1 day; 24 hours; 24HR; Count/time; H+P; H+P.HX; nRate; Number rate; Number Rate = Count/Time; P prime; QNT; Quan; Quant; Quantitative; Vomitus	4180186
1001971	呕吐次数:计数型速率:24小时:^患者:定量型	4182948
1001974	1 month; 1 month (30 days); 30 days; Finding; Findings; Nominal; Survey; SURVEY.CSSRS	4180186
1001975	1 hour; 1.0Hr; 1h p Vaso; 60 min; 60 minutes; 60M; 60min; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; Blood urea nitrogen; BUN; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; N; N2; Nit; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UN; VP	4180186
1001975	BUN 1h p Vaso SerPl-mCnc	4180186
1001975	尿素氮^在给予剂量后叶加压素之后1小时:质量浓度:时间点:血清/血浆:定量型	4182948
1001976	Anion Gap3 1h p Vaso SerPl-sCnc	4180186
1001976	1 hour; 1.0Hr; 1h p Vaso; 60 min; 60 minutes; 60M; 60min; ADH; Adiuretin; After; Ag; AnGAP; Anion Gap3; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; III; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; VP	4180186
1001976	阴离子间隙 3^在给予剂量后叶加压素之后1小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
1001977	Finding; Findings; H+P; H+P.HX; Nominal; P prime; Point in time; Random	4180186
1001977	你在一天之中遇到的最好事情:发现:时间点:^患者:名义型	4182948
1001980	19q/19p Chrom Del Tiss FISH	4180186
1001980	19p Del; Chromosom; Chromosomes; Del; Deletions; Fluorescent in situ hybridization; Molecular pathology; MOLPATH; MOLPATH.DELDUP; Number ratio; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
1001980	19号染色体长臂 缺失/19p 染色体 缺失:计数型比率:时间点:组织与涂片:定量型:FISH	4182948
1001982	B2 Microglob/Creat 24h Ur-Rto	4180186
1001982	1 day; 24 hours; 24HR; B; B2 Microglob; b2-M; Chemistry; CR; Crea; Creat; II; Microglob; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn	4180186
1001982	Beta-2-微球蛋白/肌酐:比率:24小时:尿液:定量型	4182948
1001983	mGluR1 IgG Ser Ql CBA IFA	4180186
1001983	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c707; Glu; Glutamic acid; i; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; mGluR1; mGluR1 Ab; mGluR1 IgG; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; Serum; SR	4180186
1001983	代谢型谷氨酸受体 1 抗体.IgG:存在情况或阈值:时间点:血清:序数型:CBA IFA	4182948
1001985	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey; SURVEY.GNHLTH	4180186
1001986	Chemistry; Finding; Findings; NASH grade; Ordinal; Pl; Plasma; Plsm; Point in time; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1001986	NASH grade SerPl Ql	4180186
1001986	非酒精性脂肪变性肝炎分级:发现:时间点:血清/血浆:序数型	4182948
1001988	Antigen; Antigens; BLOOD BANK; e; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells cord; Rh Blood Group System; Screen	4180186
1001988	little e Ag RBCCo Ql	4180186
1001988	e 抗原:存在情况或阈值:时间点:脐带血红细胞:序数型	4182948
1001989	Admin info; Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1001990	Conf eval note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hematology Team; notes; Point in time; Random; Visit note	4180186
1001990	Hematology Team Conf eval note	4180186
1001990	会议记录:发现:时间点:{环境}:文档型:血液学.团队	4182948
1001992	Arteriogram; c; Contr; Contra; Contrst; Dialy; Document; Films; Finding; Findings; Fistulogram; Fluor; Fluoro; Fluoroscopy; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Perc; Point in time; PTA; RADIOLOGY; Random; RFA; Spec; To be specified in another part of the message; Unspecified; Vesl; Vessels.XXX; View; Vs dial fist^W c IA & Perc trans angio; Vs dial fistula^W cont IA; Vs for dial fistula; VWS; W c IA & Perc Trans Angio; W contr IA; WC	4180186
1001992	RFA dial fist W c IA + PTA	4180186
1001992	针对透析瘘管的多重视图^采用动脉注射对比剂 & 旨在经皮腔内血管成形术的引导:发现:时间点:XXX>血管类:文档型:放射荧光透视法.血管造影术	4182948
1001995	2D US; A4C MOD; Atrial; Bdy surface; bod; Bodies; BSA; Calculated; CARD.US; Cardiac; Cardiology; Echography; ES vol; Hrt; L; LA; LAA; LAVI; Left Atrial Volume Index; LT; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Surf; ULS; Ultrasound; Ultrasound - 2-dimensional; Vol; Volume/area	4180186
1001995	LA ES vol/BSA A4C MOD	4180186
1001995	心脏收缩末期容积/体表面积:体积/面积:时间点:心脏.心房.左侧:定量型:超声.2D.A4C+圆盘单平面计算法	4182948
1001998	4 weeks; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1002001	Cycle distance ?Tm	4180186
1002001	?Tm; Cycle distance; Length; QNT; Quan; Quant; Quantitative	4180186
1002001	骑行距离:长度:XXX:^患者:定量型	4182948
1002002	1 month; 1 month (30 days); 30 days; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS	4180186
1002004	2D US; A4C MOD; Calculated; CARD.US; Cardiac; Cardiology; CO; Echography; Flow; Hrt; Hrt ventr; L; LT; LV; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular; Volume rate; vRate	4180186
1002004	LV Output A4C MOD	4180186
1002004	心输出量:体积速率:时间点:心脏.心室.左侧:定量型:超声.2D.A4C+圆盘单平面计算法	4182948
1002005	Pan; Panel; PANEL.PHENX; Panl; PhenX bone age protocol; Pnl; Point in time; Random	4180186
1002005	PhenX bone age protocol	4180186
1002005	PhenX - 骨龄方案 220301:-:时间点:^患者:-:PhenX	4182948
1002006	After; Antigen; Antigens; BLOOD BANK; E Ag^p stem trnsplt; Erythrocytes; Ordinal; p HSCT; Point in time; PR; PST; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Rh Blood Group System; Screen	4180186
1002006	E Ag p HSCT RBC Ql	4180186
1002006	E 抗原^在造血干细胞移植之后:存在情况或阈值:时间点:红细胞:序数型	4182948
1002008	4 weeks; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Survey; SURVEY.GNHLTH	4180186
1002010	Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS	4180186
1002011	C16 ceramide; C24 ceramide; Chemistry; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio	4180186
1002011	C16 ceramide/C24 ceramide Plas-sRto	4180186
1002011	N-棕榈酰基神经鞘氨醇/N-二十四烷酰基神经鞘氨醇:物质的量比率:时间点:血浆:定量型	4182948
1002012	120 min; 120 minutes; 120min; 2 hours; After; CHEMISTRY.CHALLENGE TESTING; Osmo; Osmol; Osmolality; osmolarity; p 2h FFST; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1002012	Osmolality p 2h FFST SerPl	4180186
1002012	渗透压^在液体型禁食之后2小时:渗透压:时间点:血清/血浆:定量型	4182948
1002013	Ceramide Pnl; Chemistry; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1002013	Ceramide Pnl Plas	4180186
1002013	神经酰胺组套:-:时间点:血浆:定量型	4182948
1002014	Delamanid Susc Islt	4180186
1002014	ANTIBIOTIC SUSCEPTIBILITIES; AST; Deltyba; Islt; Isol; OPC-67683; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
1002014	迪拉马尼:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
1002015	3D US; Arbitrary rate; CARD.US; Cardiac; Cardiology; Dias; Dias.max; Diast; Diastoli; Echography; Hrt; Hrt ventr; L; Largest; LT; LV; Max circ strain rate early dias; Max strain rate early dias; Maximal; Maximum; Peak; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ventricular	4180186
1002015	LV Max circ strain rate early dias 3D US	4180186
1002015	环向应变速率.心脏舒张早期.最大值:任意型速率:时间点:心脏.心室.左侧:定量型:超声.3D	4182948
1002016	Cnt; Count; Number; QNT; Quan; Quant; Quantitative; Survey; SURVEY.CSSRS	4180186
1002021	3 months; Cnt; Count; Number; QNT; Quan; Quant; Quantitative; Survey; SURVEY.CSSRS	4180186
1002022	Osmolality p 1h FFST SerPl	4180186
1002022	1 hour; 1.0Hr; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Osmo; Osmol; Osmolality; osmolarity; p 1h FFST; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1002022	渗透压^在液体型禁食之后1小时:渗透压:时间点:血清/血浆:定量型	4182948
1002023	2D US; A4C SP A-L; Atrial; Bdy surface; bod; Bodies; BSA; Calculated; CARD.US; Cardiac; Cardiology; Echography; ES vol; Hrt; L; LA; LAA; LAVI; Left Atrial Volume Index; LT; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Surf; ULS; Ultrasound; Ultrasound - 2-dimensional; Vol; Volume/area	4180186
1002023	LA ES vol/BSA A4C SP A-L	4180186
1002023	心脏收缩末期容积/体表面积:体积/面积:时间点:心脏.心房.左侧:定量型:超声.2D.A4C+单平面面积-长度计算法	4182948
1002024	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HPIV; HPIV 1+2+3+4; HPIV1; HPIV1+2+3; Human respirovirus 1; i; IAA; II; III; Immune globulin G; Immunoglobulin G; MEIA; Microbiology; Ordinal; Para; Parainflu; Parainfluenza type 1; Parainfluenza type I; PI1; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
1002024	HPIV 1+2+3+4 IgG Ser Ql IA	4180186
1002024	副流感病毒 1+2+3+4 型 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
1002028	Cancer; Conf eval note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn Onc; Gyn onc Team; notes; Point in time; Random; Visit note	4180186
1002028	Gyn onc Team Conf eval note	4180186
1002028	会议记录:发现:时间点:{环境}:文档型:妇科肿瘤学.团队	4182948
1002030	Arbitrary concentration; Chemistry; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Tears	4180186
1002030	IgE Tear-aCnc	4180186
1002030	IgE:任意型浓度:时间点:泪液:定量型	4182948
1002036	Donr; EBV; EBV Ab Pnl; Epstn; HHV-4; human herpesvirus 4; Microbiology; Mono; Mononucleosis; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Serum; SR	4180186
1002036	EBV Ab Pnl Ser Donr	4180186
1002036	Epstein Barr 病毒抗体组套:-:时间点:血清^供体:-	4182948
1002038	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1002039	Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Peds; Point in time; Random; Study report; Visit note	4180186
1002039	Peds Diag study note	4180186
1002039	诊断性检查记录:发现:时间点:{环境}:文档型:儿科学	4182948
1002040	Osmolality p 6h FFST SerPl	4180186
1002040	After; CHEMISTRY.CHALLENGE TESTING; Osmo; Osmol; Osmolality; osmolarity; p 6h FFST; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1002040	渗透压^在液体型禁食之后6小时:渗透压:时间点:血清/血浆:定量型	4182948
1002041	1 month; 1 month (30 days); 30 days; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS	4180186
1002042	Alfa; Alpha hydroxy alprazolam; Alprozolam metabolite; A-OH Alpraz; A-OH Alpraz gluc; DRUG/TOXICOLOGY; Drugs; Gluc; Glucouronide; Hydroxy alprazolam; Hydroxyalpraz; OH-Alpraz; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
1002042	A-OH Alpraz gluc Ur Ql Scn	4180186
1002042	Alpha 羟普唑仑葡萄糖醛酸:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
1002044	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; H capsul; H capsulatum; H farciminosum; Histo; Histopl; Histoplasma farciminosum; Histoplasmos; Histoplasmosis; IAA; Immune globulin M; Immunoglobulin M; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
1002044	H capsul IgM CSF IA-aCnc	4180186
1002044	荚膜组织胞浆菌 抗体.IgM:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
1002046	4 weeks; bod; Bodies; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1002049	DOCUMENT.REGULATORY; FDA label; Indexing - NCT #; Narrative; No; Num; Report	4180186
1002049	FDA label Indexing - NCT #	4180186
1002049	索引 - 全国临床试验编号:-:-:^FDA 产品标签:叙述型	4182948
1002050	Blood; Identity or presence; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1002050	NUDT15 gene Mut Anl Bld/T	4180186
1002050	NUDT15 基因 突变分析:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
1002051	Blood; full gene sequencing; Full Mut Anl; high-throughput sequencing; HTS; Identity or presence; Mitochondrial Encephalomyopathy; Mitochondrial neurogastrointestinal encephalopathy; MNGIE syndrome; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutations; Next generation sequencing; NGS; Nominal; p53R2; Point in time; Random; ribonucleotide reductase M2 B (TP53 inducible); ribonucleotide reductase regulatory TP53 inducible subunit M2B; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1002051	RRM2B Full Mut Anl Bld/T Seq	4180186
1002051	RRM2B 基因 全面突变分析:存在与否或特征标识:时间点:全血/组织:名义型:序列测定	4182948
1002052	Pericardial effusion US	4180186
1002052	CARD.US; Cardiology; Echography; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sonogram; Sonograph; Sonography; ULS; Ultrasound	4180186
1002052	心包积液:发现:时间点:心包腔:序数型:超声	4182948
1002053	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1002054	3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey	4180186
1002055	Chemistry; Globotriaosylceramide; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UR; Urn	4180186
1002055	Ceramide Trihexoside Ur-sRto	4180186
1002055	神经酰胺三己糖苷:物质的量比率:时间点:尿液:定量型	4182948
1002057	Calc; Calculi; Chemistry; Chol; Choles; Cholest; Cholest Cry; Cholesterol total; Cholesterols; Crys; Cryst; Crystal; Lipid; Ordinal; Plain Films; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Stn; Stone; Stones; Xray; X-ray	4180186
1002057	Cholest Cry Stone Ql XR diff	4180186
1002057	胆固醇结晶:存在情况或阈值:时间点:结石:序数型:X射线衍射分析	4182948
1002060	Access home int	4180186
1002060	Access home int; CLIN; Finding; Findings; Nominal; Point in time; Random	4180186
1002060	住宅内部无障碍性:发现:时间点:^患者:名义型	4182948
1002062	Blood; CELL MARKERS; Dynamic; FC; Fc gamma receptor I; Fc gamma RI; FC gammaRI; FCR I; HLA-DR; Human Leukocyte Antigen; I3; Neut; Neut CD64 + Mono HLA DR Pnl; Neutr; Neutrophils; Pan; PANEL.CELLMARK; Panl; PMN; Pnl; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
1002062	Neut CD64 + Mono HLA DR Pnl Bld FC	4180186
1002062	嗜中性粒细胞 CD64 & 单核细胞 HLA DR 组套:-:时间点:全血:定量型:流式细胞测量术	4182948
1002064	Iothalamate Ur-mCnc	4180186
1002064	Chemistry; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
1002064	碘酞酸盐:质量浓度:时间点:尿液:定量型	4182948
1002066	1-hydroxytriazolam; Alfa; Alpha hydroxy triazolam; A-OH-triazolam; DRUG/TOXICOLOGY; Drugs; Hydroxy triazolam; OH-Triazolam; OHTRZ; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Triazolam metabolite; UA; UR; Urn	4180186
1002066	A-OH-triazolam Ur Ql Scn	4180186
1002066	Alpha 羟基三唑仑:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
1002068	Antigen; Antigens; BLOOD BANK; Dextro; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells cord; Rh; Rhesus; Screen	4180186
1002068	D Ag RBCCo Ql	4180186
1002068	D 抗原:存在情况或阈值:时间点:脐带血红细胞:序数型	4182948
1002069	4 weeks; Finding; Findings; Job; Last; Occupation; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1002070	Arbitrary concentration; Chemistry; DCP; Decarboxyprothrombin; Des gamma carboxy prothrombin; PIVKA; Pl; Plasma; Plsm; Point in time; Protein induced in Vitamin K absence or antagonists; Prothrombin precursor; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker	4180186
1002070	Acarboxyprothrombin SerPl-aCnc	4180186
1002070	维生素K缺乏时诱导产生的蛋白质:任意型浓度:时间点:血清/血浆:定量型	4182948
1002074	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; C sakazakii; C sakazakii DNA; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Enterobacter sakazakii; Enterobacteriaceae; Gram Negative Bacteria; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1002074	C sakazakii DNA Bld Pos Ql NAA+probe	4180186
1002074	阪崎肠杆菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:探针法.基因扩增.靶向	4182948
1002075	ABS; Aby; Alfa; AMPA Receptor; AMPAR2; AMPAR2 Ab; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; GluA2; GluR2; GluR-B; Hydrox; II; III; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; Limbic encephalitis; OH; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1002075	AMPAR2 IgG SerPl Ql CBA IFA	4180186
1002075	Alpha-氨基-3-羟基-5-甲基-4-异噁唑丙酸受体 2 抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:CBA IFA	4182948
1002076	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Special Txs, procedures and programs; Survey; Tx; Tx, px, programs discharge; Txs	4180186
1002077	Funeral facility name	4180186
1002077	ADMIN; Ident; Identifier; Nominal; Point in time; Random	4180186
1002077	殡仪设施名称:标识符:时间点:设施:名义型	4182948
1002079	After; Antigen; Antigens; BLOOD BANK; E Ag^p transf rx; Erythrocytes; Ordinal; p transf; p transf rx; Point in time; PR; PST; QL; Qual; Qualitative; Random; React; Red blood cells; Red blood corpusles; Rh Blood Group System; Rxn; Screen; Transf React; Tx	4180186
1002079	E Ag p transf rx RBC Ql	4180186
1002079	E 抗原^在输血反应之后:存在情况或阈值:时间点:红细胞:序数型	4182948
1002080	Activated protein C cofactor; APC; Blood; Coagulation Factor V - Leiden gene; coagulation factor V (proaccelerin, labile factor); F5 HR2; Factor V gene HR2 allele; FVL; Labile factor; Molecular genetics; Molecular pathology; MOLPATH; Nominal; PCCF; PCR; Point in time; Proaccelerin gene; Random; RPRGL1; THPH2; Thrombophilia; WB; Whole blood	4180186
1002080	F5 HR2 Geno Bld	4180186
1002080	F5 基因 HR2 单体型:基因型:时间点:全血:名义型:分子遗传学类实验室方法	4182948
1002081	Penta-CP3 24h Ur-sRate	4180186
1002081	1 day; 24 hours; 24HR; 3; Chemistry; Pentacarboxyl porphyrin; Pentacarboxylporphyrin 3; Pentacarboxyporhyrin; Penta-CP; Penta-CP3; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn	4180186
1002081	五羧基卟啉 III:物质的量速率:24小时:尿液:定量型	4182948
1002082	Antigen; Antigens; CELL MARKERS; Dynamic; Entitic; Entitic number; FC; Human Leukocyte Antigen; I3; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1002082	HLA-DR Ag EntNum Mono FC	4180186
1002082	HLA-DR 抗原:实体数量:时间点:单核细胞:定量型:流式细胞测量术	4182948
1002083	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Donr; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS; T gondii; Toxo; Toxoplasmosis	4180186
1002083	T gondii IgG Ser Donr IA-aCnc	4180186
1002083	刚地弓形虫 抗体.IgG:任意型浓度:时间点:血清^供体:定量型:免疫测定法	4182948
1002084	?Tm; CLIN; dur swim; Energy/time; Power; QNT; Quan; Quant; Quantitative	4180186
1002084	Calories burned dur swim ?Tm	4180186
1002084	已消耗的热量^在游泳的过程中:功率:XXX:^患者:定量型	4182948
1002085	Chemistry; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Substance amount; TMA; TMAO; Trimet-amine	4180186
1002085	TMAO sub Ser Qn	4180186
1002085	三甲基胺 N-氧化物:物质的量:时间点:血清:定量型	4182948
1002086	Mat fetal med Prog note	4180186
1002086	病程记录:发现:时间点:{环境}:文档型:母胎医学	4182948
1002086	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Mat fetal med; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1002087	Blood; Genetic variant prog sig; Genetics; Genomic; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Molecular pathology; MOLPATH; Narrative; Point in time; Random; Report; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1002087	Genetic variant prog sig Bld/T-Imp	4180186
1002087	遗传变异预后意义:印象:时间点:全血/组织:叙述型	4182948
1002090	ABS; Aby; Antby; Anti; Antibodies; Antibody; Asp; Aspartic acid; Autoantibodies; Autoantibody; Dextro; Encephalitis; Glutamate receptor ionotropic, NMDA 1; i; Indirect Fluorescence Antibody; NMDA receptor; NMDAR; NMDAR1; N-Methylaspartate Receptors; N-Methyl-D-aspartic Acid; Ordinal; Paraneoplastic syndrome; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; Serum; SR	4180186
1002090	NMDAR1 Ab Ser Ql CBA IFA	4180186
1002090	N-甲基-D-天冬氨酸受体亚单位 1 抗体:存在情况或阈值:时间点:血清:序数型:CBA IFA	4182948
1002092	ETG EtS Ur Scn-mCnc	4180186
1002092	Chemistry; EtG; ETG EtS; Ethanol metabolite; ethyl hydrogen sulfate; EtS; Gluc; Glucouronide; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; SO4; SO4-2; Sulf; Sulfovinate; Sulfovinic acid; UA; UR; Urn	4180186
1002092	硫酸乙酯+乙基葡糖苷酸:质量浓度:时间点:尿液:定量型:毒理学筛查试验	4182948
1002094	CLIN; CLIN.RISK; Dis; Diseases; Dz; Genetics; Genomic; Ordinal; Polygenic risk score; QL; Qual; Qualitative; Risk; Risk for CHD based on GRS; Screen	4180186
1002094	Lifetime Risk for CHD based on GRS	4180186
1002094	基于遗传风险评分的发生冠心病的终生风险:似然性:一生:^患者:序数型	4182948
1002095	XR Ulna Bone dev stage	4180186
1002095	Arm; Bone dev stage; EXT; Imaging; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; RADIOLOGY; Random; Scale; UE; Up; Upper extremity; Xray; X-ray	4180186
1002095	骨骼发育阶段:评分:时间点:上肢>尺骨:定量型:X射线摄影术	4182948
1002096	Blood; Genetics; Genomic; Identity or presence; Molecular pathology; MOLPATH; Nominal; Point in time; Random; Resist; Resistanc; Resistant; Resistent; Tissue; Tissue, unspecified; Tx; Variant assoc tx resist; WB; Whole blood; Whole blood or Tissue	4180186
1002096	Variant assoc therapy resist	4180186
1002096	因为遗传变异而导致耐受的治疗:存在与否或特征标识:时间点:全血/组织:名义型	4182948
1002097	ANTIBIOTIC SUSCEPTIBILITIES; B; Bact; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec	4180186
1002097	AmpC blaDHA gene Islt/Spm Ql	4180186
1002097	细菌 beta-内酰胺耐药 AmpC blaDHA 基因:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
1002098	1 1/2 hours; 1 1/2 HR; 1.5h p carb; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; H2; Hyd; p carb; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction	4180186
1002098	Breath H2 1.5h p carb	4180186
1002098	氢/已呼出的气体^在给予剂量碳水化合物之后1.5小时:体积分数:时间点:呼出的气体:定量型	4182948
1002099	4 weeks; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1002100	ABO + Rh; ABO group and Rh type; ABO+Rh Gp; ABO+Rh Gp Pnl p stem trnsplt; ABO+Rh Gp^p stem trnsplt; After; Blood; BLOOD BANK; D phenotyping; D typing; Pan; PANEL.BLOODBANK; Panl; Pnl; Point in time; PST; Random; Rh phenotyping; Rh typing; WB; Whole blood	4180186
1002100	ABO+Rh Gp Pnl p stem trnsplt Bld	4180186
1002100	造血干细胞移植后ABO与Rh血型组套:-:时间点:全血:-	4182948
1002103	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
1002104	Average; Avg; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH	4180186
1002105	BLOOD PRESSURE MEASUREMENTS.VENOUS.MOLEC; BP; Echography; Heart; Inf; Intravenous; IV; IVC; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; VC; Venous	4180186
1002105	IVC BP by US	4180186
1002105	血管内:压力或压强:时间点:腔静脉.下:定量型:超声	4182948
1002107	S maltophilia DNA Bld Pos Ql NAA+probe	4180186
1002107	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pseudomonas maltophilia; QBR; QL; Qual; Qualitative; Random; S maltophilia; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood; Xanthomonas maltophilia	4180186
1002107	嗜麦芽窄食单胞菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:探针法.基因扩增.靶向	4182948
1002109	3D US; CARD.US; Cardiac; Cardiology; Echography; Hrt; Hrt ventr; L; Largest; Length Ratio; LT; LV; Max circ strain; Max strain; Maximal; Maximum; Peak; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ventricular	4180186
1002109	LV Max circ strain 3D US	4180186
1002109	环向应变.最大值:长度比率:时间点:心脏.心室.左侧:定量型:超声.3D	4182948
1002110	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Synthetic opioid; UA; UR; Urn	4180186
1002110	W-19 Ur Cfm-mCnc	4180186
1002110	W-19:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1002111	Chemistry; Chondroitin B sulfate; Chondroitin sulfate B; Dermatin; HS; keratosulfate; MPS panel; Mucopolysaccharides; Mucopolysaccharidosis; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SO4; SO4-2; SR; Sulf	4180186
1002111	MPS panel SerPl	4180186
1002111	硫酸皮肤素 & 硫酸类肝素 & 硫酸角质素组套:-:时间点:血清/血浆:-	4182948
1002113	Centers for Medicare and Medicaid Assessment; Deglutition; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey; Swallowing/nutritional status	4180186
1002114	Antigen; Antigens; BLOOD BANK; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells cord; Rh; Rh Blood Group System; Screen	4180186
1002114	C Ag RBCCo Ql	4180186
1002114	C 抗原:存在情况或阈值:时间点:脐带血红细胞:序数型	4182948
1002115	Develop-behav peds; Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Peds; Point in time; Random; Study report; Visit note	4180186
1002115	Develop-behav peds Diag study note	4180186
1002115	诊断性检查记录:发现:时间点:{环境}:文档型:发育行为儿科学	4182948
1002116	Glycohyodeoxycholate SerPl-sCnc	4180186
1002116	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
1002116	甘氨猪去氧胆酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
1002118	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Past; Pnl; Point in time; Random; Survey	4180186
1002120	3 months; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS	4180186
1002121	Arbitrary concentration; Average; Avg; Chemistry; HUM; Humulin; IH7; Insul; Lente; NPH; Pl; Plasma; Plsm; QNT; Quan; Quant; Quantitative; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Studies; Study; Sutdies; Ultralente	4180186
1002121	Insulin Mean SerPl-aCnc	4180186
1002121	胰岛素:任意型浓度:检查过程持续时间^平均值:血清/血浆:定量型	4182948
1002123	1 hour; 1.0Hr; 1h p carb; 60 min; 60 minutes; 60M; 60min; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; H2; Hyd; p carb; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction	4180186
1002123	Breath H2 1h p carb	4180186
1002123	氢/已呼出的气体^在给予剂量碳水化合物之后1小时:体积分数:时间点:呼出的气体:定量型	4182948
1002125	Busulfan 1h p busulfan Plas-mCnc	4180186
1002125	1 hour; 1.0Hr; 1h p busulfan; 60 min; 60 minutes; 60M; 60min; After; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Myleran; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random	4180186
1002125	白消安^在完成白消安输注之后1小时:质量浓度:时间点:血浆:定量型	4182948
1002126	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1002128	Diff lg B-cell Lymph COO Pnl Tiss	4180186
1002128	弥漫性大B细胞淋巴瘤细胞起源亚分类组套:-:时间点:组织与涂片:-	4182948
1002128	ABC; B Cell; B-ALL; B-cell acute lymphoblastic leukemia; BCELLS; BLYM; COO; Diff Lg B-cell lymph; Diff Lg B-cell lymph COO; Diff lg B-cell Lymph COO Pnl; DLBCL; GCB; Lg B-cell lymph; Pan; PANEL.PATH; Panl; Pathology; Pnl; Point in time; Random; Tissue; Tissue, unspecified	4180186
1002129	ABS; Aby; Antby; Anti; Antibodies; Antibody; Asp; Aspartic acid; Autoantibodies; Autoantibody; Dextro; Encephalitis; Glutamate receptor ionotropic, NMDA 1; i; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; NMDA receptor; NMDAR; NMDAR1; N-Methylaspartate Receptors; N-Methyl-D-aspartic Acid; Ordinal; Paraneoplastic syndrome; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; Serum; SR	4180186
1002129	NMDAR1 IgG Ser Ql CBA IFA	4180186
1002129	N-甲基-D-天冬氨酸受体亚单位 1 抗体.IgG:存在情况或阈值:时间点:血清:序数型:CBA IFA	4182948
1002131	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1002132	Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; SDOH; Survey	4180186
1002133	Osmolality p 5h FFST SerPl	4180186
1002133	After; CHEMISTRY.CHALLENGE TESTING; Osmo; Osmol; Osmolality; osmolarity; p 5h FFST; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1002133	渗透压^在液体型禁食之后5小时:渗透压:时间点:血清/血浆:定量型	4182948
1002134	C-SSRS Screen Recent; Pan; Panel; PANEL.SURVEY.CSSRS; Panl; Pnl; Point in time; Random; Survey; SURVEY.CSSRS	4180186
1002137	Modified 30s Sit to Stand w extremities	4180186
1002137	30s CST; 30-Second Chair Stand; 30sSTS; Count/time; H+P; H+P.PX; nRate; Number rate; Number Rate = Count/Time; P prime; QNT; Quan; Quant; Quantitative; Stands; Up; w upper extremities	4180186
1002137	坐位至立位^采用上肢:计数型速率:30秒钟:^患者:定量型	4182948
1002138	Calories burned dur wght training ?Tm	4180186
1002138	?Tm; CLIN; dur wght training; Energy/time; Power; QNT; Quan; Quant; Quantitative; Wt	4180186
1002138	已消耗的热量^在负重训练的过程中:功率:XXX:^患者:定量型	4182948
1002139	F9 gene Full Mut Anl Bld/T Seq	4180186
1002139	Blood; Christmas factor; Coagulation Factor 9 gene; coagulation factor IX; Coagulation Factor IX gene; Document; Finding; Findings; FIX; full gene sequencing; Full Mut Anl; HEMB; high-throughput sequencing; HTS; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; P19; Point in time; PTC; Random; sequencing of entire coding region; THPH8; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1002139	F9 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
1002142	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Microbiology; Misc; Miscellaneous; Other; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; Relative ratio; S chol+inf+typhimur; S chol+inf+typhimur Ab; Sal; Salmonel; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
1002142	S chol+inf+typhimur Ab/Pos cntrl Spec IA	4180186
1002142	猪霍乱沙门菌+婴儿沙门菌+鼠伤寒沙门菌 抗体/阳性对照:相对比率:时间点:XXX:定量型:免疫测定法	4182948
1002145	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
1002146	Blood - (umbilical) cord; BLOOD BANK; Cord (umbilical) blood; Cord bld; Cord blood; D phenotyping; D typing; KEL1; Kell Blood Group System; Pan; PANEL.BLOODBANK; Panl; Pnl; Point in time; Random; Rh Ags+K Ag Pnl; Rh phenotyping; Rh typing	4180186
1002146	Rh Ags+K Ag Pnl BldCo	4180186
1002146	Rh抗原与K抗原组套:-:时间点:脐带全血:-	4182948
1002148	Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS	4180186
1002149	Diff in Preg score; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Gestation; Gestations; Gravida; Point in time; Pregnancies; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.MTLHLTH; Tot; Totl	4180186
1002153	Admin info; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1002155	Address; ADMIN; bod; Bodies; Nominal; Point in time; Random	4180186
1002155	遗体处置设施地址:地址:时间点:设施:名义型	4182948
1002160	5-HT1C; 5HT-1C; 5-HT2C; 5-HT-2C; 5HTR2C; 5-HTR2C; 5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled; 5-hydroxytryptamine receptor 2C gene; Blood; HTR1C; HTR2C c.-759C&gt;T; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Nominal; PCR; Point in time; Random; rs3813929; serotonin receptor 2C gene; T prime; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1002160	HTR2C c.-759C>T Geno Bld/T	4180186
1002160	HTR2C 基因.c.-759C>T:基因型:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
1002164	Avail tx for variant+dx; Blood; Dx; Genetics; Genomic; Identity or presence; Molecular pathology; MOLPATH; Nominal; Point in time; Random; Related therapy; Tissue; Tissue, unspecified; Tx; WB; Whole blood; Whole blood or Tissue	4180186
1002164	Avail tx for variant+dx Bld/T	4180186
1002164	与遗传变异相关且与患者诊断相关的可用治疗:存在与否或特征标识:时间点:全血/组织:名义型	4182948
1002170	Swim distance ?Tm	4180186
1002170	?Tm; CLIN; Length; QNT; Quan; Quant; Quantitative; Swim distance	4180186
1002170	游泳距离:长度:XXX:^患者:定量型	4182948
1002171	Bacterial katG drug res mut Islt/Spm	4180186
1002171	ANTIBIOTIC SUSCEPTIBILITIES; Bact; Bacterial katG drug res mut; Drugs; Identity or presence; Islt; Islt/Spm; Isol; Molecular genetics; Mut; Mutations; Nominal; PCR; Point in time; Random; Resist; Resistanc; Resistant; Resistent; Spec	4180186
1002171	细菌 katG 基因耐药性突变:存在与否或特征标识:时间点:分离株/标本:名义型:分子遗传学类实验室方法	4182948
1002172	Hrt LVOT/AV VTI DOP	4180186
1002172	AV VTI; CARD.US; Cardiac; Cardiology; DOP; DUPLEX; Echography; Hrt; L; Length Ratio; LT; LVOT; LVOT/AV VTI; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Vel	4180186
1002172	速度-时间积分.左心室流出道/速度-时间积分.主动脉瓣:长度比率:时间点:心脏:定量型:超声.多普勒	4182948
1002175	Finding; Findings; Nominal; Othr; Point in time; Random; Survey; SURVEY.MTLHLTH	4180186
1002176	Chemistry; i; Leukocytes; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; PPT; PPT1 + TPP1 Pnl; PR; Prot; Random; WBCs; White blood cells	4180186
1002176	PPT1 + TPP1 Pnl WBC	4180186
1002176	棕榈酰蛋白硫酯酶 1 与三肽基肽酶 1 组套:-:时间点:白细胞:-	4182948
1002178	GCDCA SerPl-sCnc	4180186
1002178	Chemistry; GCDCA; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
1002178	甘氨鹅去氧胆酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
1002179	3D US; Arbitrary rate; CARD.US; Cardiac; Cardiology; Echography; Hrt; Hrt ventr; L; Largest; LT; LV; Max long atrial contract str rt; Maximal; Maximum; Peak; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ventricular	4180186
1002179	LV Max long atrial contract str rt 3D US	4180186
1002179	心房收缩应变速率.纵向.最大值:任意型速率:时间点:心脏.心室.左侧:定量型:超声.3D	4182948
1002181	Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS	4180186
1002187	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1002188	Assessment; Centers for Medicare and Medicaid Assessment; Eval; H&P; History and physical; Hosp; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1002189	Bacterial pncA drug res mut Islt/Spm	4180186
1002189	ANTIBIOTIC SUSCEPTIBILITIES; Bact; Bacterial pncA drug res mut; Drugs; Identity or presence; Islt; Islt/Spm; Isol; Molecular genetics; Mut; Mutations; Nominal; PCR; Point in time; Random; Resist; Resistanc; Resistant; Resistent; Spec	4180186
1002189	细菌 pncA 基因耐药性突变:存在与否或特征标识:时间点:分离株/标本:名义型:分子遗传学类实验室方法	4182948
1002191	5 hours; 5.0Hr; 5HR; Chemistry; CR; Crea; Creat; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UCr; UR; Urn	4180186
1002191	Creat 5h Ur-sRate	4180186
1002191	肌酐:物质的量速率:5小时:尿液:定量型	4182948
1002192	HCO3 1h p Vaso SerPl-sCnc	4180186
1002192	1 hour; 1.0Hr; 1h p Vaso; 60 min; 60 minutes; 60M; 60min; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; BIC; bicar; Bicarb; CHEMISTRY.CHALLENGE TESTING; HCO3; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SBC; SBIC; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; VP	4180186
1002192	碳酸氢盐^在给予剂量后叶加压素之后1小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
1002193	AMPAR2 IgG CSF Ql CBA IFA	4180186
1002193	ABS; Aby; Alfa; AMPA Receptor; AMPAR2; AMPAR2 Ab; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; GluA2; GluR2; GluR-B; Hydrox; II; III; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; Limbic encephalitis; OH; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
1002193	Alpha-氨基-3-羟基-5-甲基-4-异噁唑丙酸受体 2 抗体.IgG:存在情况或阈值:时间点:脑脊液:序数型:CBA IFA	4182948
1002194	Ativan; DRUG/TOXICOLOGY; Drugs; Gluc; Glucouronide; Lorazepam metabolite; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
1002194	LORazepam glucuronide Ur Ql Scn	4180186
1002194	葡萄糖苷酸劳拉西泮:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
1002198	Cntrl Substance Agreement	4180186
1002198	Cntrl Substance Agreement; Contract; DOC.ONT; Document; Finding; Findings; Point in time; Random; Subs	4180186
1002198	管制物质协议:发现:时间点:{环境}:文档型:{角色}	4182948
1002199	Variant interaction assoc therapy syner	4180186
1002199	Blood; Genetics; Genomic; Identity or presence; Interaction assoc tx synergy; Molecular pathology; MOLPATH; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Tx; WB; Whole blood; Whole blood or Tissue	4180186
1002199	因为遗传变异之间的相互作用而导致协同的治疗:存在与否或特征标识:时间点:全血/组织:名义型	4182948
1002203	C-SSRS V Young/Cog Imp-LR; Pan; Panel; PANEL.SURVEY.CSSRS; Panl; Pnl; Point in time; Random; Survey; SURVEY.CSSRS	4180186
1002207	CARD.US; Cardiology; DOP; DOP.color; DUPLEX; Echography; Point in time; QNT; Quan; Quant; Quantitative; Random; ROA; Sonogram; Sonograph; Sonography; TV; ULS; Ultrasound	4180186
1002207	TV ROA DOP.color	4180186
1002207	反流口面积:面积:时间点:三尖瓣:定量型:超声.多普勒.彩色	4182948
1002208	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey	4180186
1002213	Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS	4180186
1002214	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; Donr; EBNA; EBV; EBV NA; EIA; ELFA; ELISA; Enzyme immunoassay; Epstn; HHV-4; human herpesvirus 4; IAA; MEIA; Microbiology; Mono; Mononucleosis; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
1002214	EBV NA Ab Ser Donr Ql IA	4180186
1002214	Epstein Barr 病毒细胞核 抗体:存在情况或阈值:时间点:血清^供体:序数型:免疫测定法	4182948
1002215	T gondii IgG Ser Donr Ql IA	4180186
1002215	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Donr; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; T gondii; Toxo; Toxoplasmosis	4180186
1002215	刚地弓形虫 抗体.IgG:存在情况或阈值:时间点:血清^供体:序数型:免疫测定法	4182948
1002216	Hgb BldV-sCnc	4180186
1002216	Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Venous	4180186
1002216	血红蛋白:物质的量浓度:时间点:静脉全血:定量型	4182948
1002217	Chemistry; CR; Crea; Creat; Pentacarboxyl porphyrin; Pentacarboxyporhyrin; Penta-CP; Penta-CPI; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
1002217	Penta-CPI/Creat Ur-sRto	4180186
1002217	五羧基卟啉 I/肌酐:物质的量比率:时间点:尿液:定量型	4182948
1002218	Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS	4180186
1002219	Run distance ?Tm	4180186
1002219	?Tm; CLIN; Length; QNT; Quan; Quant; Quantitative; Run distance	4180186
1002219	跑行距离:长度:XXX:^患者:定量型	4182948
1002220	Addiction; C24H32N2O; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]pentanamide; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Synthetic opioid; UA; UR; Urn; Valeryl fentanyl	4180186
1002220	Valerylfentanyl Ur Cfm-mCnc	4180186
1002220	戊酰基芬太尼:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1002223	HTLV I+II Ab Patrn CSF Line blot-Imp	4180186
1002223	2; Ab Patrn; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bands; bnd; Cerebral spinal fluid; Cerebrospinal Fl; HTLV I+II; HTLV I+II ab band pattern; HTLV type 1+2; HTLV type I+II; Human T-cell Leukemia Virus; Human T-cell Lymphotrophic Virus; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Microbiology; Nominal; Patrn; Point in time; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
1002223	HTLV I 与 II 抗体区带模式:印象:时间点:脑脊液:名义型:线点印迹法	4182948
1002224	Pan; PANEL.PULMONARY; Panl; Pnl; Polysomnography Pnl; PULMONARY; Studies; Study; Sutdies	4180186
1002224	Polysomnography Pnl	4180186
1002227	Address; ADMIN; Nominal; Point in time; Random	4180186
1002227	殡仪设施地址:地址:时间点:设施:名义型	4182948
1002228	Agg; Aggr; COAGULATION; mcg; PA; PA Rist; Pl; Platelet rich plasma; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RIPA; RlACnc; Thrombocyte; Thrombocytes	4180186
1002228	PA Rist 5 ug/mL PRP	4180186
1002228	血小板聚集.瑞斯托菌素诱导型^5 微克/毫升:相对任意型浓度:时间点:富血小板血浆:定量型	4182948
1002233	ADHD screen report	4180186
1002233	ADHD screen report; Asympt; Asymptomatic; DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random; Scn	4180186
1002233	注意力缺陷多动障碍筛查报告:发现:时间点:^患者:文档型	4182948
1002234	HEDIS 2020 Systolic BP	4180186
1002234	BP; HEDIS 2020 Systolic BP; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
1002234	HEDIS 2020 取值集合 - 收缩压:-:时间点:^患者:-	4182948
1002235	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey	4180186
1002237	NYHA Functional Class	4180186
1002237	NYHA Functional Class; Pan; Panel; PANEL.CARDIAC; Panl; Pnl; Point in time; Random	4180186
1002237	纽约心脏病协会心功能分级:-:时间点:^患者:-:NYHA	4182948
1002241	1 day; 24 hours; 24HR; Chemistry; Mass Rate; mRate; PR; Prot; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
1002241	Protein catabolic rate 24h Ur-mRate	4180186
1002241	蛋白质分解代谢率:质量速率:24小时:尿液:定量型	4182948
1002243	Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS	4180186
1002244	Arbitrary concentration; Chemistry; Disease, Interstitial Lung; Diseases, Interstitial Lung; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ILD; Interstitial Lung Disease; KL-6; MEIA; MUC1; Mucin, Muc1; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
1002244	KL-6 SerPl IA-aCnc	4180186
1002244	涎液化糖链抗原-6:任意型浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
1002245	CARD.US; Cardiology; Echography; Finding; Findings; Heart; Inf; IVC; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sonogram; Sonograph; Sonography; ULS; Ultrasound; VC	4180186
1002245	IVC Collapse US	4180186
1002245	塌陷:发现:时间点:腔静脉.下:序数型:超声	4182948
1002253	dRVVT imm 1:1 NP+hep neut PPP	4180186
1002253	Clot; Clottable; Coag; Coagulation assay; Control; DDRVTVT; Dil; Dil Russell Vip Ven; Dilut; dRVV; dRVVT; Fac; Fact; Hep; Hepar; Heparin Nt; Heparn; i; imm 1:1 NP; imm 1:1 NP+hep neut; Neut; Neutr; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Rus; RVV; Screening test for lupus anticoagulant; Tilt tube	4180186
1002253	稀释蝰蛇毒诱导型凝血过程.因子替换^紧接着在添加1:1正常血浆+肝素中和之后:时间:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
1002254	Mono PC in S Phs NFr Mar FC	4180186
1002254	BM; BON; Bone marrow; Cell; Cellularity; Dynamic; FC; Gated cells; MAR; Marrow (bone); MGUS; minimal angle of resolution; Minimum angle of resolution; Molecular pathology; MOLPATH; Mono PC in S Phs; Monoclonal; Monoclonal gammopathy of uncertain significance; Multiple myeloma; Myeloma cells; Number fraction; Percent; Plasma cell myeloma; Plasmacyte; Plasmacytes; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime	4180186
1002254	浆细胞.单型.S 期/100 个细胞:计数型分数:时间点:骨髓:定量型:流式细胞测量术	4182948
1002255	2D US; A2C SP A-L; Atrial; Bdy surface; bod; Bodies; BSA; Calculated; CARD.US; Cardiac; Cardiology; Echography; ES vol; Hrt; L; LA; LAA; LAVI; Left Atrial Volume Index; LT; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Surf; ULS; Ultrasound; Ultrasound - 2-dimensional; Vol; Volume/area	4180186
1002255	LA ES vol/BSA A2C SP A-L	4180186
1002255	心脏收缩末期容积/体表面积:体积/面积:时间点:心脏.心房.左侧:定量型:超声.2D.A2C+单平面面积-长度计算法	4182948
1002256	After; Blood; BLOOD BANK; D phenotyping; D typing; K Ag^p transf rx; KEL1; Kell Blood Group System; Pan; PANEL.BLOODBANK; Panl; Pnl; Point in time; PST; Random; React; Rh Ags+K Ag Pnl p Transf Rx; Rh phenotyping; Rh typing; Rxn; Transf React; Transf React Pnl; Tx; WB; Whole blood	4180186
1002256	Rh Ags+K Ag Pnl p Transf Rx Bld	4180186
1002256	输血反应后Rh抗原与K抗原组套:-:时间点:全血:-	4182948
1002257	Conf eval note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gen med Team; notes; Point in time; Random; Visit note	4180186
1002257	Gen med Team Conf eval note	4180186
1002257	会议记录:发现:时间点:{环境}:文档型:普通内科学.团队	4182948
1002258	4-ethylsulfonyl-N,N-dimethyl-4,4- diphenylbutan-2-amine; Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; gamma-(Ethylsulfonyl)-N,N,alpha-trimethyl-gamma-phenylbenzenepropanamine hydrochloride; GCMS; I-C 26; Illicit; Level; Mass concentration; Methiodine; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Synthetic opioid; UA; UR; Urn	4180186
1002258	IC-26 Ur Cfm-mCnc	4180186
1002258	IC-26:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1002259	Arterial Stenosis; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Finding; Findings; Gestation; Gestations; Gravida; Ordinal; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH; Sx	4180186
1002260	Finding; Findings; Gestation; Gestations; Gravida; Ordinal; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
1002262	little c Ag p transf rx RBC Ql	4180186
1002262	After; Antigen; Antigens; BLOOD BANK; c; C Ag^p transf rx; Erythrocytes; little c Ag^p transf rx; Ordinal; p transf; p transf rx; Point in time; PR; PST; QL; Qual; Qualitative; Random; React; Red blood cells; Red blood corpusles; Rh; Rh Blood Group System; Rxn; Screen; Transf React; Tx	4180186
1002262	c 抗原^在输血反应之后:存在情况或阈值:时间点:红细胞:序数型	4182948
1002266	Keratan Sulfate SerPl-mCnc	4180186
1002266	Chemistry; Chondroitin sulfate B; keratosulfate; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SO4; SO4-2; SR; Sulf	4180186
1002266	硫酸角质素:质量浓度:时间点:血清/血浆:定量型	4182948
1002270	LV SV A2C SP A-L	4180186
1002270	2D US; A2C SP A-L; Calculated; CARD.US; Cardiac; Cardiac output/Heart beat; Cardiology; Echography; Hrt; Hrt ventr; L; LT; LV; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; SV; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular; Vol; Volume	4180186
1002270	心搏量:体积型属性:时间点:心脏.心室.左侧:定量型:超声.2D.A2C+单平面面积-长度计算法	4182948
1002272	C2.functional SerPl-aCnc	4180186
1002272	Arbitrary concentration; Comp; Complmt; HEMATOLOGY/CELL COUNTS; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1002272	补体 C2.功能性:任意型浓度:时间点:血清/血浆:定量型	4182948
1002274	Proximal RVOT Diam PSAX	4180186
1002274	2D US; CARD.US; Cardiac; Cardiology; DIA; Diam; Echography; Hrt; Hrt ventr; Length; Point in time; Proximal RVOT; QNT; Quan; Quant; Quantitative; R; Random; RT; RV; RVOT; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular	4180186
1002274	直径:长度:时间点:心脏.心室.右侧.流出道.近端:定量型:超声.2D.PSAX	4182948
1002275	Arm; Bone dev stage; Carpal bone; Carpal bones; Carpal bones and joint; EXT; Imaging; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; RADIOLOGY; Random; Scale; UE; Up; Upper extremity joint; Xray; X-ray	4180186
1002275	XR Lunate Bone dev stage	4180186
1002275	骨骼发育阶段:评分:时间点:上肢>腕部.月骨:定量型:X射线摄影术	4182948
1002277	Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.CSSRS	4180186
1002278	After; Antigen; Antigens; BLOOD BANK; C Ag^p transf rx; Erythrocytes; Ordinal; p transf; p transf rx; Point in time; PR; PST; QL; Qual; Qualitative; Random; React; Red blood cells; Red blood corpusles; Rh; Rh Blood Group System; Rxn; Screen; Transf React; Tx	4180186
1002278	C Ag p transf rx RBC Ql	4180186
1002278	C 抗原^在输血反应之后:存在情况或阈值:时间点:红细胞:序数型	4182948
1002279	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; LCMV; LCMV Ab.IgG+IgM; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
1002279	LCMV IgG+IgM CSF Ql	4180186
1002279	淋巴细胞性脉络丛脑膜炎病毒 抗体.IgG+IgM:存在情况或阈值:时间点:脑脊液:序数型	4182948
1002281	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1002285	MuV N gene Ct Spec Qn NAA+probe	4180186
1002285	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; MuV; MuV N gene; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
1002285	流行性腮腺炎病毒 N 基因:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
1002287	Exp; H+P; H+P.PX; Nominal; P prime; Point in time; Random; Set of hazard exposure; Typ	4180186
1002287	Set of hazard exposure	4180186
1002287	环境或职业危害暴露场所环境:类型:时间点:^患者:名义型	4182948
1002290	1 month; 1 month (30 days); 30 days; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Spec; Survey; SURVEY.CSSRS	4180186
1002292	Finding; Findings; Gestation; Gestations; Gravida; Ordinal; Point in time; Pregnancies; QL; Qual; Qualitative; Random; S prime; Screen; SDOH; Survey; SURVEY.MTLHLTH	4180186
1002295	AV Regurg bld vel VTI DOP	4180186
1002295	AO; AoV; AV; Bld vel; CARD.US; Cardiology; DOP; DUPLEX; Echography; Length; Point in time; QNT; Quan; Quant; Quantitative; Random; Regurg bld vel VTI; Sonogram; Sonograph; Sonography; TVI; ULS; Ultrasound; Vel; VTI	4180186
1002295	反流血流速度-时间积分:长度:时间点:主动脉瓣:定量型:超声.多普勒	4182948
1002297	4 weeks; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1002301	*^Patient; DOC.MISC; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Home health care; MISC; notes; nursing; Point in time; Pt's home; Random; S prime; Visit note	4180186
1002301	Accessibility note Pt's home Nurse	4180186
1002301	无障碍情况记录:发现:时间点:患者的家:文档型:护士	4182948
1002302	Arterial Stenosis; Finding; Findings; Ordinal; Persons; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
1002304	Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Random; Visit note; WOC	4180186
1002304	WOC OP Note	4180186
1002304	记录:发现:时间点:门诊病人:文档型:伤口、造口和大小便节制照护服务	4182948
1002305	LA ES vol A2C SP A-L	4180186
1002305	2D US; A2C SP A-L; Atrial; Calculated; CARD.US; Cardiac; Cardiology; Echography; ES vol; Hrt; L; LA; LAA; LT; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ultrasound - 2-dimensional; Vol; Volume	4180186
1002305	心脏收缩末期容积:体积型属性:时间点:心脏.心房.左侧:定量型:超声.2D.A2C+单平面面积-长度计算法	4182948
1002306	Mono.HLA-DR/100 Mono NFr Bld FC	4180186
1002306	Blood; CELL MARKERS; Dynamic; FC; Human Leukocyte Antigen; I3; Mono; Mono.HLA-DR; Mono.HLA-DR/100 Mono; Monocyte; Monos; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
1002306	单核细胞.HLA-DR/100 个单核细胞:计数型分数:时间点:全血:定量型:流式细胞测量术	4182948
1002307	Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS	4180186
1002308	After; CHEMISTRY.CHALLENGE TESTING; Osmo; Osmol; Osmolality; osmolarity; p 3h FFST; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1002308	Osmolality p 3h FFST SerPl	4180186
1002308	渗透压^在液体型禁食之后3小时:渗透压:时间点:血清/血浆:定量型	4182948
1002309	2D US; Calc; Calculation; CARD.US; Cardiac; Cardiology; Echography; EF; Frac; Fract; Fractionation; Fractions; Hrt; Hrt ventr; L; LT; LV; LVEF; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular; Volfr; Volume fraction	4180186
1002309	LV EF Biplane area-length	4180186
1002309	射血分数:体积分数:时间点:心脏.心室.左侧:定量型:超声.2D+双平面面积-长度计算法	4182948
1002310	B miyamotoi IgG SerPl IA-aCnc	4180186
1002310	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B miyamotoi; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; MEIA; Microbiology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; TBRF; Tick Borne Diseases; tick-borne relapsing fever	4180186
1002310	宫本疏螺旋体 抗体.IgG:任意型浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
1002312	120 min; 120 minutes; 120min; 2 hours; 2h p Vaso; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; k; K+; Level; p dose; Pl; Plasma; Plsm; Point in time; Potass; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; VP	4180186
1002312	Potassium 2h p Vaso SerPl-sCnc	4180186
1002312	钾^在给予剂量后叶加压素之后2小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
1002314	Centers for Medicare and Medicaid Assessment; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
1002319	H+P; H+P.HX; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1002319	抑郁严重程度:印象:时间点:^患者:序数型	4182948
1002326	ADMIN; bod; Bodies; Ident; Identifier; Nominal; Point in time; Random	4180186
1002326	Body disposition facility name	4180186
1002326	遗体处置设施名称:标识符:时间点:设施:名义型	4182948
1002330	#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; APPV; Atyp; Cnt; Count; Count/volume; CT; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); Other; PCR; Point in time; Polymerase chain reaction; Pork; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Reactive; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; Swine; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary; Viral load	4180186
1002330	APPV RNA # Spec NAA+probe	4180186
1002330	猪非典型性瘟病毒 RNA:计数型浓度:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
1002331	Bacterial eis drug res mut Islt/Spm	4180186
1002331	ANTIBIOTIC SUSCEPTIBILITIES; Bact; Bacterial eis drug res mut; Drugs; Identity or presence; Islt; Islt/Spm; Isol; Molecular genetics; Mut; Mutations; Nominal; PCR; Point in time; Random; Resist; Resistanc; Resistant; Resistent; Spec	4180186
1002331	细菌 eis 基因耐药性突变:存在与否或特征标识:时间点:分离株/标本:名义型:分子遗传学类实验室方法	4182948
1002334	vWF Cp Act PPP Chro-cCnc	4180186
1002334	Activ; Actvty; ADAMTS13; ADAMTS-13; Catalytic Concentration; Chromogenic assay; COAGULATION; ENZY; Enzymatic assay; Fac; Fact; FRET; Movements; Plas; Platelet poor plasma; Point in time; PR; QNT; Quan; Quant; Quantitative; Random; TTP; Von will; Vonwillebrand; vWCP; vWf; vWF Cp; vWF Cp Act; VWFCP; VWF-cp	4180186
1002334	von Willebrand 因子裂解蛋白酶活性:催化浓度:时间点:贫血小板血浆:定量型:凝血因子酶学测定法	4182948
1002337	Avian influenza; Bird flu; FLUA; FLUAV; FLUAV PB1 gene; FLUV; Fowl plague; high-throughput sequencing; HTS; Influ; Influenza A; Influenza A virus; Islt; Isol; Microbiology; Next generation sequencing; NGS; Nominal; Point in time; Random	4180186
1002337	FLUAV PB1 gene Islt-Seq	4180186
1002337	流感病毒 A PB1 基因:序列:时间点:分离株:名义型:序列测定	4182948
1002338	5 hours; 5.0Hr; 5HR; Chemistry; CR; Crea; Creat; Mass rate; mRate; QNT; Quan; Quant; Quantitative; UA; UCr; UR; Urn	4180186
1002338	Creat 5h Ur-mRate	4180186
1002338	肌酐:质量速率:5小时:尿液:定量型	4182948
1002339	Pan; Panel; PANEL.SURVEY.CSSRS; Panl; Pnl; Point in time; Random; Survey; SURVEY.CSSRS	4180186
1002340	Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS	4180186
1002341	Blood; Document; Finding; Findings; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Mut; Mut Anl; Mutations; PCR; Point in time; Random; thiopurine S-methyltransferase; Thiopurine S-methyltransferase gene; Tissue; Tissue, unspecified; TPMT + NUDT15; WB; Whole blood; Whole blood or Tissue	4180186
1002341	TPMT + NUDT15 Mut Anl Bld/T	4180186
1002341	TPMT 基因 & NUDT15 基因 突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
1002342	Assessment; Centers for Medicare and Medicaid Assessment; Eval; H&P; History and physical; Hosp; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1002345	SUD score	4180186
1002345	H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Subs; SUD score	4180186
1002345	物质使用障碍评分:评分:时间点:^患者:定量型	4182948
1002347	HEDIS 2020 BMI; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
1002347	HEDIS 2020 BMI	4180186
1002347	HEDIS 2020 取值集合 - 体质指数:-:时间点:^患者:-	4182948
1002349	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
1002351	PC DNA content + prolif Pnl Mar FC	4180186
1002351	BM; BON; Bone marrow; Cell cycle analysis; Deoxyribonucleic acid; Dynamic; FC; HEMATOLOGY/CELL COUNTS; MAR; Marrow (bone); MGUS; minimal angle of resolution; Minimum angle of resolution; Monoclonal gammopathy of uncertain significance; Multiple myeloma; Myeloproliferative Disorder; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; PC DNA content + prolif Pnl; Ploidy; Pnl; Point in time; Random	4180186
1002351	浆细胞 DNA 含量与增殖组套:-:时间点:骨髓:-:流式细胞测量术	4182948
1002352	Antigen; Antigens; Cerebral spinal fluid; Cerebrospinal Fl; Coccidiodes; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; Mass concentration; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; San Joaquin Valley fever; species; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; spp; SUDS; Valley fever	4180186
1002352	Coccidioides Ag CSF IA-mCnc	4180186
1002352	球孢子菌属单个未知种 抗原:质量浓度:时间点:脑脊液:定量型:免疫测定法	4182948
1002353	APOA1 Full Mut Anl Bld/T Seq	4180186
1002353	Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; high-throughput sequencing; HTS; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1002353	APOA1 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
1002357	1 hour; 1.0Hr; 60 min; 60 minutes; 60M; 60min; Blood urea nitrogen; BUN; Chemistry; Level; Mass concentration; N; N2; Nit; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Spec; SR; UN	4180186
1002357	BUN 1h spec SerPl-mCnc	4180186
1002357	尿素氮^1小时标本:质量浓度:时间点:血清/血浆:定量型	4182948
1002358	LV Max long strain 3D US	4180186
1002358	3D US; CARD.US; Cardiac; Cardiology; Echography; Hrt; Hrt ventr; L; Largest; Length Ratio; LT; LV; Max long strain; Max strain; Maximal; Maximum; Peak; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ventricular	4180186
1002358	纵向应变.最大值:长度比率:时间点:心脏.心室.左侧:定量型:超声.3D	4182948
1002361	BM; BON; Bone marrow; Cell; Cellularity; Dynamic; FC; HEMATOLOGY/CELL COUNTS; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Myeloma cells; Number fraction; Percent; Plasmacyte; Plasmacytes; Point in time; Polyclonal PCs; QNT; Quan; Quant; Quantitative; Random	4180186
1002361	Polyclonal PCs/Cells NFr Mar FC	4180186
1002361	浆细胞.多克隆型/已计数的细胞:计数型分数:时间点:骨髓:定量型:流式细胞测量术	4182948
1002362	Rh Ags+K Ag Pnl infant Bld	4180186
1002362	Blood; BLOOD BANK; D phenotyping; D typing; K Ag^infant; KEL1; Kell Blood Group System; Pan; PANEL.BLOODBANK; Panl; Pnl; Point in time; Random; Rh Ags+K Ag Pnl infant; Rh phenotyping; Rh typing; WB; Whole blood	4180186
1002362	婴儿期Rh抗原与K抗原组套:-:时间点:全血:-	4182948
1002363	HSV1 DNA Bld Ql NAA+non-probe	4180186
1002363	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; Herpes simplex virus type 1; HSV; HSV1; i; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1002363	单纯疱疹病毒 1 型 DNA:存在情况或阈值:时间点:全血:序数型:非探针法.基因扩增.靶向	4182948
1002364	Addiction; C22H27FN2O2; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; N-(2-fluorophenyl)-2-methoxy-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Synthetic opioid; UA; UR; Urn	4180186
1002364	Ocfentanil Ur Cfm-mCnc	4180186
1002364	奥芬太尼:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1002365	LV Max long strain rate early dias 3D US	4180186
1002365	3D US; Arbitrary rate; CARD.US; Cardiac; Cardiology; Dias; Dias.max; Diast; Diastoli; Echography; Hrt; Hrt ventr; L; Largest; LT; LV; Max long strain rate early dias; Max strain rate early dias; Maximal; Maximum; Peak; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ventricular	4180186
1002365	纵向应变速率.心脏舒张早期.最大值:任意型速率:时间点:心脏.心室.左侧:定量型:超声.3D	4182948
1002366	Testost Amn-sCnc	4180186
1002366	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Testo; Testos; Testost	4180186
1002366	睾酮:物质的量浓度:时间点:羊水:定量型	4182948
1002367	Osmolality 2h p Vaso SerPl	4180186
1002367	120 min; 120 minutes; 120min; 2 hours; 2h p Vaso; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; Osmo; Osmol; Osmolality; osmolarity; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; VP	4180186
1002367	渗透压^在给予剂量后叶加压素之后2小时:渗透压:时间点:血清/血浆:定量型	4182948
1002368	Durat; H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1002368	睡眠持续时间:时间:时间点:^患者:定量型	4182948
1002369	Chemistry; CR; Crea; Creat; Hexacarbox; Hexacarboxyl porphyrin; Hexacarboxylic acid porphyrin I; Hexacarboxylporphyrins; Hexacarboxyporphy; Hexacarboxyporphyrin; Hexacarboxyporphyrin I; Hexa-CP; Hexa-CP I; Hexaporphyrin; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
1002369	Hexa-CP I/Creat Ur-sRto	4180186
1002369	六羧基卟啉 I/肌酐:物质的量比率:时间点:尿液:定量型	4182948
1002372	ADHD inattentive severity	4180186
1002372	ADHD inattentive severity; H+P; H+P.HX; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen; Sx	4180186
1002372	注意力缺陷多动障碍注意力涣散症状严重程度:印象:时间点:^患者:序数型	4182948
1002373	CLIN; Energy/time; EXCZ; Levels; Levl; LV; LVL; peak W exer; Point in time; Post; Postdose; Post-dose; Power; QNT; Quan; Quant; Quantitative; Random; W exercise; Watt; Watts^peak W exer	4180186
1002373	Power lev peak W exer	4180186
1002373	功率水平^运动过程中的峰值:功率:时间点:^患者:定量型	4182948
1002377	Before; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; Percent; Point in time; pre carb; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction	4180186
1002377	Breath methane pre carb	4180186
1002377	甲烷/已呼出的气体^在给予剂量碳水化合物之前:体积分数:时间点:呼出的气体:定量型	4182948
1002378	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Special Txs, procedures and programs; Survey; Tx; Txs	4180186
1002379	After; CHEMISTRY.CHALLENGE TESTING; Osmo; Osmol; Osmolality; osmolarity; p 7h FFST; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1002379	Osmolality p 7h FFST SerPl	4180186
1002379	渗透压^在液体型禁食之后7小时:渗透压:时间点:血清/血浆:定量型	4182948
1002381	After; Antigen; Antigens; BLOOD BANK; e; E Ag^p transf rx; Erythrocytes; little e Ag^p transf rx; Ordinal; p transf; p transf rx; Point in time; PR; PST; QL; Qual; Qualitative; Random; React; Red blood cells; Red blood corpusles; Rh Blood Group System; Rxn; Screen; Transf React; Tx	4180186
1002381	little e Ag p transf rx RBC Ql	4180186
1002381	e 抗原^在输血反应之后:存在情况或阈值:时间点:红细胞:序数型	4182948
1002383	Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
1002383	HEDIS 2020 取值集合:-:时间点:^患者:-	4182948
1002387	ABO+Rh Gp Pnl infant Bld	4180186
1002387	ABO + Rh; ABO group and Rh type; ABO+Rh Gp; ABO+Rh Gp Pnl infant; ABO+Rh Gp^infant; Blood; BLOOD BANK; D phenotyping; D typing; Pan; PANEL.BLOODBANK; Panl; Pnl; Point in time; Random; Rh phenotyping; Rh typing; WB; Whole blood	4180186
1002387	婴儿期ABO与Rh血型组套:-:时间点:全血:-	4182948
1002388	120 min; 120 minutes; 120min; 2 hours; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; GTT ISI 2h Pnl; HUM; Humulin; IH7; Insul; Lente; NPH; Pan; PANEL.CHALLENGE; Panl; Pl; Plasma; Plsm; Pnl; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
1002388	GTT ISI 2h Pnl SerPl	4180186
1002388	葡萄糖耐量与胰岛素敏感性2小时组套:-:-:血清/血浆:-	4182948
1002394	Centers for Medicare and Medicaid Assessment; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
1002395	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; CMV; Cytomegalo virus; Cytomgal; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HHV-5; Human Herpesvirus-5; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCMV; PCMV DNA; PCR; Point in time; Polymerase chain reaction; Pork; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; Swine; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
1002395	PCMV DNA Ct Spec Qn NAA+probe	4180186
1002395	猪巨细胞病毒 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
1002398	AMPAR1 Ab Ser Ql CBA IFA	4180186
1002398	ABS; Aby; Alfa; AMPA Receptor; AMPAR1; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; GluA1; GluR1; GluR-A; Hydrox; i; III; Indirect Fluorescence Antibody; Limbic encephalitis; OH; Ordinal; Point in time; PR; QL; Qual; Qualitative; Quisqualate Receptor; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; Serum; SR	4180186
1002398	Alpha-氨基-3-羟基-5-甲基-4-异噁唑丙酸受体 1 抗体:存在情况或阈值:时间点:血清:序数型:CBA IFA	4182948
1002403	Assessment; DOC.MISC; Eval; Finding; Findings; H&P; History and physical; Home access eval status; MISC; Nominal; Point in time; Random	4180186
1002403	Home access eval status	4180186
1002403	住宅无障碍情况评价状态:发现:时间点:^患者:名义型	4182948
1002405	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Balm; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1002405	Balm IgE Qn	4180186
1002405	蜜蜂花 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
1002406	3-(cystein-S-yl)-acetaminophen; ACET; Acetamidophenol; Acetaminoph; Acetaminophen-cysteine conjugate; Acetominophen; APAP; APAP-CYS; APAP-Cysteine; c209; C55; Cys; DRUG/TOXICOLOGY; Drugs; Hepatotoxicity; Hydroxyacetanilide; Level; N-(4-Hydroxyphenyl)acetanilide; N-Acetyl-p-aminophenol; N-acetyl-p-benzoquinone imine (NAPQI); p-Acetamidophenol; Paracetamol; p-Hydroxyacetanilide; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tylenol; u209	4180186
1002406	APAP-Cysteine SerPl-sCnc	4180186
1002406	对乙酰氨基酚-半胱氨酸加合物:物质的量浓度:时间点:血清/血浆:定量型	4182948
1002411	H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale	4180186
1002411	抑郁症评分:评分:时间点:^患者:定量型	4182948
1002413	30M p carb; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; p carb; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction	4180186
1002413	Breath methane 30M p carb	4180186
1002413	甲烷/已呼出的气体^在给予剂量碳水化合物之后30分钟:体积分数:时间点:呼出的气体:定量型	4182948
1002416	Chr 1 polysomy; Chromosom; Chromosomes; Fluorescent in situ hybridization; i; Molecular pathology; MOLPATH; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified	4180186
1002416	Chr 1 polysomy Tiss Ql FISH	4180186
1002416	染色体 1 多体性:存在情况或阈值:时间点:组织与涂片:序数型:FISH	4182948
1002419	Asympt; Asymptomatic; Depression screen report; DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random; Scn	4180186
1002419	Depression screen report	4180186
1002419	抑郁筛查报告:发现:时间点:^患者:文档型	4182948
1002422	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; EDDP; i; II; III; Illicit; Methadone metabolite; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
1002422	EDDP Ur Ql Scn	4180186
1002422	2-亚乙基-1,5-二甲基-3,3-四氢吡咯:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
1002423	ADHD consistency score	4180186
1002423	ADHD consistency score; H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale	4180186
1002423	注意力缺陷多动障碍问题一致性评分:评分:时间点:^患者:定量型	4182948
1002425	Chemistry; Level; Mass concentration; Omnipaque; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
1002425	Iohexol Ur-mCnc	4180186
1002425	碘海醇:质量浓度:时间点:尿液:定量型	4182948
1002431	Radiology Initial eval note	4180186
1002431	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; Initial eval note; notes; Point in time; Random; Visit note	4180186
1002431	初步评价记录:发现:时间点:{环境}:文档型:放射医学	4182948
1002433	Breath H2 30M p carb	4180186
1002433	30M p carb; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; H2; Hyd; p carb; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction	4180186
1002433	氢/已呼出的气体^在给予剂量碳水化合物之后30分钟:体积分数:时间点:呼出的气体:定量型	4182948
1002434	Access of home entrance	4180186
1002434	Access of home entrance; CLIN; Finding; Findings; Nominal; Point in time; Random	4180186
1002434	住宅入口无障碍性:发现:时间点:^患者:名义型	4182948
1002436	ANTIBIOTIC SUSCEPTIBILITIES; Bact; Bacterial rrs drug res mut; Drugs; Identity or presence; Islt; Islt/Spm; Isol; Molecular genetics; Mut; Mutations; Nominal; PCR; Point in time; Random; Resist; Resistanc; Resistant; Resistent; Spec	4180186
1002436	Bacterial rrs drug res mut Islt/Spm	4180186
1002436	细菌 rrs 基因耐药性突变:存在与否或特征标识:时间点:分离株/标本:名义型:分子遗传学类实验室方法	4182948
1002437	UGT1A1 allele Geno Bld/T	4180186
1002437	BILIQTL1; Blood; Crigler-Najjar syndrome, type I; Gilbert Syndrome; GNT1; HUG-BR1; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; UDP glucuronosyltransferase 1 family, polypeptide A1; UDP glycosyltransferase 1 family, polypeptide A1 gene; UDPGT; UDPGT 1-1; UGT1; UGT1A; UGT1A1 allele; UGT1A5; WB; Whole blood; Whole blood or Tissue	4180186
1002437	UGT1A1 基因等位基因:基因型:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
1002442	GUDCA SerPl-sCnc	4180186
1002442	Chemistry; GUDCA; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
1002442	甘氨熊去氧胆酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
1002445	4 weeks; Job; Occupation; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Survey; SURVEY.GNHLTH	4180186
1002448	ABO + Rh; ABO + Rh Pnl; ABO group and Rh type; ABO+Rh Gp; Blood; BLOOD BANK; Blood product unit; Blood Product Unit (Pack); D phenotyping; D typing; Pan; PANEL.BLOODBANK; Panl; Pnl; Point in time; Random; Rh phenotyping; Rh typing; WB; Whole blood	4180186
1002448	ABO + Rh Pnl Bld BPU	4180186
1002448	ABO与Rh血型组套:-:时间点:全血^血液制品单位:-	4182948
1002449	Finding; Findings; Gestation; Gestations; Gravida; Ordinal; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
1002450	CollagenVII IgG SerPl Ql IA	4180186
1002450	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; COL7; Collagen type 7; CollagenVII; EIA; ELFA; ELISA; Enzyme immunoassay; Epidermolysis bullosa acquisita; IAA; Immune globulin G; Immunoglobulin G; MEIA; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
1002450	胶原 VII 型 抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:免疫测定法	4182948
1002454	Arm; Bone dev stage; Carpal bone; Carpal bones; Carpal bones and joint; EXT; Imaging; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; RADIOLOGY; Random; Scale; UE; Up; Upper extremity joint; Xray; X-ray	4180186
1002454	XR Trapezium Bone dev stage	4180186
1002454	骨骼发育阶段:评分:时间点:上肢>腕部.大多角骨:定量型:X射线摄影术	4182948
1002455	Chemistry; NASH score; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1002455	NASH score SerPl	4180186
1002455	非酒精性脂肪变性肝炎评分:评分:时间点:血清/血浆:定量型	4182948
1002459	Cnt; Count; Number; QNT; Quan; Quant; Quantitative; Survey; SURVEY.CSSRS	4180186
1002668	BP.ATOM	4180186
1002689	OB.US	4180186
1002697	View of myself in past 7D	4180186
1002749	PANEL.BDYTMP	4180186
1002785	PANEL.OB.US	4180186
1002954	NEONAT	4180186
1003082	PANEL.VITALS	4180186
1003128	BP.MOLEC	4180186
1003219	RESP.ATOM	4180186
1003302	HRTRATE.MOLEC	4180186
1003383	BDYWGT.ATOM	4180186
1003669	BDYTMP.MOLEC	4180186
1003813	EntSub	4180186
1003935	HEMODYN.ATOM	4180186
1003944	Where was your mother's father born	4180186
1004040	BP.VENOUS.MOLEC	4180186
1004118	RAD	4180186
1004135	Trac	4180186
1004140	HRTRATE.TIMED.MOL	4180186
1004161	Orthostatic hypotension in last 7D	4180186
1004162	XR diffraction	4180186
1004164	Heart.atrium.left+Pulmonary veins	4180186
1004214	Flag for Date 1st cancer Rx (any).COC not populated	4180186
1004216	Flag for Date of death - Canada not populated	4180186
1004282	Eye+Orbit.bilateral	4180186
1004284	Ser/Plas/BldV	4180186
1004326	ClockTime	4180186
1004423	BldA+BldV	4180186
1004435	BCG	4180186
1004461	I felt guilty in past 7D	4180186
1004464	Each time you ate bread, toast or dinner rolls, how much did you usually eat in the past 30D	4180186
1004465	How often did you eat cold cereal in the past 30D	4180186
1004467	How often did you eat cheese in the past 30D	4180186
1004471	How often did you eat macaroni and cheese in the past 30D	4180186
1004472	Each time you ate macaroni and cheese, how much did you usually eat in the past 30D	4180186
1004474	Each time you ate mexican foods, how much did you usually eat in the past 30D	4180186
1004476	Each time you drank milk, how much did you usually drink in the past 30D	4180186
1004477	What kind of milk did you usually drink in the past 30D	4180186
1004480	Each time you drank orange juice, how much did you usually drink in the past 30D	4180186
1004483	How often did you eat yogurt in past 30D	4180186
1004486	How often did you eat hot or cold cereals in past 30D	4180186
1004491	How often did you eat a green leafy or lettuce SALAD, with or without other vegetables, in past 30D	4180186
1004525	How often did you eat whole grain bread in past 30D	4180186
1004528	How often did you take B complex or stress tab type multiple vitamins	4180186
1004529	How many Y did you take B complex or stress tab type multiple vitamins	4180186
1004531	How many Y did you take calcium, alone or combined with something else such as in a bone health supplement or in an antacid	4180186
1004534	How many Y did you take flaxseed	4180186
1004539	How many Y did you take glucosamine, alone or combined with something else	4180186
1004541	How many Y did you take iron	4180186
1004544	How often did you take regular one a day type, centrum or thera type multiple vitamins	4180186
1004545	How many Y did you take regular one a day type, centrum or thera type multiple vitamins	4180186
1004547	How many Y did you take coenzyme Q 10	4180186
1004549	How many Y did you take saw palmetto	4180186
1004551	How many Y did you take selenium	4180186
1004552	How often did you take vitamin B 12	4180186
1004553	How many Y did you take vitamin B 12	4180186
1004554	How often did you take vitamin B 6	4180186
1004555	How many Y did you take vitamin B 6	4180186
1004558	How many Y did you take vitamin C	4180186
1004560	How many Y did you take vitamin D, alone	4180186
1004563	How many Y did you take vitamin E	4180186
1004567	How often did you have milk, either to drink or on cereal in past 30D	4180186
1004570	How often did you eat a green leafy or lettuce salad, with or without other vegetables in past 30D	4180186
1004571	How often did you eat other white potatoes in past 30D	4180186
1004572	How often did you eat doughnuts, sweet rolls, danish, muffins, or pop-tarts in past 30D	4180186
1004573	How often did you eat cookies, cake, pie, or brownies in past 30D	4180186
1004577	About how often did you eat eggs, fried or scrambled in margarine, butter, or oil in past 12Mo	4180186
1004581	About how often did you eat fruit (not juices) in past 12Mo	4180186
1004584	About how often did you eat french fries, home fries, or hash brown potatoes in past 12Mo	4180186
1004587	About how often did you eat salad dressings, regular fat, in past 12Mo	4180186
1004588	About how often did you eat rice in past 12Mo	4180186
1004589	About how often did you eat margarine, butter, or oil on rice or pasta in past 12Mo	4180186
1004722	When I was in pain I grimaced in past 7D	4180186
1004723	When I was in pain I would lie down in past 7D	4180186
1004730	When I was in pain I asked for help doing things that needed to be done in past 7D	4180186
1004731	When I was in pain it showed on my face (squinching eyes, opening eyes wide, frowning) in past 7D	4180186
1004733	When I was in pain I asked one or more people to leave me alone in past 7D	4180186
1004737	I had pain so bad it made me cry in past 7D	4180186
1004738	When I was in pain I squirmed in past 7D	4180186
1004739	When I was in pain I used a cane or something else for support in past 7D	4180186
1004741	When I was in pain I became quiet and withdrawn in past 7D	4180186
1004747	When I was in pain I moaned, whined or whimpered in past 7D	4180186
1004750	When I was in pain my upper body would tense up in past 7D	4180186
1004753	When I was in pain I thrashed in past 7D	4180186
1004759	When I was in pain I avoided physical contact with others in past 7D	4180186
1004762	How much did pain interfere with your ability to participate in leisure activities in past 7D	4180186
1004764	How much did pain interfere with your ability to concentrate in past 7D	4180186
1004765	How much did pain interfere with your day to day activities in past 7D	4180186
1004768	How much did pain interfere with the things you usually do for fun in past 7D	4180186
1004769	How much did pain interfere with your family life in past 7D	4180186
1004771	How much did pain interfere with your relationships with other people in past 7D	4180186
1004772	How much did pain interfere with your ability to work (include work at home) in past 7D	4180186
1004773	How much did pain make it difficult to fall asleep in past 7D	4180186
1004774	How much did pain feel like a burden to you in past 7D	4180186
1004776	How often was pain distressing to you in past 7D	4180186
1004778	How often was your pain so severe you could think of nothing else in past 7D	4180186
1004779	How much did pain interfere with your ability to participate in social activities in past 7D	4180186
1004782	How much did pain interfere with your ability to make trips from home that kept you gone for more than 2H in past 7D	4180186
1004785	How often did you avoid social activities because it might make you hurt more in past 7D	4180186
1004787	How often did pain prevent you from walking more than 1 mile in past 7D	4180186
1004788	How often did pain prevent you from standing for more than one hour in past 7D	4180186
1004792	How much did pain interfere with your ability to remember things in past 7D	4180186
1004796	How often did pain restrict your social life to your home in past 7D	4180186
1004797	How often did pain keep you from getting into a standing position in past 7D	4180186
1004799	How irritable did you feel because of pain in past 7D	4180186
1004800	How much did pain interfere with your enjoyment of life in past 7D	4180186
1004802	To what degree did you have to push yourself to get things done because of your fatigue in past 7D	4180186
1004803	To what degree did your fatigue make you feel slowed down in your thinking in past 7D	4180186
1004806	How often are you less effective at work due to your fatigue (include work at home) in past 7D	4180186
1004807	How often did your fatigue make you feel slowed down in your thinking in past 7D	4180186
1004812	How often were you too tired to do errands in past 7D	4180186
1004814	How often did your fatigue interfere with your ability to engage in recreational activities in past 7D	4180186
1004815	How often did you have trouble finishing things because of your fatigue in past 7D	4180186
1004817	How often did you have to limit your social activities because of your fatigue in past 7D	4180186
1004818	How often were you too tired to do your household chores in past 7D	4180186
1004820	How often were you too tired to take a bath or shower in past 7D	4180186
1004821	How often did your fatigue make it difficult to organize your thoughts when doing things at home in past 7D	4180186
1004823	How often was it an effort to carry on a conversation because of your fatigue in past 7D	4180186
1004829	How often did your fatigue limit you at work (include work at home) in past 7D	4180186
1004835	How often did you have enough energy to exercise strenuously in past 7D	4180186
1004836	How often were you less effective at home due to your fatigue in past 7D	4180186
1004838	To what degree did your fatigue make you more forgetful in past 7D	4180186
1004839	To what degree did your fatigue interfere with your ability to engage in recreational activities in past 7D	4180186
1004842	To what degree did your fatigue interfere with your physical functioning in past 7D	4180186
1004844	To what degree did you have trouble finishing things because of your fatigue in past 7D	4180186
1004845	To what degree did your fatigue make you feel less alert in past 7D	4180186
1004850	How often did you experience extreme exhaustion in past 7D	4180186
1004852	How often did you feel your fatigue was beyond your control in past 7D	4180186
1004855	How often were you sluggish in past 7D	4180186
1004856	How often did you run out of energy in past 7D	4180186
1004858	How often did you feel tired in past 7D	4180186
1004861	How often did you have enough energy to enjoy the things you do for fun in past 7D	4180186
1004863	How often were you too tired to feel happy in past 7D	4180186
1004866	How tired did you feel on average in past 7D	4180186
1004868	How exhausted were you on average in past 7D	4180186
1004870	How fatigued were you on average in past 7D	4180186
1004873	How physically drained were you on average in past 7D	4180186
1004876	On how many D was your fatigue worse in the morning in past 7D	4180186
1004879	How fatigued were you on the day you felt least fatigued in past 7D	4180186
1004884	I feel fatigued during the past 7D	4180186
1004887	I felt tired in past 7D	4180186
1004888	I had trouble starting things because I was tired in past 7D	4180186
1004891	I was too tired to eat in past 7D	4180186
1004892	I needed help doing my usual activities in past 7D	4180186
1004903	I tried to get even when I was angry with someone in past 7D	4180186
1004904	I felt angry in past 7D	4180186
1004906	I felt like breaking things in past 7D	4180186
1004908	When I was angry, I sulked in past 7D	4180186
1004911	I felt bitter about things in past 7D	4180186
1004915	I felt angrier than I thought I should in past 7D	4180186
1004917	I was stubborn with others in past 7D	4180186
1004918	I felt annoyed in past 7D	4180186
1004919	I had a bad temper in past 7D	4180186
1004923	I felt like I needed help for my anger in past 7D	4180186
1004929	I felt frightened in past 7D	4180186
1004930	It scared me when I felt nervous in past 7D	4180186
1004931	I felt anxious in past 7D	4180186
1004932	I felt like I needed help for my anxiety in past 7D	4180186
1004934	I felt upset in past 7D	4180186
1004935	I had a racing or pounding heart in past 7D	4180186
1004937	I had sudden feelings of panic in past 7D	4180186
1004939	I had trouble paying attention in past 7D	4180186
1004941	I felt fidgety in past 7D	4180186
1004942	I felt something awful would happen in past 7D	4180186
1004945	I worried about other people's reactions to me in past 7D	4180186
1004946	I found it hard to focus on anything other than my anxiety in past 7D	4180186
1004949	I felt nervous in past 7D	4180186
1004950	I felt indecisive in past 7D	4180186
1004951	Many situations made me worry in past 7D	4180186
1004955	I felt tense in past 7D	4180186
1004958	I felt worthless in past 7D	4180186
1004960	I withdrew from other people in past 7D	4180186
1004962	I felt that I was not as good as other people in past 7D	4180186
1004963	I felt sad in past 7D	4180186
1004964	I felt that I wanted to give up on everything in past 7D	4180186
1004965	I felt that I was to blame for things in past 7D	4180186
1004968	I felt disappointed in myself in past 7D	4180186
1004969	I felt that I was not needed in past 7D	4180186
1004971	I felt depressed in past 7D	4180186
1004973	I felt discouraged about the future in past 7D	4180186
1004974	I felt unhappy in past 7D	4180186
1004978	I felt upset for no reason in past 7D	4180186
1004980	I felt that my life was empty in past 7D	4180186
1004981	I felt emotionally exhausted in past 7D	4180186
1004984	My sleep was restful in past 7D	4180186
1004986	I was satisfied with my sleep in past 7D	4180186
1004988	My sleep quality was...in past 7D	4180186
1004989	I got enough sleep in past 7D	4180186
1004990	It was easy for me to fall asleep in past 7D	4180186
1004991	I laid in bed for hours waiting to fall asleep in past 7D	4180186
1004995	I woke up and had trouble falling back to sleep in past 7D	4180186
1004997	My sleep was restless in past 7D	4180186
1004998	I felt lousy when I woke up in past 7D	4180186
1005002	I worried about not being able to fall asleep in past 7D	4180186
1005003	I felt worried at bedtime in past 7D	4180186
1005004	I had trouble stopping my thoughts at bedtime in past 7D	4180186
1005005	I felt sad at bedtime in past 7D	4180186
1005009	I tossed and turned at night in past 7D	4180186
1005012	I tried to sleep whenever I could in past 7D	4180186
1005013	My daytime activities are disturbed by poor sleep in past 7D	4180186
1005016	I had a hard time getting things done because I was sleepy in past 7D	4180186
1005017	I had a hard time concentrating because I was sleepy in past 7D	4180186
1005018	I had problems during the day because of poor sleep in past 7D	4180186
1005019	I had a hard time concentrating because of poor sleep in past 7D	4180186
1005023	I still felt sleepy when I woke up in past 7D	4180186
1005024	I had enough energy in past 7D	4180186
1005028	I was satisfied with the amount of time I spend doing leisure activities in past 7D	4180186
1005032	I was satisfied with my ability to do leisure activities in past 7D	4180186
1005036	I was happy with how much I do for my friends in past 7D	4180186
1005041	I was satisfied with my ability to do things for my family in past 7D	4180186
1005042	I was satisfied with how much work I can do (include work at home) in past 7D	4180186
1005043	I feel good about my ability to do things for my family in past 7D	4180186
1005046	I was happy with how much I do for my family in past 7D	4180186
1005047	I was satisfied with my ability to work (include work at home) in past 7D	4180186
1005050	I was satisfied with my ability to do household chores and tasks in past 7D	4180186
1005052	I was satisfied with my ability to perform my daily routines in past 7D	4180186
1005053	I was satisfied with my ability to meet the needs of those who depend on me in past 7D	4180186
1005058	I felt scared in past 7D	4180186
1005059	I worried about what could happen to me in past 7D	4180186
1005062	I worried when I went to bed at night in past 7D	4180186
1005067	It was hard for me to relax in past 7D	4180186
1005069	I felt scared that I might have trouble breathing because of my asthma in past 7D	4180186
1005071	I felt wheezy because of my asthma in past 7D	4180186
1005072	I had trouble sleeping at night because of my asthma in past 7D	4180186
1005073	It was hard for me to play sports or exercise because of my asthma in past 7D	4180186
1005074	It was hard to take a deep breath because of my asthma in past 7D	4180186
1005076	I coughed because of my asthma in past 7D	4180186
1005078	I had asthma attacks in past 7D	4180186
1005081	I was bothered by the amount of time I spent wheezing in past 7D	4180186
1005082	It was hard for me to play with pets because of my asthma in past 7D	4180186
1005087	I didn't care about anything in past 7D	4180186
1005088	I wanted to be by myself in past 7D	4180186
1005089	I thought that my life was bad in past 7D	4180186
1005091	I felt alone in past 7D	4180186
1005092	I could not stop feeling sad in past 7D	4180186
1005094	I felt everything in my life went wrong in past 7D	4180186
1005096	Being sad made it hard for me to do things with my friends in past 7D	4180186
1005100	Being tired made it hard for me to play or go out with my friends as much as I'd like in past 7D	4180186
1005101	I felt more tired than usual when I woke up in the morning in past 7D	4180186
1005103	I felt weak in past 7D	4180186
1005108	I was so tired it was hard for me to pay attention in past 7D	4180186
1005110	I was too tired to do things outside in past 7D	4180186
1005113	I was too tired to go up and down a lot of stairs in past 7D	4180186
1005114	I was too tired to read in past 7D	4180186
1005115	I was too tired to take a bath or shower in past 7D	4180186
1005116	I was too tired to watch television in past 7D	4180186
1005118	I could ride a bike in past 7D	4180186
1005120	I could walk more than one block in past 7D	4180186
1005122	I could keep up when I played with other kids in past 7D	4180186
1005123	I could get out of bed by myself in past 7D	4180186
1005125	I could stand up by myself in past 7D	4180186
1005127	I could walk up stairs without holding on to anything in past 7D	4180186
1005129	I used a walker, cane or crutches to get around in past 7D	4180186
1005130	I could carry my books in my backpack in past 7D	4180186
1005131	I could move my legs in past 7D	4180186
1005132	I could get up from a regular toilet in past 7D	4180186
1005134	I could go up one step in past 7D	4180186
1005135	I could stand up on my tiptoes in past 7D	4180186
1005137	I have been physically able to do the activities I enjoy most in past 7D	4180186
1005138	I could run a mile in past 7D	4180186
1005142	I felt angry when I had pain in past 7D	4180186
1005143	I had trouble doing schoolwork when I had pain in past 7D	4180186
1005144	I had trouble sleeping when I had pain in past 7D	4180186
1005146	It was hard for me to remember things when I had pain in past 7D	4180186
1005147	I hurt all over my body in past 7D	4180186
1005149	It was hard for me to walk one block when I had pain in past 7D	4180186
1005152	It was hard to have fun when I had pain in past 7D	4180186
1005153	It was hard to stay standing when I had pain in past 7D	4180186
1005154	It was hard for me to pay attention when I had pain in past 7D	4180186
1005157	I felt good about my friendships in past 7D	4180186
1005165	I was able to talk about everything with my friends in past 7D	4180186
1005166	I was good at making friends in past 7D	4180186
1005168	Other kids wanted to be my friend in past 7D	4180186
1005175	I could pour a drink from a full pitcher in past 7D	4180186
1005176	I could pull a shirt on over my head by myself in past 7D	4180186
1005182	I felt mad in past 7D	4180186
1005183	I was so angry I felt like throwing something in past 7D	4180186
1005184	I was so angry I felt like yelling at somebody in past 7D	4180186
1005200	How often did pain make you feel depressed in past 7D	4180186
1005209	I needed help with a bath in past 7D	4180186
1005216	I had trouble breathing because of my asthma in past 7D	4180186
1005217	I could put on my socks by myself in past 7D	4180186
1005218	I could write with a pen or pencil in past 7D	4180186
1005224	I could dial a phone in past 7D	4180186
1005227	I could wash my face with a cloth in past 7D	4180186
1005229	I could move my hands or fingers in past 7D	4180186
1005253	25-Hydroxyvitamin D	4180186
1005263	Lysosomal storage disorders newborn screening comment-discussion	4180186
1005264	Fabry disease newborn screening comment-discussion	4180186
1005268	Niemann Pick disease A+B newborn screening comment-discussion	4180186
1005284	I felt sad in the past 7D	4180186
1005285	I felt tired in the past 7D	4180186
1005286	PROMIS.PEDS	4180186
1005288	POC	4180186
1005292	JDS/JSCC	4180186
1005319	PhenX measure - tobacco - 30D quantity and frequency	4180186
1005330	PhenX measure - substance - 30D frequency	4180186
1005369	PhenX measure - alcohol - maximum drinks in 24H	4180186
1005483	PhenX measure - respiratory - exercise capacity - 6M walk test	4180186
1005484	PhenX - respiratory - exercise capacity - 6M walk test protocol 090601	4180186
1005573	PhenX - gross motor function - 6-12Y protocol 131203	4180186
1005879	Where was your biological mother born	4180186
1005880	Where was your mother's mother born	4180186
1005881	Where was your father's mother born	4180186
1005903	Niemann Pick disease A+B	4180186
1005911	MCncDiff	4180186
1005919	Do you now smoke cigarettes every D, some D, or not at all	4180186
1005920	Has there ever been a period in your life when you smoked cigarettes every day for at least 30D	4180186
1005930	During the past 30D, on how many D did you smoke part or all of a cigarette	4180186
1005931	What is your best estimate of the number of D you smoked part or all of a cigarette during the past 30D	4180186
1005948	Has there ever been a period of several D or more when you spent so much time drinking or recovering from the effects of alcohol that you had little time for anything else	4180186
1005976	Do, or did, you smoke more frequently during the first Hs after waking than during the rest of the day	4180186
1005982	Did you ever use marijuana at least 21 times in a single Y	4180186
1005983	Has there ever been a period of a Mo or more when a great deal of your time was spent using marijuana, getting marijuana, or getting over its effects	4180186
1005999	Was there ever a period of a Mo or more when a great deal of your time was spent getting over this drug or its effects	4180186
1006007	Have you often used this drug, used steadily, more D or in larger amounts than you intended to	4180186
1006023	Drug used in past 30D	4180186
1006030	What Mo did you start living there	4180186
1006036	How many Ys have or did you live there	4180186
1006040	During the past 12Mo, has there been water or dampness in your home from broken pipes, leaks, heavy rain, or floods	4180186
1006044	During which Mo do you usually start using air conditioning to cool this house or apartment	4180186
1006048	During which Mo do you usually start using heating devices	4180186
1006070	How many H did you work last W at all jobs or businesses	4180186
1006071	Do you usually work 35H or more per W in total at all jobs or businesses	4180186
1006082	Since the age 16, did you ever work for 6Mo or more	4180186
1006087	In what Y did you stop working at this job	4180186
1006098	Overall, for how many Y were you involved in this hobby	4180186
1006113	In what Mo and Y did child begin the first or next attendance at day care or preschool outside the home	4180186
1006128	Did you go to the dry cleaners during the past W	4180186
1006129	Did you bring home any items from the cleaners that were dry-cleaned during the past W	4180186
1006137	During the last 48H, the study period, did you or anyone else park a car or other motor vehicle in	4180186
1006138	During the last 48H, the study period, did you or anyone else start a car or other motor vehicle in	4180186
1006139	During the last 48H, the study period, was there any diesel vehicles parked around the house	4180186
1006166	Which of the following repairs was done in your home during the past 12Mo	4180186
1006173	In the past Y were new carpets or rugs installed	4180186
1006176	Number of D vacuum has been used since changing bag or emptying the collection chamber	4180186
1006187	In this age range, did you drink alcoholic beverages at least once a W for 6Mo or more	4180186
1006188	For how many Y did you drink alcoholic beverages at least once a W for 6Mo or more	4180186
1006190	Average H per W you participated in strenuous exercise activities or sports like swimming laps, aerobics, calisthenics, running, jogging, basketball, cycling on hills, racquetball during this age range	4180186
1006191	Average Mo per Y you participated in strenuous exercise activities or sports like swimming laps, aerobics, calisthenics, running, jogging, basketball, cycling on hills, racquetball during this age range	4180186
1006193	Average Mo per Y you participated in moderate exercise activities or sports like brisk walking, golf, volleyball, cycling on level streets, recreational tennis, or softball during this age range	4180186
1006194	Physical activity in past Y	4180186
1006195	Average H per D did you spend doing this activity	4180186
1006197	For how many H per D were you exposed to smoke from other peoples cigarettes or tobacco products during this time at this location	4180186
1006204	How many Y in total did you take premarin - exclude those periods when you temporarily stopped	4180186
1006214	When using progestin or progesterone, for how many D each Mo would you usually take it	4180186
1006232	Y of diagnosis of clinician-diagnosed illness	4180186
1006245	Are you considering quitting smoking during the next 6Mo	4180186
1006268	How many total tablets per W of pain-relieving medication	4180186
1006271	In the past 3Y have you taken statins, lovastatin - mevacor, atorvastatin - lipitor, rosuvastain - crestor, pravastatin - pravachol, simvastatin - zocor, fluvastatin - lescol	4180186
1006272	In the past 3Y have you taken steroids, predniSONE, dexamethasone - decadron, solumedrol - medrol dose-pack	4180186
1006286	How often have you added this item to babys bottle or breast milk in past 2W	4180186
1006291	How many servings of this beverage per D did your child drink	4180186
1006307	Does your child now take vitamins with fluoride in them or any other kind of fluoride tablets, drops or supplements	4180186
1006326	If your baby was breastfed or fed breast milk in past 7D, about how long did an average breastfeeding session last	4180186
1006327	How many times in the past 7D was your baby fed pumped breast milk to drink	4180186
1006328	The amount of this beverage per serving during the past W	4180186
1006332	How many servings of this beverage per W did your child drink	4180186
1006337	Pre-bronchodilator forced expiratory volume in 1 second attempt	4180186
1006338	Pre-bronchodilator forced vital capacity attempt	4180186
1006359	Thoracic and cardiac surgery.medical student	4180186
1006360	Pulmonary disease.medical student	4180186
1006363	Oxygen therapy type during walk test	4180186
1006365	Stopped or paused before 6M	4180186
1006366	Reason stopped or paused before 6M	4180186
1006371	Dyspnea^resting	4180186
1006388	Do you usually cough like this on most days for 3 consecutive Mo or more during the Y	4180186
1006389	For how many Y have you had this cough	4180186
1006391	Do you usually bring up phlegm like this as much as twice a D, 4 or more D of the W	4180186
1006394	Do you bring up phlegm like this on most D for 3 consecutive Mo or more during the Y	4180186
1006396	Have you had periods or episodes of increased cough and phlegm lasting for 3W or more each Y	4180186
1006397	For how long have you had at least 1 cough and phlegm episode per Y	4180186
1006399	Does your chest ever sound wheezy or whistling most Ds or nights	4180186
1006414	In the last 3Y, how many such illnesses, with increased phlegm, did you have which lasted a W or more	4180186
1006444	Have you ever worked for a Y or more in any dusty job	4180186
1006453	How many cigarettes do you smoke per D now	4180186
1006454	On the average of the entire time you smoked, how many cigarettes did you smoke per D	4180186
1006466	How many cigars are you smoking per W now	4180186
1006468	Total Y worked in dusty job	4180186
1006479	In the last 12Mo, have you had wheezing or whistling in your chest at any time	4180186
1006480	In the last 12Mo, does your chest ever sound wheezy or whistling when you have a cold	4180186
1006485	In the past 12Mo, have you been bothered by sneezing or a runny or blocked nose when you did not have a cold or the flu	4180186
1006486	In the past 12Mo, have you been bothered by watery, itchy, or burning eyes when you did not have a cold or the flu	4180186
1006490	In the past Y, have you been to the emergency room or hospitalized for lung problems	4180186
1006497	Have you had wheezing or whistling in the chest in the last 12Mo	4180186
1006498	How many attacks of wheezing have you had in the last 12Mo	4180186
1006501	In the last 12Mo, has your chest sounded wheezy during or after exercise	4180186
1006502	In the last 12Mo, have you had a dry cough at night, apart from a cough associated with a cold or chest infection	4180186
1006509	Have you had this itchy rash at any time in the last 12Mo	4180186
1006511	Has this itchy rash cleared completely at any time during the last 12Mo	4180186
1006512	In the last 12Mo, how often, on average, have you been kept awake at night by this itchy rash	4180186
1006586	Total patients age 18-54 Y dialysing at facility at end of reporting period	4180186
1006588	Dialysis patients age 18 to 54 Y employed full-time or part-time at end of reporting period	4180186
1006615	In the last 12Mo, how often, on average, has your childs sleep been disturbed due to wheezing	4180186
1006619	In the last 12Mo, has your child had a dry cough at night, apart from a cough associated with a cold or chest infection	4180186
1006621	In the past 12Mo, has your child had a problem with sneezing, or a runny or blocked nose, when he or she did not have a cold or the flu	4180186
1006622	In the past 12Mo, has this nose problem been accompanied by itchy, watery eyes	4180186
1006623	In the past 12Mo, how much did this nose problem interfere with your childs daily activities	4180186
1006637	Over the past 3Mo, I have coughed	4180186
1006638	Over the past 3Mo, I have brought up phlegm - sputum	4180186
1006639	Over the past 3Mo, I have had shortness of breath	4180186
1006640	Over the past 3Mo, I have had attacks of wheezing	4180186
1006641	During the past 3Mo, how many severe or very unpleasant attacks of chest trouble have you had	4180186
1006643	Over the past 3Mo, in an average W, how many good Ds, with little chest trouble, have you had	4180186
1006818	Including any methods you may have already told me about and methods you may have used only once, during the last 12Mo, which of these methods did you and she use to prevent pregnancy or sexually transmitted diseases	4180186
1006820	How long, how many Mo, have you and your partner been trying to get pregnant	4180186
1006835	How many Mo have you used nolvadex	4180186
1006850	What was your D per Mo pattern of progesterone use	4180186
1006869	Over the past 4W how often were you able to get an erection during sexual activity	4180186
1006871	Over the past 4W when you attempted sexual intercourse, how often were you able to penetrate - enter your partner	4180186
1006873	Over the past 4W during sexual intercourse, how difficult was it to maintain your erection to completion of intercourse	4180186
1006874	Over the past 4W how many times have you attempted sexual intercourse	4180186
1006875	Over the past 4W when you attempted sexual intercourse, how often was it satisfactory for you	4180186
1006877	Over the past 4W when you had sexual stimulation or intercourse, how often did you ejaculate	4180186
1006880	Over the past 4W how would you rate your level of sexual desire	4180186
1006881	Over the past 4W how satisfied have you been with your overall sex life	4180186
1006882	Over the past 4W how satisfied have you been with your sexual relationship with your partner	4180186
1006900	How many W or Mo did that pregnancy last	4180186
1006902	In which Mos of the pregnancy did you have frequent nausea or vomiting	4180186
1006904	During the 3Mo before you got pregnant, how many times did you drink 4 alcoholic drinks or more in one sitting	4180186
1006905	During the last 3Mo of your pregnancy, how many alcoholic drinks did you have in an average W	4180186
1006921	On how many of these occasions did you or your partner use a condom in the past 12Mo	4180186
1006935	During the last 12Mo has your child had difficulty drawing or coloring	4180186
1006936	During the last 12Mo has your child appeared to have difficulty seeing	4180186
1006953	In the past 12Mo, how many times has he or she seen an eye doctor for his or her myopia, nearsightedness	4180186
1006960	For the past 3Mo or longer, have you had dry eyes, foreign body sensation with itching and burning, sandy feeling, not related to allergy	4180186
1006961	Do you currently use artificial tears or prescription medication for dry eyes regularly for 3Mo or longer	4180186
1006972	When did your child first start wearing an eye patch	4180186
1006976	In the last 3Mo of your pregnancy, how many cigarettes did you smoke on an average D	4180186
1006982	What Y did your sunlight exposure change	4180186
1006987	During the Mos of April through September, how many H each D of this leisure time did you spend outside in direct sunlight between 10 AM and 4 PM	4180186
1006988	Did your main daytime activities during your leisure time have you over water for a total of three or more H a D, for example sailing, fishing or swimming	4180186
1007163	I am fascinated by dates	4180186
1007323	During the past 30D, about how often did you feel nervous	4180186
1007324	During the past 30D, about how often did you feel hopeless	4180186
1007325	During the past 30D, about how often did you feel restless or fidgety	4180186
1007327	Taking them altogether, did these feelings occur more often in the past 30D than is usual for you, about the same as usual, or less often than usual	4180186
1007328	During the past 30D, how many Ds out of 30 were you totally unable to work or carry out your normal activities because of these feelings	4180186
1007329	Not counting the D you reported in response to 3, how many D in the past 30 were you able to do only half or less of what you would normally have been able to do, because of these feelings	4180186
1007466	On how many Ds in the last 3Mo did you have a headache, if headache lasted more than 1D, count each D	4180186
1007469	Because of your headaches on how many Ds in the last 3Mo did you not do household work	4180186
1007489	If more injuries with LOC, how many longer than 30M	4180186
1007503	Jaw at rest for 5S	4180186
1007504	Mouth open for 5S	4180186
1007526	Has there been a period of several Ws when you felt you had to count something, like the squares in a tile floor, and couldn't resist doing it even when you tried to	4180186
1007532	Have there been periods of several Ds or more when your childs friends or other family members told you that your child seemed unusually happy or high	4180186
1007538	Has your child had periods lasting several Ds or more when he or she felt depressed or irritable, and then other periods when he or she felt extremely high, elated, and overflowing with energy	4180186
1007544	Have you experienced such highs in the past 12Mo	4180186
1007545	If yes, please estimate how many D you spent in highs during the last 12Mo	4180186
1007578	About how old were you the first time you had a period of 2Ws like this	4180186
1007583	Falling asleep in past 7D	4180186
1007584	Sleep during the night in past 7D	4180186
1007585	Waking up too early in past 7D	4180186
1007586	Sleeping too much in past 7D	4180186
1007588	Decreased appetite in past 7D	4180186
1007591	Concentration or decision making in past 7D	4180186
1007592	Thoughts of death or suicide in past 7D	4180186
1007593	General interest in past 7D	4180186
1007595	Feeling slowed down in past 7D	4180186
1007626	Do you normally work or attend school during the D and sleep at night	4180186
1007639	How many Hs and Ms does it take for you to fully awaken from a nap	4180186
1007643	How many Hs of sleep per night do you think you need to feel fully rested the next day	4180186
1007658	How does this loss of sleep affect you the next D with respect to your mood	4180186
1007666	When you tried to shift your sleep schedule to an earlier bedtime, at least 1 to 2H earlier, did you have difficulty falling asleep	4180186
1007676	In the past Y, have you awakened during the night and had a hard time getting back to sleep	4180186
1007685	How old were you when you first experienced this kind of difficulty with sleeping, for at least 1Mo	4180186
1007689	Do you feel so sleepy during the D that it interrupts your normal activities, such as driving, reading, or concentrating at work or school, even when you have had enough sleep the night before	4180186
1007694	What is the longest period of time that you have felt this overwhelming desire to go to sleep, on most Ds	4180186
1007695	When you do doze off during the D and take a nap, do you find this sleep refreshing	4180186
1007792	Have you ever had any sudden loss of vision, or blurring, lasting 24 H or longer	4180186
1007795	Have you ever had a sudden spell of double vision, which lasted 24 H or longer	4180186
1007805	Have you ever had any sudden episode of paralysis or weakness on one side of your body, including your face, arm, or leg which lasted at least 24 H	4180186
1007845	Sleep or behavior disorders diagnosed or suspected in your child's brothers, sisters, or parents	4180186
1007869	Did your main daytime activities during a typical work W have you on water for a total of three or more H a D, for example working on a boat	4180186
1007873	In the past 12Mo, how many times have you seen an eye doctor for your glaucoma	4180186
1007877	Have you ever had a period lasting one Mo or longer when most of the time you felt worried, tense, or anxious	4180186
1007909	Made yourself vomit often in last 3Mo in order to avoid gaining weight	4180186
1007910	How many times per W on average over the past 3Mo have you used laxatives or diuretics to prevent weight gain or counteract the effects of eating	4180186
1007911	How many times per W on average over the past 3Mo have you fasted - skipped at least 2 meals in a row - to prevent weight gain or counteract the effects of eating	4180186
1007914	Have you been taking birth control pills during the past 3Mo	4180186
1007946	How many Hs were you sleeping then	4180186
1008036	My child - 6-12Y	4180186
1008061	Have you brought this bag with you and are these all the medications that you have taken in the past 2W	4180186
1008123	Was all of the solution was consumed in 10M	4180186
1008146	Have you had any surgery on your hands or wrists in the past 3Mo	4180186
1008159	30S	4180186
1008164	2M	4180186
1008170	Seconds held, if less than 10S	4180186
1008183	How long you spend doing this activity on this D	4180186
1008189	What two Ds do you consider your weekend Ds	4180186
1008200	In a typical W, during the past 4W, did you do this activity	4180186
1008201	How many total Hs a W did you usually do it	4180186
1008203	Problems with the 7D PAR interview	4180186
1008205	Do you think this was a valid 7D PAR interview	4180186
1008206	Reason not a valid 7D PAR interview	4180186
1008219	Procedure for completing 7D activity diary explained to participant	4180186
1008226	How many Ds was actigraph worn	4180186
1008245	Kinds of physical activity you usually performed while on the job this last Y	4180186
1008247	H sitting each D in this situation	4180186
1008248	Kinds of physical activity you usually performed during leisure time this last Y	4180186
1008277	I can be physically active during my free time on most Ds even if it is very hot or cold outside	4180186
1008278	I can ask my best friend to be physically active with me during my free time on most Ds	4180186
1008281	I can be physically active during my free time on most Ds no matter how busy my D is	4180186
1008292	Are you pregnant, or is there a chance you could become pregnant during the next Mo	4180186
1008293	Have you received any vaccinations in the past 4W	4180186
1008299	Has the child take cortisone, predniSONE, other steroids, or anticancer drugs or had x-ray treatments in the past 3Mo	4180186
1008300	Has the child received a transfusion of blood or blood products or been given a medicine called immune gamma globulin in the past Y	4180186
1008311	Travelled to country this Y	4180186
1008313	Travelled to country 2Ys ago	4180186
1008315	Travelled to country 4Ys ago	4180186
1008316	Travelled to country 5Ys ago	4180186
1008317	Stay was longer than 30 consecutive Ds this Y	4180186
1008319	Stay was longer than 30 consecutive Ds 2Ys ago	4180186
1008320	Stay was longer than 30 consecutive Ds 3Ys ago	4180186
1008322	Stay was longer than 30 consecutive Ds 5Ys ago	4180186
1008341	How much difficulty do you have standing or being on your feet for about 2Hs	4180186
1008390	How many of these do you smoke per D	4180186
1008409	Now thinking about your physical health, which includes physical illness and injury, for how many Ds during the past 30D was your physical health not good	4180186
1008410	Now thinking about your mental health, which includes stress, depression, and problems with emotions, for how many Ds during the past 30D was your mental health not good	4180186
1008411	During the past 30D, for about how many Ds did poor physical or mental health keep you from doing your usual activities, such as self-care, work, or recreation	4180186
1008418	Did you use one of the following forms of birth control each time you had sexual intercourse in the past 7D	4180186
1008431	Seizures requiring therapy for 6Mo	4180186
1008446	Claudication for 6Mo	4180186
1008526	Skin ulceration for >6Mo	4180186
1008603	In the last Mo, how often have you felt that you were unable to control the important things in your life	4180186
1008604	In the last Mo, how often have you felt nervous and stressed	4180186
1008605	In the last Mo, how often have you felt confident about your ability to handle your personal problems	4180186
1008611	In the last Mo, how often have you felt difficulties were piling up so high that you could not overcome them	4180186
1008720	How many times in the last Y have you purposely set fire to a house, building, car, or other property or tried to do so	4180186
1008721	How many times in the last Y have you broken city curfew laws	4180186
1008722	How many times in the last Y have you avoided paying for things such as movies, bus or subway rides, and food or computer services	4180186
1008723	How many times in the last Y have you gone into or tried to go into a building to steal something	4180186
1008724	How many times in the last Y have you stolen or tried to steal money or things worth 5 dollars or less	4180186
1008725	How many times in the last Y have you stolen or tried to steal money or things worth between 5 and 50 dollars	4180186
1008726	How many times in the last Y have you stolen or tried to steal money or things worth more than 50 but less than 100 dollars	4180186
1008729	How many times in the last Y have you snatched someone's purse or wallet or picked someones pocket	4180186
1008731	How many times in the last Y have you knowingly bought, sold or held stolen goods or tried to do any of these things	4180186
1008732	How many times in the last Y have you gone joyriding	4180186
1008733	How many times in the last Y have you stolen or tried to steal a motor vehicle such as a car or motorcycle	4180186
1008735	How many times in the last Y have you used or tried to use a credit or bank cards without the owners permission	4180186
1008736	How many times in the last Y have you tried to cheat someone by selling them something that was worthless or not what you said it was	4180186
1008737	How many times in the last Y have you attacked someone with a weapon or with the idea of seriously hurting or killing them	4180186
1008739	How many times in the last Y have you used a weapon, force, or strong-arm methods to get money or things from people	4180186
1008740	How many times in the last Y have you thrown objects such as rocks or bottles at people, other than events you have already mentioned	4180186
1008742	How many times in the last Y have you been paid for having sexual relations with someone	4180186
1008744	How many times in the last Y have you had or tried to have sexual relations with someone against their will, other than events you just mentioned	4180186
1008745	How many times in the last Y have you sold marijuana or hashish, pot, grass, hash	4180186
1008749	How many times in the past Y	4180186
1008753	How many times in the last Y have you lied about your age to get into some place or to buy something	4180186
1008754	How many times in the last Y have you cheated on school tests	4180186
1008756	How many times in the last Y have you carried a hidden weapon	4180186
1008757	How many times in the last Y have you been loud, rowdy, or unruly in a public place so that people complained about it or you got in trouble	4180186
1008759	How many times in the last Y have you made obscene telephone calls such as calling someone and saying dirty things	4180186
1008760	How many times in the last Y have you been drunk in a public place	4180186
1008763	How many times in the last Y did you steal, or try to steal, money or things worth between 5 and 100 dollars	4180186
1008764	How many times in the last Y did you steal, or try to steal, money or things worth between 100 and 500 dollars	4180186
1008766	How many times in the last Y have you knowingly bought, sold, or held stolen goods or tried to do any of these things	4180186
1008767	How many times in the last Y have you converted a vehicle, that is, taken a motor vehicle such as a car or motorcycle for a ride or drive without the owner's permission, when you didn't mean to keep or sell it	4180186
1008772	How many times in the last Y have you been so angry with a child that you hit them	4180186
1008773	How many times in the last Y have you attacked an adult with a weapon or with the idea of seriously hurting or killing them	4180186
1008774	How many times in the last Y have you hit an adult with the idea of hurting them	4180186
1008775	How many times in the last Y have you used a weapon, force or strong arm methods to rob a person, shop, bank, or other business	4180186
1008777	How many times in the last Y have you embezzled money - that means used money entrusted to your care for some purpose not intended	4180186
1008780	How many times in the last Y did you give false information on a tax form, an insurance claim, or on applications for a loan or bank account	4180186
1008781	How many times in the last Y did you use a false name or alias so you couldn't be identified	4180186
1008782	How many times in the last Y did you move away from a flat or house without paying the final bills or rent	4180186
1008783	How many times in the last Y have you made illegal copies of computer software or video files	4180186
1008784	How many times in the last Y did you buy something on credit and then never made the payments	4180186
1008789	How many times in the last Y have you used a harder drug, such as heroin, cocaine or LSD	4180186
1008790	How many times in the last Y have you paid someone to have sex with you	4180186
1008791	How many times in the last Y have you been paid, or received other favors for having sex with someone	4180186
1008865	Before you turned 12Y old (when you were in grade school), were you ever physically abused	4180186
1008881	Has pain that has been most uncomfortable in this area the past 12Mo	4180186
1008894	During the past 12Mo, have you had pain in the area shaded on the diagram	4180186
1008970	What Ys did this happen	4180186
1008972	How often did you have stomach contents - liquid or food moving upwards to your throat or mouth - regurgitation in the past 7D	4180186
1008973	How often did you have pain in the center of the upper stomach in the past 7D	4180186
1008974	How often did you have nausea in the past 7D	4180186
1008981	Have you been exposed to loud noise or listened to music with headphone in the past 24H	4180186
1008982	How many Hs ago did the noise or music end	4180186
1009015	UPPS-P	4180186
1009182	For how many Y have you been exposed to this loud sound	4180186
1009183	How many H per W have you been exposed	4180186
1009377	Parents separated in last 12Mo	4180186
1009401	Y exposure started	4180186
1009406	How many Hs per D were you exposed	4180186
1009412	Do you drink alcohol regularly, every W	4180186
1009427	RelSRat	4180186
1009461	End stage renal disease medical evidence report, medicare entitlement &or patient registration - OMB CMS form 2728	4180186
1009469	End stage renal disease co-morbidities ICD code	4180186
1009470	End stage renal disease patients in dialysis treatment - end stage renal disease form 2728	4180186
1009537	I felt exhausted in the past 7D	4180186
1009540	I was too tired to do my household chores in the past 7D	4180186
1009541	I was too tired to leave the house in the past 7D	4180186
1009547	I had trouble finishing things because I was too tired in the past 7D	4180186
1009549	I was too tired to eat in the past 7D	4180186
1009550	I was so tired that I needed to rest during the day in the past 7D	4180186
1009552	I needed help doing my usual activities because of weakness in the past 7D	4180186
1009553	I had to limit my social activity because I was physically weak in the past 7D	4180186
1009585	I had to read something several times to understand it in the past 7D	4180186
1009588	I had trouble remembering new information, like phone numbers or simple instructions in the past 7D	4180186
1009590	My thinking was slow in the past 7D	4180186
1009593	I made simple mistakes more easily in the past 7D	4180186
1009595	I had trouble remembering whether I did things I was supposed to do, like taking a medicine or buying something I needed in the past 7D	4180186
1009598	I reacted slowly to things that were said or done in the past 7D	4180186
1009599	I had trouble forming thoughts in the past 7D	4180186
1009601	I had trouble making decisions in the past 7D	4180186
1009602	I had trouble planning out steps of a task in the past 7D	4180186
1009605	I got impatient with other people in the past 7D	4180186
1009606	I was irritable around other people in the past 7D	4180186
1009607	I was bothered by little things in the past 7D	4180186
1009609	I was in conflict with others in the past 7D	4180186
1009610	I felt impulsive in the past 7D	4180186
1009611	People told me that I talked in a loud or excessive manner in the past 7D	4180186
1009612	I said or did things that other people probably thought were inappropriate in the past 7D	4180186
1009613	I suddenly became emotional for no reason in the past 7D	4180186
1009614	I felt restless in the past 7D	4180186
1009617	I threatened violence toward people or property in the past 7D	4180186
1009641	I had to force myself to get up in the morning in the past 7D	4180186
1009642	I had trouble stopping my thoughts at bedtime in the past 7D	4180186
1009644	I had trouble sleeping because of bad dreams in the past 7D	4180186
1009649	I can keep up with my family responsibilities in the past 7D	4180186
1009650	I am able to do all of my regular family activities in the past 7D	4180186
1009652	I am able to do all of my regular activities with friends in the past 7D	4180186
1009653	I can keep up with my social commitments in the past 7D	4180186
1009654	I am able to participate in leisure activities in the past 7D	4180186
1009655	I am able to perform my daily routines in the past 7D	4180186
1009656	I can keep up with my work in the past 7D	4180186
1009657	I have trouble meeting the needs of my family in the past 7D	4180186
1009658	I have to limit my regular family activities in the past 7D	4180186
1009659	I am able to do all of the family activities that people expect me to do in the past 7D	4180186
1009661	I am able to maintain my friendships as much as I would like in the past 7D	4180186
1009662	I can do everything for my friends that I want to do in the past 7D	4180186
1009663	I am able to do all of the activities with friends that people expect me to do in the past 7D	4180186
1009665	I feel limited in the amount of time I have to visit friends in the past 7D	4180186
1009667	I am able to do all of my regular leisure activities in the past 7D	4180186
1009669	I am able to do my hobbies or leisure activities in the past 7D	4180186
1009673	I have to limit social activities outside my home in the past 7D	4180186
1009675	I can do all the leisure activities that I want to do in the past 7D	4180186
1009681	I am able to do all of my usual work in the past 7D	4180186
1009683	My ability to do my work is as good as it can be in the past 7D	4180186
1009686	I am able to do all of the work that people expect me to do in the past 7D	4180186
1009687	I am limited in doing my work in the past 7D	4180186
1009689	I am bothered by my limitations in regular family activities in the past 7D	4180186
1009691	I am bothered by limitations in my regular activities with friends in the past 7D	4180186
1009696	I am satisfied with my current level of activity with family members in the past 7D	4180186
1009699	I am disappointed in my ability to socialize with friends in the past 7D	4180186
1009701	I feel that others are disappointed in my ability to do community activities in the past 7D	4180186
1009702	I am disappointed in my ability to do leisure activities in the past 7D	4180186
1009703	I am bothered by limitations in doing my hobbies or leisure activities in the past 7D	4180186
1009706	I am disappointed in my ability to work in the past 7D	4180186
1009707	I am bothered by limitations in performing my daily routines in the past 7D	4180186
1009776	I felt too sad to do things with friends in the past 7D	4180186
1009780	I was bored in the past 7D	4180186
1009781	I felt frustrated in the past 7D	4180186
1009783	I had trouble sleeping in the past 7D	4180186
1009784	I felt that no one loved me in the past 7D	4180186
1009785	I cried more often than usual in the past 7D	4180186
1009786	I felt too sad to do my schoolwork in the past 7D	4180186
1009788	Being worried made it hard for me to be with my friends in the past 7D	4180186
1009794	I worry about how my health will affect my future in the past 7D	4180186
1009795	Because of my health, I worry about having a boyfriend or girlfriend in the past 7D	4180186
1009797	I get nervous more easily than other people in the past 7D	4180186
1009804	It was hard to do schoolwork because I was angry in the past 7D	4180186
1009805	I felt angry in the past 7D	4180186
1009806	I was so mad that I felt like throwing something in the past 7D	4180186
1009807	I was so mad that I felt like hitting something in the past 7D	4180186
1009810	I was so mad that I acted grouchy towards other people in the past 7D	4180186
1009813	I was happy with the friends I had in the past 7D	4180186
1009814	I felt comfortable talking with my friends in the past 7D	4180186
1009815	I had fun with my friends in the past 7D	4180186
1009816	I was able to talk openly with my friends in the past 7D	4180186
1009817	I was able to stand up for myself in the past 7D	4180186
1009818	I think I have fewer friends than other people my age in the past 7D	4180186
1009819	My friends ignored me in the past 7D	4180186
1009822	I got along with my parents or guardians in the past 7D	4180186
1009824	I was happy at home in the past 7D	4180186
1009826	I got along well with my teachers in the past 7D	4180186
1009829	My parents or guardians seem to know what's important to me in the past 7D	4180186
1009830	I felt comfortable talking with my parents or guardians in the past 7D	4180186
1009844	Being tired made it hard to play or go out with my friends as much as I would like in the past 7D	4180186
1009847	I had energy or strength in the past 7D	4180186
1009848	I could do my usual things at home in the past 7D	4180186
1009850	I needed help doing my usual things at home in the past 7D	4180186
1009851	I felt weak in the past 7D	4180186
1009853	I had pain in the past 7D	4180186
1009854	When you had pain, how long did it last in the past 7D	4180186
1009855	I had trouble watching TV when I had pain in the past 7D	4180186
1009857	I could walk between rooms in the past 7D	4180186
1009860	I could get up from the floor by myself in the past 7D	4180186
1009861	I could sit on a bench without support for 15M in the past 7D	4180186
1009866	I could walk on rough, uneven surfaces such as lawns, gravel driveway in the past 7D	4180186
1009869	I could get in and out of a bus in the past 7D	4180186
1009870	I could walk while wearing a backpack full of books in the past 7D	4180186
1009871	I could do exercise that others my age can do in the past 7D	4180186
1009872	I could move up and down curbs using a wheelchair in the past 7D	4180186
1009877	I could manage getting on and off the tub bench from a wheelchair in the past 7D	4180186
1009878	I could manage getting on and off the toilet from a wheelchair in the past 7D	4180186
1009879	I could stand up from an armless straight chair using my wheelchair in the past 7D	4180186
1009880	I could move on slightly uneven surfaces, cracked pavement, using a wheelchair in the past 7D	4180186
1009882	I could move for 30M using a wheelchair in the past 7D	4180186
1009885	I could do a wheelie, like popping front wheels off the floor and balancing on back wheels, using my wheelchair in the past 7D	4180186
1009886	I could reach for a high object from my wheelchair in the past 7D	4180186
1009888	I could open a door that faced away from my wheelchair in the past 7D	4180186
1009889	I could open a door that was facing my wheelchair in the past 7D	4180186
1009890	I could lock and unlock my wheelchair brakes in the past 7D	4180186
1009894	With a walking aid, I could walk for 15M in the past 7D	4180186
1009895	With a walking aid, I could walk for 30M in the past 7D	4180186
1009897	With a walking aid, I could walk on rough, uneven surfaces like lawns or gravel driveway in the past 7D	4180186
1009898	With a walking aid, I could walk up and down inclines or ramps in the past 7D	4180186
1009899	With a walking aid, I could walk up and down curbs in the past 7D	4180186
1009900	With a walking aid, I could open and close inside or outside doors to walk between rooms in the past 7D	4180186
1009903	With a walking aid, I could walk up stairs without holding on to anything in the past 7D	4180186
1009909	I was able to use a spoon to bring food up to my mouth in the past 7D	4180186
1009911	I was able to pull my pants back up after using the toilet in the past 7D	4180186
1009912	I was able to hold a plate full of food in the past 7D	4180186
1009913	I was able to cut a piece of paper in half with scissors in the past 7D	4180186
1009915	I was able to take a bath by myself in the past 7D	4180186
1009918	I was able to put on my shoes by myself in the past 7D	4180186
1009921	I was able to brush my teeth by myself in the past 7D	4180186
1009923	I was able to put on my clothes by myself in the past 7D	4180186
1009924	I was able to zip up my clothes in the past 7D	4180186
1009925	I worried about dying in the past 7D	4180186
1009926	I had a lot of pain in the past 7D	4180186
1009927	My pain was so bad that I needed to take medicine for it in the past 7D	4180186
1009944	Cause of death.secondary	4180186
1009963	Dialysis.primary	4180186
1009977	Cardiovascular disease.medical student	4180186
1009996	How many times a W did you eat fast food or snacks or pizza in past 7D	4180186
1009998	How many soda and sweetened drinks, regular, not diet, did you drink each D in past 7D	4180186
1009999	How many D in the past W did you miss taking one or more of your medications	4180186
1010002	On those D that you engage in moderate to strenuous exercise, how many M, on average, do you exercise	4180186
1010003	How many times in the past Y have you have X or more drinks in a D	4180186
1010005	How many standard drinks containing alcohol do you have on a typical D	4180186
1010007	How much stress have you been experiencing in the past W, including today	4180186
1010011	In the past Y, have you used drugs other than those required for medical reasons	4180186
1010021	Have you used tobacco in the last 30D	4180186
1010023	Would you be interested in quitting tobacco use within the next few W	4180186
1010043	PPP/Bld	4180186
1010057	Views + obliques	4180186
1010071	Data items collected at inpatient facility admission or agency discharge only - transfer to facility	4180186
1010073	Neuro & emotional & behavioral status - discharge from agency	4180186
1010074	Neuro & emotional & behavioral status - resumption of care	4180186
1010079	One or more unhealed pressure ulcer(s) at stage 2 or higher - interim, post acute care discharge	4180186
1010091	Temporal orientation &or mental status - acute	4180186
1010109	Vital signs, weight, height, head circumference & oximetry panel	4180186
1010110	Medical services received in past 2Mo - Long term care hospital	4180186
1010225	Juniperus scopulorum	4180186
1010317	Bothered by back pain in last 4W	4180186
1010318	Bothered by pain in your arms, legs, or joints - knees, hips, etc - in last 4W	4180186
1010320	Bothered by headaches in last 4W	4180186
1010321	Bothered by chest pain in last 4W	4180186
1010322	Bothered by dizziness in last 4W	4180186
1010323	Bothered by fainting spells in last 4W	4180186
1010324	Bothered by feeling your heart pound or race in last 4W	4180186
1010326	Bothered by constipation, loose stools, or diarrhea in last 4W	4180186
1010329	Feeling restless so that it is hard to sit still in last 4W	4180186
1010330	Getting tired very easily in last 4W	4180186
1010331	Muscle tension, aches, or soreness in last 4W	4180186
1010332	Trouble falling asleep or staying asleep in last 4W	4180186
1010333	Trouble concentrating on things, such as reading a book or watching TV in last 4W	4180186
1010336	Do you often eat, within any 2H period, what most people would regard as an unusually large amount of food	4180186
1010337	Has this been as often, on average, as twice a W for the last 3Mo	4180186
1010339	Took more than twice the recommended dose of laxatives often in last 3Mo in order to avoid gaining weight	4180186
1010341	Exercised for more than an hour specifically to avoid gaining weight after binge eating often in last 3Mo in order to avoid gaining weight	4180186
1010342	You drank alcohol, even though a doctor suggested that you stop drinking because of a problem with your health, more than once in last 6Mo	4180186
1010343	You drank alcohol, were high from alcohol, or hung over while you were working, going to school, or taking care of children or other responsibilities more than once in last 6Mo	4180186
1010346	You drove a car after having several drinks or after drinking too much more than once in last 6Mo	4180186
1010375	Trouble sleeping in past 4W	4180186
1010379	Feeling afraid as if something awful might happen in last 2W	4180186
1010381	Volume expired during 2.0 s of forced expiration	4180186
1010382	Volume expired during 1.0 s of forced expiration measured	4180186
1010414	Race, ethnicity, sex, primary language, disability - Health & Human Services (HHS) panel	4180186
1010423	UPPS	4180186
1010445	NIHSS	4180186
1010458	PCL-C	4180186
1010460	Repeated disturbing dreams of a stressful experience from the past in the last Mo	4180186
1010461	Suddenly acting or feeling as if a stressful experience were happening again - as if you were reliving it - in the last Mo	4180186
1010462	Feeling very upset when something reminded you of a stressful experience from the past in the last Mo	4180186
1010463	Having physical reactions, heart pounding, trouble breathing or sweating, when something reminded you of a stressful experience from the past in the last Mo	4180186
1010466	Trouble remembering important parts of a stressful experience from the past in the last Mo	4180186
1010467	Loss of interest in things that you used to enjoy in the last Mo	4180186
1010473	Being super alert or watchful on guard in the last Mo	4180186
1010475	Repeated disturbing memories, thoughts, or images of a stressful experience from the past in the last Mo	4180186
1010476	Probe.amp.tar detection limit = 20 copies/mL	4180186
1010479	Reported.PHQ	4180186
1010484	ESRD	4180186
1010489	FACIT	4180186
1010490	I get headaches in the past 7D	4180186
1010492	I feel tired in the past 7D	4180186
1010493	I have been short of breath in the past 7D	4180186
1010496	I feel sexually attractive in the past 7D	4180186
1010497	I am bothered by hair loss in the past 7D	4180186
1010499	I worry about the effect of stress on my illness in the past 7D	4180186
1010501	I am able to feel like a woman in the past 7D	4180186
1010502	I have trouble controlling my urine in the past 7D	4180186
1010503	I urinate more frequently than usual in the past 7D	4180186
1010504	It burns when I urinate in the past 7D	4180186
1010508	I am able to get around by myself in the past 7D	4180186
1010509	I have concerns about my ability to have children in the past 7D	4180186
1010511	I am able to concentrate in the past 7D	4180186
1010517	I am able to read like I used to in the past 7D	4180186
1010519	I am able to drive a vehicle - my car, truck, etc - in the past 7D	4180186
1010524	I can remember new things in the past 7D	4180186
1010525	I get frustrated that I cannot do the things I used to in the past 7D	4180186
1010526	I am afraid of having a seizure - convulsion - in the past 7D	4180186
1010527	I have trouble with my eyesight in the past 7D	4180186
1010533	I am losing weight in the past 7D	4180186
1010535	I can digest my food well in the past 7D	4180186
1010536	I have diarrhea in the past 7D	4180186
1010537	I have a good appetite in the past 7D	4180186
1010540	Caring for my ostomy appliance is difficult in the past 7D	4180186
1010546	I have pain in my back in the past 7D	4180186
1010548	I am bothered by odor coming from my vagina in the past 7D	4180186
1010551	I am afraid the treatment will harm my body in the past 7D	4180186
1010552	I am bothered by constipation in the past 7D	4180186
1010553	I have discomfort when I urinate in the past 7D	4180186
1010554	I have difficulty swallowing solid foods in the past 7D	4180186
1010559	I am able to enjoy meals with family or friends in the past 7D	4180186
1010564	I have gained weight in the past 7D	4180186
1010567	I have vaginal bleeding or spotting in the past 7D	4180186
1010569	I have a loss of appetite in the past 7D	4180186
1010571	I have trouble swallowing food in the past 7D	4180186
1010572	I am bothered by gas - flatulence - in the past 7D	4180186
1010574	I am bothered by a change in my eating habits in the past 7D	4180186
1010577	I avoid going out to eat because of my illness in the past 7D	4180186
1010579	I am satisfied with how I am coping with my illness in the past 7D	4180186
1010580	I am losing hope in the fight against my illness in the past 7D	4180186
1010584	I am able to work - include work at home - in the past 7D	4180186
1010586	I am able to enjoy life in the past 7D	4180186
1010589	I am enjoying the things I usually do for fun in the past 7D	4180186
1010591	I have a lack of energy in the past 7D	4180186
1010593	Because of my physical condition, I have trouble meeting the needs of my family in the past 7D	4180186
1010594	I have pain in the past 7D	4180186
1010595	I am bothered by side effects of treatment in the past 7D	4180186
1010599	I get emotional support from my family in the past 7D	4180186
1010600	I get support from my friends in the past 7D	4180186
1010601	My family has accepted my illness in the past 7D	4180186
1010603	I feel close to my partner, or the person who is my main support, in the past 7D	4180186
1010606	I am bothered by jaundice or yellow color to my skin in the past 7D	4180186
1010607	I have had fevers - episodes of high body temperature - in the past 7D	4180186
1010608	I have had a change in the way food tastes in the past 7D	4180186
1010609	I have had chills in the past 7D	4180186
1010612	I feel fatigued in the past 7D	4180186
1010613	I am able to eat the foods that I like in the past 7D	4180186
1010614	I am able to communicate with others in the past 7D	4180186
1010616	I have pain in my mouth, throat or neck in the past 7D	4180186
1010617	My mouth is dry in the past 7D	4180186
1010621	I am unhappy with how my face and neck look in the past 7D	4180186
1010624	I drink alcohol - beer, wine, etc - in the past 7D	4180186
1010629	I feel tightness in my chest in the past 7D	4180186
1010630	Breathing is easy for me in the past 7D	4180186
1010633	I feel uncertain about my future health in the past 7D	4180186
1010634	I worry that I might get new symptoms of my illness in the past 7D	4180186
1010639	I have trouble sleeping at night in the past 7D	4180186
1010641	I have swelling at my melanoma site in the past 7D	4180186
1010643	I am bothered by the amount of swelling in the past 7D	4180186
1010646	Swelling keeps me from wearing clothes or shoes I want to wear in the past 7D	4180186
1010648	I have good range of movement in my arm or leg in the past 7D	4180186
1010649	I have noticed new changes in my skin - lumps, bumps, color in the past 7D	4180186
1010651	I have aches and pains in my bones in the past 7D	4180186
1010652	I have noticed blood in my stool in the past 7D	4180186
1010653	I isolate myself from others because of my condition in the past 7D	4180186
1010657	I worry about getting infections in the past 7D	4180186
1010660	I am bothered by worsening eyesight in the past 7D	4180186
1010664	I have trouble hearing in the past 7D	4180186
1010665	I have swelling in my stomach area in the past 7D	4180186
1010667	I have cramps in my stomach area in the past 7D	4180186
1010668	I have certain parts of my body where I experience pain in the past 7D	4180186
1010671	I bleed easily in the past 7D	4180186
1010673	I am bothered by discharge or bleeding from my vulva in the past 7D	4180186
1010675	I am bothered by swelling, fluid in my legs, in the past 7D	4180186
1010676	I am bothered by discomfort in my groin or legs in the past 7D	4180186
1010678	I am bothered by pain or numbness in my vulva area in the past 7D	4180186
1010680	I have discomfort when I'm sitting in the past 7D	4180186
1010681	I am bothered by wearing compression stockings in the past 7D	4180186
1010690	Physical well being	4180186
1010691	Social - family well being	4180186
1010698	Functional assessment of chronic illness therapy - cancer specific symptom indexes panel	4180186
1010717	I have a feeling of fullness or heaviness in my stomach area in the past 7D	4180186
1010718	I have had itching in the past 7D	4180186
1010720	I get tired easily in the past 7D	4180186
1010721	I have trouble concentrating in the past 7D	4180186
1010752	I feel light-headed, dizzy in the past 7D	4180186
1010754	I have numbness or tingling in my hands in the past 7D	4180186
1010757	I am bothered by skin problems in the past 7D	4180186
1010759	I have trouble moving my bowels in the past 7D	4180186
1010760	I have weakness in my legs in the past 7D	4180186
1010781	I experience vomiting during or after my tube feeding in the past 7D	4180186
1010783	Tube feeding limits what I can do outside of the house - for example shopping, driving or yard work - in the past 7D	4180186
1010784	Tube feeding limits my activities with my friends in the past 7D	4180186
1010785	During the use of tube feeding, I can eat and drink by mouth in the past 7D	4180186
1010787	I have the desire to eat in the past 7D	4180186
1010788	I worry that having a feeding tube means my health is worse in the past 7D	4180186
1010790	I worry about the tube getting plugged or blocked in the past 7D	4180186
1010791	I worry about getting an infection from the feeding tube in the past 7D	4180186
1010792	I worry about losing weight because I have a feeding tube in the past 7D	4180186
1010793	I feel that I have lost control of my food choices because I have a feeding tube in the past 7D	4180186
1010798	Getting a feeding tube was the right decision for me in the past 7D	4180186
1010799	Functional assessment of cancer therapy for patients with EGFRI inhibitors questionnaire - 18 items	4180186
1010804	I am bothered by a change in my skins sensitivity to the sun in the past 7D	4180186
1010805	My skin condition interferes with my ability to sleep in the past 7D	4180186
1010806	My skin condition affects my mood in the past 7D	4180186
1010807	My skin condition interferes with my social life in the past 7D	4180186
1010809	I avoid going out in public because of how my skin looks in the past 7D	4180186
1010811	Changes in my skin condition make daily life difficult in the past 7D	4180186
1010813	My eyes are dry in the past 7D	4180186
1010814	I am bothered by sensitivity around my fingernails or toenails in the past 7D	4180186
1010815	Sensitivity around my fingernails makes it difficult to perform household tasks in the past 7D	4180186
1010816	I am bothered by increased facial hair in the past 7D	4180186
1010818	I have numbness or tingling in my feet in the past 7D	4180186
1010819	I feel discomfort in my hands in the past 7D	4180186
1010820	I feel discomfort in my feet in the past 7D	4180186
1010824	I have trouble walking in the past 7D	4180186
1010834	The effects of treatment are worse than I had imagined in the past 7D	4180186
1010835	I have confidence in my nurse-s in the past 7D	4180186
1010836	I regret having the bone marrow transplant in the past 7D	4180186
1010837	I have frequent colds-infections in the past 7D	4180186
1010839	I have tremors in the past 7D	4180186
1010840	My illness is a personal hardship for my close family members in the past 7D	4180186
1010844	I have trouble remembering things in the past 7D	4180186
1010846	I get depressed easily in the past 7D	4180186
1010847	I get annoyed easily in the past 7D	4180186
1010851	My hands are swollen in the past 7D	4180186
1010852	My legs or feet are swollen in the past 7D	4180186
1010853	I have pain in my fingertips in the past 7D	4180186
1010854	I am bothered by the way my hands or nails look in the past 7D	4180186
1010859	22 deg C incubation	4180186
1010860	28 deg C incubation	4180186
1010868	Functional assessment of chronic illness therapy - symptom specific measures panel	4180186
1010869	Functional assessment of chronic illness therapy - pediatric measures panel	4180186
1010872	I am worried about my weight in the past 7D	4180186
1010873	Most food tastes unpleasant to me in the past 7D	4180186
1010877	I have difficulty eating rich or heavy foods in the past 7D	4180186
1010878	My family or friends are pressuring me to eat in the past 7D	4180186
1010879	When I eat, I seem to get full quickly in the past 7D	4180186
1010884	I have been emotionally distressed in the past 7D	4180186
1010890	I worry about spreading the infection in the past 7D	4180186
1010891	I am hopeful about the future in the past 7D	4180186
1010892	I find comfort in my faith or spiritual beliefs in the past 7D	4180186
1010893	I feel that I can manage things that come up around this infection in the past 7D	4180186
1010897	I have concerns about my ability to become pregnant in the past 7D	4180186
1010900	I tend to blame myself for the infection in the past 7D	4180186
1010902	I have had difficulty telling my partner - spouse about the infection in the past 7D	4180186
1010904	I am depressed about the infection in the past 7D	4180186
1010905	I have told my partner - spouse about my infection in the past 7D	4180186
1010906	I get emotional support from my partner - spouse in the past 7D	4180186
1010907	I have told family members about my infection in the past 7D	4180186
1010909	I have people to help me if I need it in the past 7D	4180186
1010911	I move my bowels more frequently than usual in the past 7D	4180186
1010912	I am afraid to be far from a toilet in the past 7D	4180186
1010917	I have abdominal cramps or discomfort due to my diarrhea in the past 7D	4180186
1010918	My problem with diarrhea keeps - wakes - me up at night in the past 7D	4180186
1010920	I wear protection for soiling of stool in the past 7D	4180186
1010922	I feel listless - washed out - in the past 7D	4180186
1010923	I have trouble starting things because I am tired in the past 7D	4180186
1010926	I need to sleep during the day in the past 7D	4180186
1010927	S-100	4180186
1010928	I am too tired to eat in the past 7D	4180186
1010933	I have pain in my chest in the past 7D	4180186
1010934	I am motivated to do my usual activities in the past 7D	4180186
1010937	Movement of my arm on this side is painful in the past 7D	4180186
1010939	My arm on this side feels numb in the past 7D	4180186
1010940	I have stiffness of my arm on this side in the past 7D	4180186
1010944	I have bone pain even when I sit or lie still in the past 7D	4180186
1010950	Bone pain wakes me up at night in the past 7D	4180186
1010954	My family has trouble understanding when my bone pain interferes with my activity in the past 7D	4180186
1010956	I have had trouble forming thoughts in the past 7D	4180186
1010957	My thinking has been slow in the past 7D	4180186
1010960	I have had trouble remembering where I put things, like my keys or my wallet in the past 7D	4180186
1010961	I have had trouble remembering new information, like phone numbers or simple instructions in the past 7D	4180186
1010962	I have had trouble recalling the name of an object while talking to someone in the past 7D	4180186
1010964	I have used the wrong word when I referred to an object in the past 7D	4180186
1010965	I have had trouble saying what I mean in conversations with others in the past 7D	4180186
1010966	I have walked into a room and forgotten what I meant to get or do there in the past 7D	4180186
1010972	Other people have told me I seemed to have trouble remembering information in the past 7D	4180186
1010973	I have had to work harder than usual to keep track of what I was doing in the past 7D	4180186
1010974	My thinking has been slower than usual in the past 7D	4180186
1010976	I have had to use written lists more often than usual so I would not forget things in the past 7D	4180186
1010978	I have trouble shifting back and forth between different activities that require thinking in the past 7D	4180186
1010980	Other people have told me I seemed to have trouble thinking clearly in the past 7D	4180186
1010984	I have been able to bring to mind words that I wanted to use while talking to someone in the past 7D	4180186
1010985	I have been able to remember things, like where I left my keys or wallet, in the past 7D	4180186
1010986	I have been able to remember to do things, like take medicine or buy something I needed, in the past 7D	4180186
1010987	I am able to pay attention and keep track of what I am doing without extra effort in the past 7D	4180186
1010988	My mind is as sharp as it has always been in the past 7D	4180186
1010989	My memory is as good as it has always been in the past 7D	4180186
1010993	I have been upset about these problems in the past 7D	4180186
1010995	These problems have interfered with my ability to work in the past 7D	4180186
1010997	These problems have interfered with the quality of my life in the past 7D	4180186
1011003	I have mood swings in the past 7D	4180186
1011004	I am irritable in the past 7D	4180186
1011009	I worry my condition will not improve if my treatment is delayed in the past 7D	4180186
1011010	My partner worries about me when my blood counts are low in the past 7D	4180186
1011012	I am bothered by headaches in the past 7D	4180186
1011013	I need to rest during the day in the past 7D	4180186
1011015	I worry about problems with bruising or bleeding in the past 7D	4180186
1011018	I am bothered by blood in my urine or stool in the past 7D	4180186
1011019	I avoid or limit physical activity, because of concern with bleeding or bruising, in the past 7D	4180186
1011020	I am frustrated by not being able to do my usual activities in the past 7D	4180186
1011024	I am bothered by bleeding in my gums or mouth in the past 7D	4180186
1011027	I worry that my treatment dose will be reduced, because of low blood counts, in the past 7D	4180186
1011028	For women only - I am bothered by vaginal bleeding in the past 7D	4180186
1011030	I am comfortable discussing my condition with friends in the past 7D	4180186
1011031	I have to limit my sexual activity because of my condition in the past 7D	4180186
1011037	I must urinate frequently to avoid leaking in the past 7D	4180186
1011039	I have discomfort in my pelvic area in the past 7D	4180186
1011040	I have pain in my pelvic area in the past 7D	4180186
1011041	I have cramping in my pelvic area in the past 7D	4180186
1011043	I have confidence in my doctors in the past 7D	4180186
1011058	Additional concerns - FACT-H&N	4180186
1011085	Physical well being - FACIT-CD	4180186
1011119	Toxoplasma gondii Ab.IgE	4180186
1011120	Histoplasma capsulatum Ab.IgE	4180186
1011121	Blastomyces dermatitidis Ab.IgE	4180186
1011126	Lactalbumin Ab.IgE	4180186
1011128	How short of breath did you get dressing yourself without help in the past 7D	4180186
1011129	How short of breath did you get walking 50 steps-paces on flat ground at a normal speed without stopping in the past 7D	4180186
1011130	How short of breath did you get walking up 20 stairs - 2 flights - without stopping in the past 7D	4180186
1011131	How short of breath did you get preparing meals in the past 7D	4180186
1011132	How short of breath did you get washing dishes in the past 7D	4180186
1011133	How short of breath did you get sweeping or mopping in the past 7D	4180186
1011134	How short of breath did you get making a bed in the past 7D	4180186
1011135	How short of breath did you get lifting something weighing 10-20 lbs, about 4.5-9kg , like a large bag of groceries, in the past 7D	4180186
1011136	How short of breath did you get carrying something weighing 10-20 lbs, about 4.5-9kg, like a large bag of groceries, from one room to another in the past 7D	4180186
1011137	How short of breath did you get walking faster than your usual speed for half a mile, almost 1 km, without stopping in the past 7D	4180186
1011141	How short of breath did you get taking a bath without help in the past 7D	4180186
1011142	How short of breath did you get taking a shower in the past 7D	4180186
1011144	How short of breath did you get standing for at least 5M in the past 7D	4180186
1011146	How short of breath did you get walking half a mile, almost 1 km, on flat ground at a normal speed, without stopping in the past 7D	4180186
1011149	How short of breath did you get walking up 30 stairs, 3 flights, without stopping in the past 7D	4180186
1011150	How short of breath did you get lifting something weighing less than 5 lbs, about 2 kg, like a houseplant, in the past 7D	4180186
1011151	How short of breath did you get lifting something weighing 5-10 lbs, about 2-4.5 kg, like a basket of clothes in the past 7D	4180186
1011153	How short of breath did you get carrying something weighing less than 5 lbs, about 2 kg, like a houseplant, from one room to another in the past 7D	4180186
1011154	How short of breath did you get carrying something weighing 5-10 lbs, about 2-4.5 kg, like a basket of clothes, from one room to another in the past 7D	4180186
1011155	How short of breath did you get getting in or out of a car in the past 7D	4180186
1011156	How short of breath did you get dining out in the past 7D	4180186
1011157	How short of breath did you get low-intensity leisure activity - gardening, etc, in the past 7D	4180186
1011158	How short of breath did you get moderate-intensity leisure activity - bicycling on level terrain, etc, in the past 7D	4180186
1011159	How short of breath did you get walking, faster than your usual speed, for 50 steps without stopping in the past 7D	4180186
1011162	How short of breath did you get talking while walking in the past 7D	4180186
1011163	How short of breath did you get scrubbing the floor or counter in the past 7D	4180186
1011166	Functional assessment of chronic illness therapy - spiritual well being questionnaire - 12 items - version 4	4180186
1011167	I feel peaceful in the past 7D	4180186
1011172	I feel a sense of harmony within myself in the past 7D	4180186
1011176	I know that whatever happens with my illness things will be okay in the past 7D	4180186
1011180	I feel loved in the past 7D	4180186
1011183	I feel forgiven for any harm I may have ever caused in the past 7D	4180186
1011184	Throughout the course of my day, I feel a sense of thankfulness for my life in the past 7D	4180186
1011185	Throughout the course of my day, I feel a sense of thankfulness for what others bring to my life in the past 7D	4180186
1011188	Functional assessment of chronic illness therapy - spiritual well being - non-illness questionnaire - version 4	4180186
1011192	I have confidence in my pharmacist-s in the past 7D	4180186
1011193	My pharmacist is available to answer my questions in the past 7D	4180186
1011195	My pharmacist is aware of my treatment-related needs in the past 7D	4180186
1011196	My pharmacist responds to my treatment-related needs in the past 7D	4180186
1011251	I have to take my condition into account when making plans in the past 7D	4180186
1011253	I am bothered by muscle pains in the past 7D	4180186
1011256	I am depressed about my condition in the past 7D	4180186
1011259	I am frustrated by my condition in the past 7D	4180186
1011261	My family has trouble understanding when my condition gets worse in the past 7D	4180186
1011264	Heat worsens my symptoms in the past 7D	4180186
1011269	I maintain contact with my friends in the past 7D	4180186
1011270	I have family members who will take on my responsibilities in the past 7D	4180186
1011271	I feel that my family appreciates me in the past 7D	4180186
1011273	I am constipated in the past 7D	4180186
1011274	I have swelling in parts of my body in the past 7D	4180186
1011277	I make each day count in the past 7D	4180186
1011278	I have peace of mind in the past 7D	4180186
1011282	I am able to openly discuss my concerns with the people closest to me in the past 7D	4180186
1011283	I feel a sense of purpose in my life in the past 7D	4180186
1011285	Emotional well being - living with HIV	4180186
1011286	Functional and global well being	4180186
1011287	Social well being	4180186
1011292	It is hard to tell other people about my infection in the past 7D	4180186
1011295	I am embarrassed by my illness in the past 7D	4180186
1011296	My thinking is slower than before in the past 7D	4180186
1011298	Social - family well being - FAMS	4180186
1011309	I eat as much as I want in the past 7D	4180186
1011310	I eat enough food for me to do whatever I need to do in the past 7D	4180186
1011311	Most food tastes bad to me in the past 7D	4180186
1011312	As soon as I start eating, I feel like stopping in the past 7D	4180186
1011313	I am afraid to eat because it may make me sick in the past 7D	4180186
1011314	My family or friends try to get me to eat more in the past 7D	4180186
1011317	I feel like I am getting better in the past 7D	4180186
1011321	I have trouble running like other people in the past 7D	4180186
1011323	I get ill easily in the past 7D	4180186
1011325	I feel happy in the past 7D	4180186
1011326	When I try to do something, I usually believe I will do it well in the past 7D	4180186
1011327	The cancer-tumor experience makes me a stronger person in the past 7D	4180186
1011328	The cancer-tumor experience has taught me to appreciate life in the past 7D	4180186
1011329	I often feel that other people are better than me in the past 7D	4180186
1011331	I often switch from good moods to bad moods in the past 7D	4180186
1011332	I worry when I go back to the hospital or clinic in the past 7D	4180186
1011333	I get nervous - frightened easily in the past 7D	4180186
1011334	I worry about having a good life in the future in the past 7D	4180186
1011335	I worry about being able to have a girlfriend or boyfriend because of my illness in the past 7D	4180186
1011340	Other people avoid hanging out with me because I am different in the past 7D	4180186
1011341	I feel lonely in the past 7D	4180186
1011343	My parents worry too much about me in the past 7D	4180186
1011345	I am worried about how thin I am in the past 7D	4180186
1011346	What would be important about how you feel about eating, food, and how food affects your life in the past 7D	4180186
1011347	I often feel that other children are better than me in the past 4W	4180186
1011348	I think I have fewer friends than other children in the past 7D	4180186
1011349	Other children avoid playing with me because I am different in the past 7D	4180186
1011350	I would rather play alone than with other children in the past 7D	4180186
1011355	My child's arms or legs seem weak in the past 4W	4180186
1011357	My child has trouble writing with a pen or pencil in the past 4W	4180186
1011360	When my child tries to do something, s-he usually believes s-he will do it well in the past 4W	4180186
1011363	My child often feels inferior to other people in the past 4W	4180186
1011365	My child is moody or irritable in the past 4W	4180186
1011367	My child gets nervous - frightened easily in the past 4W	4180186
1011368	My child worries about having a good life in the future in the past 4W	4180186
1011371	My child worries about being able to go to college because of his-her illness in the past 4W	4180186
1011374	Emotional well being and illness experience - FAACT-peds-adoles	4180186
1011376	Other people pick on - tease my child in the past 4W	4180186
1011378	Other people avoid hanging out with my child because s-he is different in the past 4W	4180186
1011379	My child seems lonely in the past 4W	4180186
1011380	My child prefers to do something alone in the past 4W	4180186
1011386	The illness experience has taught my child to appreciate life in the past 4W	4180186
1011387	The illness experience makes my child a stronger person in the past 4W	4180186
1011388	I often feel that other children are better than me in the past 7D	4180186
1011392	When my child tries to do something, s-he usually believes s-he will do it well in the past 7D	4180186
1011393	My child often feels inferior to other people in the past 7D	4180186
1011394	My child worries about getting another cancer-tumor in the past 7D	4180186
1011395	My child is moody or irritable in the past 7D	4180186
1011396	My child worries when we go back to the hospital or clinic in the past 7D	4180186
1011397	My child gets nervous - frightened easily in the past 7D	4180186
1011398	My child worries about having a good life in the future in the past 7D	4180186
1011400	My child worries about getting a job because of his-her illness in the past 7D	4180186
1011401	My child has fewer friends than others in the past 7D	4180186
1011402	Other people avoid hanging out with my child because s-he is different in the past 7D	4180186
1011403	My child seems lonely in the past 7D	4180186
1011407	My child eats enough to do whatever s-he needs to do in the past 7D	4180186
1011408	My child is worried about his-her weight in the past 7D	4180186
1011411	As soon as my child starts eating, s-he feels like stopping in the past 7D	4180186
1011414	My child has been throwing up in the past 7D	4180186
1011417	My child feels like s-he is getting better in the past 7D	4180186
1011420	My child has trouble getting dressed on his-her own in the past 7D	4180186
1011421	My child has trouble running like other people in the past 7D	4180186
1011422	My child gets tired easily in the past 7D	4180186
1011426	Other people pick on - tease my child in the past 7D	4180186
1011430	My child prefers to play alone in the past 7D	4180186
1011433	I have trouble running like other people in the past 4W	4180186
1011434	I get tired easily in the past 4W	4180186
1011435	My arms or legs are weak in the past 4W	4180186
1011436	I get ill easily in the past 4W	4180186
1011438	I feel happy in the past 4W	4180186
1011441	The illness experience has taught me to appreciate life in the past 4W	4180186
1011442	I often feel that other people are better than me in the past 4W	4180186
1011446	I get nervous - frightened easily in the past 4W	4180186
1011447	I worry about having a good life in the future in the past 4W	4180186
1011448	I worry about being able to date because of my illness history in the past 4W	4180186
1011449	I worry about being able to go to college because of my illness history in the past 4W	4180186
1011464	It is hard for me to concentrate in school in the past 4W	4180186
1011468	Emotional well being and illness experience - FACT-Br -peds-adoles	4180186
1011470	Social - family well being - FACT-Br-peds	4180186
1011471	Physical well being - FACT-Br -peds-parent	4180186
1011473	Emotional well being - FACT-Br -peds-parent_child	4180186
1011475	Social and family well being - FACT-Br -peds-parent_adoles	4180186
1011478	My child is bothered by poor hearing in the past 4W	4180186
1011479	My child is bothered by headaches in the past 4W	4180186
1011481	My child needs to work harder than his-her peers to get school work done in the past 4W	4180186
1011482	My child's school performance is worse than it was before s-he was diagnosed in the past 4W	4180186
1011483	My child forgets things easily in the past 4W	4180186
1011484	It is hard for my child to concentrate in school in the past 4W	4180186
1011485	My child has to read things several times so s-he can understand them in the past 4W	4180186
1011486	When my child plays games or sports, s-he reacts more slowly than his-her peers in the past 4W	4180186
1011490	Being tired made me sad in the past 7D	4180186
1011494	Emotional well being and illness experience - FAACT-peds-child	4180186
1011497	I have looked forward with enjoyment to things in the past 7D	4180186
1011498	I have blamed myself unnecessarily when things went wrong in the past 7D	4180186
1011501	Things have been getting on top of me in the past 7D	4180186
1011503	I have felt sad or miserable in the past 7D	4180186
1011507	Pr	4180186
1011508	Being tired made it hard for me to play or go out with my friends as much as I'd like in the past 7D	4180186
1011511	CMS - head & face exam panel	4180186
1011550	I am satisfied with my present level of comfort in the past 7D	4180186
1011553	Functional assessment of chronic illness therapy - spiritual well being questionnaire - version 4	4180186
1011574	Received PRN pain medications or was offered and declined in the last 5D	4180186
1011586	Outpatient antibiotics prescribed in past Mo	4180186
1011606	Ophthalmoscopy	4180186
1011646	M3	4180186
1011647	Nothing seems to give me much pleasure in the last 2W or more	4180186
1011649	I have had thoughts of suicide in the last 2W or more	4180186
1011650	I have difficulty sleeping in the last 2W or more	4180186
1011651	I have been sleeping too much in the last 2W or more	4180186
1011653	I have been eating more in the last 2W or more	4180186
1011654	I feel tense, anxious or can't sit still in the last 2W or more	4180186
1011660	I am jumpy or feel startled easily in the last 2W or more	4180186
1011661	I feel dull, numb, or detached in the last 2W or more	4180186
1011676	I can't concentrate or focus in the last 2W or more	4180186
1011689	I avoid places that strongly remind me of a bad experience in the last 2W or more	4180186
1011698	MFr.DF	4180186
1011726	HKOI	4180186
1011727	AD8	4180186
1011733	SAMHSA	4180186
1011766	Compared to one Y ago, how would you rate your emotional problems, such as feeling anxious,depressed or irritable, now	4180186
1011767	Compared to one Y ago, how would you rate your physical health in general now	4180186
1011772	During the past 4W, how much of the time has your physical health or emotional problems interfered with your social activities - like visiting with friends, relatives, etc	4180186
1011774	Have you been a happy person during the past 4W	4180186
1011776	Have you felt downhearted and blue during the past 4W	4180186
1011781	Did you feel full of pep during the past 4W	4180186
1011782	During the past 4W, how much did pain interfere with your normal work - including both work outside the home and house work	4180186
1011784	During the past 4W, to what extent has your physical health or emotional problems interfered with your normal social activities with family, friends, neighbors or groups	4180186
1011789	As a result of your physical health, have you accomplished less than you would like in the past 4W	4180186
1011801	As a result of any emotional problems, you didn't do work or other activities as carefully as usual in the past 4W	4180186
1011804	Parents' evaluation of developmental status - developmental milestones	4180186
1011830	PROMIS-10 Global Physical Health score	4180186
1011831	VR-36 Mental health score - oblique method	4180186
1011834	VR-36 Vitality score - oblique method	4180186
1011835	VR-36 General health score - oblique method	4180186
1011838	VR-36 Physical functioning score - oblique method	4180186
1011839	VR-36 Physical component summary score - oblique method	4180186
1011841	VR-36 Mental health score - orthogonal method	4180186
1011843	VR-36 Social functioning score - orthogonal method	4180186
1011844	VR-36 Vitality score - orthogonal method	4180186
1011846	VR-36 General health score - orthogonal method	4180186
1011850	VR-12 Mental health score - oblique method	4180186
1011851	VR-12 Role emotion score - oblique method	4180186
1011853	VR-12 Vitality score - oblique method	4180186
1011854	VR-12 General health score - oblique method	4180186
1011855	VR-12 Bodily pain score - oblique method	4180186
1011856	VR-12 Role physical score - oblique method	4180186
1011857	VR-12 Physical functioning score - oblique method	4180186
1011858	VR-36 Mental component summary score - orthogonal method	4180186
1011859	VR-36 Physical component summary score - orthogonal method	4180186
1011861	VR-12 Physical component summary score - oblique method	4180186
1011862	VR-12 Physical component summary score - orthogonal method	4180186
1011934	HOOS	4180186
1011935	KOOS	4180186
1011936	MMSE	4180186
1011938	AUDIT-C	4180186
1011939	CDR	4180186
1011940	BOMC	4180186
1011942	VR	4180186
1011943	FaB	4180186
1011944	MAST	4180186
1011950	CDI	4180186
1011953	KCCQ	4180186
1011955	TWEAK	4180186
1011961	BINS	4180186
1011964	Total score - Ages and stages questionnaires 4 Mo	4180186
1011966	Total score - Ages and stages questionnaires 8 Mo	4180186
1011967	Total score - Ages and stages questionnaires 9 Mo	4180186
1011969	Total score - Ages and stages questionnaires 12 Mo	4180186
1011972	Total score - Ages and stages questionnaires 18 Mo	4180186
1011973	Total score - Ages and stages questionnaires 20 Mo	4180186
1011976	Total score - Ages and stages questionnaires 27 Mo	4180186
1011977	Total score - Ages and stages questionnaires 30 Mo	4180186
1011978	Total score - Ages and stages questionnaires 33 Mo	4180186
1011980	MoCA	4180186
1012016	RHEA	4180186
1012029	ColorRto	4180186
1012034	History and physical note - recommended C-CDA R1.1 & R2.0 & R2.1 sections	4180186
1012041	Dedication to Excellence + Inspiration to All	4180186
1012044	Ser/Plas+CSF	4180186
1012054	Wound.exudate	4180186
1012066	Overall quality of life over the past Mo	4180186
1012067	Overall physical well being over the past Mo	4180186
1012068	Overall emotional well being over the past 1Mo	4180186
1012069	Social interaction with other people - family, friends, or others - over the past Mo	4180186
1012072	Wound bed & edge panel	4180186
1012080	Oxygen saturation.calc from carbon dioxide.partial pressure	4180186
1012088	SFr.DF	4180186
1012098	VSP	4180186
1012099	Infections present &or treated during this pregnancy for live birth	4180186
1012106	I had outbreaks of uncontrolled anger or physically attacked others in last W	4180186
1012107	I had uncontrollable sexual encounters of which I was later ashamed or which made me angry in last W	4180186
1012108	I felt disgusted by myself in last W	4180186
1012113	I hurt myself by cutting, burning, strangling, headbanging etc. in last W	4180186
1012115	I tried to commit suicide in last W	4180186
1012118	I displayed high-risk behavior by knowingly driving too fast, running around on the roofs of high buildings, balancing on bridges, etc. in last W	4180186
1012121	It was hard for me to concentrate in last W	4180186
1012122	I felt helpless in last W	4180186
1012124	I felt disgust in last W	4180186
1012127	I didn't believe in my right to live in last W	4180186
1012128	I was lonely in last W	4180186
1012129	I experienced stressful inner tension in last W	4180186
1012130	I had images that I was very much afraid of in last W	4180186
1012131	I hated myself in last W	4180186
1012132	I wanted to punish myself in last W	4180186
1012133	I suffered from shame in last W	4180186
1012135	I suffered from voices and noises from inside or outside my head in last W	4180186
1012136	Criticism had a devastating effect on me in last W	4180186
1012152	von Willebrand factor.ristocetin cofactor	4180186
1012154	Multisection limited for physiologic artery study	4180186
1012156	Zscore	4180186
1012157	CYP2D6 gene & CYP2C19 gene	4180186
1012167	Antigens absent	4180186
1012198	Bld.preductal+Bld.postductal	4180186
1012213	Capillary electrophoresis	4180186
1012218	X & Y aneuploidy risk	4180186
1012229	Glycine CSF	4180186
1012248	Infant was transferred within 24H of delivery	4180186
1012274	Surgery.medical student	4180186
1012275	Infections present &or treated during this pregnancy for fetal death	4180186
1012306	MDiff	4180186
1012330	Alcoholic drinks per D	4180186
1012337	Payment source.primary	4180186
1012339	Ds in intensive care unit	4180186
1012347	AHRQ	4180186
1012403	Work Hs per W	4180186
1012429	interRAI long term care facility	4180186
1012435	interRAI community health assessment - mental health supplement	4180186
1012436	interRAI community health assessment - functional supplement	4180186
1012437	interRAI community health assessment	4180186
1012438	Pre-hospital transport mode.other	4180186
1012441	Demographic information+history of occupation	4180186
1012465	Streptococcus pneumoniae DNA & Haemophilus influenza DNA & Pseudomonas aeruginosa	4180186
1012472	Antibody screen.cell I	4180186
1012473	Antibody screen.cell III	4180186
1012477	Antigens present	4180186
1012507	Patient safety event report - hospital - patient information form - version 1.2	4180186
1012522	BPAP activity	4180186
1012532	Carbapenemase Nordmann-Poirel	4180186
1012534	Patient safety event report - hospital - device or medical &or surgical supply, including health information technology - version 1.2	4180186
1012550	Ergonomics or human &or device interface issue	4180186
1012552	Indirect antiglobulin test	4180186
1012572	Bld.pos growth	4180186
1012573	Probe.mag capture	4180186
1012587	Adequacy of breastmilk &or formula	4180186
1012596	Physical findings.nutrition	4180186
1012608	CDC.CS	4180186
1012630	Darkfield exam, DFA, or special stain was performed & test findings	4180186
1012635	Syphilis treatment was given & treatment description	4180186
1012660	Disability information & assistance needed panel	4180186
1012662	HHS.ACA Section 4302.ONC	4180186
1012667	How intense was your average pain in the past 7D	4180186
1012708	ACC-AHA Pooled Cohort.Goff 2013	4180186
1012712	Within the last Mo, how often have you experienced cultural factors	4180186
1012714	Within the last Mo, how often have you experienced psychosocial factors	4180186
1012715	Within the last Mo, how often have you experienced physical factors	4180186
1012718	Ser+Plas	4180186
1012722	WBC.DNA	4180186
1012724	WBC.DNA+Plas.cfDNA	4180186
1012731	Rate all your health care in the last 12Mo	4180186
1012740	Mental health.case manager	4180186
1012767	Coagulation surface induced.lupus sensitive actual	4180186
1012769	Coagulation surface induced.lupus sensitive.excess phospholipid actual	4180186
1012781	Number of visits to this healthcare entity in the last 12Mo	4180186
1012790	Accreditation, certification, & licensure panel	4180186
1012798	Over the past W, are you able to dress yourself, including shoelaces and buttons	4180186
1012804	Over the past W, are you able to cut your meat	4180186
1012805	Over the past W, are you able to lift a full cup or glass to your mouth	4180186
1012808	Over the past W, are you able to wash and dry your body	4180186
1012809	Plas^Donor	4180186
1012816	Over the past W, are you able to open a new milk carton	4180186
1012818	Over the past W, are you able to get on and off the toilet	4180186
1012822	Over the past W, are you able to open car doors	4180186
1012823	Over the past W, are you able to open jars which have been previously opened	4180186
1012824	Over the past W, are you able to turn faucets on and off	4180186
1012827	Over the past W, are you able to do chores such as vacuuming or yard work	4180186
1012828	Help from another person usually needed for hygiene, reach, gripping and opening things, &or errands and chores	4180186
1012836	During the past 2Ws, how much have you been bothered by emotional problems such as feeling anxious, depressed, irritable or downhearted and blue	4180186
1012837	ScoreDiff	4180186
1012839	Ser/Plas/Urine	4180186
1012841	Spine.lumbar.epidural space	4180186
1012843	Spine.thoracic.epidural space	4180186
1012844	Pleural space.bilateral	4180186
1012849	During the past 2Ws, has your physical and emotional health limited your social activities with family, friends, neighbors or groups	4180186
1012850	During the past 2Ws, how much bodily pain have you generally had	4180186
1012852	During the past 2Ws, how would you rate your health in general	4180186
1012853	During the past 2Ws, was someone available to help you if you needed and wanted help	4180186
1012855	SDAI	4180186
1012858	How often have you had four or more drinks in one D during the past Y	4180186
1012865	ACT	4180186
1012866	Electronic health record implementation stage	4180186
1012867	Electronic health record implementation stage panel	4180186
1012894	How have things been going for you during the past 4Ws	4180186
1012895	During the past 4Ws, was someone available to help you if you needed and wanted help	4180186
1012911	Aids or devices usually used for dressing & grooming, arising, eating, &or walking	4180186
1012921	Help from another person is usually needed for dressing & grooming, arising, eating, &or walking	4180186
1012922	Aids or devices usually used for hygiene, reach, grip, &or activities	4180186
1012923	IEEE Rosetta panel	4180186
1012928	Pain severity in the past W - 0-10 numeric rating	4180186
1012934	My child got tired easily in past 7D	4180186
1012936	Rate all your child's health care in the last 12Mo	4180186
1012940	My child felt stressed in past 7D	4180186
1012941	My child had trouble sleeping when he or she had pain in past 7D	4180186
1012945	Antibody investigation	4180186
1012973	NI-ICG	4180186
1012978	TempDiff	4180186
1012980	IEEE Rosetta cardiovascular panel	4180186
1012982	IEEE Rosetta gas monitoring panel	4180186
1012983	IEEE Rosetta gas delivery panel	4180186
1012987	IEEE Rosetta infusion panel	4180186
1012988	IEEE Rosetta respiratory panel	4180186
1012991	{Role}	4180186
1012992	IEEE Rosetta infant microenvironment panel	4180186
1013008	Oxygen target	4180186
1013092	Highest level of education in a non-nursing degree panel	4180186
1013397	Surgical history relevant to physical therapy ICD9 procedure code	4180186
1013416	Licensed nursing staff.employment position	4180186
1013426	XXX.swab	4180186
1013429	HARK	4180186
1013435	Within the last Y, have you been kicked, hit, slapped, or otherwise physically hurt by your partner or ex-partner	4180186
1013458	On a typical weekend D in the past W, how much time did the patient spend watching TV &or DVDs	4180186
1013460	On a typical weekend D in the past W, how much time did the patient spend playing video games and computer games	4180186
1013498	APTA	4180186
1013525	12Mo	4180186
1013542	Salivary gland protein 1 & Carbonic anhydrase 6 & Parotid secretory protein Ab	4180186
1013543	Salivary gland protein 1 & Carbonic anhydrase 6 & Parotid secretory protein	4180186
1013545	Salivary gland protein 1 & Carbonic anhydrase 6 & Parotid secretory protein Ab.IgA & IgG & IgM panel	4180186
1013546	BIA	4180186
1013571	Clinical knowledge, decision making, & mental workload panel	4180186
1013578	Identification of suspect product & notification	4180186
1013611	Electroretinogram	4180186
1013614	{Nursing unit}.{Job position}	4180186
1013625	How often have you added cereal to your baby's bottle of formula or pumped (or expressed) breast milk in the past 2W	4180186
1013627	HLA-A & B & C (class I)	4180186
1013630	I believed in helping my family, no matter what in past 4W	4180186
1013631	I could depend on my family in past 4W	4180186
1013633	I could talk to someone in my family about my problems in past 4W	4180186
1013634	I could talk to someone in my family if I needed to in past 4W	4180186
1013635	I could talk to someone in my family if something was bothering me in past 4W	4180186
1013637	I felt a sense of togetherness with my family in past 4W	4180186
1013638	I felt everyone in my family loved me in past 4W	4180186
1013639	I felt I had a strong relationship with my family in past 4W	4180186
1013642	I felt loved by my family in past 4W	4180186
1013643	I felt my family believed in me in past 4W	4180186
1013644	I felt really important to my family in past 4W	4180186
1013646	I felt that I could trust the people in my family in past 4W	4180186
1013647	I felt that I had nothing to look forward to in past 7D	4180186
1013649	I felt that my family loved me in past 4W	4180186
1013652	I felt that nothing was interesting in past 7D	4180186
1013653	I felt totally accepted by my family in past 4W	4180186
1013654	I felt very close to my family in past 4W	4180186
1013655	I found that things in my life were overwhelming in past 7D	4180186
1013656	I got all the help I needed from my family in past 4W	4180186
1013657	I got the support I needed from my family in past 4W	4180186
1013658	I have been able to bring to mind words that I wanted to use while talking to someone in past 7D	4180186
1013660	I have been able to focus my attention in past 7D	4180186
1013662	I have been able to get my point across when talking with someone in past 7D	4180186
1013664	I have been able to handle many tasks at once without losing track of what I was doing in past 7D	4180186
1013666	I have been able to learn new things easily, like telephone numbers or instructions in past 7D	4180186
1013667	I have been able to mentally focus in past 7D	4180186
1013671	I have been able to remember the name of a familiar object in past 7D	4180186
1013672	I have been able to remember the name of a familiar person in past 7D	4180186
1013675	I have been able to shift back and forth between two activities that require thinking in past 7D	4180186
1013678	I have been able to think clearly without extra effort in past 7D	4180186
1013681	I have had difficulty multi-tasking in past 7D	4180186
1013683	I have had to use written lists more often than usual so I would not forget things in past 7D	4180186
1013684	I have had to work harder than usual to express myself clearly in past 7D	4180186
1013688	I have had trouble concentrating in past 7D	4180186
1013689	I have had trouble finding my way to a familiar place in past 7D	4180186
1013690	I have had trouble forming thoughts in past 7D	4180186
1013691	I have had trouble keeping track of what I was doing when interrupted in past 7D	4180186
1013693	I have had trouble remembering new information, like phone numbers or simple instructions in past 7D	4180186
1013694	I have had trouble remembering where I put things, like my keys or my wallet in past 7D	4180186
1013695	I have had trouble remembering whether I did things I was supposed to do, like taking a medicine or buying something I needed in past 7D	4180186
1013696	I have had trouble shifting back and forth between different activities that require thinking in past 7D	4180186
1013698	I have hidden my problems with memory, concentration, or making mental mistakes so that others would not notice in past 7D	4180186
1013699	I have made mistakes when writing down phone numbers in past 7D	4180186
1013700	I have needed medical instructions repeated because I could not keep them straight in past 7D	4180186
1013701	I have walked into a room and forgotten what I meant to get or do there in past 7D	4180186
1013703	I knew that my family would be there if I needed them in past 4W	4180186
1013704	I knew what I could expect from others in my family in past 4W	4180186
1013705	I wanted to help my family however I could in past 4W	4180186
1013706	It has seemed like my brain was not working as well as usual in past 7D	4180186
1013707	It was easy to be close to everyone in my family in past 4W	4180186
1013714	My ability to remember things that I need to do has been as good as usual in past 7D	4180186
1013715	My child believed in helping our family, no matter what in past 4W	4180186
1013717	My child felt everyone in our family loved each other in past 4W	4180186
1013719	My child felt he or she could depend on our family in past 4W	4180186
1013720	My child felt he or she could talk to someone in our family if something was bothering him or her in past 4W	4180186
1013722	My child felt he or she got the support he or she needed from our family in past 4W	4180186
1013723	My child felt he or she had a strong relationship with our family in past 4W	4180186
1013724	My child felt he or she really belonged in our family in past 4W	4180186
1013726	My child felt important in our family in past 4W	4180186
1013727	My child felt it was easy for him or her to be close to everyone in our family in past 4W	4180186
1013728	My child felt loved by our family in past 4W	4180186
1013731	My child felt that he or she could trust the people in our family in past 4W	4180186
1013732	My child felt that he or she had similar values and beliefs as others in our family in past 4W	4180186
1013733	My child felt that our family believed in him or her in past 4W	4180186
1013734	My child felt that our family loved him or her in past 4W	4180186
1013735	My child felt that our family really respected him or her in past 4W	4180186
1013736	My child felt that our family showed that they cared about him or her in past 4W	4180186
1013738	My child felt that people in our family helped each other in past 4W	4180186
1013740	My child felt very close to our family in past 4W	4180186
1013742	My child knew he or she could rely on our family in past 4W	4180186
1013743	My child knew he or she could talk to someone in our family about his or her problems in past 4W	4180186
1013744	My child knew he or she could talk to someone in our family if he or she needed to in past 4W	4180186
1013745	My child knew he or she could trust others in our family in past 4W	4180186
1013750	My child knew what he or she could expect from others in our family in past 4W	4180186
1013752	My family showed that they cared about me in past 4W	4180186
1013753	My family treated me fairly in past 4W	4180186
1013755	My memory has been as good as usual in past 7D	4180186
1013756	My mind has been as sharp as usual in past 7D	4180186
1013757	My problems with memory, concentration, or making mental mistakes have interfered with my ability to do things I enjoy in past 7D	4180186
1013758	My problems with memory, concentration, or making mental mistakes have interfered with my ability to work in past 7D	4180186
1013760	My reactions in everyday situations have been slow in past 7D	4180186
1013761	My thinking has been as fast as usual in past 7D	4180186
1013765	My thinking has been slower than usual in past 7D	4180186
1013768	People in my family made me feel good about myself in past 4W	4180186
1013775	Everyone in my family loved each other in past 4W	4180186
1013776	Everyone in my family loved me in past 4W	4180186
1013777	How much did pain interfere with doing your tasks away from home (e.g., getting groceries, running errands) in past 7D	4180186
1013847	Dyskinesia duration per D	4180186
1013879	Can pronounce detente	4180186
1013881	Can pronounce facade	4180186
1013935	I could comb my hair by myself in past 7D	4180186
1013938	I could put beads on a string in past 7D	4180186
1013943	I felt too nervous to be with a group of kids my age in past 7D	4180186
1013946	I wanted to be alone because I was so angry in past 7D	4180186
1013948	I was so mad I did not want to talk to people in past 7D	4180186
1013952	It was hard to have fun with friends because I was in pain in past 7D	4180186
1013967	American National Adult Reading Test panel	4180186
1013969	Heart.ventricle.left.mid inferior septum	4180186
1013970	Heart.ventricle.left.mid inferior lateral	4180186
1013972	Heart.ventricle.left.basal inferior septum	4180186
1013973	Heart.ventricle.left.basal inferior lateral	4180186
1013975	Mitral valve.annulus.medial	4180186
1013976	BPI.short	4180186
1013980	During the past 24H, how has pain interfered with your walking ability	4180186
1013981	During the past 24H, how has pain interfered with your normal work	4180186
1013985	US.doppler.PW	4180186
1014022	How much time did you usually spend walking on one of those D	4180186
1014023	During the last 7D, on how many D did you walk for at least 10M at a time	4180186
1014025	During the last 7D, on how many D did you do moderate physical activities like carrying light loads, bicycling at a regular pace, or doubles tennis for at least 10M at a time	4180186
1014051	Mean distance to access a patient	4180186
1014052	Mean time required to gather essential resources for a patient encounter	4180186
1014053	Mean distance required to gather essential resources for a patient encounter	4180186
1014117	PROMIS alcohol - negative consequences - version 1.0 T-score	4180186
1014118	PROMIS alcohol - alcohol use - version 1.0 T-score	4180186
1014120	PROMIS social isolation - version 2.0 T-score	4180186
1014122	PROMIS informational support - version 2.0 T-score	4180186
1014124	PROMIS companionship - version 2.0 T-score	4180186
1014126	PROMIS satisfaction with social roles and activities - version 2.0 T-score	4180186
1014127	PROMIS pain behavior - version 1.0 T-score	4180186
1014129	PROMIS satisfaction with participation in DSA - version 1.0 T-score	4180186
1014130	PROMIS sleep related impairment - version 1.0 T-score	4180186
1014131	PROMIS sleep disturbance - version 1.0 T-score	4180186
1014133	PROMIS emotional distress - anxiety - version 1.0 T-score	4180186
1014134	PROMIS emotional distress - anger - version 1.0 T-score	4180186
1014137	PROMIS physical function - version 1.0 T-score	4180186
1014138	PROMIS pediatric physical function - upper extremity - version 1.0 T-score	4180186
1014139	PROMIS pediatric peer relationships - version 1.0 T-score	4180186
1014140	PROMIS pediatric pain interference - version 1.0 T-score	4180186
1014142	PROMIS pediatric fatigue - version 1.0 T-score	4180186
1014145	PROMIS physical function - version 1.2 T-score	4180186
1014147	Anorectal/Stool	4180186
1014152	Follow-up attempt within 24H	4180186
1014181	Year included in Morbidity and Mortality Weekly Report	4180186
1014186	XXX MC	4180186
1014188	CDC.PHIN	4180186
1014239	Heart.ventricle.left.apex	4180186
1014240	Gradient.end diastole.max	4180186
1014260	Calculated.FibroMeter	4180186
1014261	Calculated.HepaScore	4180186
1014267	Posterior descending from right coronary artery	4180186
1014272	Diagonal artery 1	4180186
1014273	Diagonal artery 2	4180186
1014275	Mid distal left circumflex artery	4180186
1014277	Posterolateral from left circumflex artery	4180186
1014288	ArMass	4180186
1014289	ArLen	4180186
1014294	Atrioventricular nodal artery	4180186
1014295	Heart.ventricle.left.inferior	4180186
1014296	Heart.ventricle.left.lateral anterior	4180186
1014297	Heart.ventricle.left.lateral posterior	4180186
1014327	Coronary arteries.segment	4180186
1014330	Multisection 3D post processing	4180186
1014332	Multisection for congenital disease	4180186
1014334	Ureter.bilateral	4180186
1014339	Deep biopsy.needle	4180186
1014359	Compared to a few Y ago, does the patient have more trouble remembering things that have happened recently than she or he used to	4180186
1014360	Compared to a few Y ago, does he or she have more trouble recalling conversations a few days later	4180186
1014363	Compared to a few Y ago, is the patient less able to manage his or her medication independently	4180186
1014364	Compared to a few Y ago, does the patient need more assistance with transport (either private or public)	4180186
1014368	Fluid intake.oral.medication	4180186
1014370	Fluid output.urine nephrostomy	4180186
1014371	Fluid output.gastrointestinal ostomy	4180186
1014372	Fluid output.gastrointestinal drain	4180186
1014374	Fluid output.neurological drain	4180186
1014376	Fluid output.pressure injury	4180186
1014384	Cells.CD3+CD8+CD27-	4180186
1014386	Subjective refraction	4180186
1014387	Electrooculogram	4180186
1014388	Pelli-Robson eye chart	4180186
1014389	ETDRS eye chart	4180186
1014398	Palpebral fissure.right	4180186
1014399	Palpebral fissure.left	4180186
1014410	Pupil.left	4180186
1014412	Electroretinography panel	4180186
1014414	Optic nerve.right	4180186
1014416	Creatine uptake	4180186
1014419	Macula.left	4180186
1014424	Ocular fundus.right	4180186
1014425	Ocular fundus.left	4180186
1014430	Visual pathway.right	4180186
1014431	Visual pathway.left	4180186
1014453	Respiratory.lower	4180186
1014499	VR-12 Physical component summary score change - orthogonal method	4180186
1014501	VR-12 Mental component summary score change - oblique method	4180186
1014529	90D	4180186
1014530	14D	4180186
1014531	6Mo	4180186
1014532	1Y	4180186
1014546	Docosahexaenoate intake	4180186
1014555	Amino acid.essential intake panel	4180186
1014578	Amino acid.nonessential intake panel	4180186
1014579	Amino acid.nonessential intake	4180186
1014592	Fiber.soluble intake	4180186
1014593	Fiber.insoluble intake	4180186
1014600	Vitamin B3 intake	4180186
1014601	Vitamin B5 intake	4180186
1014604	US.2D.A4C+Calc by single plane method of disks	4180186
1014609	Vitamin B2 intake	4180186
1014638	Fluid intake.enteral tube.nutritional formula volume	4180186
1014663	Birth certificate number	4180186
1014673	Special medical equipment &or resuscitation needs	4180186
1014676	Heart.ventricle.right.outflow tract.proximal	4180186
1014677	Heart.ventricle.right.outflow tract.distal	4180186
1014694	Chorioretina.right	4180186
1014697	MCncSq	4180186
1014703	Social, psychological & behavioral observations - 2015 Edition Health IT Certification Criteria set	4180186
1014736	Enteral tube.nutritional formula concentration	4180186
1014768	MR.spectroscopy	4180186
1014770	MR.angio	4180186
1014776	Multisection for low grade tumor	4180186
1014779	Multisection for postoperative	4180186
1014780	Multisection for metastasis	4180186
1014793	Surfactant replacement	4180186
1014800	IPAQ	4180186
1014820	How often have you had a sensation of not emptying your bladder completely after you finished urinating over the past Mo	4180186
1014821	CDC	4180186
1014828	How often have you had to urinate again less than 2H after you finished urinating over the past Mo	4180186
1014829	How often have you found you stopped and started again several times when you urinated over the past Mo	4180186
1014835	Multisection for graft	4180186
1014838	Multisection for pregnancy+first trimester	4180186
1014842	Multisection for In vitro fertilization	4180186
1014847	Multisection for multiple gestation pregnancy	4180186
1014848	Multisection for multiple gestation pregnancy+first trimester	4180186
1014852	Multisection limited for multiple gestation pregnancy	4180186
1014853	Multisection limited for pregnancy	4180186
1014855	Guidance for change of central venous catheter	4180186
1014868	Guidance for tissue sampling of chorionic villus	4180186
1014871	Multisection for transplanted pancreas	4180186
1014873	Multisection for transplanted kidney vessels	4180186
1014878	Service &or equipment &or product note	4180186
1014879	Respiratory.upper	4180186
1014880	Respiratory	4180186
1014882	Cardiac arrest within 24H prior to procedure	4180186
1014884	Pelvis+^Fetus	4180186
1014885	IPSS	4180186
1014902	PT+CT	4180186
1014904	Breast.right & ^Breast specimen.right	4180186
1014906	Multisection limited for pediatrics	4180186
1014908	NM.SPECT	4180186
1014910	Guidance for needle localization && Views	4180186
1014920	RelEngRat	4180186
1014927	Standard resting metabolic rate	4180186
1014929	Predicted resting metabolic rate	4180186
1014934	Voids.incontinent	4180186
1014999	Multisection for sarcoidosis	4180186
1015001	Views limited for infection or inflammation	4180186
1015007	Verified side &or site of procedure	4180186
1015022	Lymph node.bilateral	4180186
1015024	Strain.max	4180186
1015028	US.3D	4180186
1015039	NM.SPECT+CT	4180186
1015041	Extremity.unilateral	4180186
1015055	Body temperature.max	4180186
1015066	Diagnostic imaging report - recommended C-CDA R2.0 & R2.1 sections	4180186
1015067	Consultation note - recommended C-CDA R2.0 & R2.1 sections	4180186
1015068	Continuity of Care Document - recommended C-CDA R2.0 & R2.1 sections	4180186
1015070	Pulmonary artery.left	4180186
1015071	Pulmonary artery.right	4180186
1015074	Pelvis+	4180186
1015075	Breast.left &&	4180186
1015076	Breast.right &&	4180186
1015085	Enhanced encounter note - recommended CDP Set 1 R1.0 & R1.1 sections	4180186
1015087	Interval document - recommended CDP Set 1 R1.0 & R1.1 sections	4180186
1015092	Probe.amp.tar.primer-probe set H5a	4180186
1015096	ACE.BRFSS	4180186
1015103	How often did a parent or adult in your home ever hit, beat, kick, or physically hurt you in any way	4180186
1015110	Oxygen.inspiratory	4180186
1015111	Oxygen.expiratory	4180186
1015137	Views blood pool+ejection fraction+first pass	4180186
1015138	Multisection for hemangioma	4180186
1015140	Views ventilation+perfusion quantitative	4180186
1015154	RelSCnc	4180186
1015159	Episode of care diagnosis.secondary	4180186
1015165	Respiratory pathogens DNA &	4180186
1015173	Multisection for Meckel's diverticulum	4180186
1015176	PrThr	4180186
1015185	NDI	4180186
1015195	Metabolic equivalent of task by measured resting metabolic rate panel	4180186
1015196	Metabolic equivalent of task by population resting metabolic rate panel	4180186
1015198	Resting metabolic rate panel	4180186
1015210	2Y	4180186
1015211	Photometric	4180186
1015216	RF	4180186
1015218	RF.video	4180186
1015224	HOOSJR	4180186
1015226	Amount of hip pain experienced while walking on an uneven surface in the last W	4180186
1015228	Degree of difficulty experienced due to your knee while rising from sitting in the last W	4180186
1015230	Degree of difficulty experienced due to your hip while lying in bed (turning over, maintaining hip position) in the last W	4180186
1015231	Degree of difficulty experienced due to your hip while sitting in the last W	4180186
1015235	Amount of knee pain experienced while standing upright in the last W	4180186
1015246	XR.portable	4180186
1015250	Risk evaluation & mitigation strategies	4180186
1015254	How much of the time did your asthma keep you from getting as much done at work, school or at home in the past 4W	4180186
1015255	How often have you had shortness of breath during the past 4W	4180186
1015256	How often did your asthma symptoms (wheezing, coughing, shortness of breath, chest tightness or pain) wake you up at night or earlier than usual in the morning during the past 4W	4180186
1015258	How would you rate your asthma control during the past 4W	4180186
1015259	DAST	4180186
1015264	Views AP + lateral	4180186
1015265	Views AP + lateral + oblique	4180186
1015268	(Views AP^W R-bending + W L-bending) + (view lateral^W flexion + W extension)	4180186
1015269	Views Sunrise & tunnel	4180186
1015271	Views R-oblique & L-oblique	4180186
1015272	Views lateral & Mortise & Broden	4180186
1015273	Views PA + lateral	4180186
1015274	Views PA + lateral + oblique	4180186
1015275	Views PA + oblique	4180186
1015278	RF.portable	4180186
1015286	Views AP + lateral frog	4180186
1015290	(Views) + (view AP	4180186
1015292	(View oblique) + (Views AP + lateral	4180186
1015293	(View oblique) + (views	4180186
1015294	(Views 2) + (views	4180186
1015298	Y of education	4180186
1015308	Supporting information about local extention &or metastasis for staging	4180186
1015327	Chromosome 12 trisomy & chromosome region 11q22.3 & 13q14 & 17p13.1 deletion	4180186
1015328	Chromosome 3 & 7 & 17 aneuploidy & chromosome region 9p21 deletion	4180186
1015341	Chromosome region Xp22.33 &or Yp11.32 deletion+duplication	4180186
1015386	ALSFRS-R	4180186
1015401	3-Hydroxy-3-Methylglutaryl-coenzyme A reductase Ab.IgG	4180186
1015404	Multisection^WO & W contrast IV && Multisection^W contrast IV	4180186
1015431	Cardiovascular disease.case manager	4180186
1015432	Cardiovascular disease.nurse practitioner	4180186
1015433	Cardiovascular disease.nurse	4180186
1015434	Inpatient Rehabilitation Facility - Patient Assessment Instrument - version 1.4	4180186
1015437	Vascular surgery.nurse practitioner	4180186
1015438	Vascular surgery.physician assistant	4180186
1015440	Surgery.interdisciplinary	4180186
1015441	Surgery.nurse practitioner	4180186
1015444	Orthopaedic surgery.physician assistant	4180186
1015446	Neurological surgery.nurse practitioner	4180186
1015447	Neurological surgery.nurse	4180186
1015449	Colon and rectal surgery.nurse practitioner	4180186
1015450	Colon and rectal surgery.nurse	4180186
1015452	Cardiovascular disease.clinical nurse specialist	4180186
1015453	Gastroenterology.clinical nurse specialist	4180186
1015457	Anesthesiology.nurse	4180186
1015458	Blood banking and transfusion medicine.nurse	4180186
1015460	Dentistry.technician	4180186
1015463	Diabetology.case manager	4180186
1015465	Endocrinology.nurse	4180186
1015466	Endocrinology.nurse practitioner	4180186
1015467	Gastroenterology.nurse	4180186
1015490	Does the patient use a wheelchair or scooter	4180186
1015492	Indicate the type of wheelchair or scooter used	4180186
1015494	Did the patient have major surgery during the 100D prior to admission	4180186
1015504	Chest>Mediastinum.superior	4180186
1015518	Exchanged drugs &or money for sex in the past Y	4180186
1015520	Sexual activity with known IV drug user in the past Y	4180186
1015525	BSDS	4180186
1015534	Reason for missed treatment	4180186
1015537	Geriatric medicine.case manager	4180186
1015538	Geriatric medicine.interdisciplinary	4180186
1015539	Geriatric medicine.nurse	4180186
1015540	Geriatric medicine.nurse practitioner	4180186
1015543	Hematology+Medical oncology.pharmacist	4180186
1015544	Hematology+Medical oncology.nurse	4180186
1015545	Hematology+Medical oncology.nurse practitioner	4180186
1015546	Hematology+Medical oncology.team	4180186
1015554	Mental health.nurse practitioner	4180186
1015555	Mental health.physician	4180186
1015556	Mental health.physician assistant	4180186
1015557	Mental health.team	4180186
1015558	Multi-specialty program.case manager	4180186
1015559	Multi-specialty program.nurse	4180186
1015560	Nephrology.nurse	4180186
1015565	Nuclear medicine.nurse	4180186
1015571	eyes closed+on solid surface	4180186
1015573	eyes closed+on foam surface	4180186
1015578	Number of 10 [ft_i] marks	4180186
1015581	Number of turns in 2M	4180186
1015597	Nutrition and dietetics.interdisciplinary	4180186
1015599	Nutrition and dietetics.team	4180186
1015600	MDQ	4180186
1015602	Employment type.compensation and sector	4180186
1015608	(Views AP + lateral + oblique) + (view^W manual stress)	4180186
1015610	(Views AP + lateral + oblique) + (view	4180186
1015611	(Views AP + lateral + Merchants) + (views	4180186
1015614	Spinal cord injury medicine.nurse	4180186
1015619	Urology.nurse	4180186
1015621	Urology.physician assistant	4180186
1015622	Wound care management.nurse	4180186
1015626	Occupational therapy.interdisciplinary	4180186
1015627	Ophthalmology.nurse	4180186
1015628	Ophthalmology.technician	4180186
1015629	Optometry.technician	4180186
1015632	View && Views supine + upright	4180186
1015634	(Views 2 or 3) + (Views^W flexion + W extension)	4180186
1015639	Pelvis && Lower extremity.right>Hip	4180186
1015640	Views 2 && View	4180186
1015642	Views GE 2 for pediatrics	4180186
1015643	Views 2 + Views lateral-decubitus	4180186
1015646	Views for bone density+vertebral fracture	4180186
1015648	View AP && Views GE 2	4180186
1015649	Neutrophil membrane Ab.IgM	4180186
1015653	VCF	4180186
1015655	Expression of ideas and wants during 3D assessment period	4180186
1015656	Understanding verbal content during 3D assessment period	4180186
1015657	Should brief interview for mental status be conducted during 3D assessment period	4180186
1015661	Eating - functional ability during 3D assessment period	4180186
1015663	Oral hygiene - functional ability during 3D assessment period	4180186
1015668	Shower &or bathe self - functional goal recorded during 3D assessment period	4180186
1015669	Upper body dressing - functional ability during 3D assessment period	4180186
1015670	Upper body dressing - functional goal recorded during 3D assessment period	4180186
1015671	Lower body dressing - functional ability during 3D assessment period	4180186
1015672	Lower body dressing - functional goal recorded during 3D assessment period	4180186
1015674	Putting on and taking off footwear - functional goal recorded during 3D assessment period	4180186
1015676	Roll left and right - functional goal recorded during 3D assessment period	4180186
1015679	Lying to sitting on side of bed - functional ability during 3D assessment period	4180186
1015682	Sit to stand - functional goal recorded during 3D assessment period	4180186
1015685	Toilet transfer - functional ability during 3D assessment period	4180186
1015687	Car transfer - functional ability during 3D assessment period	4180186
1015688	Car transfer - functional goal recorded during 3D assessment period	4180186
1015689	Walk 10 feet - functional ability during 3D assessment period	4180186
1015690	Walk 10 feet - functional goal recorded during 3D assessment period	4180186
1015691	Walk 50 feet with two turns - functional ability during 3D assessment period	4180186
1015692	Walk 50 feet with two turns - functional goal recorded during 3D assessment period	4180186
1015693	Walk 150 feet - functional ability during 3D assessment period	4180186
1015694	Walk 150 feet - functional goal recorded during 3D assessment period	4180186
1015696	Walking 10 feet on uneven surfaces - functional goal recorded during 3D assessment period	4180186
1015698	1 step (curb) - functional goal recorded during 3D assessment period	4180186
1015699	4 steps - functional ability during 3D assessment period	4180186
1015700	4 steps - functional goal recorded during 3D assessment period	4180186
1015701	12 steps - functional ability during 3D assessment period	4180186
1015702	12 steps - functional goal recorded during 3D assessment period	4180186
1015705	Wheel 50 feet with two turns - functional ability during 3D assessment period	4180186
1015725	Recreational therapy.interdisciplinary	4180186
1015728	Psychology.team	4180186
1015729	Psychiatry.team	4180186
1015730	Psychiatry.nurse practitioner	4180186
1015732	Psychiatry.interdisciplinary	4180186
1015734	Primary care.physician assistant	4180186
1015741	Physical therapy.nurse	4180186
1015742	Physical therapy.interdisciplinary	4180186
1015743	Physical medicine and rehab.team	4180186
1015748	Pastoral care.team	4180186
1015751	Palliative care.pharmacist	4180186
1015754	Pain medicine.nurse	4180186
1015755	Otolaryngology.nurse	4180186
1015757	Rheumatology.nurse	4180186
1015762	(Views 2 or 3) + (Views	4180186
1015763	(Views GE 5) + (Views GE 1	4180186
1015767	(Views AP + oblique + odontoid) + (View lateral^W flexion + W extension)	4180186
1015769	(Views AP + odontoid) + (View lateral^W flexion + W extension)	4180186
1015770	(View Sunrise) + (View tunnel	4180186
1015772	(Views 4) + (view AP	4180186
1015773	(Views AP + oblique + odontoid) + (View lateral	4180186
1015775	(View oblique) + (View lateral	4180186
1015776	(Views AP + odontoid) + (View lateral	4180186
1015783	Views AP + lateral && Views	4180186
1015785	View && Views	4180186
1015788	PCAM	4180186
1015811	CT && CT.angio	4180186
1015812	Gradient strip ARD	4180186
1015816	VA C&P exam.multiple exam note	4180186
1015818	Medical genetics.nurse	4180186
1015819	Physical medicine and rehab.interdisciplinary	4180186
1015820	Pharmacology.team	4180186
1015822	Radiology.nurse	4180186
1015823	Radiology.technician	4180186
1015826	Cardiovascular disease.physician assistant	4180186
1015827	Pharmacology.nurse	4180186
1015837	Abdomen+	4180186
1015846	Level 3 emergency medical services patient care report - recommended CDA R1 & R2 set	4180186
1015850	ACSCP Study II	4180186
1016183	Positive Affect Survey - CAT item bank - ages 18+	4180186
1016187	Positive Affect Survey - fixed length form - ages 18+	4180186
1016205	General Life Satisfaction Survey version 2.0 - parent report - fixed length form- ages 3-12	4180186
1016208	Emotional Support Survey - age 18+ - T-score	4180186
1016232	Loneliness Survey version 2.0 - fixed length form - ages 8-17	4180186
1016238	3Y	4180186
1016246	Prior functioning.stairs	4180186
1016293	LTVH	4180186
1016295	UCLA Loneliness Scale v3	4180186
1016300	California Teachers Study	4180186
1016302	SWAN ADHD	4180186
1016308	DI-PAD CGP V 1.4	4180186
1016314	Able to hold position for 50S - trial 1	4180186
1016315	Able to hold position for 50S - trial 2	4180186
1016316	Internal medicine.nurse practitioner	4180186
1016319	Internal medicine.pharmacist	4180186
1016380	Sexual activity with known Chlamydia trachomatis &or Neisseria gonorhoeae case	4180186
1016381	Male sexual partner in last 12Mo	4180186
1016383	Number of sexual partners in last 12Mo	4180186
1016387	Vital signs, weight, height, head circumference, oxygen saturation & BMI panel	4180186
1016394	Payment source.secondary	4180186
1016414	Human cell and tissue establishment registration & product listing	4180186
1016416	Diagnostic imaging report - example sections & entries	4180186
1016464	Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making you sit or lie down to rest during the day	4180186
1016466	Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making your working around the house or yard difficult	4180186
1016467	Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making your going places away from home difficult	4180186
1016479	Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making you short of breath	4180186
1016480	Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making you tired, fatigued or low on energy	4180186
1016481	Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making you stay in a hospital	4180186
1016500	Porcine epidemic diarrhea virus Ab.IgA	4180186
1016503	Influenza virus A porcine origin nucleoprotein Ab.IgG	4180186
1016509	Womens health.nurse	4180186
1016514	Thoracic and cardiac surgery.nurse	4180186
1016524	NKDEP	4180186
1016526	Is there evidence of an acute change in mental status from the patient's baseline during 3D assessment period	4180186
1016527	Did the (abnormal) behavior fluctuate during the day, that is, tend to come and go or increase and decrease in severity during 3D assessment period	4180186
1016528	Did the patient have difficulty focusing attention, for example, being easily distractible or having difficulty keeping track of what was being said during 3D assessment period	4180186
1016538	LCDS v3.00 - Swallowing &or nutritional status	4180186
1016562	Streptococcus pneumoniae Danish serotype 5 Ab,IgG	4180186
1016568	Cigarettes smoked per D	4180186
1016571	Views for placement check of central venous catheter	4180186
1016582	Dressing yourself was limited by heart failure over the past 2W	4180186
1016584	Showering or bathing was limited by heart failure over the past 2W	4180186
1016588	Hurrying or jogging (as if to catch a bus) was limited by heart failure over the past 2W	4180186
1016589	Change in symptoms of heart failure compared with 2W ago	4180186
1016590	Swelling in your feet, ankles or legs when you woke up over the past 2W	4180186
1016594	Shortness of breath limited your ability to do what you wanted over the past 2W	4180186
1016604	Participation in visiting family or friends out of your home limited by heart failure over the past 2W	4180186
1016605	Participation in intimate relationships with loved ones limited by heart failure over the past 2W	4180186
1016623	OASIS C2 - Patient history and diagnoses - start of care or resumption of care	4180186
1016629	Community health care.case manager	4180186
1016648	OASIS C2 - Elimination status - start of care or resumption of care	4180186
1016652	OASIS C2 - ADL and IADLs - start of care or resumption of care	4180186
1016653	OASIS C2 - Functional abilities and goals - start of care or resumption of care	4180186
1016656	OASIS C2 - Medications - start of care or resumption of care	4180186
1016698	Comatose during 3D assessment period	4180186
1016699	Does the patient walk - admission performance during 3D assessment period	4180186
1016701	Indicate the type of wheelchair or scooter used during 3D assessment period	4180186
1016702	Does the patient walk - discharge performance during 3D assessment period	4180186
1016714	rPARQ	4180186
1016727	Ebola & Marburg virus RNA	4180186
1016739	Minimum Data Set (MDS) - version 3.0 - Resident Assessment Instrument (RAI) version 1.14.1	4180186
1016748	Most recent admission &or entry or reentry into this facility	4180186
1016749	Hearing.ability to hear in last 7D	4180186
1016752	Express ideas and wants in last 7D	4180186
1016763	Observed.PHQ-9.CMS	4180186
1016775	View for clip placement	4180186
1016781	Guidance for drainage+placement of suprapubic catheter	4180186
1016792	Multisection for left ventricular function	4180186
1016795	Decreased weight within the last 2W	4180186
1016796	FPAR	4180186
1016798	Sexual activity in the last 3Mo	4180186
1016808	Color.favorite	4180186
1016816	Porcine reproductive and respiratory syndrome virus Ab.IgG	4180186
1016821	Conditions prior to medical or treatment regimen change or inpatient stay that took place within past 14D	4180186
1016822	Most recent inpatient discharge date in the last 14D	4180186
1016825	Cognitive, behavioral, and psychiatric symptoms demonstrated at least one time per W	4180186
1016833	Non-agency caregiver ability and willingness to assist with medical procedures &or treatments	4180186
1016844	Memory &or recall ability in the last 7D	4180186
1016851	MDS v3.0 - RAI v1.14.1, v1.15.1 - Mobility - admission performance during 3D assessment period	4180186
1016861	Indicators of pain or possible pain in the last 5D	4180186
1016870	Proportion of total calories the resident received through parenteral or tube feeding in the 7D - while not a resident	4180186
1016871	Proportion of total calories the resident received through parenteral or tube feeding in last 7D - while a resident	4180186
1016872	Proportion of total calories the resident received through parenteral or tube feeding during entire 7D	4180186
1016877	Height, weight & blood pressure panel	4180186
1016892	Skin and pressure injury &or injury treatments during assessment period	4180186
1016893	Amount of hip pain experienced while going up or down stairs in the last W	4180186
1016894	Degree of difficulty experienced due to your hip while rising from sitting in the last W	4180186
1016895	Degree of difficulty experienced due to your hip while bending to floor &or pick up an object in the last W	4180186
1016901	Number of D antidepressant received in last 7D or since admission &or reentry if less than 7D	4180186
1016905	Number of D diuretic received in last 7D or since admission &or reentry if less than 7D	4180186
1016909	Procedures performed during last 14D - while not a resident	4180186
1016910	Procedures performed during last 14D - while a resident	4180186
1016917	Number of D of passive range of motion in last 7 calendar D	4180186
1016918	Patient demographic & administrative information panel	4180186
1016919	Occupational therapy - concurrent minutes in the last 7D	4180186
1016920	Occupational therapy - group minutes in the last 7D	4180186
1016923	Physical therapy - group minutes in the last 7D	4180186
1016924	Physical therapy - individual minutes in the last 7D	4180186
1016925	Speech-language pathology and audiology services - concurrent minutes in the last 7D	4180186
1016933	Number of D of training & skill practice in transfer in last 7 calendar D	4180186
1016935	Number of D of training & skill practice in walking in last 7 calendar D	4180186
1016936	Number of D of training & skill practice in dressing or grooming in last 7 calendar D	4180186
1016938	Number of D of training & skill practice in amputation or prosthesis care in last 7 calendar D	4180186
1016939	Number of D of training & skill practice in communication in last 7 calendar D	4180186
1016954	Weight gain of 5% or more in the last month or gain of 10% or more in last 6Mo	4180186
1016956	Physical therapy - co-treatment minutes during 7D assessment period	4180186
1016964	Cause of death classification+related information	4180186
1016975	MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Swallowing &or nutritional status - NSD, ND, SSD, SD	4180186
1016976	MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Swallowing &or nutritional status - NOD, SP, SOD	4180186
1016993	MDS v3.0 - RAI v1.14.1 - Nursing home & Swing bed OMRA (NO & SO) item set	4180186
1016994	MDS v3.0 - RAI v1.14.1 - Nursing home OMRA start of therapy and discharge (NSD) & Swing bed OMRA start of therapy and discharge (SSD) item set	4180186
1016996	MDS v3.0 - RAI v1.14.1 - Nursing home OMRA-discharge (NOD) & Swing bed OMRA-discharge (SOD) item set	4180186
1016997	MDS v3.0 - RAI v1.14.1 - Nursing home & Swing bed OMRA start of therapy (NS & SS) item set	4180186
1017010	Staff assessment of resident mood (PHQ-9-OV) - symptom presence in the last 2W	4180186
1017031	(Multisection^WO contrast) + (Multisection for left ventricular function^W contrast IV)	4180186
1017040	KCCQ-12	4180186
1017041	PAM	4180186
1017059	Work Hs per D	4180186
1017060	Combat zone &or hazardous duty work dates	4180186
1017064	Reportable condition response description.brief	4180186
1017072	Taking an active role in my child's health care is the most important thing that affects his or her health	4180186
1017086	Taking an active role in this person's health care is one of the most important factors in determining her or his health and ability to function	4180186
1017094	I am able to help this person maintain lifestyle changes (like eating right or exercising) for her or his condition	4180186
1017101	Pupil.bilateral	4180186
1017160	Guidance for cholangioscopy+removal of calculus	4180186
1017170	Guidance for exchange of gastrostomy tube	4180186
1017201	Guidance for placement of gastrojejunostomy tube	4180186
1017218	Neck+Chest>Soft tissue	4180186
1017226	Guidance GE 3 for injection of trigger point	4180186
1017241	Neutrophil cytoplasmic Ab.IgG & Saccharomyces cerevisiae Ab.IgA & IgG	4180186
1017263	Addiction medicine.physician	4180186
1017264	Addiction medicine.team	4180186
1017265	Addiction medicine.case manager	4180186
1017266	Addiction medicine.nurse	4180186
1017267	Addiction medicine.therapist	4180186
1017285	Shortness of breath in last 7D	4180186
1017286	Problem conditions in last 7D	4180186
1017287	Inpatient discharge facility within the past 14D	4180186
1017332	Medication intervention since admission &or reentry	4180186
1017348	Number of pressure injuries present upon admission &or reentry - unstageable due to non-removable dressing	4180186
1017350	Number of pressure injuries present upon admission &or reentry - unstageable due to coverage of wound bed by slough &or eschar	4180186
1017363	Stage 2 pressure injuries not present or at a lesser stage on admission &or reentry	4180186
1017366	Unstageable pressure injuries due to non-removable dressing not present or at a lesser stage on admission &or reentry	4180186
1017368	Unstageable pressure injury due to deep tissue injury not present or at a lesser stage on admission &or reentry	4180186
1017369	Calculated.ELF	4180186
1017387	How often have you had five or more drinks in one D during the past Y	4180186
1017400	Within the past 12Mo the food we bought just didn't last and we didn't have money to get more	4180186
1017404	Person completing form title	4180186
1017432	Intravascular diastolic goal	4180186
1017440	Cholesterol.in LDL goal	4180186
1017449	Number of D opiod received in last 7D or since admission &or reentry if less than 7D	4180186
1017451	Antipsychotic medications since admission or entry or reentry or the prior OBRA assessment, whichever is more recent	4180186
1017461	Wander or elopement alarm used during assessment period	4180186
1017464	MDS v3.0 - RAI v1.15.1 - Nursing home & Swing bed OMRA start of therapy (NS & SS) item set	4180186
1017465	MDS v3.0 - RAI v1.15.1 - Nursing home & Swing bed tracking (NT & ST) item set	4180186
1017467	MDS v3.0 - RAI v1.15.1 - Nursing home discharge (ND) & Swing bed discharge (SD) item set	4180186
1017468	MDS v3.0 - RAI v1.15.1 - Nursing home OMRA start of therapy and discharge (NSD) & Swing bed OMRA start of therapy and discharge (SSD) item set	4180186
1017482	CT.perfusion && CT.angio	4180186
1017500	How many times have you had chest pain, chest tightness or angina on average over the past 4W	4180186
1017502	How much has your chest pain, chest tightness or angina limited your enjoyment of life over the past 4W	4180186
1017531	During the last 7D, on how many D did you do vigorous physical activities like heavy lifting, digging, heavy construction, or climbing up stairs as part of your work for at least 10M at a time	4180186
1017533	During the last 7D, on how many D did you do moderate physical activities like carrying light loads as part of your work, not including walking, for at least 10M at a time	4180186
1017537	How much time did you usually spend on one of those D walking as part of your work during the last 7D	4180186
1017540	How much time did you usually spend on one of those D traveling in a train, bus, car, tram, or other kind of motor vehicle during the last 7D	4180186
1017542	How much time did you usually spend on one of those D to bicycle from place to place during the last 7D	4180186
1017544	How much time did you usually spend on one of those D walking from place to place during the last 7D	4180186
1017551	How much time did you usually spend on one of those D doing moderate physical activities inside your home during the last 7D	4180186
1017554	How much time did you usually spend on one of those D walking in your leisure time during the last 7D	4180186
1017555	During the last 7D, on how many D did you do vigorous physical activities like aerobics, running, fast bicycling, or fast swimming in your leisure time for at least 10M at a time	4180186
1017556	How much time did you usually spend on one of those D doing vigorous physical activities in your leisure time during the last 7D	4180186
1017558	How much time did you usually spend on one of those D doing moderate physical activities in your leisure time during the last 7D	4180186
1017560	During the last 7D, how much time did you usually spend sitting on a weekday	4180186
1017579	How much time did you usually spend doing moderate physical activities on one of those D	4180186
1017600	How often are you aware of your knee problem	4180186
1017605	Do you feel grinding, hear clicking or any other type of noise from your hip during the last W	4180186
1017606	Difficulties spreading legs wide apart during the last W	4180186
1017627	OASIS D - Sensory status - start of care or resumption of care or follow-up	4180186
1017628	OASIS D - Integumentary status - start of care or resumption of care	4180186
1017633	OASIS D - Neuro & emotional & behavioral status - start of care or resumption of care	4180186
1017646	How severe is your hip stiffness after sitting, lying or resting later in the day during the last W	4180186
1017654	Amount of hip pain experienced while walking on flat surface in the last W	4180186
1017656	Degree of difficulty experienced due to your hip while sitting or lying during the last W	4180186
1017658	Amount of hip pain experienced while walking of a hard surface (asphalt, concrete, etc.) in the last W	4180186
1017659	Amount of hip pain experienced while bending your hip fully in the last W	4180186
1017660	Degree of difficulty experienced due to your hip while putting on socks or stockings in the last W	4180186
1017662	Degree of difficulty experienced due to your hip while walking on uneven surface during the last W	4180186
1017667	Acute heart failure within 24H prior to procedure	4180186
1017675	Position &or immobilizer used during EMS transport	4180186
1017690	Degree of difficulty experienced due to your hip while squatting during the last W	4180186
1017692	Degree of difficulty experienced due to your hip while going shopping in the last W	4180186
1017694	Degree of difficulty experienced due to your hip while walking on a flat surface in the last W	4180186
1017695	Degree of difficulty experienced due to your hip while standing in the last W	4180186
1017697	Degree of difficulty experienced due to your hip while doing light domestic duties (cooking, dusting, etc) in the last W	4180186
1017698	Degree of difficulty experienced due to your hip while doing heavy domestic duties (moving heavy boxes, scrubbing floors, etc) in the last W	4180186
1017701	Degree of difficulty experienced due to your hip while taking off socks or stockings in the last W	4180186
1017702	Degree of difficulty experienced due to your hip while rising from bed in the last W	4180186
1017706	RelSoundInt	4180186
1017707	Cancer-associated gene Ab	4180186
1017714	Degree of difficulty experienced due to your knee while kneeling during the last W	4180186
1017717	Degree of difficulty experienced due to your knee while running during the last W	4180186
1017718	Degree of difficulty experienced due to your knee while squatting during the last W	4180186
1017723	Do you feel grinding, hear clicking or any other type of noise when your knee moves during the last W	4180186
1017727	Amount of knee pain experienced while walking on flat surface in the last W	4180186
1017728	Amount of knee pain experienced while bending knee fully in the last W	4180186
1017730	Degree of difficulty experienced due to your knee while putting on socks or stockings in the last W	4180186
1017731	Degree of difficulty experienced due to your knee while going shopping in the last W	4180186
1017736	Degree of difficulty experienced due to your knee while doing light domestic duties (cooking, dusting, etc) in the last W	4180186
1017737	Degree of difficulty experienced due to your knee while doing heavy domestic duties (moving heavy boxes, scrubbing floors, etc) in the last W	4180186
1017738	Degree of difficulty experienced due to your knee while getting on or off toilet in the last W	4180186
1017741	Degree of difficulty experienced due to your knee while lying in bed (turning over, maintaining hip position) in the last W	4180186
1017744	Degree of difficulty experienced due to your knee while descending stairs in the last W	4180186
1017749	I have been able to remember where I put things, like my keys or my wallet in past 7D	4180186
1017765	Drug regimen review identified potential medication issues in the last 3D	4180186
1017796	MDS v3.0 - RAI v1.16.1 - Nursing home OMRA-discharge (NOD) & Swing bed OMRA-discharge (SOD) item set	4180186
1017800	MDS v3.0 - RAI v1.16.1 - Nursing home & Swing bed OMRA (NO & SO) item set	4180186
1017801	MDS v3.0 - RAI v1.16.1 - Nursing home & Swing bed OMRA start of therapy (NS & SS) item set	4180186
1017826	100 Cells.CD19	4180186
1017839	100 Cells.CD3+CD4+	4180186
1017841	Compared to 10Y ago, has there been any change in remembering a few shopping items without a list	4180186
1017842	Compared to 10Y ago, has there been any change in remembering things that happened recently (such as recent outings, events in the news)	4180186
1017843	Compared to 10Y ago, has there been any change in recalling conversations a few days later	4180186
1017845	Compared to 10Y ago, has there been any change in repeating stories &or questions	4180186
1017850	Compared to 10Y ago, has there been any change in verbally giving instructions to others	4180186
1017852	Compared to 10Y ago, has there been any change in communicating thoughts in a conversation	4180186
1017856	Compared to 10Y ago, has there been any change in describing a program he or she has watched on TV	4180186
1017858	Compared to 10Y ago, has there been any change in following a map to find a new location	4180186
1017859	Compared to 10Y ago, has there been any change in reading a map and helping with directions when someone else is driving	4180186
1017860	Compared to 10Y ago, has there been any change in finding one's car in a parking lot	4180186
1017861	Compared to 10Y ago, has there been any change in finding the way back to a meeting spot in the mall or other location	4180186
1017862	Compared to 10Y ago, has there been any change in finding his or her way around a familiar neighborhood	4180186
1017866	Compared to 10Y ago, has there been any change in the ability to anticipate weather changes and plan accordingly (i.e., bring a coat or umbrella)	4180186
1017867	Compared to 10Y ago, has there been any change in developing a schedule in advance of anticipated events	4180186
1017868	Compared to 10Y ago, has there been any change in thinking things through before acting	4180186
1017870	Compared to 10Y ago, has there been any change in keeping living and work space organized	4180186
1017871	Compared to 10Y ago, has there been any change in balancing the checkbook without error	4180186
1017874	Compared to 10Y ago, has there been any change in using an organized strategy to manage a medication schedule involving multiple medications	4180186
1017875	Compared to 10Y ago, has there been any change in the ability to do two things at once	4180186
1017885	Karnofsky	4180186
1017893	Intervention &or services provided panel	4180186
1017923	I have trouble doing all of my regular leisure activities with others in the past 7D	4180186
1017925	Compared to 10Y ago, has there been any change in finding my way around a familiar neighborhood	4180186
1017926	Compared to 10Y ago, has there been any change in finding my way back to a meeting spot in the mall or other location	4180186
1017928	Compared to 10Y ago, has there been any change in describing a program I have watched on TV	4180186
1017930	Compared to 10Y ago, has there been any change in remembering where I have placed objects	4180186
1017936	Compared to 10Y ago, has there been any change in planning a sequence of stops on a shopping trip	4180186
1017940	Compared to 10Y ago, has there been any change in finding my way around a house visited many times	4180186
1017973	Shower &or bathe self - functional ability	4180186
1018001	Rose Dyspnea Scale panel	4180186
1018024	Gynecology.nurse practitioner	4180186
1018030	Access to transportation &or mobility status	4180186
1018118	Calculated.NephroCheck	4180186
1018119	EBMT	4180186
1018121	Anesthesiology.team	4180186
1018122	Endocrinology.team	4180186
1018124	Neurological surgery.team	4180186
1018130	PESI	4180186
1018135	I worried about dying in past 7D	4180186
1018144	I felt irritable in past 7D	4180186
1018146	How often did pain make it hard for you to walk more than 5 minutes at a time in past 7D	4180186
1018147	How much did you worry about pain in past 7D	4180186
1018148	How much did pain interfere with your ability to pay attention in past 7D	4180186
1018151	I felt unloved in past 7D	4180186
1018152	I felt like crying in past 7D	4180186
1018163	Guidance GE 3 levels for injection	4180186
1018170	Condition triggering emergency operation center response activation	4180186
1018190	Over the last W, on how many nights has your or your child's sleep been disturbed because of the eczema	4180186
1018192	Over the last W, on how many D has your or your child's skin been weeping or oozing clear fluid because of the eczema	4180186
1018194	Over the last W, on how many D has your or your child's skin been flaking off because of the eczema	4180186
1018195	Over the last W, on how many D has your or your child's skin felt dry or rough because of the eczema	4180186
1018208	Satisfaction with knee &or hip replacement result	4180186
1018214	CRQ-SAI	4180186
1018231	PROMIS pediatric pain interference - version 2.0 T-score	4180186
1018235	I had so much pain I had to stop what I was doing in past 7D	4180186
1018239	My child had trouble doing schoolwork when he or she had pain in past 7D	4180186
1018241	It was hard for my child to remember things when he or she had pain in past 7D	4180186
1018244	It was hard for my child to have fun when he or she had pain in past 7D	4180186
1018245	My child hurt all over his or her body in past 7D	4180186
1018247	My child hurt a lot in past 7D	4180186
1018248	My child missed school when he or she had pain in past 7D	4180186
1018249	It was hard for my child to stay standing when he or she had pain in past 7D	4180186
1018250	Epithelial cell adhesion molecule Ab	4180186
1018252	Matrix metalloproteinases-9 Ab	4180186
1018267	Inpatient Rehabilitation Facility - Patient Assessment Instrument - version 3.0	4180186
1018270	Clinical pathology.team	4180186
1018282	RAPID3	4180186
1018288	Over the past W, are you able to participate in recreational activities and sports as you would like, if you wish	4180186
1018290	Over the past W, are you able to deal with feelings of anxiety or being nervous	4180186
1018291	Over the past W, are you able to deal with feelings of depression or feeling blue	4180186
1018301	It is hard for your child to concentrate in school in past 4W - frequency	4180186
1018302	It is hard for your child to do more than one thing at a time in past 4W	4180186
1018304	It is hard for your child to find the right words to say what he or she means in past 4W - frequency	4180186
1018305	It is hard for your child to learn new things in past 4W	4180186
1018308	It is hard for your child to take notes in class in past 4W	4180186
1018309	It is hard for your child to understand pictures that show how to make something in past 4W	4180186
1018310	It takes your child longer than other people to get his or her school work done in past 4W - frequency	4180186
1018314	Your child forgets what he or she is going to say in past 4W - frequency	4180186
1018315	Your child forgets what his or her parents or teachers ask him or her to do in past 4W	4180186
1018317	Your child has to read things several times to understand them in past 4W - frequency	4180186
1018318	Your child has to use written lists more often than other people his or her age so he or she will not forget things in past 4W - frequency	4180186
1018319	Your child has to work really hard to pay attention or he or she makes mistakes in past 4W - frequency	4180186
1018320	Your child has trouble keeping track of what he or she is doing if he or she gets interrupted in past 4W	4180186
1018322	Your child has trouble remembering the date or day of the week in past 4W	4180186
1018324	Your child has trouble remembering to do things like school projects or chores in past 4W - frequency	4180186
1018326	Your child reacts slower than most people his or her age when he or she plays games in past 4W - frequency	4180186
1018333	Your child has to read things several times to understand them in past 4W - severity	4180186
1018334	Your child has a hard time keeping track of his or her homework in past 4W - severity	4180186
1018335	Your child forgets what he or she is going to say in past 4W - severity	4180186
1018336	Your child forgets to bring things to and from school that he or she needs for homework in past 4W - severity	4180186
1018338	It takes your child longer than other people to get his or her school work done in past 4W - severity	4180186
1018339	It is hard for your child to find the right words to say what he or she means in past 4W - severity	4180186
1018375	I have a hard time keeping track of my homework in past 4W - frequency	4180186
1018379	It is hard for me to take notes in class in past 4W	4180186
1018382	I forget to bring things to and from school that I need for homework in past 4W - severity	4180186
1018384	I have trouble paying attention to the teacher in past 4W - severity	4180186
1018386	I have trouble remembering where I put things, like my watch or my homework in past 4W	4180186
1018388	It is hard for me to pay attention to one thing for more than 5-10 minutes in past 4W	4180186
1018390	I have trouble keeping track of what I am doing if I get interrupted in past 4W	4180186
1018392	I forget what my parents or teachers ask me to do in past 4W	4180186
1018394	I have trouble remembering the names of people I know in past 4W	4180186
1018396	When I have a big project to do, I have trouble deciding where to start in past 4W	4180186
1018402	I have to use written lists more often than other people my age so I will not forget things in past 4W - frequency	4180186
1018404	I have to work really hard to pay attention or I make mistakes in past 4W - frequency	4180186
1018407	It is hard for me to pay attention to something boring I have to do in past 4W	4180186
1018409	I have to read things several times to understand them in past 4W - severity	4180186
1018410	I react slower than most people my age when I play games in past 4W - severity	4180186
1018413	I forget what I am going to say in past 4W - severity	4180186
1018414	I have to use written lists more often than other people my age so I will not forget things in past 4W - severity	4180186
1018416	I have to work really hard to pay attention or I make mistakes in past 4W - severity	4180186
1018417	Your child has trouble remembering the names of people he or she has just met in past 4W	4180186
1018418	CUDOS	4180186
1018424	???lead	4180186
1018485	Escherichia coli (oppA) gene	4180186
1018546	PROMIS pediatric physical function: mobility - version 1.0 T-score	4180186
1018592	Hair/Nail/Skin	4180186
1018594	Vendor test code to LOINC mapping data set	4180186
1018605	CYBB gene full & NCF1 gene	4180186
1018611	During the past Mo, how often did you eat any kind of fried potatoes, including french fries, home fries, or hash brown potatoes	4180186
1018615	During the past Mo, how often did you eat pizza	4180186
1018617	During the past Mo, how often did you eat red meat, such as beef, pork, ham, or sausage	4180186
1018626	Anaerobic culture+Antimicrobial neutralizer	4180186
1018629	Pain intensity, Enjoyment of life, General activity (PEG)	4180186
1018633	CBA IFA	4180186
1018634	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when dressing yourself without help	4180186
1018636	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when walking up 20 stairs (2 flights) without stopping	4180186
1018637	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when preparing meals	4180186
1018641	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when lifting something weighing 10-20 lbs (about 4.5-9 kg, like a large bag of groceries)	4180186
1018643	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when walking (faster than your usual speed) for a half mile (almost 1 km) without stopping	4180186
1018646	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when putting on socks or stockings	4180186
1018648	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when walking 10 steps or paces on flat ground at a normal speed without stopping	4180186
1018652	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when walking up 30 stairs (3 flights) without stopping	4180186
1018654	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when lifting something weighing less than 5 lbs (about 2 kg, like a houseplant)	4180186
1018655	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when lifting something weighing 5-10 lbs (about 2-4.5 kg, like a basket of clothes)	4180186
1018656	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when lifting something weighing more than 20 lbs (about 9 kg, like a medium-sized suitcase)	4180186
1018658	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when carrying something weighing 5-10 lbs (about 2-4.5 kg, like a basket of clothes) from one room to another	4180186
1018663	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when walking (faster than your usual speed) for 50 steps without stopping	4180186
1018664	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when walking (faster than your usual speed) for at least 1 mile (a little more than 1.5 km) without stopping	4180186
1018665	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had singing or humming	4180186
1018666	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when talking while walking	4180186
1018681	Thinking about the past 4W, my child's life was ideal	4180186
1018682	Thinking about the past 4W, my child's life was the best	4180186
1018685	Thinking about the past 4W, my child's life was great	4180186
1018689	Thinking about the past 4W, the conditions of my child's life were excellent	4180186
1018697	Thinking about the past 4W, my child felt he or she lived as well as other kids	4180186
1018700	Thinking about the past 4W, my child was happy with his or her social life	4180186
1018701	Thinking about the past 4W, my child was happy with his or her family life	4180186
1018703	Thinking about the past 4W, my child was happy with his or her life at home	4180186
1018706	Thinking about the past 4W, my child was satisfied with his or her free time	4180186
1018710	Thinking about the past 4W, my child was happy with his or her life	4180186
1018712	Thinking about the past 4W, my child felt good about his or her life	4180186
1018713	Thinking about the past 4W, my child had a good life	4180186
1018714	Thinking about the past 4W, my child felt positive about his or her life	4180186
1018718	Thinking about the past 4W, my child liked the way he or she lived his or her life	4180186
1018720	Thinking about the past 4W, my child's life went well	4180186
1018725	Thinking about the past 4W, my life was ideal	4180186
1018727	Thinking about the past 4W, my life was outstanding	4180186
1018728	Thinking about the past 4W, my life was excellent	4180186
1018729	Thinking about the past 4W, my life was great	4180186
1018731	Thinking about the past 4W, my life was going very well	4180186
1018733	Thinking about the past 4W, the conditions of my life were excellent	4180186
1018735	Thinking about the past 4W, I was happy with the way things were	4180186
1018736	Thinking about the past 4W, I had what I wanted in life	4180186
1018737	Thinking about the past 4W, I had what I needed in life	4180186
1018738	Thinking about the past 4W, I got the things I wanted in life	4180186
1018740	Thinking about the past 4W, I enjoyed my life more than most kids enjoyed their lives	4180186
1018741	Thinking about the past 4W, I lived as well as other kids	4180186
1018748	Thinking about the past 4W, I was happy with my life in my neighborhood	4180186
1018749	Thinking about the past 4W, I was happy with my life in my community	4180186
1018752	Thinking about the past 4W, I was satisfied with my life	4180186
1018756	Thinking about the past 4W, I felt good about my life	4180186
1018757	Thinking about the past 4W, I had a good life	4180186
1018766	Thinking about the past 4W, I was satisfied with my life in general	4180186
1018798	MDS v3.0 - RAI v1.17.1, 1.17.2 - Nursing home & Swing bed tracking (NT & ST) item set	4180186
1018815	MDS v3.0 - RAI v1.17.2 - Swallowing &or nutritional status - IPA	4180186
1018829	Occupational therapy since the start date of the residents most recent Medicare Part A stay	4180186
1018854	My child felt good about his or her friendships in past 7D	4180186
1018855	My child was able to have fun with his or her friends in past 7D	4180186
1018857	My child was a good friend in past 7D	4180186
1018858	Other kids wanted to talk to my child in past 7D	4180186
1018859	My child and his or her friends helped each other out in past 7D	4180186
1018861	My child felt accepted by other kids his or her age in past 7D	4180186
1018864	My child was able to count on his or her friends in past 7D	4180186
1018865	My child played alone and kept to himself or herself in past 7D	4180186
1018866	My child liked being around other kids his or her age in past 7D	4180186
1018867	My child spent time with his or her friends in past 7D	4180186
1018872	My child could get down on his or her knees without holding on to something in past 7D	4180186
1018879	My child could walk across the room in past 7D	4180186
1018881	My child could stand up without help in past 7D	4180186
1018883	My child could move his or her legs in past 7D	4180186
1018885	My child could bend over to pick something up in past 7D	4180186
1018890	My child used a wheelchair to get around in past 7D	4180186
1018891	My child could carry his or her books in a backpack in past 7D	4180186
1018903	MDS v3.0 - RAI v1.17.2 - Swallowing &or nutritional status - ND, SD	4180186
1018907	Palliative care.social worker	4180186
1018910	Physical medicine and rehab.social worker	4180186
1018923	Addiction medicine.attending	4180186
1018927	Cardiovascular disease.resident	4180186
1018928	Colon and rectal surgery.attending	4180186
1018929	Colon and rectal surgery.fellow	4180186
1018930	Colon and rectal surgery.resident	4180186
1018932	Dentistry.attending	4180186
1018933	Dentistry.resident	4180186
1018934	Dermatology.attending	4180186
1018935	Dermatology.resident	4180186
1018937	Endocrinology.fellow	4180186
1018939	Gastroenterology.attending	4180186
1018941	Gastroenterology.resident	4180186
1018942	General medicine.attending	4180186
1018943	Geriatric medicine.attending	4180186
1018944	Geriatric medicine.fellow	4180186
1018945	Geriatric medicine.resident	4180186
1018947	Gynecology.resident	4180186
1018949	Hematology+Medical oncology.fellow	4180186
1018951	Infectious disease.attending	4180186
1018953	Infectious disease.resident	4180186
1018954	Internal medicine.attending	4180186
1018955	Internal medicine.intern	4180186
1018956	Internal medicine.resident	4180186
1018957	Interventional radiology.resident	4180186
1018958	Mental health.attending	4180186
1018961	Nephrology.fellow	4180186
1018963	Neurological surgery.attending	4180186
1018964	Neurological surgery.resident	4180186
1018966	Neurology.resident	4180186
1018968	Nuclear medicine.resident	4180186
1018974	Ophthalmology.fellow	4180186
1018975	Ophthalmology.resident	4180186
1018976	Optometry.resident	4180186
1018977	Oral and maxillofacial surgery.attending	4180186
1018978	Oral and maxillofacial surgery.resident	4180186
1018980	Orthopaedic surgery.resident	4180186
1018981	Otolaryngology.attending	4180186
1018982	Otolaryngology.resident	4180186
1018984	Palliative care.resident	4180186
1018988	Physical therapy.resident	4180186
1018992	Podiatry.attending	4180186
1018994	Primary care.attending	4180186
1018997	Psychiatry.resident	4180186
1018999	Pulmonary disease.attending	4180186
1019002	Radiation oncology.attending	4180186
1019003	Radiation oncology.resident	4180186
1019005	Rheumatology.attending	4180186
1019007	Rheumatology.resident	4180186
1019012	Surgery.intern	4180186
1019014	Thoracic and cardiac surgery.attending	4180186
1019017	Transplant surgery.attending	4180186
1019018	Transplant surgery.resident	4180186
1019019	Urology.attending	4180186
1019030	Thromboembolism.team	4180186
1019060	My back pain has spread down my leg(s) at some time in the last 2W	4180186
1019068	Overall, how bothersome has your back pain been in the last 2W	4180186
1019111	STarT Back	4180186
1019122	New cases per D	4180186
1019136	Thromboelastography.rotational	4180186
1019140	When my child was in pain he or she asked people to let him or her be by himself or herself in past 7D	4180186
1019143	When my child was in pain he or she cried in past 7D	4180186
1019146	When my child was in pain he or she became quiet in past 7D	4180186
1019147	When my child was in pain he or she asked for help getting around in past 7D	4180186
1019148	When my child was in pain he or she groaned in past 7D	4180186
1019149	When my child was in pain he or she stayed away from other people in past 7D	4180186
1019150	When my child was in pain he or she asked for medicine in past 7D	4180186
1019152	When my child was in pain he or she protected the part of his or her body that hurt in past 7D	4180186
1019155	When my child was in pain he or she didn't let anyone touch him or her in past 7D	4180186
1019158	When my child was in pain he or she got angry at people in past 7D	4180186
1019159	When my child was in pain he or she didn't want anyone to touch him or her in past 7D	4180186
1019160	When my child was in pain he or she avoided standing in past 7D	4180186
1019161	When my child was in pain he or she asked people to bring him or her things (food, games) in past 7D	4180186
1019162	When my child was in pain he or she couldn't stay still in past 7D	4180186
1019163	When my child was in pain he or she was restless in past 7D	4180186
1019164	When my child was in pain he or she tried to think of something nice or fun in past 7D	4180186
1019166	When my child was in pain he or she had to stop what he or she was doing in past 7D	4180186
1019169	When my child was in pain he or she tried to rest or relax in past 7D	4180186
1019170	When my child was in pain he or she complained in past 7D	4180186
1019175	When my child was in pain he or she said mean words to people in past 7D	4180186
1019176	When my child was in pain he or she got mad and threw or hit something in past 7D	4180186
1019178	When my child was in pain he or she had tears in his or her eyes in past 7D	4180186
1019183	When my child was in pain it showed on his or her face in past 7D	4180186
1019184	When my child was in pain he or she told people he or she couldn't do things with them in past 7D	4180186
1019185	When my child was in pain he or she asked for someone to help him or her in past 7D	4180186
1019188	DTS	4180186
1019241	I felt dizzy in past 7D	4180186
1019242	My breathing was fast in past 7D	4180186
1019243	My hands shook in past 7D	4180186
1019245	My body shook in past 7D	4180186
1019246	I had a headache in past 7D	4180186
1019248	My back hurt in past 7D	4180186
1019250	I had pain that really bothered me in past 7D	4180186
1019253	I threw up in past 7D	4180186
1019255	My child wanted to be by himself or herself in past 7D	4180186
1019256	My child felt alone in past 7D	4180186
1019259	It was hard for my child to do school work because he or she felt sad in past 7D	4180186
1019266	My child could not stop feeling sad in past 7D	4180186
1019268	My child felt scared that he or she might have trouble breathing because of asthma in past 7D	4180186
1019271	My child was bothered by the amount of time he or she spent wheezing in past 7D	4180186
1019273	My child had trouble walking because of asthma in past 7D	4180186
1019277	My child's chest felt tight because of asthma in past 7D	4180186
1019280	My child coughed because of his or her asthma in past 7D	4180186
1019283	My child's asthma bothered him or her in past 7D	4180186
1019284	My child missed school because of asthma in past 7D	4180186
1019285	How many D were you strong enough to carry heavy things with your hands in past 7D	4180186
1019286	How many D were you strong enough to go up and down stairs in past 7D	4180186
1019287	How many D were you strong enough to reach above your head to get heavy things in past 7D	4180186
1019288	How many D were you strong enough to open a heavy door in past 7D	4180186
1019292	How many D were you strong enough to pour a drink from a full pitcher or carton in past 7D	4180186
1019293	How many D were you strong enough to open a jar by yourself in past 7D	4180186
1019294	How many D were you strong enough to carry your school books in past 7D	4180186
1019300	How many D was your child strong enough to reach above his or her head to get heavy things in past 7D	4180186
1019302	How many D was your child strong enough to hold a full plate or tray of food in past 7D	4180186
1019304	How many D was your child strong enough to jump up and down in past 7D	4180186
1019307	How many D was your child strong enough to carry his or her school books in past 7D	4180186
1019308	How many D was your child strong enough to get down on the floor in past 7D	4180186
1019309	How many D was your child strong enough to lift heavy things over his or her head in past 7D	4180186
1019310	I felt concerned about what was going on in my life in past 7D	4180186
1019311	Small things upset me in past 7D	4180186
1019313	I felt under pressure in past 7D	4180186
1019314	I felt that my problems kept piling up in past 7D	4180186
1019316	I forgot things in past 7D	4180186
1019317	I felt like my thinking was slower than usual in past 7D	4180186
1019318	I felt unable to remember answers, even for questions I knew the answer to in past 7D	4180186
1019322	My thoughts went very fast in past 7D	4180186
1019323	I was slow to react to things in past 7D	4180186
1019325	I felt unable to manage things in my life in past 7D	4180186
1019328	Small things upset my child in past 7D	4180186
1019332	My child felt overwhelmed in past 7D	4180186
1019333	My child felt so upset that he or she could not remember what happened or what he or she did in past 7D	4180186
1019336	My child felt unable to manage things in his or her life in past 7D	4180186
1019338	My child felt calm in past 7D	4180186
1019340	My child felt satisfied in past 7D	4180186
1019344	My child felt positive in past 7D	4180186
1019346	My child felt relaxed in past 7D	4180186
1019347	My child felt comfortable in past 7D	4180186
1019348	My child felt fulfilled in past 7D	4180186
1019349	My child felt respected in past 7D	4180186
1019350	My child felt appreciated in past 7D	4180186
1019351	My child felt proud in past 7D	4180186
1019352	My child felt he or she had much to be proud about in past 7D	4180186
1019353	My child felt pleased in past 7D	4180186
1019354	My child felt great in past 7D	4180186
1019357	My child had very strong happy feelings in past 7D	4180186
1019358	My child felt joyful in past 7D	4180186
1019360	My child felt his or her life was pleasurable in past 7D	4180186
1019361	My child smiled a lot in past 7D	4180186
1019362	My child laughed a lot in past 7D	4180186
1019364	My child was in a good mood in past 7D	4180186
1019365	My child was in good spirits in past 7D	4180186
1019366	My child felt good in past 7D	4180186
1019371	My child felt wide awake in past 7D	4180186
1019372	My child felt refreshed in past 7D	4180186
1019373	My child felt active in past 7D	4180186
1019375	My child felt strong in past 7D	4180186
1019378	I felt peaceful in past 7D	4180186
1019379	I felt satisfied in past 7D	4180186
1019380	I felt content in past 7D	4180186
1019382	I felt thankful in past 7D	4180186
1019384	I felt carefree in past 7D	4180186
1019390	I felt proud in past 7D	4180186
1019391	I had much to be proud about in past 7D	4180186
1019392	I felt pleased in past 7D	4180186
1019395	I felt happy in past 7D	4180186
1019396	I had very strong happy feelings in past 7D	4180186
1019397	I felt joyful in past 7D	4180186
1019399	My life was pleasurable in past 7D	4180186
1019401	I laughed a lot in past 7D	4180186
1019405	I felt good in past 7D	4180186
1019406	I felt blissful in past 7D	4180186
1019407	I felt enthusiastic in past 7D	4180186
1019408	I felt energetic in past 7D	4180186
1019410	I felt wide awake in past 7D	4180186
1019412	I felt active in past 7D	4180186
1019414	I felt strong in past 7D	4180186
1019415	I felt healthy in past 7D	4180186
1019425	How many D did you run for 10M or more in past 7D	4180186
1019427	How many D did your child play sports for 10M or more in past 7D	4180186
1019431	How many D did your child exercise or play so hard that he or she felt tired in past 7D	4180186
1019433	How many D did your child exercise really hard for 10M or more in past 7D	4180186
1019434	How many D was your child physically active for 10M or more in past 7D	4180186
1019435	How many D did your child run for 10M or more in past 7D	4180186
1019442	Eight or more drinks in a D	4180186
1019481	Number of falls in the past 3Mo	4180186
1019483	Staphylococcus aureus methicillin resistance SCCmec & mecA+mecC genes	4180186
1019487	MOS Social Support Survey	4180186
1019491	Have you been bothered by any illness, bodily disorder, pains, or fears about your health during the past Mo	4180186
1019492	Have you felt down-hearted and blue during the past Mo	4180186
1019628	Bld^Fetus	4180186
1019629	Bld^Mother	4180186
1019630	Bld^Patient	4180186
1019661	PRP^Control	4180186
1019698	Antibody screen	4180186
1019850	Parotid.FNA	4180186
1019877	Genotyping	4180186
1019878	Phenotyping	4180186
1019893	HA	4180186
1019894	PPP^control	4180186
1019897	Nicotiana tabacum cigarette	4180186
1019905	LW super little b	4180186
1019907	Blood group Ag & Hemoglobin S inferred phenotype panel	4180186
1019916	Kidney.FNA	4180186
1019917	Neck mass.FNA	4180186
1019922	Submandibular.FNA	4180186
1019924	Abdomen.FNA	4180186
1019927	XXX stain	4180186
1019928	Bld.buffy coat	4180186
1019930	Heart.atrium.right.high	4180186
1019931	Heart.atrium.right.low	4180186
1019934	Aggl.adult RBC	4180186
1019936	High sensitivity	4180186
1019940	Coag.two stage	4180186
1019945	Aorta.root.annulo-aortic junction	4180186
1019955	Anterior chamber.right	4180186
1019960	Renal artery.bilateral	4180186
1019965	Bld^newborn	4180186
1019966	Bones.long	4180186
1019967	Brachiocephalic artery.bilateral	4180186
1019969	Brachiocephalic artery.right	4180186
1019974	Carpal bones	4180186
1019979	Choroidea.left	4180186
1019982	Ciliary body.right	4180186
1019985	Conjunctiva.left	4180186
1019986	Conjunctiva.right	4180186
1019988	Contact lens.left	4180186
1019989	Contact lens.prescription.left	4180186
1019993	Cornea.right	4180186
1019997	Ear.left	4180186
1019998	Ear.left+Head	4180186
1019999	Ear.right	4180186
1020000	Ear.right+Head	4180186
1020010	Gastrointestinal tract.upper+Small bowel	4180186
1020013	Glasses prescription	4180186
1020015	Glasses prescription.lens.right	4180186
1020024	Heart.atrium.left.appendage	4180186
1020043	Iris.left	4180186
1020048	Lacrimal gland.right	4180186
1020052	LM glasses.lens.left	4180186
1020054	Lung.bilateral	4180186
1020056	Mastoid.right	4180186
1020060	Head+Neck>Nasopharynx & Neck	4180186
1020061	Neurologic balance+Coordination	4180186
1020066	Optic lens.left	4180186
1020067	Optic lens.right	4180186
1020090	Pulmonary vein.left upper	4180186
1020091	Pulmonary vein.right lower	4180186
1020097	RBC^Donor	4180186
1020103	Retina.left	4180186
1020106	Ser+RBC^control	4180186
1020108	Ser/Plas^BPU	4180186
1020119	Spine.lumbar space	4180186
1020125	Tibia.left+Fibula.left	4180186
1020126	Tibia.right+Fibula.right	4180186
1020128	Lower extremity.bilateral>Tibial artery	4180186
1020130	Lower extremity.right>Tibial artery	4180186
1020152	Vitreous body.left	4180186
1020153	Vitreous body.right	4180186
1020158	Head>Zygomatic arch.left	4180186
1021111	Paravertebral muscles	4180186
1021166	Pleural space.right	4180186
1021441	Body site	4180186
1022168	8H^max	4180186
1022177	8H^min	4180186
1023678	Thyroxine binding capacity	4180186
1023858	Antigens	4180186
1023947	CAct	4180186
1025545	Multisection post mortem	4180186
1025569	Are you able to paint the walls of a room with a brush or roller for 2H without stopping to rest	4180186
1025607	Have you felt so sad, discouraged, hopeless, or had so many problems that you wondered if anything was worthwhile during the past Mo	4180186
1025608	How happy, satisfied, or pleased have you been with your personal life during the past Mo	4180186
1025614	How concerned or worried about your health have you been during the past Mo	4180186
1025617	How depressed or cheerful have you been during the past Mo	4180186
1025635	Are you able to rake leaves or sweep for 1H without stopping to rest	4180186
1025636	Are you able to swim laps for 30M at a moderate pace	4180186
1025637	Are you able to row a boat for 30M without stopping to rest	4180186
1025664	Are you able to stand on one foot with your eyes closed for 30S	4180186
1025676	Are you able to dance energetically for 1H	4180186
1025678	Are you able to hand wash and wax a car for 2H without stopping to rest	4180186
1025680	Emotional+informational support	4180186
1025683	Emotional+informational support score	4180186
1025693	Are you able to continuously swing a baseball bat or tennis racket back and forth for 5M	4180186
1025696	LW super little a Ag	4180186
1025704	MFQ	4180186
1025718	Aggl.capture	4180186
1025733	When I was in pain I tried not to move in past 7D	4180186
1025734	When I was in pain I asked for help with doing things in past 7D	4180186
1025736	When I was in pain I yelled for someone to help me in past 7D	4180186
1025738	When I was in pain I used something for support (cane, crutches, wheelchair) to move from place to place in past 7D	4180186
1025739	When I was in pain I limped in past 7D	4180186
1025745	When I was in pain I talked about my pain in past 7D	4180186
1025746	When I was in pain I didn't let anyone touch me in past 7D	4180186
1025747	When I was in pain I rubbed my body where it hurt in past 7D	4180186
1025748	When I was in pain I moved slower in past 7D	4180186
1025749	When I was in pain I got angry at people in past 7D	4180186
1025752	When I was in pain I asked people to bring me things (food, games) in past 7D	4180186
1025754	When I was in pain I was restless in past 7D	4180186
1025756	When I was in pain I went to sleep in past 7D	4180186
1025757	When I was in pain I had to stop what I was doing in past 7D	4180186
1025758	When I was in pain I avoided lifting or carrying heavy things in past 7D	4180186
1025759	When I was in pain I stayed near to someone who cares about me in past 7D	4180186
1025762	When I was in pain I asked to see a doctor in past 7D	4180186
1025763	When I was in pain I pulled away if someone touched me where it hurt in past 7D	4180186
1025766	When I was in pain I said mean words to people in past 7D	4180186
1025768	When I was in pain I sighed in past 7D	4180186
1025769	When I was in pain I took breaks from what I was doing in past 7D	4180186
1025770	When I was in pain I told people I couldn't do my usual chores in past 7D	4180186
1025772	When I was in pain I told people I couldn't do things with them in past 7D	4180186
1025773	When I was in pain I asked for someone to help me in past 7D	4180186
1025775	When I was in pain I felt my body get tense in past 7D	4180186
1025778	My child was too tired to read in past 7D	4180186
1025779	My child was too tired to eat in past 7D	4180186
1025780	My child needed to sleep during the day in past 7D	4180186
1025781	My child had trouble finishing things because he or she was too tired in past 7D	4180186
1025782	My child felt too tired to spend time with his or her friends in past 7D	4180186
1025783	Being tired made it hard for my child to keep up with schoolwork in past 7D	4180186
1025785	My child felt more tired than usual when he or she woke up in the morning in past 7D	4180186
1025786	My child was so tired it was hard for him or her to pay attention in past 7D	4180186
1025788	My child was too tired to do things outside in past 7D	4180186
1025789	Being tired kept my child from having fun in past 7D	4180186
1025790	My child had trouble starting things because he or she was too tired in past 7D	4180186
1025792	My child was too tired to go up and down a lot of stairs in past 7D	4180186
1025794	Being tired made it hard for my child to play or go out with friends as much as he or she would like in past 7D	4180186
1025795	My child was too tired to focus on his or her work in past 7D	4180186
1025796	My child was too tired to enjoy the things he or she likes to do in past 7D	4180186
1025797	My child was too tired to watch television in past 7D	4180186
1025798	My child was too tired to take a bath or shower in past 7D	4180186
1025799	My child felt weak in past 7D	4180186
1025804	7-Alpha,12-alpha dihydroxycholest-4-en-3-one & 7-Alpha hydroxy-4-cholesten-3-one panel	4180186
1025807	RelFldResist	4180186
1025816	My child worried about what could happen to him or her in past 7D	4180186
1025820	It was hard for my child to relax in past 7D	4180186
1025823	My child was worried he or she might die in past 7D	4180186
1025826	My child was afraid of going to school in past 7D	4180186
1025852	My child felt as if he or she needed to move his or her legs a lot in past 7D	4180186
1025854	My child's muscles felt tight in past 7D	4180186
1025856	My child's mouth was dry in past 7D	4180186
1025859	My child was sweaty, even when he or she was not exercising or playing hard in past 7D	4180186
1025863	My child felt dizzy in past 7D	4180186
1025866	My child's legs shook in past 7D	4180186
1025867	My child's body shook in past 7D	4180186
1025868	My child had a headache in past 7D	4180186
1025869	My child's neck hurt in past 7D	4180186
1025870	My child's back hurt in past 7D	4180186
1025872	My child had pain that really bothered him or her in past 7D	4180186
1025873	My child's appetite changed in past 7D	4180186
1025875	My child threw up in past 7D	4180186
1025877	My child's neck felt tight in past 7D	4180186
1025885	Mouse bioassay.neutralization	4180186
1025901	Lectin	4180186
1025909	Fluid intake & output panel	4180186
1025913	Vital signs, weight & height panel	4180186
1025978	CT.angio	4180186
1025979	CT.fast	4180186
1025980	CT.measured	4180186
1025982	Dentistry.hygienist	4180186
1026000	Lekholm & Zarb classification	4180186
1026004	Mam	4180186
1026005	Measured.Bolton analysis	4180186
1026046	US.2D.mod.single-plane	4180186
1026047	US.2D.mod.single-plane ellipse.calculated	4180186
1026049	US.derived from Chitty 1994	4180186
1026051	US+Estimated from AC.ASUM 2000	4180186
1026052	US+Estimated from AC.Hansmann 1985	4180186
1026053	US+Estimated from AC.Jeanty 1982	4180186
1026054	US+Estimated from AC.Lessoway 1998	4180186
1026055	US+Estimated from AC.Merz 1988	4180186
1026059	US.estimated from Arbuckle 1993 female singleton	4180186
1026060	US.estimated from Arbuckle 1993 female twins	4180186
1026061	US.estimated from Arbuckle 1993 male singleton	4180186
1026064	US.estimated from AXT.Shinozuka 1996	4180186
1026065	US+Estimated from BD.Jeanty 1982	4180186
1026067	US+Estimated from BPD&TTD.Hansmann 1986	4180186
1026073	US+Estimated from BPD.Osaka 1989	4180186
1026074	US+Estimated from BPD.Rempen 1991	4180186
1026075	US+Estimated from BPD.Shinozuka 1996	4180186
1026076	US+Estimated from BPD.Tokyo 1986	4180186
1026078	US.estimated from Campbell 1991	4180186
1026080	US.estimated from Chitty 1994	4180186
1026083	US+Estimated from CRL.ASUM 2000	4180186
1026086	US+Estimated from CRL.Jeanty 1982	4180186
1026089	US+Estimated from CRL.Shinozuka 1996	4180186
1026090	US+Estimated from CRL.Tokyo 1986	4180186
1026091	US.estimated from EFW1.Shinozuka 1996	4180186
1026093	US.estimated from EFW3.Shinozuka 1996	4180186
1026098	US+Estimated from FL.Lessoway 1998	4180186
1026099	US+Estimated from FL.Osaka 1989	4180186
1026100	US+Estimated from FL.Shinozuka 1996	4180186
1026101	US+Estimated from FL.Tokyo 1986	4180186
1026104	US+Estimated from GSD.Daya 1991	4180186
1026106	US+Estimated from GSD.Tokyo 1986	4180186
1026107	US+Estimated from GSL.Hansmann 1979	4180186
1026108	US+Estimated from GSL.Nyberg 1992	4180186
1026113	US.estimated from Hansmann 1986	4180186
1026114	US+Estimated from HC derived.Chitty 1997	4180186
1026115	US+Estimated from HC measured.Chitty 1997	4180186
1026116	US+Estimated from HC.ASUM 2000	4180186
1026117	US+Estimated from HC.Hansmann 1985	4180186
1026121	US+Estimated from HC.Merz 1988	4180186
1026122	US+Estimated from HL.ASUM 2000	4180186
1026124	US+Estimated from IOD.Mayden 1982	4180186
1026125	US+Estimated from IOD.Trout 1994	4180186
1026126	US.estimated from Jeanty 1982	4180186
1026128	US.estimated from length of vertebra.Tokyo 1986	4180186
1026129	US.estimated from Merz 1988	4180186
1026134	US+Estimated from OFD.Hansmann 1986	4180186
1026136	US+Estimated from OOD.Mayden 1982	4180186
1026138	US.estimated from radius length.Jeanty 1983	4180186
1026139	US.estimated from Rempen 1991	4180186
1026140	US.estimated from Shinozuka 1996	4180186
1026142	US+Estimated from TAD.Eriksen 1985	4180186
1026143	US+Estimated from TAD.Hansmann 1979	4180186
1026146	US+Estimated from TC.Nimrod 1986	4180186
1026151	US+Estimated from TTD.Hansmann 1985	4180186
1026152	US+Estimated from TTD.Lessoway 1998	4180186
1026153	US.estimated from Williams 1982	4180186
1026154	US.measured from Chitty 1994	4180186
1026164	Crithidia luciliae IF	4180186
1026166	Urine+Ser/Plas	4180186
1026191	SMA@ gene	4180186
1026196	Probe.amp.tar detection limit = 500 IU/mL	4180186
1026197	Probe.amp.tar detection limit = 50 IU/mL	4180186
1026235	Thoracic and cardiac surgery	4180186
1026240	Surgery.nurse	4180186
1026266	MSRat	4180186
1026268	InvLen	4180186
1026270	CompliRto	4180186
1026313	Views PA & lateral	4180186
1026314	Views PA & lateral & oblique	4180186
1026315	Views PA + lateral + oblique + apical lordotic	4180186
1026316	Views PA + apical lordotic	4180186
1026390	Views inlet + outlet	4180186
1026393	Views PA + lateral + R-oblique + L-oblique	4180186
1026396	(Views AP + lateral) for scoliosis	4180186
1026399	Views ventilation & perfusion	4180186
1026400	Multisection.sagittal	4180186
1026401	Guidance for aspiration+placement of drainage tube	4180186
1026409	View for fetal age	4180186
1026453	Views of foreign body	4180186
1026459	Views AP + lateral + oblique + odontoid	4180186
1026460	Views AP + lateral + oblique + spot	4180186
1026461	Views AP + lateral + oblique + Sunrise	4180186
1026462	Views AP + lateral + odontoid	4180186
1026464	Views AP + lateral + spot	4180186
1026465	Views AP + lateral + Sunrise	4180186
1026467	Views AP + lateral + tunnel	4180186
1026475	Views AP + Y	4180186
1026479	Views lateral + Mortise	4180186
1026481	Views R-oblique + L-oblique	4180186
1026483	Views PA + R-lateral	4180186
1026485	Views PA + lateral + L-oblique	4180186
1026488	Views PA + lateral + Sunrise	4180186
1026489	Views PA + R-oblique + L-oblique	4180186
1026491	Views Stenver + Arcelin	4180186
1026493	Views oblique + Sunrise + tunnel	4180186
1026497	Views lateral + Caldwell + Waters	4180186
1026500	Chest>Aortic arch & Upper extremity>Upper extremity artery	4180186
1026503	Carotid artery.external.left	4180186
1026511	Subclavian artery.left	4180186
1026514	Jugular vein.left	4180186
1026529	Spine.lumbar vessels	4180186
1026532	Tibia.left	4180186
1026534	Finger.fifth.left	4180186
1026535	Finger.fourth.left	4180186
1026536	Finger.second.left	4180186
1026538	Views Grashey + axillary + Y	4180186
1026546	Views ulnar deviation + radial deviation	4180186
1026547	Views + lateral frog	4180186
1026549	Adrenal vein.left	4180186
1026550	Views+PA	4180186
1026551	Ribs.left+Chest	4180186
1026552	Views lateral + Waters	4180186
1026556	Views AP + inlet + outlet	4180186
1026558	Views inlet + outlet + oblique	4180186
1026568	Views anterior + lateral	4180186
1026569	Views AP + West Point + outlet	4180186
1026572	Views Caldwell + Waters	4180186
1026574	Views PA + lateral + Waters	4180186
1026577	Views lateral + Towne	4180186
1026581	Carotid artery.cervical.right	4180186
1026584	Carotid artery.internal.right	4180186
1026585	Jugular vein.right	4180186
1026586	Leg.right	4180186
1026595	Views AP + lateral + Swimmers	4180186
1026605	Views Merchants 30 degrees + Merchants 45 degrees + Merchants 60 degrees	4180186
1026606	Views Sunrise 20 degrees + Sunrise 40 degrees + Sunrise 60 degrees	4180186
1026607	Views survey limited for metastasis	4180186
1026608	Breast.duct.bilateral	4180186
1026610	Spine.epidural space	4180186
1026614	Spine.thoracolumbar	4180186
1026615	How short of breath did you get dressing yourself without help over past 7D	4180186
1026616	How short of breath did you get walking 50 steps or paces on flat ground at a normal speed without stopping over past 7D	4180186
1026618	How short of breath did you get preparing meals over past 7D	4180186
1026619	How short of breath did you get washing dishes over past 7D	4180186
1026620	How short of breath did you get sweeping or mopping over past 7D	4180186
1026621	How short of breath did you get making a bed over past 7D	4180186
1026622	How short of breath did you get lifting something weighing 10-20 lbs (about 4.5-9 kg, like a large bag of groceries) over past 7D	4180186
1026625	How short of breath did you get taking a bath without help over past 7D	4180186
1026626	How short of breath did you get taking a shower over past 7D	4180186
1026627	How short of breath did you get putting on socks or stockings over past 7D	4180186
1026629	How short of breath did you get walking 10 steps or paces on flat ground at a normal speed without stopping over past 7D	4180186
1026630	Subclavian vessels.bilateral	4180186
1026634	How short of breath did you get walking up 30 stairs (3 flights) without stopping over past 7D	4180186
1026635	How short of breath did you get lifting something weighing less than 5 lbs (about 2 kg, like a houseplant) over past 7D	4180186
1026636	How short of breath did you get lifting something weighing 5-10 lbs (about 2-4.5 kg, like a basket of clothes) over past 7D	4180186
1026638	How short of breath did you get carrying something weighing less than 5 lbs (about 2 kg, like a houseplant) from one room to another over past 7D	4180186
1026640	How short of breath did you get getting in or out of a car over past 7D	4180186
1026643	How short of breath did you get moderate-intensity leisure activity (bicycling on level terrain, etc.) over past 7D	4180186
1026644	How short of breath did you get walking (faster than your usual speed) for 50 steps without stopping over past 7D	4180186
1026645	How short of breath did you get walking (faster than your usual speed) for at least 1 mile (a little more than 1.5 km) without stopping over past 7D	4180186
1026646	How short of breath did you get singing or humming over past 7D	4180186
1026648	How short of breath did you get scrubbing the floor or counter over past 7D	4180186
1026665	Finger.second.right	4180186
1026687	Finger.fifth.right	4180186
1026702	Healthcare-associated infection flag	4180186
1026766	PEG	4180186
1026832	PROMIS self-efficacy for managing daily activities - version 1.0 T-score	4180186
1026925	Number of menstrual periods per Y	4180186
1026927	LaCnc	4180186
1026939	Other intervention &or service provided	4180186
1026945	Guidance for drainage+placement of chest tube	4180186
1026946	Guidance for deep drainage+placement of drainage catheter	4180186
1027031	Pain onset.hours ago	4180186
1027045	Pain severity.face	4180186
1027047	Pain severity.activity	4180186
1027066	MAric	4180186
1027086	SARA	4180186
1027090	Gait & turn & tandem gait assessment	4180186
1027104	Guidance for dilation of existing nephrostomy tract+placement of nephrostomy tube at new site	4180186
1027106	Alpha globin gene cluster & HS-40 region deletion+duplication	4180186
1027121	View for foreign body	4180186
1027122	Courtesy consultation.XXX	4180186
1027126	View comparison	4180186
1027128	Views PA + lateral + oblique upright	4180186
1027129	Views PA + R-lateral + R-oblique + L-oblique upright	4180186
1027130	Views R-oblique + L-oblique upright	4180186
1027138	Views+view uptake	4180186
1027143	Planned intervention &or services duration - time frame	4180186
1027144	Planned intervention &or services duration - visits	4180186
1027171	Has season or migrant farm work been your or your family's main source of income at any point in past 2Y	4180186
1027181	Adenovirus & Bocavirus DNA panel	4180186
1027183	Herpes simplex virus 1 & 2 & Varicella zoster virus DNA panel	4180186
1027189	Geno	4180186
1027195	Functional limitation in range of motion in the last 7D	4180186
1027201	Allergy+Immunology	4180186
1027215	Multisection for perfusion^WO & W contrast IV && Multisection^W contrast IV	4180186
1027216	Guidance additional for angioplasty	4180186
1027227	Abdomen>Ileal conduit	4180186
1027245	Views Grashey + axillary	4180186
1027247	Views Grashey + West Point	4180186
1027249	Gastric artery.right	4180186
1027277	Views AP + inlet + outlet + oblique	4180186
1027281	Views PA & oblique	4180186
1027282	Carotid artery.cervical.bilateral	4180186
1027283	Ribs.bilateral+Chest	4180186
1027284	Ribs.right+Chest	4180186
1027295	Fluid output.wound drain	4180186
1027303	Wound.edge	4180186
1027316	ENT	4180186
1027318	Views AP internal rotation + AP external rotation + axillary	4180186
1027320	View AP internal rotation + Grashey + axillary + outlet	4180186
1027322	Views AP internal rotation + AP external rotation	4180186
1027323	Views AP internal rotation + AP external rotation + axillary + outlet	4180186
1027324	Views AP internal rotation + AP external rotation + axillary + Y	4180186
1027325	Views AP + axillary + outlet + 30 degree caudal angle	4180186
1027326	Views lateral + PA	4180186
1027329	Views Grashey + axillary + outlet	4180186
1027330	Views Grashey + axillary + outlet + Zanca	4180186
1027331	Views + inlet + outlet	4180186
1027333	Views 3 + ulnar deviation	4180186
1027334	Views lateral + outlet	4180186
1027335	Views & view	4180186
1027336	Views + Mortise	4180186
1027338	Views + lateral crosstable	4180186
1027339	Views 2 + oblique	4180186
1027340	Views 2 + Sunrise	4180186
1027341	Views 2 + Sunrise + tunnel	4180186
1027343	Views 3 + Sunrise	4180186
1027348	Views + Sunrise	4180186
1027349	Views internal rotation + external rotation + axillary	4180186
1027353	Views 3 + Carpal tunnel	4180186
1027356	Views axillary + transcapular	4180186
1027357	Views 3 + submentovertex	4180186
1027360	Views 5 + oblique	4180186
1027363	Views + Swimmers	4180186
1027368	Views Stryker Notch + West Point	4180186
1027370	Views PA + R-lateral + L-lateral	4180186
1027372	Views PA + R-lateral + L-lateral + Caldwell + Towne	4180186
1027393	Guidance limited for localization of tumor	4180186
1027396	(View Sunrise) + (View tunnel^W standing)	4180186
1027408	Views first pass+ventricular volume	4180186
1027409	Views first pass+wall motion	4180186
1027412	Views for blood flow+shunt detection	4180186
1027429	Views gated+ejection fraction	4180186
1027433	View gated	4180186
1027434	Views gated+wall motion	4180186
1027435	Views wall motion+ejection fraction	4180186
1027440	Views ventilation & equilibrium & washout	4180186
1027449	Actin.muscle specific	4180186
1027460	EngCnt	4180186
1027464	Extension.passive range of motion	4180186
1027466	Abduction.passive range of motion	4180186
1027467	Adduction.active range of motion	4180186
1027469	Internal rotation.active range of motion	4180186
1027470	Internal rotation.passive range of motion	4180186
1027472	External rotation.passive range of motion	4180186
1027476	Probe.amp detection limit = 400 copies/mL	4180186
1027478	Probe.amp detection limit = 75 copies/mL	4180186
1027479	Probe.amp detection limit = 1.9 log copies/mL	4180186
1027485	Body mass index	4180186
1027508	Lead screen test status &or results	4180186
1027509	Hematocrit test status &or results	4180186
1027510	Views 2 + apical lordotic	4180186
1027512	Views PA + lateral upright	4180186
1027522	Brain+Pituitary+Sella turcica	4180186
1027524	Multisection endorectal	4180186
1027527	Views AP + lateral for measurement	4180186
1027533	Guidance for biopsy.excisional	4180186
1027534	Multisection transabdominal + transvaginal	4180186
1027539	Gastrointestinal tract.upper+Gallbladder	4180186
1027544	Contributing factor.patient-related	4180186
1027546	Contributing factor.delay &or premature	4180186
1027555	Event description.food &or nutrition	4180186
1027556	Event description.fall	4180186
1027557	Event description.accident	4180186
1027558	Event description.general nursing care	4180186
1027561	Event description.transfusion service	4180186
1027562	Event description.administrative	4180186
1027563	Event description.complaint	4180186
1027567	Event description.adverse event	4180186
1027569	Contributing factor.organization	4180186
1027570	Contributing factor.communication &or documentation	4180186
1027571	PFGE	4180186
1027572	SatFr	4180186
1027594	(Views 2) + (views^W standing)	4180186
1027596	Retic	4180186
1027636	Sulfatide Ab.IgG & Ab.IgM panel	4180186
1027641	1W 37 deg C incubation	4180186
1027642	15M reading	4180186
1027643	Esophageal brush	4180186
1027646	BAL	4180186
1027649	Views 2 + R-oblique + L-oblique	4180186
1027664	Vessels.left	4180186
1027683	Spine.cervicothoracic junction	4180186
1027684	Views AP (supine KUB & upright) & PA upright chest	4180186
1027695	Cryoglobulin IgA & IgG & IgM	4180186
1027701	Views GE 3 && view PA	4180186
1027705	Peripheral arteries.bilateral	4180186
1027706	Reported.PHQ-9	4180186
1027720	Homovanillate & Creatinine	4180186
1027742	Cat hair+Cat dander Ab.IgG	4180186
1027743	Cat hair+Cat dander Ab	4180186
1027745	L little u 20 Ag	4180186
1027749	Disialylganglioside GD1b Ab.IgG	4180186
1027764	Monosialoganglioside GM1 Ab.IgM	4180186
1027770	Salmonella typhi D Ab	4180186
1027776	Spermatozoa.midpiece Ab.IgG	4180186
1027778	Spermatozoa.tail Ab.IgA	4180186
1027779	Spermatozoa.tail Ab.IgG	4180186
1027782	Spermatozoa.tail tip Ab.IgG	4180186
1027793	Streptococcus pneumoniae group A Ag	4180186
1027795	Streptococcus pneumoniae group B Ag	4180186
1027798	Treponema identified	4180186
1027822	Spermatozoa Ab.IgA+IgG	4180186
1027827	Rheumatoid factor & cyclic citrullinated peptide Ab	4180186
1027879	Platelet glycoprotein disorder panel	4180186
1027896	Plasma cell DNA content & proliferation panel	4180186
1027900	During the past 4W, I am limited in my work	4180186
1027901	During the past 4W, because of my health situation I have problems in my work with fatigue AndOr lack of energy	4180186
1027902	During the past 4W, I am content with my current income	4180186
1027903	During the past 4W, I am content with the fringe benefits provided by my employer	4180186
1027904	During the past 4W, I consider that employees with health problems are treated well in my organization	4180186
1027907	During the past 4W, I feel valuable to my colleagues	4180186
1027911	During the past 4W, I have the feeling I am taken seriously by people in my working environment	4180186
1027913	During the past 4W, I feel powerless in my work	4180186
1027914	During the past 4W, I have control over the work I do	4180186
1027915	During the past 4W, I am suited to my work	4180186
1027916	During the past 4W, I am self-confident in my work	4180186
1027919	During the past 4W, I consider that my work gives me a goal in life	4180186
1027924	von Willebrand factor cleaving protease activity	4180186
1027932	Neutrophil CD64 & Monocyte HLA DR panel	4180186
1027951	TPMT gene & NUDT15 gene targeted mutation analysis	4180186
1027956	Velocity-time integral.left ventricular outflow tract/velocity-time integral.aortic valve	4180186
1027959	Area strain.max	4180186
1027975	Regurgitant pressure gradient.diastole.mean	4180186
1027979	HTR2C gene.c.551-3008C>G	4180186
1027980	CYP4F2 gene.c.1297G>A	4180186
1028014	Regurgitant blood flow velocity.mean	4180186
1028024	Upper extremity>Ulna	4180186
1028027	Upper extremity>Hand.metacarpal.fifth	4180186
1028030	Upper extremity>Finger.fifth.proximal phalanx	4180186
1028031	Upper extremity>Finger.fifth.middle phalanx	4180186
1028032	Upper extremity>Finger.third.middle phalanx	4180186
1028036	Upper extremity>Wrist.capitate	4180186
1028039	Upper extremity>Wrist.lunate	4180186
1028040	Upper extremity>Wrist.scaphoid	4180186
1028041	Upper extremity>Wrist.trapezium	4180186
1028043	Upper extremity>Radius	4180186
1028046	Sit to stand^with use of upper extremities	4180186
1028047	Dirofilaria immitis Ab.IgG	4180186
1028070	TmSCnc	4180186
1028072	How much of the time has pain made it hard for you to sleep at night over the past 5D	4180186
1028073	How often have you limited your participation in rehabilitation therapy sessions due to pain over the past 5D	4180186
1028074	How often have you limited your day-to-day activities because of pain over the past 5D	4180186
1028075	IRF-PAI v4.0 - Swallowing &or nutritional status - admission	4180186
1028090	Preferred language & interpreter need	4180186
1028163	Actual lethality or medical damage most recent suicide attempt	4180186
1028166	Date of initial or first suicide attempt	4180186
1028167	Actual lethality or medical damage initial or first suicide attempt	4180186
1028194	Plasma cells.monotypic.S phase	4180186
1028195	Cortisol post corticotropin releasing hormone stimulation panel	4180186
1028214	Anaplasma phagocytophilum & Ehrlichia chaffeensis Ab.IgG & IgM panel	4180186
1028220	Dermatan sulfate & heparan sulfate & keratan sulfate panel	4180186
1028228	Metabotropic glutamate receptor 1 Ab.IgG	4180186
1028238	Mechanical circulatory support+consultation note	4180186
1028239	Inattention in last 3D	4180186
1028244	Disorganized thinking in last 3D	4180186
1028248	CAM.CMS	4180186
1028263	Blood flow reversal.holodiastolic	4180186
1028268	Blood flow reversal.systolic	4180186
1028269	Atrial contraction strain rate.longitudinal.max	4180186
1028270	Atrial contraction strain rate.circumferential.max	4180186
1028282	Cytosolic 5'-nucleotidase 1A Ab.IgG	4180186
1028284	General medicine.team	4180186
1028287	Gynecologic oncology.team	4180186
1028299	Lower extremity.bilateral>Lower extremity arteries+Lower extremity veins	4180186
1028300	Head>Skull & Neck>Spine.cervical & Chest>Spine.thoracic & Abdomen>Spine.lumbar & Pelvis>Sacrum+Coccyx	4180186
1028320	Ethyl sulfate & Ethyl glucuronide panel	4180186
1028321	Palmitoyl protein thioesterase 1 & Tripeptidyl peptidase 1 panel	4180186
1028345	Did you or others you live with eat smaller meals or skip meals because you didn't have money for food in the past 2M	4180186
1028355	Have you been at the emergency department more than twice in the last 6Mo	4180186
1028357	Hospitalized in the last 6Mo	4180186
1028361	Brassica oleracea var capitata f rubra Ab.IgE	4180186
1028364	Brassica oleracea var botrytis cooked	4180186
1028372	HTLV I & II Ab.IgG panel	4180186
1028375	L little u 20	4180186
1028377	A little u super little b	4180186
1028378	A little u super little b Ag	4180186
1028379	J little k3 Ag	4180186
1028380	F little y3 Ag	4180186
1028389	Mumps virus RNA & N gene panel	4180186
1028396	Glucose tolerance & insulin sensitivity 2H panel	4180186
1028398	Rh antigens & K Ag post transfusion reaction panel	4180186
1028406	ABO & Rh group post hematopoietic stem cell transplant panel	4180186
1028410	Rh antigens & K Ag post hematopoietic stem cell transplant panel	4180186
1028438	Toxoplasma gondii Ab.IgG panel	4180186
1028499	A little u super little b Ab	4180186
1028511	Extremity.unilateral>Extremity vessels	4180186
1028521	PCPCM	4180186
1028540	Views limited for therapy or embolization or infusion	4180186
1028574	little c E Ag	4180186
1028585	Collagen type VII Ab.IgG	4180186
1028676	Gradient.systole.mean	4180186
1028684	Bowel function.status	4180186
1028685	Circulation.status	4180186
1028687	Communication with community resources.status	4180186
1028688	Consciousness.status	4180186
1028692	Growth and development.status	4180186
1028693	Health care supervision.status	4180186
1028694	Hearing.status	4180186
1028696	Interpersonal relationship.status	4180186
1028698	Mental health.status	4180186
1028699	Neglect.status	4180186
1028702	Oral health.status	4180186
1028703	Pain.status	4180186
1028704	Personal care.status	4180186
1028706	Postpartum function.status	4180186
1028707	Pregnancy function.status	4180186
1028708	Reproductive function.status	4180186
1028714	Sexuality.status	4180186
1028716	Sleep and rest pattern.status	4180186
1028717	Social contact.status	4180186
1028718	Speech and language.status	4180186
1028720	Substance use.status	4180186
1028721	Urinary function.status	4180186
1028722	Vision.status	4180186
1028723	Abuse.behavior	4180186
1028725	Bowel function.behavior	4180186
1028727	Circulation.behavior	4180186
1028731	Communication with community resources.behavior	4180186
1028732	Communication with community resources.knowledge	4180186
1028733	Consciousness.behavior	4180186
1028736	Digestion-hydration.knowledge	4180186
1028737	Family planning.behavior	4180186
1028738	Family planning.knowledge	4180186
1028739	Grief.behavior	4180186
1028743	Health care supervision.behavior	4180186
1028744	Health care supervision.knowledge	4180186
1028746	Hearing.knowledge	4180186
1028748	Income.knowledge	4180186
1028751	Medication regimen.behavior	4180186
1028752	Medication regimen.knowledge	4180186
1028754	Mental health.knowledge	4180186
1028756	Neglect.knowledge	4180186
1028758	Neuro-musculo-skeletal function.knowledge	4180186
1028760	Nutrition.knowledge	4180186
1028761	Oral health.behavior	4180186
1028762	Oral health.knowledge	4180186
1028763	Pain.behavior	4180186
1028765	Personal care.behavior	4180186
1028766	Personal care.knowledge	4180186
1028768	Physical activity.knowledge	4180186
1028770	Postpartum function.knowledge	4180186
1028772	Pregnancy function.knowledge	4180186
1028773	Reproductive function.behavior	4180186
1028776	Residence.knowledge	4180186
1028778	Respiration.knowledge	4180186
1028780	Role change.knowledge	4180186
1028783	Sexuality.behavior	4180186
1028784	Sexuality.knowledge	4180186
1028785	Skin.behavior	4180186
1028787	Sleep and rest pattern.behavior	4180186
1028789	Social contact.behavior	4180186
1028790	Social contact.knowledge	4180186
1028793	Spirituality.behavior	4180186
1028797	Urinary function.behavior	4180186
1028798	Urinary function.knowledge	4180186
1028800	Vision.knowledge	4180186
1028801	TCRB & Immunoglobulin heavy chain gene rearrangements	4180186
1028816	Probe.amp.tar detection limit = 200 copies/mL	4180186
1028831	1W cold incubation	4180186
1028839	4D cold incubation	4180186
1028840	4H cold incubation	4180186
1028841	5D cold incubation	4180186
1028852	Aerobic culture	4180186
1028854	Aggl	4180186
1028858	Aggl.rapid	4180186
1028859	Aggl.ring test	4180186
1028860	Aggl.rivanol	4180186
1028862	Aggl.standard tube	4180186
1028863	Aggr	4180186
1028869	Alkali denat	4180186
1028877	Angiography.single plane	4180186
1028883	Bacterial subtyping	4180186
1028897	Views + radial head capitellar	4180186
1028901	Views GE 4 + PA + lateral	4180186
1028918	Comp fix	4180186
1028925	Chromatography.column	4180186
1028927	CIE	4180186
1028928	Clinical.estimated	4180186
1028938	Concentration.McMaster	4180186
1028948	CT	4180186
1028949	CT spiral	4180186
1028951	Culture.FDA method	4180186
1028952	Culture.standard plate count	4180186
1028959	Seq	4180186
1028961	Cholesterol.in HDL+Cholesterol.in VLDL	4180186
1028975	Direct spectrophotometry	4180186
1028980	Duke	4180186
1028984	EIA	4180186
1028985	EIA.3rd IS	4180186
1028986	EIA.RST	4180186
1028987	EKG	4180186
1028990	Electrophoresis pH 6.3	4180186
1028993	Electrophoresis pH 8.9	4180186
1028995	Electrophoresis.citrate agar	4180186
1028997	Probe.amp.tar detection limit = 50 copies/mL	4180186
1029002	Chromo	4180186
1029003	ERCP	4180186
1029008	Estimated from gestational age.Merz 1987	4180186
1029022	Flow cytometry	4180186
1029023	Probe.amp.tar detection limit = 400 copies/mL	4180186
1029035	Probe.amp.tar detection limit = 500 copies/mL	4180186
1029036	Coag.derived	4180186
1029037	Fungal subtyping	4180186
1029038	FISH	4180186
1029040	Submandibular gland.right	4180186
1029041	Submandibular gland.bilateral	4180186
1029043	Gas dilution.rebreathing	4180186
1029074	IB	4180186
1029077	IF	4180186
1029082	Imm	4180186
1029099	ISE	4180186
1029105	Kremer	4180186
1029106	SAB	4180186
1029109	Lap	4180186
1029144	MIC	4180186
1029149	Microscopy.electron.negative stain	4180186
1029151	Microscopy.light	4180186
1029152	Microscopy.light.HPF	4180186
1029153	Microscopy.light.LPF	4180186
1029155	MLC	4180186
1029156	Modified Giemsa	4180186
1029157	Molgen	4180186
1029158	MRI	4180186
1029168	Neut	4180186
1029181	Organism specific culture.NPIP method	4180186
1029182	Ova and parasite preparation	4180186
1029185	PAGE	4180186
1029191	PEG assay	4180186
1029211	Pinworm examination	4180186
1029212	Platelet aggr	4180186
1029213	Plethysmograph.body box	4180186
1029250	Probe.amp	4180186
1029258	Probe.amp.sig	4180186
1029259	Multisection perfusion+wall motion	4180186
1029260	Views GE 6	4180186
1029261	Probe.amp.tar	4180186
1029265	Alpha-1-fetoprotein & Choriogonadotropin & Estriol	4180186
1029273	RAST	4180186
1029275	Reaction: lactate to pyruvate	4180186
1029287	Ab.IgG2	4180186
1029288	Ab.IgG3	4180186
1029298	Glock & McLean	4180186
1029300	Body fld+Ser/Plas	4180186
1029301	Ser/Plas+Plr fld	4180186
1029304	SBT	4180186
1029306	SCncDiff	4180186
1029307	Screen	4180186
1029314	Sputum/Gast fld	4180186
1029319	Sheep cell aggl	4180186
1029364	Refractometry.automated	4180186
1029381	3D RT incubation	4180186
1029384	US.2D	4180186
1029389	US.2D.calculated	4180186
1029390	US.2D.left ventricular outflow tract.calculated	4180186
1029391	US.2D.LVOT area.calculated	4180186
1029392	US.2D.mitral valve flow area.calculated	4180186
1029395	Vanillylmandelate & Creatinine	4180186
1029397	US.2D.mod.biplane ellipse.calculated	4180186
1029398	Bld+Inhl gas	4180186
1029399	BldC+Inhl gas	4180186
1029401	BldMV+Inhl gas	4180186
1029402	BldV+Inhl gas	4180186
1029403	US.2D.mod.biplane.calculated	4180186
1029404	MRat	4180186
1029406	US.2D.pulmonic valve flow area.calculated	4180186
1029407	US.2D.pulmonic valve.calculated	4180186
1029410	US.calculated	4180186
1029413	US.continuity.Vmax+Area	4180186
1029416	US.continuity.VTI+Diameter	4180186
1029417	US.cubed.calculated	4180186
1029418	Views & view AP	4180186
1029421	US.derived	4180186
1029423	US.derived from OFD&O-O TD	4180186
1029426	US.derived.EMP	4180186
1029428	US.derived.planimetry	4180186
1029430	US.derived.ROT	4180186
1029432	US.doppler.calculated	4180186
1029433	US.doppler.CW	4180186
1029434	US.doppler.derived	4180186
1029438	US.doppler.velocity+Area.calculated	4180186
1029440	US.doppler.Vmax+LVOT.calculated	4180186
1029441	US.doppler.Vmax+Aorta.calculated	4180186
1029443	US.doppler.Vmax+Diameter.calculated	4180186
1029445	US.doppler.VTI+Area.calculated	4180186
1029446	US.doppler.VTI+Diameter.calculated	4180186
1029450	US+Estimated from AC&BPD	4180186
1029452	US+Estimated from AC&BPD&FL&HC	4180186
1029453	US+Estimated from AC&BPD&FL&HC.Hadlock 1985	4180186
1029455	US+Estimated from AC&BPD&FL.Hadlock 1984	4180186
1029456	US+Estimated from AC&BPD&FL.Hadlock 1985	4180186
1029457	US+Estimated from AC&BPD&FL.Woo 1985	4180186
1029459	US+Estimated from AC&BPD.Hadlock 1984	4180186
1029461	US+Estimated from AC&BPD.Thurnau 1983	4180186
1029463	US+Estimated from AC&BPD.Weinberger 1984	4180186
1029464	US+Estimated from AC&FL	4180186
1029465	US+Estimated from AC&FL&HC	4180186
1029467	US+Estimated from AC&FL&HC.Hadlock 1985	4180186
1029468	US+Estimated from AC&FL&HC.Ott 1986	4180186
1029469	US+Estimated from AC&FL&HC.Vintzileos 1987	4180186
1029472	US+Estimated from AC&FL.Hadlock 1985	4180186
1029476	US+Estimated from AC&HC.Hadlock 1984	4180186
1029478	US+Estimated from AC.Campbell 1975	4180186
1029480	US+Estimated from AC.Hadlock 1984	4180186
1029484	US+Estimated from AC.Vintzileos 1987	4180186
1029485	US+Estimated from AC.Warsof 1977	4180186
1029493	US+Estimated from AD&BPD&FL.Rose 1987	4180186
1029497	US+Estimated from AD&FL.Rose 1987	4180186
1029498	US.estimated from area corrected BPC	4180186
1029500	RBCCo	4180186
1029507	US+Estimated from BPD	4180186
1029508	US+Estimated from BPD.Campbell 1975	4180186
1029510	US+Estimated from BPD.Hadlock 1982	4180186
1029515	US+Estimated from BPD.Kurtz 1980	4180186
1029523	US.estimated from cerebellum.Goldstein 1987	4180186
1029525	US+Estimated from CRL	4180186
1029532	US+Estimated from CRL.Yeh 1988	4180186
1029534	US.estimated from fibula length.Jeanty 1984	4180186
1029537	US+Estimated from FL.Hadlock 1984	4180186
1029539	US+Estimated from FL.Hohler 1982	4180186
1029541	US+Estimated from FL.Mercer 1987	4180186
1029543	US+Estimated from FL.Obrien 1982	4180186
1029545	US+Estimated from GSD.Hellman 1969	4180186
1029548	US+Estimated from HC.Hadlock 1982	4180186
1029550	US+Estimated from HC.Hadlock 1984	4180186
1029551	US+Estimated from HC.Hoffbauer 1979	4180186
1029552	US+Estimated from HC.Jeanty 1984	4180186
1029553	US+Estimated from HL	4180186
1029554	US+Estimated from HL.Jeanty 1984	4180186
1029555	US+Estimated from HL.Merz 1987	4180186
1029562	US.estimated from ulna length.Jeanty 1984	4180186
1029566	US.measured	4180186
1029567	US.measured.ellipse overlay	4180186
1029572	US.Teichholz.calculated	4180186
1029573	US.traced	4180186
1029576	VC	4180186
1029579	Viability count.FDA method	4180186
1029588	Westergren	4180186
1029591	Wintrobe	4180186
1029600	ACnt	4180186
1029604	Aper	4180186
1029606	Arb	4180186
1029610	ArResis	4180186
1029612	ArVRat	4180186
1029613	Bib	4180186
1029614	CCnc	4180186
1029615	CCnt	4180186
1029616	CRto	4180186
1029618	Circ	4180186
1029621	Cmplx	4180186
1029626	ElpotRat	4180186
1029630	EntCat	4180186
1029633	EntVol	4180186
1029637	FldConduct	4180186
1029639	Force	4180186
1029640	Hx	4180186
1029650	MCnc	4180186
1029652	MCnt	4180186
1029660	CARE	4180186
1029672	NCnc	4180186
1029678	NCnt	4180186
1029691	NFr	4180186
1029707	OD	4180186
1029712	Osmol	4180186
1029713	Pn	4180186
1029714	PPres	4180186
1029716	Pres	4180186
1029717	PresRat	4180186
1029720	Rden	4180186
1029722	RelVol	4180186
1029723	RelVRat	4180186
1029732	SRat	4180186
1029733	SRto	4180186
1029736	Tele	4180186
1029737	Temp	4180186
1029738	ThrACnc	4180186
1029740	Time	4180186
1029741	TimeDif	4180186
1029742	Titr	4180186
1029745	TRto	4180186
1029746	Txt	4180186
1029748	VCnt	4180186
1029749	Vel	4180186
1029750	VelRat	4180186
1029752	VFr	4180186
1029753	Visc	4180186
1029754	Vol	4180186
1029755	VRat	4180186
1029757	VRatRto	4180186
1029758	VRto	4180186
1029759	Xad	4180186
1029761	10H	4180186
1029762	10M	4180186
1029763	12H	4180186
1029764	15M	4180186
1029765	18H	4180186
1029769	Albumin CSF	4180186
1029771	Digoxin>12h post dose	4180186
1029775	Glycine plas	4180186
1029783	Amylase.fld	4180186
1029786	IgG.CSF	4180186
1029787	Creatinine dial fld	4180186
1029790	24H	4180186
1029794	Coagulation surface induced^after addition of protein C activator/Coagulation surface induced	4180186
1029796	2Mo	4180186
1029797	2W	4180186
1029800	3D	4180186
1029801	3H	4180186
1029802	3Mo	4180186
1029804	48H	4180186
1029806	4W	4180186
1029807	5D	4180186
1029808	5H	4180186
1029809	6H	4180186
1029813	Enctr	4180186
1029818	XXX	4180186
1029828	Coagulation surface induced^after addition of protein C activator+factor V depleted plasma	4180186
1029836	Airway.distal	4180186
1029844	Views AP + AP L-lateral-decubitus	4180186
1029845	View for transit	4180186
1029848	Am fld space.quadrant four	4180186
1029849	Am fld space.quadrant one	4180186
1029850	Am fld space.quadrant three	4180186
1029851	Am fld space.quadrant two	4180186
1029853	Views AP + oblique prone	4180186
1029859	Views supine + lateral-decubitus	4180186
1029861	Views PA + AP lateral-decubitus	4180186
1029868	Hydroxyisovalerylcarnitine	4180186
1029870	Aorta.abdominal.distal	4180186
1029872	Aorta.isthmus	4180186
1029874	Aorta.thoracic.arch	4180186
1029887	Deoxycorticosterone	4180186
1029889	Apnea monitor.alarm	4180186
1029890	Arterial system.XXX	4180186
1029908	SSA	4180186
1029912	Bil fld	4180186
1029930	BldCo	4180186
1029933	BldV	4180186
1029939	Breast.FNA	4180186
1029963	Diameter.diastole	4180186
1029998	Calculus	4180186
1030002	NAPIIA	4180186
1030004	Cancer case.XXX	4180186
1030011	Cancer.XXX	4180186
1030013	Cancer.XXX pediatric staging	4180186
1030015	Cancer.XXX.anatomic site	4180186
1030040	Cervical canal.external os	4180186
1030055	Cnjt	4180186
1030060	Col	4180186
1030061	Colon.lumen	4180186
1030065	Crn	4180186
1030068	Lactate dehydrogenase.pericard fld	4180186
1030069	Lactate dehydrogenase.serum	4180186
1030070	Pericard fld+Ser/Plas	4180186
1030074	Ctp	4180186
1030075	Cvm	4180186
1030078	Body fld.spun	4180186
1030080	Pericard fld.spun	4180186
1030081	Plr fld.spun	4180186
1030082	Synv fld.spun	4180186
1030083	Periton fld.spun	4180186
1030088	Dial fld	4180186
1030089	Dial fld prt	4180186
1030090	Digital artery.left	4180186
1030093	Dorsal pedal artery.left	4180186
1030105	Eggylk	4180186
1030109	Follow-up &or Recurrence &or Death section	4180186
1030111	Accession number & class of case & sequence number override flag	4180186
1030113	{HIV ART medication} doses missed 3D ago	4180186
1030140	Endomet	4180186
1030141	A wave	4180186
1030163	Age&site&morphology override flag	4180186
1030166	Alcoholic drinks per drinking D	4180186
1030167	Alcoholic drinks per W	4180186
1030173	Animal pharmacology &or toxicology section	4180186
1030284	Circumference.at umbilicus	4180186
1030294	Tiss fat	4180186
1030297	Coding system 1970&80&90	4180186
1030334	Femoral artery.left	4180186
1030339	Femoral artery.right	4180186
1030344	Femur.diaphysis	4180186
1030354	Fibroblasts	4180186
1030372	Fibula.diaphysis	4180186
1030389	Date of other vaccinations given within 4W prior to the date of vaccine causing adverse event	4180186
1030397	Body fld	4180186
1030401	Date.vaccination contraindication &or precaution effective	4180186
1030406	Flu.nonbiological	4180186
1030463	Dominant nodule.additional dimension 1	4180186
1030464	Dominant nodule.additional dimension 2	4180186
1030467	Dosage & administration section	4180186
1030475	E wave	4180186
1030480	ED clinical finding practitioner ID	4180186
1030482	ED consultant practitioner ID	4180186
1030518	Gast fld	4180186
1030525	Extension.collaborative staging	4180186
1030530	Extent of invasion deepest	4180186
1030567	Genital fld	4180186
1030568	Glasgow coma score.eye opening	4180186
1030569	Glasgow coma score.motor	4180186
1030570	Glasgow coma score.verbal	4180186
1030577	Gradient.systole	4180186
1030581	Guidance for percutaneous aspiration.fine needle	4180186
1030582	Guidance for percutaneous biopsy.fine needle	4180186
1030591	Hematologic transplant & endocrine procedures	4180186
1030609	Genital muc	4180186
1030629	History of psychiatric symptoms & diseases	4180186
1030645	Hospital admission Dx	4180186
1030662	Hospital sequence number & diagnostic confirmation override flag	4180186
1030663	Great toe arteries.left	4180186
1030678	Great toe arteries.right	4180186
1030689	Indications & usage section	4180186
1030731	Invasive component size.additional dimension 2	4180186
1030741	Head.lateral cerebral ventricles	4180186
1030763	Lung & leukemia CNS radiation status	4180186
1030770	Heart.atrium.septum	4180186
1030795	Method for calculating time interval of 1st course of treatment	4180186
1030826	Newborn intensive care unit admission diagnosis	4180186
1030837	Number of D hospitalized due to vaccination adverse event	4180186
1030839	Number of hospital D since last outpatient visit	4180186
1030843	Number of tumors & histologies	4180186
1030850	Heart.atrium.left	4180186
1030875	Other vaccines given within 4W prior to vaccination that caused adverse reaction	4180186
1030894	Package label.Top panel	4180186
1030902	Heart.valve.XXX	4180186
1030926	Physical findings.skin pressure injury	4180186
1030934	Heart.ventricle.left.apical anterior	4180186
1030936	Heart.ventricle.left.apical septum	4180186
1030948	Heart.ventricle.left.basal anterior septum	4180186
1030954	Heart.ventricle.left.basal inferior	4180186
1030957	Heart.ventricle.left.basal posterior	4180186
1030959	Primary site & TNM-stage group override flag	4180186
1030960	Heart.ventricle.left.basal septum	4180186
1030969	Heart.ventricle.left.epicardium	4180186
1030982	Heart.ventricle.left.lateral apical	4180186
1030985	Heart.ventricle.left.mid anterior	4180186
1030991	Readmission to the same hospital within 30D of surgical discharge	4180186
1030993	Heart.ventricle.left.mid anterior septum	4180186
1031013	Heart.ventricle.left.mid lateral	4180186
1031016	Heart.ventricle.left.mid posterior	4180186
1031031	Heart.ventricle.left.outflow tract	4180186
1031072	Heart.ventricle.right	4180186
1031077	Heart.ventricle.right.anterior wall	4180186
1031081	Site&laterality&sequence number override flag	4180186
1031085	Heart.ventricle.right.outflow tract	4180186
1031102	Specimen size.additional dimension 2	4180186
1031112	Heart.ventricle.septum	4180186
1031116	Stage.summary & distant metastasis 1 override flag	4180186
1031118	Stage.summary & TNM-M override flag	4180186
1031169	Hepatic artery.wedge	4180186
1031177	Surgical operation note preoperative Dx	4180186
1031185	Systemic therapy &or surgery sequence	4180186
1031196	Thickness.diastolic	4180186
1031197	Humerus.diaphysis	4180186
1031218	Iliac artery.left	4180186
1031221	Treatment-subsequent & other section	4180186
1031223	Trial objectives & purpose section	4180186
1031246	Index finger arteries.left	4180186
1031249	Index finger arteries.right	4180186
1031273	Views upright + L-lateral-decubitus	4180186
1031275	View PA && View upright	4180186
1031282	Volume.forced expiration	4180186
1031286	Isolate+Ser	4180186
1031298	Y first seen at this hospital for	4180186
1031346	Velocity.systole	4180186
1031380	Behavioral &or mental health screen assessment	4180186
1031381	Behavioral &or mental health screen finding recency	4180186
1031437	Date range (from_through) described by plan	4180186
1031444	Date.onset or exacerbation	4180186
1031445	Little finger arteries.left	4180186
1031456	Destination site latitude	4180186
1031458	Destination site name & address	4180186
1031486	ED practitioner ID	4180186
1031492	ED referring practitioner ID	4180186
1031494	Line	4180186
1031524	Follow-up (referred to) provider &or specialist	4180186
1031525	Follow-up (referred to) provider &or specialist, address	4180186
1031526	Follow-up (referred to) provider &or specialist, appointment date	4180186
1031528	Follow-up (referred to) provider &or specialist, name	4180186
1031530	Follow-up (referred to) provider &or specialist, phone	4180186
1031531	Follow-up (referred to) provider &or specialist, provider type	4180186
1031565	History of present alcohol &or substance abuse	4180186
1031576	Include all data of the selected type that represents observations made 30D or fewer before the starting date of service	4180186
1031580	Include all data of the selected type that represents observations made two Y or less before the starting date of service	4180186
1031599	Lipoprotein analysis status &or results	4180186
1031610	Medication name + ID	4180186
1031621	Medication.current	4180186
1031660	Ordering practitioner ID	4180186
1031684	Middle finger arteries.right	4180186
1031709	Mlk.raw	4180186
1031715	Primary practitioner ID	4180186
1031724	Progress note+attainment of goals	4180186
1031725	Progress note+attainment of goals date range	4180186
1031740	Mitral valve.leaflet.anterior	4180186
1031792	Mmlk	4180186
1031808	Staff practitioner ID	4180186
1031876	Abnormal lab values in last 90D	4180186
1031879	Accepts instructions & respond appropriately to criticism from supervisors	4180186
1031967	Ocular fld	4180186
1032008	Ovarian artery.left	4180186
1032017	Ovarian artery.right	4180186
1032018	Bathing &or hygiene deficit	4180186
1032025	Behavioral Signs & Symptoms	4180186
1032031	Bladder - frequency of incontinence during 2D assessment period	4180186
1032034	Ovary.left.largest follicle	4180186
1032046	Bowel - frequency of incontinence during 2D assessment period	4180186
1032062	Ovary.right.largest follicle	4180186
1032072	Car transfer during 2D assessment period	4180186
1032084	Caretaking &or parenting.behavior	4180186
1032085	Caretaking &or parenting	4180186
1032087	Carries out very short & simple instructions	4180186
1032096	Chair-bed to chair transfer during 2D assessment period	4180186
1032125	Communicable &or infectious condition function	4180186
1032134	Conditions &or diseases make resident's cognitive, ADL, mood or behavior patterns unstable	4180186
1032135	Conditions prior to medical or treatment regimen change or inpatient stay within past 14D	4180186
1032158	Pericard fld	4180186
1032227	Discharge delayed at least 24H	4180186
1032305	Plas+Urine	4180186
1032311	Expresses sadness &or anger &or empty feeling over lost roles &or status	4180186
1032314	Plas/RBC	4180186
1032340	Feeling bad about yourself - or that you are a failure or have let yourself or your family down in last 2W	4180186
1032341	Feeling down, depressed, or hopeless in last 2W	4180186
1032345	Fell in past 31D-180D	4180186
1032362	Plr fld	4180186
1032369	Frequently lift &or carry	4180186
1032379	Popliteal artery.left	4180186
1032387	Geriatric depression scale.short version total	4180186
1032414	Hearing aid present & not used regularly	4180186
1032415	Hearing aid present & used	4180186
1032423	Posterior tibial artery.left	4180186
1032432	Posterior tibial artery.right	4180186
1032434	Continuity assessment record and evaluation tool - home health admission	4180186
1032486	Insufficient fluid; did NOT consume all or almost all liquids provided during last 3D	4180186
1032487	Intake &or output	4180186
1032521	Prostate cancer.XXX	4180186
1032555	Lower body dressing during 2D assessment period	4180186
1032556	Lying to sitting on side of bed during 2D assessment period	4180186
1032558	Maintains attention & concentration for extended periods	4180186
1032565	PRP	4180186
1032572	Major treatments used on or 1D prior to day of death panel	4180186
1032577	Make light meal during 2D assessment period	4180186
1032582	Management of inhalant &or mist medications	4180186
1032607	Medical or treatment regimen change in past 14D	4180186
1032617	Pulmonary artery.main	4180186
1032625	Memory recall &or ability	4180186
1032626	Memory &or recall - none of above are recalled	4180186
1032673	Neighborhood &or workplace safety.behavior	4180186
1032713	Number of D recreation therapy administered for greater than 15M	4180186
1032718	Number of D diuretic medication received	4180186
1032720	Number of D hypnotic medication received	4180186
1032721	Number of D of active range of motion	4180186
1032723	Number of D of passive range of motion	4180186
1032724	Number of D of splint or brace assistance	4180186
1032728	Number of D of training & skill practice in dressing or grooming	4180186
1032733	Number of D with at least 15M of occupational therapy in the last 7D	4180186
1032736	Number of D with at least 15M of respiratory therapy in the last 7D	4180186
1032739	Number of emergency room visits in last 90D	4180186
1032763	Pulmonic valve.distal	4180186
1032775	Occasionally lift &or carry	4180186
1032806	Other current or more detailed diagnoses & ICD9 codes	4180186
1032821	Other disruptive or dangerous behavioral symptoms not directed towards others, including self-injurious behaviors during 2D assessment period	4180186
1032836	Radial artery.right	4180186
1032842	Overall Plan of Care &or Advance Care Directives	4180186
1032845	Radiation.Rx	4180186
1032851	Pain Effect on Function during last 2D	4180186
1032859	Pain presence during last 2D	4180186
1032860	Pain severity during last 2D	4180186
1032891	Perceived difficulty in last 2W	4180186
1032905	Physical behavioral symptoms directed toward others during 2D assessment period	4180186
1032915	Planning & preparing light meals	4180186
1032922	Poor appetite or overeating in last 2W	4180186
1032930	Preferred activity setting - inside NH &or off unit	4180186
1032942	Primarily uses wheelchair for mobility during 2D assessment period	4180186
1033009	Putting on &or taking off footwear during 2D assessment period	4180186
1033011	Renal artery.left	4180186
1033020	Renal artery.right	4180186
1033038	Recurrent lung aspirations in last 90D	4180186
1033045	Renal pelvis.left	4180186
1033048	Remembers locations & worklike procedures	4180186
1033069	Resident assessment protocol 14--Dehydration &or Fluid maint - triggered	4180186
1033087	Resident assessment protocol 5--ADL functional &or Rehab - proceed with care	4180186
1033105	Residential history 5Y prior to entry	4180186
1033112	Respiratory status without oxygen therapy during 2D assessment period	4180186
1033114	Respiratory system.airway	4180186
1033117	Responsibility &or legal guardian	4180186
1033123	Respiratory system.alveolus	4180186
1033156	Shower &or bathe self during 2D assessment period	4180186
1033159	Retinal artery.right	4180186
1033161	Sit to lying during 2D assessment period	4180186
1033162	Sit to stand during 2D assessment period	4180186
1033163	Sitting endurance - able to tolerate sitting for 15M during 2D assessment period	4180186
1033168	Ring finger arteries.left	4180186
1033204	Stand &or walk	4180186
1033211	Ser	4180186
1033234	Support Needs &or Caregiver Assistance	4180186
1033238	Ser+CSF	4180186
1033273	Thoughts that you would be better off dead, or of hurting yourself in some way in last 2W	4180186
1033274	Through D 15, provide an estimate of the number of D when at least 1 therapy service can be expected to have been delivered	4180186
1033280	Toilet hygiene during 2D assessment period	4180186
1033286	Total minutes of occupational therapy in the last 7D	4180186
1033287	Total minutes of physical therapy in the last 7D	4180186
1033288	Total minutes of psychological therapy by any licensed mental health professional in the last 7D	4180186
1033294	Total population of age 15-19Y	4180186
1033295	Total population of age 20-24Y	4180186
1033296	Total population of age 25-29Y	4180186
1033299	Total population of age 30-34Y	4180186
1033301	Total population of age 40-44Y	4180186
1033302	Total population of age 45-49Y	4180186
1033303	Total population of age 50-54Y	4180186
1033306	Ser/Plas	4180186
1033311	Total population of age 80-84Y	4180186
1033312	Total population of age birth to 28D	4180186
1033313	Total population of age GE 85Y	4180186
1033316	Total recreation therapy in last 7D	4180186
1033332	Treated for urinary tract infection in past 14D	4180186
1033337	Trouble concentrating on things, such as reading the newspaper or watching television in last 2W	4180186
1033359	Understands & remembers detailed instructions	4180186
1033386	Uses signs &or gestures &or sounds	4180186
1033410	Walk 150 ft (45 m) during 2D assessment period	4180186
1033411	Walk 50 feet with two turns during 2D assessment period	4180186
1033412	Walk 50 ft (15 m) during 2D assessment period	4180186
1033417	Walk 10 ft (3 m) during 2D assessment period	4180186
1033433	Wheel 50 ft (15 m) during 2D assessment period	4180186
1033434	Wheel 10 ft (3 m) during 2D assessment period	4180186
1033436	Wheel short ramp during 2D assessment period	4180186
1033448	Semen+Cvm	4180186
1033461	Spine.XXX	4180186
1033463	Max	4180186
1033467	Sputum/Bronchial	4180186
1033490	Sptt	4180186
1033512	Humerus.diaphysis.right	4180186
1033519	Maxilla.left+Mandible.left	4180186
1033520	Maxilla.right+Mandible.right	4180186
1033522	Nasal bone.diaphysis	4180186
1033525	Radius.diaphysis.right	4180186
1033545	Fluid intake.upper GI tube	4180186
1033548	Fluid output.burn	4180186
1033551	Fluid output.emesis	4180186
1033552	Subclavian vein.right	4180186
1033553	Fluid output.gastric tube	4180186
1033554	Fluid output.insensible	4180186
1033555	Fluid output.misc	4180186
1033557	Fluid output.pericardial drain	4180186
1033558	Fluid output.peritoneal drain	4180186
1033561	Fluid output.urinary incontinence	4180186
1033562	Fluid output.urine	4180186
1033567	Pressure gradient.mean.XXX	4180186
1033570	Superficial tissue.FNA	4180186
1033586	Circumference.max	4180186
1033596	Diastole.max	4180186
1033597	Fluid intake.chest tube	4180186
1033598	Fluid intake.enema	4180186
1033599	Fluid intake.enteral tube	4180186
1033600	Fluid intake.gastrostomy tube	4180186
1033602	Fluid intake.intravascular	4180186
1033605	Fluid intake.peritoneal	4180186
1033607	Fluid intake.total	4180186
1033617	Systole.mean	4180186
1033620	Volume.XXX	4180186
1033621	Antepartum &or postpartum.behavior	4180186
1033622	Antepartum &or postpartum.knowledge	4180186
1033623	Antepartum &or postpartum.status	4180186
1033626	Communicable &or infectious condition function.behavior	4180186
1033627	Communicable &or infectious condition function.knowledge	4180186
1033631	Dressing &or grooming deficit	4180186
1033645	Cigarettes smoked.current (pack per day)	4180186
1033646	Cigarettes smoked.total (pack per year)	4180186
1033654	Throat+Neck	4180186
1033659	ACMG	4180186
1033663	Ear.bilateral	4180186
1033681	Use public transportation during 2D assessment period	4180186
1033682	Tibia.diaphysis	4180186
1033686	TLGI/TSMI	4180186
1033687	Lung tiss	4180186
1033696	Tricuspid valve.regurgitant jet	4180186
1033698	TSMI	4180186
1033702	Ulc	4180186
1033707	Umbilical artery.at fetus	4180186
1033708	Umbilical artery.at placenta	4180186
1033718	Urine sed	4180186
1033720	Usual occupation Hx	4180186
1033721	Unk sub	4180186
1033722	Uterine artery.left	4180186
1033723	Uterine artery.right	4180186
1033728	Ventilator.intermitten mandatory	4180186
1033737	WBC	4180186
1033740	Wound.deep	4180186
1033758	Beta-2-Microglobulin.CSF	4180186
1033762	Ser/Plas^normal control	4180186
1033766	Additional ICD diagnosis 1 in last 7D	4180186
1033767	Additional ICD diagnosis 2 in last 7D	4180186
1033769	Additional ICD diagnosis 4 in last 7D	4180186
1033772	Additional ICD diagnosis 7 in last 7D	4180186
1033776	Assessment &or tracking type	4180186
1033787	Psychosis in last 7D	4180186
1033788	Behavioral symptom - presence & frequency	4180186
1033816	Swallowing &or nutritional status	4180186
1033835	First assessment since the most recent admission &or reentry	4180186
1033848	Short-term memory OK in last 7D	4180186
1033849	Long-term memory OK in last 7D	4180186
1033850	Memory &or recall ability	4180186
1033861	Disorganized thinking in last 7D	4180186
1033863	Psychomotor retardation in last 7D	4180186
1033868	Little interest or pleasure in doing things in last 2W.presence	4180186
1033870	Feeling down, depressed or hopeless in last 2W.presence	4180186
1033872	Trouble falling or staying asleep, or sleeping too much in last 2W.presence	4180186
1033876	Poor appetite or overeating in last 2W.presence	4180186
1033877	Poor appetite or overeating in last 2W.frequency	4180186
1033878	Feeling bad about yourself - or that you are a failure or have let yourself or your family down in last 2W.presence	4180186
1033880	Trouble concentrating on things, such as reading the newspaper or watching television in last 2W.presence	4180186
1033881	Trouble concentrating on things, such as reading the newspaper or watching television in last 2W.frequency	4180186
1033882	Thoughts that you would be better off dead, or of hurting yourself in some way in last 2W.presence	4180186
1033883	Thoughts that you would be better off dead, or of hurting yourself in some way in last 2W.frequency	4180186
1033888	Feeling or appearing down, depressed or hopeless in last 2W.presence	4180186
1033891	Indicating that (s)he feels bad about self, is a failure, or has let self or family down in last 2W.frequency	4180186
1033893	States that life isn't worth living, wishes for death, or attempts to harm self in last 2W.frequency	4180186
1033897	Hallucinations in last 7D	4180186
1033898	Illusions in last 7D	4180186
1033899	Delusions in last 7D	4180186
1033900	Psychoses - none of the above in last 7D	4180186
1033912	Wandering - presence and frequency in last 7D	4180186
1033915	Change in behavioral or other symptoms in last 7D	4180186
1033956	Bed mobility in last 7D	4180186
1033957	Transfer in last 7D	4180186
1033959	Toileting in last 7D	4180186
1033966	Grooming &or personal hygiene in last 7D	4180186
1033973	crutch normally used in last 7D	4180186
1033976	Limb prosthesis normally used in last 7D	4180186
1033977	Mobility aids - none of the above were normally used in last 7D	4180186
1033979	Indwelling catheter used in last 7D	4180186
1033980	External catheter used in last 7D	4180186
1033983	Appliances - none of the above used in last 7D	4180186
1033987	Urinary continence in last 7D	4180186
1033991	Cancer in last 30D	4180186
1033993	Atrial fibrillation and other dysrhythmias in last 7D	4180186
1033995	Deep venous thrombosis &or pulmonary embolus or pulmonary thrombo-embolism in last 7D	4180186
1033996	Heart failure in last 7D	4180186
1033997	Hypertension in last 7D	4180186
1033998	Hypotension in last 7D	4180186
1034000	Cirrhosis in last 7D	4180186
1034001	Gastroesophageal reflux disease &or pressure injury in last 7D	4180186
1034003	Benign prostatic hyperplasia in last 7D	4180186
1034004	Renal insufficiency or renal failure &or end-stage renal disease in last 7D	4180186
1034007	Pneumonia in last 7D	4180186
1034008	Septicemia in last 7D	4180186
1034009	Tuberculosis in last 7D	4180186
1034011	Viral hepatitis in last 7D	4180186
1034014	Hyperkalemia in last 7D	4180186
1034015	Hyperlipidemia in last 7D	4180186
1034016	Thyroid disorder in last 7D	4180186
1034018	Osteoporosis in last 7D	4180186
1034023	Cerebral palsy in last 7D	4180186
1034024	Cerebrovascular accident &or transient ischemic attack &or stroke in last 7D	4180186
1034025	Non-Alzheimer's dementia in last 7D	4180186
1034026	Hemiplegia &or hemiparesis in last 7D	4180186
1034029	Multiple sclerosis in last 7D	4180186
1034030	Parkinson's disease in last 7D	4180186
1034031	Seizure disorder in last 7D	4180186
1034032	Traumatic brain injury in last 7D	4180186
1034033	Protein or calorie malnutrition or at risk for malnutrition in last 7D	4180186
1034034	Anxiety disorder in last 7D	4180186
1034049	Limited activities because of pain in last 5D	4180186
1034051	Non-verbal sounds of pain in last 5D	4180186
1034053	Facial expressions of pain in last 5D	4180186
1034054	Protective body movements or postures in last 5D	4180186
1034056	Adequacy of current therapeutic regimen to control pain in last 7D	4180186
1034061	Life expectancy of less than 6M	4180186
1034064	Fall one or more times in the last 2 to 6Mo prior to admission	4180186
1034065	Any fracture related to a fall in the 6Mo prior to admission	4180186
1034072	Holding food in mouth &or cheeks or residual food in mouth after meals in last 7D	4180186
1034074	Complaints of difficulty or pain with swallowing in last 7D	4180186
1034076	Weight loss of 5% or more in the last Mo or loss of 10% or more in last 6Mo	4180186
1034079	Mechanically altered diet - require change in texture of food or liquids in last 7D	4180186
1034084	Broken or loosely fitting full or partial denture in last 7D	4180186
1034087	Obvious or likely cavity or broken natural teeth in last 7D	4180186
1034089	Mouth or facial pain, discomfort or difficulty with chewing in last 7D	4180186
1034090	Dental status - none of the above in last 7D	4180186
1034098	Number of pressure ulcers present upon admission &or reentry - stage 3	4180186
1034101	Number of pressure ulcers present upon admission &or reentry - stage 4	4180186
1034104	Number of pressure ulcers present upon admission &or reentry - unstageable due to non-removable dressing	4180186
1034108	EngFr	4180186
1034109	Language.preferred	4180186
1034111	Moving or speaking so slowly that other people have noticed. Or the opposite - being so fidgety or restless that (s)he has been moving around a lot more than usual in last 2W.presence	4180186
1034112	Cane &or crutch normally used in last 7D	4180186
1034114	Number of pressure ulcers present upon admission &or reentry - unstageable due to coverage of wound bed by slough &or eschar	4180186
1034116	Date of onset of pressure ulcers onset in this facility - newest unstageable due to coverage of wound bed by slough &or eschar	4180186
1034123	Other foot or lower extremity open lesion(s) or infections in last 7D	4180186
1034124	Wound infection other than on foot or lower extremity in last 7D	4180186
1034126	Open lesion(s) other than ulcers, rashes, cuts in last 7D	4180186
1034132	Pressure reducing device for bed provided in last 7D	4180186
1034135	Pressure injury care provided in last 7D	4180186
1034136	Surgical wound care provided in last 7D	4180186
1034137	Application of nonsurgical dressings (with or without topical medications) other than to feet provided in last 7D	4180186
1034139	Application of dressings to feet (with or without topical medications) provided in last 7D	4180186
1034140	Skin and pressure injury treatments - none of above provided in last 7D	4180186
1034141	Number of D injectable substances received in last 7D or since admission &or reentry if less than 7D	4180186
1034145	Antidepressant received in last 7D or since admission &or reentry if less than 7D	4180186
1034147	Anticoagulant received in last 7D or since admission &or reentry if less than 7D	4180186
1034148	Medications received - none of the above were received in last 7D or since admission &or reentry if less than 7D	4180186
1034149	Special treatments and programs in last 14D	4180186
1034152	Radiation in last 14D - while not a resident	4180186
1034153	Radiation in last 14D - while a resident	4180186
1034154	Oxygen therapy in last 14D - while not a resident	4180186
1034156	Suctioning in last 14D - while not a resident	4180186
1034158	Tracheostomy care in last 14D - while not a resident	4180186
1034162	BIPAP &or CPAP machine in last 14D - while not a resident	4180186
1034164	IV medications in last 14D - while not a resident	4180186
1034167	Transfusions in last 14D - while a resident	4180186
1034168	Dialysis in last 14D - while not a resident	4180186
1034170	Hospice care in last 14D - while not a resident	4180186
1034172	Respite care in last 14D - while not a resident	4180186
1034173	Respite care in last 14D - while a resident	4180186
1034175	Isolation or quarantine for active infectious disease in last 14D - while a resident	4180186
1034177	Therapies in last 7D	4180186
1034189	Number of D with at least 15M of recreational and music therapy in last 7D	4180186
1034193	Number of physician visits in last 14D	4180186
1034209	Therapies ordered to begin in first 14D of stay	4180186
1034237	Respiratory treatments in last 14D	4180186
1034238	Cancer treatments in last 14D	4180186
1034241	Pressure injuries - unstageable due to coverage of wound bed by slough &or eschar	4180186
1034243	EmailAddr	4180186
1034260	Average fluid intake per day by parenteral or tube feedings in the 7D	4180186
1034264	Number of D of rehabilitative or restorative techniques	4180186
1034265	Number of D of rehabilitative or restorative training and skill practice	4180186
1034266	Vaccine Adverse Event Reporting System panel	4180186
1034269	DEEDS	4180186
1034292	Number of female sexual partners in 6Mo before symptom onset	4180186
1034296	Date of actual exposure to blood &or body fluid	4180186
1034329	Views & (view	4180186
1034332	Views 2 & (views	4180186
1034354	Weight & Height tracking panel	4180186
1034361	Number of D to wean patient who is now independent from ventilator	4180186
1034362	Tissue transglutaminase Ab.IgA & IgG panel	4180186
1034372	Reported.howRu	4180186
1034388	Reported.PHQ-2.CARE	4180186
1034407	Horizontal adduction.active range of motion	4180186
1034447	Hand dominance - 12Y	4180186
1034468	Upper arm.mid.right	4180186
1034470	PhenX - hand dominance - 12Y and older protocol 020602	4180186
1034524	Calculated & derived values	4180186
1034550	Thyroxine free	4180186
1034567	ADL & IADLs	4180186
1034595	OCT	4180186
1034628	Patient &or caregiver received high risk drug education	4180186
1034668	Gliadin peptide Ab.IgA & IgG panel	4180186
1034694	When confused within the last 14D	4180186
1034701	Wound infection (other than foot) in last 7D	4180186
1034704	Huntington's disease in last 7D	4180186
1034712	Malnutrition in last 7D	4180186
1034713	Post traumatic stress disorder in last 7D	4180186
1034718	Number of D injection of any type were received in last 5D or since admission &or reentry if less than 7D	4180186
1034719	Number of D insulin injections were received in last 7D or since admission &or reentry if less than 7D	4180186
1034722	Diuretic received in last 7D or since admission &or reentry if less than 7D	4180186
1034749	Cognitive loss &or dementia - care area triggered	4180186
1034753	ADL functional &or rehabilitation potential - care area triggered	4180186
1034771	Dehydration &or fluid maintenance - care area triggered	4180186
1034772	Dehydration &or fluid maintenance - addressed in care plan	4180186
1034895	Frequency (number in past Mo) of chest discomfort	4180186
1034909	Pain in the chest, left arm or shoulder or jaw within 72H of death	4180186
1034912	Cardiopulmonary resuscitation &or cardioversion performed within 24H of death	4180186
1034923	Acute episode of pain, discomfort or tightness in the chest, left arm or jaw within 72H of the hospitalization or in-hospital event	4180186
1034937	MR.functional	4180186
1034947	A wave duration.pulmonary vein	4180186
1034955	IFCC	4180186
1036709	2,4,5,6(1H,3H)-Pyrimidinetetrone	4180186
1036712	AQP1 Protein	4180186
1036712	AQP CHIP Protein	4180186
1036712	AQP-CHIP Protein	4180186
1036712	Aquaporin 1 Protein	4180186
1036712	Aquaporin CHIP	4180186
1036712	Aquaporin-CHIP	4180186
1036712	Channel Forming Integral Membrane Protein Of 28 kDa	4180186
1036712	Channel-Forming Integral Membrane Protein Of 28 kDa	4180186
1036712	CHIP28 Protein	4180186
1036713	Eurotium oryzae	4180186
1036715	Blood Volumes	4180186
1036715	Volume, Blood	4180186
1036715	Volumes, Blood	4180186
1036720	Body Weights	4180186
1036720	Weight, Body	4180186
1036720	Weights, Body	4180186
1036722	Cardiac Outputs	4180186
1036722	Output, Cardiac	4180186
1036722	Outputs, Cardiac	4180186
1036725	Collagen alpha1(II)	4180186
1036725	Collagen, Type II	4180186
1036725	Collagen Type II, alpha1 Chain	4180186
1036725	Collagen Type II, alpha1 Subunit	4180186
1036725	Procollagen Type II	4180186
1036725	Procollagen, Type II	4180186
1036725	Type II Collagen	4180186
1036725	Type II Procollagen	4180186
1036729	alpha Fucose	4180186
1036729	alpha-Fucose	4180186
1036729	Deoxygalactose	4180186
1036730	Fetal Heart Rate	4180186
1036730	Fetal Heart Rates	4180186
1036730	Heart Rates, Fetal	4180186
1036730	Rate, Fetal Heart	4180186
1036730	Rates, Fetal Heart	4180186
1036731	Cardiac Sound	4180186
1036731	Cardiac Sounds	4180186
1036731	Heart Sound	4180186
1036731	Sound, Cardiac	4180186
1036731	Sound, Heart	4180186
1036731	Sounds, Cardiac	4180186
1036731	Sounds, Heart	4180186
1036733	Chemotherapy, Hot	4180186
1036733	Chemotherapy, Hyperthermic Intraperitoneal	4180186
1036733	Chemotherapy, Intraperitoneal Hyperthermic	4180186
1036733	HIPEC	4180186
1036733	Hot Chemotherapy	4180186
1036733	Hyperthermic Chemotherapy, Intraperitoneal	4180186
1036733	Intraperitoneal Chemotherapy, Hyperthermic	4180186
1036733	Intraperitoneal Hyperthermic Chemotherapies	4180186
1036733	Intraperitoneal Hyperthermic Chemotherapy	4180186
1036740	Index, Mitotic	4180186
1036740	Indices, Mitotic	4180186
1036740	Mitotic Indices	4180186
1036741	Intolerance, Orthostatic	4180186
1036743	Hypertonic Shock	4180186
1036743	Hypertonic Shocks	4180186
1036743	Hypertonic Stress	4180186
1036743	Hypertonic Stresses	4180186
1036743	Hypotonic Shock	4180186
1036743	Hypotonic Shocks	4180186
1036743	Hypotonic Stress	4180186
1036743	Hypotonic Stresses	4180186
1036743	Osmotic Pressures	4180186
1036743	Osmotic Shock	4180186
1036743	Osmotic Shocks	4180186
1036743	Osmotic Stress	4180186
1036743	Osmotic Stresses	4180186
1036743	Pressure, Osmotic	4180186
1036743	Pressures, Osmotic	4180186
1036743	Shock, Hypertonic	4180186
1036743	Shock, Hypotonic	4180186
1036743	Shock, Osmotic	4180186
1036743	Shocks, Hypertonic	4180186
1036743	Shocks, Hypotonic	4180186
1036743	Shocks, Osmotic	4180186
1036743	Stresses, Hypertonic	4180186
1036743	Stresses, Hypotonic	4180186
1036743	Stresses, Osmotic	4180186
1036743	Stress, Hypertonic	4180186
1036743	Stress, Hypotonic	4180186
1036743	Stress, Osmotic	4180186
1036744	Piloerections	4180186
1036746	Social Risk Factors	4180186
1036746	Social Risk Factor	4180186
1036746	Risk Factors, Social	4180186
1036746	Risk Factor, Social	4180186
1036746	Factors, Social Risk	4180186
1036746	Factor, Social Risk	4180186
1036746	Correlates, Health	4180186
1036746	Factor, Risk	4180186
1036746	Health Correlates	4180186
1036746	Population at Risk	4180186
1036746	Populations at Risk	4180186
1036746	Risk Factor	4180186
1036746	Risk Factor Score	4180186
1036746	Risk Factor Scores	4180186
1036746	Risk Score	4180186
1036746	Risk Scores	4180186
1036746	Score, Risk	4180186
1036746	Score, Risk Factor	4180186
1036748	Ejection Fractions, Ventricular	4180186
1036748	Ejection Fraction, Ventricular	4180186
1036748	End-Diastolic Volumes, Ventricular	4180186
1036748	End-Diastolic Volume, Ventricular	4180186
1036748	End-Systolic Volumes, Ventricular	4180186
1036748	End-Systolic Volume, Ventricular	4180186
1036748	Fractions, Ventricular Ejection	4180186
1036748	Fraction, Ventricular Ejection	4180186
1036748	Stroke Volumes	4180186
1036748	Ventricular Ejection Fraction	4180186
1036748	Ventricular Ejection Fractions	4180186
1036748	Ventricular End Diastolic Volume	4180186
1036748	Ventricular End-Diastolic Volume	4180186
1036748	Ventricular End-Diastolic Volumes	4180186
1036748	Ventricular End Systolic Volume	4180186
1036748	Ventricular End-Systolic Volume	4180186
1036748	Ventricular End-Systolic Volumes	4180186
1036748	Volumes, Stroke	4180186
1036748	Volume, Stroke	4180186
1036748	Volumes, Ventricular End-Diastolic	4180186
1036748	Volumes, Ventricular End-Systolic	4180186
1036748	Volume, Ventricular End-Diastolic	4180186
1036748	Volume, Ventricular End-Systolic	4180186
1036749	Benzenesulfonamide, 4-amino-N-(6-chloro-3-pyridazinyl)-	4180186
1036749	Monosodium Salt Sulfachlorpyridazine	4180186
1036749	Sulfachloropyridazine	4180186
1036749	Sulfachlorpyridazine, Monosodium Salt	4180186
1036749	Sulphachlorpyridazine	4180186
1036750	Neoplasms, Uveal	4180186
1036750	Neoplasm, Uveal	4180186
1036750	Uveal Neoplasm	4180186
1036751	Function, Left Ventricular	4180186
1036751	Functions, Left Ventricular	4180186
1036751	Left Ventricular Function	4180186
1036751	Left Ventricular Functions	4180186
1036751	Ventricular Functions, Left	4180186
1036752	Function, Right Ventricular	4180186
1036752	Functions, Right Ventricular	4180186
1036752	Right Ventricular Function	4180186
1036752	Right Ventricular Functions	4180186
1036752	Ventricular Functions, Right	4180186
1036753	Viscosities	4180186
1036755	Ratios, Waist-Hip	4180186
1036755	Ratios, Waist-to-Hip	4180186
1036755	Ratio, Waist-Hip	4180186
1036755	Ratio, Waist-to-Hip	4180186
1036755	Waist Hip Ratio	4180186
1036755	Waist-Hip Ratios	4180186
1036755	Waist to Hip Ratio	4180186
1036755	Waist-to-Hip Ratio	4180186
1036755	Waist-to-Hip Ratios	4180186
1036756	10-hydroxy-octadecanoic acid	4180186
1036756	10-hydroxyoctadecanoic acid	4180186
1036756	Octadecanoic acid, 10-hydroxy-	4180186
1036758	2,2-dimethylvinyl chloride	4180186
1036758	DMVC	4180186
1036759	1-octen-3-ol, (+-)-isomer	4180186
1036759	1-octen-3-ol, (R)-isomer	4180186
1036759	octenol	4180186
1036761	2-phenylpropanol	4180186
1036761	phenylpropanol	4180186
1036765	2-Propenoic acid, 3-(3-methyl-2-thienyl)-	4180186
1036765	CP 20107	4180186
1036765	CP-20,107	4180186
1036766	(+)-3-carene	4180186
1036766	3-carene, (R)-isomer	4180186
1036766	3-carene, (S)-(cis)-isomer	4180186
1036766	bicyclo(4.1.0)hept-3-ene, 3,7,7-trimethyl-	4180186
1036766	delta-3-carene	4180186
1036766	delta(3)-carene	4180186
1036766	delta3-carene	4180186
1036768	acetamide, monosodium salt	4180186
1036770	3 alpha beta-HSD deficiency	4180186
1036770	3 alpha beta-hydroxysteroid dehydrogenase deficiency	4180186
1036770	3 alpha beta-hydroxysteroid dehydrogenase, type 2, deficiency of	4180186
1036770	3beta-Hsd Deficiency	4180186
1036770	3 Beta-Hsd Deficiency	4180186
1036770	3beta-Hsd Deficiency Congenital Adrenal Hyperplasia	4180186
1036770	3beta-Hydroxysteroid Dehydrogenase Deficiency	4180186
1036770	3-Beta Hydroxysteroid Dehydrogenase Deficiency	4180186
1036770	3 beta-ol Dehydrogenase Deficiency	4180186
1036770	3b-Hydroxysteroid Dehydrogenase Deficiency	4180186
1036770	HSDB3	4180186
1036770	Type II 3beta-Hydroxysteroid Dehydrogenase Deficiency	4180186
1036771	Al Gazali Donnai Mueller syndrome	4180186
1036771	Hirschsprung Disease with Hypoplastic Nails and Dysmorphic Facial Features	4180186
1036771	Hirschsprung's disease, hypoplastic nails, and dysmorphic facial features	4180186
1036771	Hirschsprung's disease, hypoplastic nails, and minor dysmorphic features	4180186
1036773	Obetine	4180186
1036773	TISACID	4180186
1036773	Almax	4180186
1036773	aluminum-magnesium hydroxide carbonate	4180186
1036773	aluminum-magnesium hydroxycarbonate	4180186
1036773	Deprece	4180186
1036773	Magnesium, (carbonato(2-))heptahydroxy(aluminum)tri-, dihydrate	4180186
1036774	damascone	4180186
1036782	GSK2857916	4180186
1036782	GSK 2857916	4180186
1036782	GSK-2857916	4180186
1036784	lup-20(29)-ene-3,28-diol, 3,28-diacetate, (3 beta)-	4180186
1036784	betulinol diacetate	4180186
1036784	betulinol biacetate	4180186
1036784	betulinic alcohol	4180186
1036784	betuline	4180186
1036784	betulin diacetate	4180186
1036784	(+)-betulin diacetate	4180186
1036784	(+)-betulin	4180186
1036784	3,28-di-O-acetylbetulin	4180186
1036784	3,28-diacetoxy-betulin	4180186
1036784	betulinol	4180186
1036784	lup-20(29)-en-3 alpha, 28,30-triol	4180186
1036784	lup-20(29)-ene-3alpha,28-diol	4180186
1036784	lup-20(29)-ene-3 beta,28-diol	4180186
1036786	Chondrodysplasia punctata, brachytelephalangic	4180186
1036789	Vocabria	4180186
1036789	sodium (3S,11aR)-8-(((2,4-difluorophenyl)methyl)carbamoyl)-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo(3,2-a)pyrido(1,2-d)pyrazin-6-olate	4180186
1036789	S-265744B	4180186
1036789	S-265744	4180186
1036789	GSK-1265744B	4180186
1036789	GSK1265744B	4180186
1036789	GSK-1265744A	4180186
1036789	GSK1265744A	4180186
1036789	GSK-1265744	4180186
1036789	cabotegravir sodium	4180186
1036789	cabotegravir extended-release injectable suspension	4180186
1036789	Apretude	4180186
1036789	(3S,11aR)-N-((2,6-difluoropyridin-3-yl)methyl)-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro(1,3)oxazolo(3,2-a)pyrido(1,2-d)pyrazine-8-carboxamide	4180186
1036789	GSK1265744	4180186
1036789	GSK744	4180186
1036789	N-((2,4-difluorophenyl)methyl)-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro(1,3)oxazolo(3,2-a)pyrido(1,2-d)pyrazine-8-carboxamide	4180186
1036794	REGN-10933	4180186
1036795	1,2,3-Propanetricarboxylic acid, 1-chloro-2-hydroxy-, (R*,R*)-(-)-	4180186
1036795	chlorocitric acid, (R*,R*)-(+)-isomer	4180186
1036795	threo-chlorocitric acid	4180186
1036796	2',3'-cyclic CMP	4180186
1036796	cifostodine barium (2:1) salt	4180186
1036796	cifostodine monosodium salt	4180186
1036796	cytidine 2',3'-phosphate	4180186
1036796	cytidine, cyclic 2',3'-(hydrogen phosphate)	4180186
1036796	cytidine cyclic 2,3 monophosphate	4180186
1036796	cytidine cyclic-2',3'-monophosphate	4180186
1036798	winlevi	4180186
1036798	CB-03-01	4180186
1036798	cortexolone 17alpha-propionate	4180186
1036800	1,2,3-Propanetricarboxylic acid, 2-hydroxy-, copper(2+) salt (1:2)	4180186
1036800	cupric citrate	4180186
1036801	9,19-Cyclolanostane-3,6,16,25-tetrol, 20,24-epoxy-, (3beta,6alpha,16beta,24R)-	4180186
1036801	astramembrangenin	4180186
1036801	cyclogalegigenin	4180186
1036801	GRN510	4180186
1036806	glutaric acid dimethyl ester	4180186
1036806	pentanedioic acid, 1,5-dimethyl ester	4180186
1036806	pentanedioic acid, dimethyl ester	4180186
1036808	Ataxia, Adult-Onset, With Oculomotor Apraxia	4180186
1036808	Ataxia, Early-Onset, With Oculomotor Apraxia And Hypoalbuminemia	4180186
1036808	Ataxia-oculomotor apraxia 1	4180186
1036808	Ataxia-oculomotor apraxia syndrome	4180186
1036808	Ataxia-telangiectasia-like syndrome	4180186
1036808	Cerebellar Ataxia, Early-Onset, With Hypoalbuminemia	4180186
1036808	Early-Onset Ataxia with Ocular Motor Apraxia and Hypoalbuminemia	4180186
1036808	Early-onset cerebellar ataxia with hypoalbuminemia	4180186
1036814	evkeeza	4180186
1036814	evinacumab-dgnb	4180186
1036814	REGN1500	4180186
1036814	REGN-1500	4180186
1036816	Gaucher Disease, Collodion Type	4180186
1036817	ABT-493	4180186
1036818	Glycogenosis Of Liver And Muscle, Autosomal Recessive	4180186
1036818	GSD9B	4180186
1036818	GSD IXB	4180186
1036818	Phosphorylase Kinase Deficiency Of Liver And Muscle, Autosomal Recessive	4180186
1036821	2,2'-((4-((2-hydroxyethyl)amino)-3-nitrophenyl)imino)bis(ethanol)	4180186
1036823	Dnmt1-Related Dementia, Deafness, and Sensory Neuropathy	4180186
1036823	Hereditary Sensory and Autonomic Neuropathy Type 1 with Dementia and Hearing Loss	4180186
1036823	Hereditary Sensory Neuropathy Type Ie	4180186
1036823	Hsnie	4180186
1036823	Hsn Ie	4180186
1036824	HPMA	4180186
1036825	Hypertrichosis, Congenital Generalized	4180186
1036825	Macias-Flores Garcia-Cruz Rivera syndrome	4180186
1036834	maftivimab-ebgn	4180186
1036834	REGN3479	4180186
1036834	REGN-3479	4180186
1036835	margenza	4180186
1036835	MGAH-22	4180186
1036835	MGAH22 antibody	4180186
1036836	DHFR Deficiency	4180186
1036837	Menhaden oil, lead salt	4180186
1036838	mercury nitrate ammoniate (1:2:2)	4180186
1036840	abietic acid methyl ester	4180186
1036842	Myopathy, Myosclerotic	4180186
1036842	Myosclerosis, Congenital, of Lowenthal	4180186
1036845	HSAN2A	4180186
1036845	HSAN2B	4180186
1036845	HSAN IIA	4180186
1036845	HSN2A	4180186
1036845	HSN IIA	4180186
1036845	Neuropathy, Hereditary Sensory And Autonomic, Type IIA	4180186
1036845	Neuropathy, Hereditary Sensory, Type IIA	4180186
1036847	Noma neonatorum	4180186
1036847	Oral gangrene	4180186
1036847	Oro-facial noma	4180186
1036851	EchoGen	4180186
1036859	cis-isopulegone	4180186
1036859	isopulegone	4180186
1036859	pulegone, (R)-isomer	4180186
1036859	pulegone, (S)-isomer	4180186
1036861	7-(4,7-Diazaspiro(2.5)oct-7-yl)-2-(2,8-dimethylimidazo(1,2-b)pyridazin-6-yl)-4H-pyrido(1,2-a)pyrimidin-4-one	4180186
1036863	2-Benzoxazolamine, 5-(4-amino-1-(1-methylethyl)-1H-pyrazolo(3,4-d)pyrimidin-3-yl)-	4180186
1036863	3-(2-Amino-1,3-benzoxazol-5-yl)-1-isopropyl-1H-pyrazolo(3,4-d)pyrimidin-4-amine	4180186
1036865	6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo(3.1.1)heptan-3-yl)pyridin-3-yl)pyrazolo(1,5-a)pyridine-3-carbonitrile	4180186
1036865	LOXO-292	4180186
1036865	serpercatinib	4180186
1036868	Carbonic acid, disilver(1+) salt	4180186
1036869	SCA15 Spinocerebellar Ataxia 15	4180186
1036870	Thyrospora solani	4180186
1036871	tafasitamab-cxix	4180186
1036871	monjuvi	4180186
1036871	MOR00208	4180186
1036871	MOR-00208	4180186
1036871	MOR-208	4180186
1036871	MOR208 monoclonal antibody	4180186
1036871	XmAb5574	4180186
1036871	XMAB-5574	4180186
1036873	tepmetko	4180186
1036873	3-(1-(3-(5-((1-Methyl-4-piperidinyl)methoxy)-2-pyrimidinyl)benzyl)-6-oxo-1,6-dihydro-3-pyridazinyl)benzonitrile	4180186
1036873	benzonitrile, 3-(1,6-dihydro-1-((3-(5-((1-methyl-4-piperidinyl)methoxy)-2-pyrimidinyl)phenyl)methyl)-6-oxo-3-pyridazinyl)-	4180186
1036874	tinea faciei incognito	4180186
1036876	Ectotrichophyton verrucosum	4180186
1036876	Favotrichophyton verrucosum	4180186
1036878	Calcinosis, Tumoral, With Hyperphosphatemia	4180186
1036878	Hyperphosphatemia Hyperostosis	4180186
1036878	Hyperphosphatemia Hyperostosis Syndrome	4180186
1036878	Hyperphosphatemia Tumoral Calcinosis	4180186
1036878	Hyperphosphatemic Familial Tumoral Calcinosis	4180186
1036878	Lipocalcinogranulomatosis	4180186
1036878	Morbus Teutschlaender	4180186
1036878	Primary Hyperphosphatemic Tumoral Calcinosis	4180186
1036878	Teutschlaender Disease, Familial	4180186
1036878	Tumoral Calcinosis, Primary Hyperphosphatemic	4180186
1036880	Cerebroretinal Vasculopathy, Hereditary	4180186
1036880	Retinopathy, Vascular, With Cerebral And Renal Involvement And Raynaud And Migraine Phenomena	4180186
1036881	verquvo	4180186
1036881	BAY 1021189	4180186
1036883	lupkynis	4180186
1036883	ISA 247	4180186
1036883	ISA-247	4180186
1036883	ISATX247	4180186
1036883	ISA(TX)247	4180186
1175101	Opipramol SerPl-mCnc	4180186
1175101	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1175101	奥匹哌醇:质量浓度:时间点:血清/血浆:定量型	4182948
1175104	14-Hydroxydihydromorphinone; Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Lortab; Numorphan; Numorphone; Opana; Ordinal; OxyContin; Percocet; Percodan; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Tissue; Tissue, unspecified; Vicodin	4180186
1175104	oxyCODONE+oxyMORphone Tiss Ql Scn	4180186
1175104	羟考酮+羟吗啡酮:存在情况或阈值:时间点:组织与涂片:序数型:毒理学筛查试验	4182948
1175106	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.PROMIS; T prime; T-score	4180186
1175108	Admin; CLIN; Nominal; Point in time; Pronoun; Random; Typ	4180186
1175108	Personal pronoun Reported	4180186
1175108	人称代词:类型:时间点:^患者:名义型:报告法	4182948
1175109	Nominal; Point in time; Public Health; Public Health Documents; PUBLICHEALTH; Random; Typ	4180186
1175109	大众传播模板:类型:时间点:文档:名义型	4182948
1175110	4 weeks; Cnc; Conc; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175115	Asp; CAT scan; Computed tomography; Computerized tomography; CT scan; Cyst asp; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Lung; Lung-R; Perc; Point in time; Pulmonary; Pulmonology; R; Rad; RADIOLOGY; Random; Respiratory; RT; Thorax	4180186
1175115	CT Guided Lung-R Cyst asp	4180186
1175115	旨在经皮囊肿抽吸的引导:发现:时间点:胸部>肺.右侧:文档型:CT	4182948
1175116	CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Imaging; Misc; Miscellaneous; Other; Point in time; Rad; RADIOLOGY; Random; Spec; To be specified in another part of the message; Unspecified	4180186
1175116	CT by reconstr	4180186
1175116	基于重建的多层:发现:时间点:XXX:文档型:CT	4182948
1175117	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175119	CAT scan; Computed tomography; Computerized tomography; CT scan; Document; EXT; Extr-R; Finding; Findings; Foot joint-R; Foot-R; Ft; Guid; Guide; Guided; Imaging; Inj; Jnt; LE; Leg; LE-R; Low; Lower extremity; MSK; Musculoskeletal; Ortho; Orthopedics; Point in time; R; Rad; Radiology; Random; RLE; RT	4180186
1175119	CT Guided Foot joint-R Inj	4180186
1175119	旨在注射的引导:发现:时间点:下肢.右侧>足部关节:文档型:CT	4182948
1175121	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175122	4 weeks; Finding; Findings; Last; Must use written lists so will not forget things; Ordinal; Othr; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175123	Airway prob impact orthodont trtmt; Dental; Dentistry; Nominal; Orthodontic Tx; Point in time; Random; Tx; Typ	4180186
1175123	Airway prob impact orthodont trtmt	4180186
1175123	影响正畸治疗情况的气道问题:类型:时间点:^患者:名义型	4182948
1175124	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175125	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hematology; Heme; notes; Point in time; Random; Visit note	4180186
1175125	Hematology Phone Note	4180186
1175125	记录:发现:时间点:电话就医:文档型:血液学	4182948
1175126	Pan; Panel; PANEL.SURVEY.MTLHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.MTLHLTH	4180186
1175127	Abd; Abd.reper; Abdo; Abdomen+; Abdominal; c; CAT scan; Cath; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Drain; Drain+cath place; Exudate; Finding; Findings; Guid; Guide; Guided; Imaging; Point in time; Rad; RADIOLOGY; Random; Removal of fluid; Retroperitoneal; W contr IV; WC	4180186
1175127	CT Guided Retroper Drain+cath--W cont IV	4180186
1175127	旨在引流+引流导管置入的引导^采用静脉注射对比剂:发现:时间点:腹部>腹膜后腔:文档型:CT	4182948
1175130	1 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; Ceftaz; Ceftaz 1.0 ug/mL; Forj; Fortaz; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tazicef; Tazj; TB; Tuberculosis	4180186
1175130	cefTAZidime 1 ug/mL Islt SlowMyco	4180186
1175130	头孢他啶 1.0 微克/毫升:抗生素敏感性:时间点:分离株:定量型或序数型:针对慢长型分枝杆菌的方法	4182948
1175131	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175134	Peanut (rAra h) 6 IgE Qn	4180186
1175134	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f013; f13; f447; Immune globulin E; Immunoglobulin E; NR1B1; Peanut; Peanut (rAra h) 6; Point in time; QNT; Quan; Quant; Quantitative; Random; RAR alpha form; RARalpha; Retinoic acid receptor alpha; Serum; SR	4180186
1175134	落花生 重组 (rAra h) 6 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
1175135	3h p levo; After; c99; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; Levothyroxine; Levo-thyroxine; L-thyroxine; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T4; T-4; thyroid hormone; Thyrox; Thyroxin; Thyrx; Total T4; TT4	4180186
1175135	T4 3h p levo SerPl-mCnc	4180186
1175135	甲状腺素^在剂量左旋甲状腺素之后3小时:质量浓度:时间点:血清/血浆:定量型	4182948
1175139	AIDS; Blood; high-throughput sequencing; HIV 1 RNA RT + PR + IN; HIV type 1; HIV type I; HIV1; HTS; Human immunodeficiency virus; i; ID; Infectious Disease; InfectiousDisease; Microbiology; Next generation sequencing; NGS; Nominal; Pl; PlasBld; Plasma; Plsm; Point in time; PR; Random; REV; Ribonucleic acid; RT; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; WB; Whole blood	4180186
1175139	HIV 1 RNA RT + PR + IN SerPlBld-Seq	4180186
1175139	HIV 1 型 RNA 逆转录酶与蛋白酶与整合酶基因:序列:时间点:血清/血浆/全血:名义型:序列测定	4182948
1175140	Date emerg response plan release; DOC.MISC; MISC; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1175140	Date emerg response plan release	4180186
1175140	紧急响应方案发布日期:日期:时间点:文档:定量型	4182948
1175143	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1175144	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175147	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; S prime; Screen; Survey; SURVEY.PROMIS	4180186
1175148	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175152	Bruc; Brucella IgG+IgM Pnl; Brucellosis; ID; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; QL; Qual; Qualitative; Random; Screen; Serum; species; spp; SR	4180186
1175152	Brucella sp IgG+IgM Ser Ql	4180186
1175152	布鲁氏菌属抗体.IgG 与 IgM 组套:-:时间点:血清:序数型	4182948
1175155	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175163	1 week; Finding; Findings; Health Assessment Questionnaire; Last; Ordinal; Ql; Qual; Qualitative; S prime; Screen; Survey	4180186
1175165	Asp; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Fld; Guid; Guide; Guided; Imaging; Jnt; PC fluid asp; Pelvic; Perc; Point in time; R; Rad; RADIOLOGY; Random; RT; Sac; SI joint; SI joints; SIJ; SIJ-R	4180186
1175165	CT Guided SIJ-R Arthrocentesis	4180186
1175165	旨在经皮穿刺抽吸的引导:发现:时间点:盆腔>骶髂关节.右侧:文档型:CT	4182948
1175166	Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Telemedicine; Visit note	4180186
1175166	会诊记录:发现:时间点:远程医疗:文档型:疼痛医学	4182948
1175167	Cnt; Count; Dental; Dentistry; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Teeth+gum	4180186
1175167	Overbite teeth	4180186
1175167	覆咬合牙齿:数量(计数):时间点:牙齿与牙龈:定量型	4182948
1175170	Cnt; Count; Ear Nose Throat; ENT; Lung; Number; Oto; Otolaryngology; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Studies; Study; Sutdies	4180186
1175170	Num obstructive hypopnea	4180186
1175170	阻塞性低通气:数量(计数):检查过程持续时间:^患者:定量型	4182948
1175171	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Telemedicine; Visit note	4180186
1175171	记录:发现:时间点:远程医疗:文档型:药物基因组学	4182948
1175172	1 month; 1 month (30 days); 30 days; Count/time; Last; month; nRate; Number rate; Number Rate = Count/Time; Othr; QNT; Quan; Quant; Quantitative; Survey; SURVEY.NHANES	4180186
1175173	#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Circo virus; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); Other; PCR; PCV; PCV2d; Point in time; Polymerase chain reaction; Pork; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; Swine; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary; Viral load	4180186
1175173	PCV2d DNA # Spec NAA+probe	4180186
1175173	猪圆环病毒 2d 型 DNA:计数型浓度:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
1175174	4 weeks; Cogn func; cognition; cognitive status; FCN; Func; Funct; Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; promise; Survey; SURVEY.PROMIS	4180186
1175177	Activ; Actvty; Finding; Findings; Last; Levels; Levl; LV; LVL; Movements; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175178	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1175178	Eculizumab Ser-mCnc	4180186
1175178	依库珠单抗:质量浓度:时间点:血清:定量型	4182948
1175179	CDC Emergency Operations Centers; CDC EOC; Centers for Disease Control and Prevention; Pan; Panel; PANEL.SURVEY.CDC; Panl; Pnl; Point in time; Random; Survey; SURVEY.CDC	4180186
1175180	Rapid response team Prog note	4180186
1175180	病程记录:发现:时间点:{环境}:文档型:快速反应团队	4182948
1175180	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1175183	Bilirub BldA-sCnc	4180186
1175183	ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Bili; Bilirubins; Billirubin; Blood arterial; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; TBIL	4180186
1175183	胆红素:物质的量浓度:时间点:动脉全血:定量型	4182948
1175184	Apo CIII-0/Apo CIII-2 SerPl	4180186
1175184	APO; Apo CIII-0; Apo CIII-2; Apolipo; Apolipoprot; Apolipoproteins; Chemistry; II; Mass concentration ratio; Mass ratio; MCRto; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1175184	载脂蛋白 CIII-0/载脂蛋白 CIII-2:质量比率:时间点:血清/血浆:定量型	4182948
1175187	PH emerg event name	4180186
1175187	Ident; Identifier; Nominal; PH emerg event name; Point in time; Public Health; PUBLICHEALTH; Random	4180186
1175187	公共卫生突发事件名称:标识符:时间点:^事件:名义型	4182948
1175192	CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Lung; Point in time; Pulmonary; Pulmonology; Rad; Radiofreq abl; RADIOLOGY; Random; Respiratory; Thorax	4180186
1175192	CT Guided Lung Radiofreq abl	4180186
1175192	旨在射频消融术的引导:发现:时间点:胸部>肺:文档型:CT	4182948
1175196	Blood; HEMATOLOGY/CELL COUNTS; i; II; NK; NK cyto IL2 3.75:1 E:T; PBMC; Peripheral blood mononuclear cells; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; RlACnc; WB; Whole blood	4180186
1175196	NK cyto IL2 3.75:1 E:T/Pos cntrl Bld MC	4180186
1175196	自然杀伤细胞细胞毒性.IL-2 刺激型 效应细胞/靶细胞比 3.75:1/阳性对照:相对任意型浓度:时间点:全血单个核细胞:定量型	4182948
1175197	Clin Path; Clinical path Team; Conf eval note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Laboratory medicine; notes; Path; Point in time; Random; Visit note	4180186
1175197	Clinical path Team Conf eval note	4180186
1175197	会议记录:发现:时间点:{环境}:文档型:临床病理学.团队	4182948
1175199	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Telemedicine; Visit note	4180186
1175199	记录:发现:时间点:远程医疗:文档型:运动医学	4182948
1175200	Abortus blauw; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blue-eared pig disease; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin A; Immune globulin M; Immunoglobulin A; Immunoglobulin M; Lelystad virus; MEIA; Microbiology; Misc; Miscellaneous; Mystery swine disease; Other; Point in time; Porcine epidemic abortion & respiratory syndrome; Porcine reproductive and respiratory syndrome; Pork; Pos; Pos cntrl; PRRS; PRRS virus Ab.IgA; PRRSV; PRRSV Ab; PRRSV virus IgA+IgM; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Seuchenhafter spatabort der schweine; SIRSV; Spec; SUDS; Swine; Swine infertility and respiratory syndrome; Syndrome dysgenesique et respiratoire porcin; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
1175200	PRRSV IgA+IgM/Pos cntrl Spec IA	4180186
1175200	猪繁殖与呼吸综合征病毒 抗体.IgA+IgM/阳性对照:相对比率:时间点:XXX:定量型:免疫测定法	4182948
1175201	C trac; C trach; C tracho; C trachomatis; C&S; Chlam; Chlam trac; Chlamid; CT; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; LGV; Lymphogranuloma venereum; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; Throat; Trachoma; Upper respiratory	4180186
1175201	C trach Throat Ql Cult	4180186
1175201	沙眼衣原体:存在情况或阈值:时间点:咽喉:序数型:微生物特异性培养	4182948
1175205	DOC.MISC; Ident; Identifier; MISC; Nominal; Point in time; Random	4180186
1175205	报告名称:标识符:时间点:报告:名义型	4182948
1175209	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS; Trouble paying attention to teacher	4180186
1175213	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; S prime; Screen; Survey; SURVEY.PROMIS	4180186
1175214	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175216	Finding; Findings; i; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175217	Cardio; Cardiology; Care plan; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Heart Disease; Heart function; notes; Point in time; Random; Treatment plan; Visit note	4180186
1175217	医疗服务计划记录:发现:时间点:{环境}:文档型:心力衰竭	4182948
1175218	3 Self-Sustaining Sequence Replication; 3SR SR; Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Implnt dev; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M tb; M tuberculosis; Microbiology; Mtb; Myco; Mycobact; Mycobacterium tuberculosum; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Prostheses; Prosthesis; Prosthetic; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TB; TMA; Transcription mediated amplification; Tuberculosis	4180186
1175218	M tb DNA Implnt dev Ql NAA+probe	4180186
1175218	结核分枝杆菌 DNA:存在情况或阈值:时间点:植入装置:序数型:探针法.基因扩增.靶向	4182948
1175220	Chronic Respiratory Questionnaire Self-Administered, Standardized Format; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
1175223	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175225	Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Heart Disease; LDL6; LDL6c; LDLc; LDL-C; Level; Lipid; Low density lipoprotein cholesterol; Low density lipoprotein cholesterols; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
1175225	LDL6c SerPl-sCnc	4180186
1175225	胆固醇.LDL 6 之中的:物质的量浓度:时间点:血清/血浆:定量型	4182948
1175226	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; R; RT; Screen; Survey; SURVEY.PROMIS	4180186
1175227	LysoPC(20:0) DBS-mCnc	4180186
1175227	Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Level; LysoPC(20:0); Mass Concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
1175227	溶血磷脂酰胆碱(20:0):质量浓度:时间点:全血.斑点:定量型	4182948
1175234	Finding; Findings; Narrative; Point in time; Random; Report; Survey; SURVEY.CDC	4180186
1175236	Hu3 Ab CSF Line blot-aCnc	4180186
1175236	ABS; Aby; ANNA 3; ANNA-3; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Hu; Hu3; III; Neuronal nuclear type III; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
1175236	神经元细胞核 3 型 抗体:任意型浓度:时间点:脑脊液:定量型:线点印迹法	4182948
1175239	Chief of staff email	4180186
1175239	ADMIN; Nominal; Point in time; Random	4180186
1175239	办公厅主任电子邮件地址:电子邮件地址:时间点:工作人员:名义型	4182948
1175240	Acd; Acid; Blood; C20:5w3; Chemistry; Eicosapentaenoic acid; EPA; Fatty acid; Icosapentaenoate; Lipid; Mass fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Timnodonate; Timnodonic Acid; WB; Whole blood	4180186
1175240	EPA/Fatty acids.C14-C22 MFr Bld	4180186
1175240	二十碳五烯酸/脂肪酸类.C14-C22:质量分数:时间点:全血:定量型	4182948
1175241	1 month; 1 month (30 days); 30 days; Count/time; f026; f26; Last; month; nRate; Number rate; Number Rate = Count/Time; Othr; Pig; Porcine; QNT; Quan; Quant; Quantitative; Survey; SURVEY.NHANES; Sus spp; Swine	4180186
1175242	4 fluorobenzoyl propionic acid; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; FBPA; GCMS; Haloperidol metabolite; III; Level; Mass concentration; Point in time; Propanoic acid; Propioate; Propioic acid; Propionic acid; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
1175242	FBPA Ur Cfm-mCnc	4180186
1175242	3-(4-氟苯基)丙酸:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1175245	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Hep; Hep E; Hepatis; Hepatit; Hepatology; HEV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Liver; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1175245	HEV RNA SerPl Ql NAA+probe	4180186
1175245	戊型肝炎病毒 RNA:存在情况或阈值:时间点:血清/血浆:序数型:探针法.基因扩增.靶向	4182948
1175246	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Collapsin response mediator protein 5; Collapsin response mediator protein 5 Ab; CRMP5; CRMP-5; Neuro; Neurology; Point in time; POP66; QNT; Quan; Quant; Quantitative; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; ULIP	4180186
1175246	CV2 Ab CSF Line blot-aCnc	4180186
1175246	CV2 抗体:任意型浓度:时间点:脑脊液:定量型:线点印迹法	4182948
1175247	H capsul; H capsul H; H capsulatum; H capsulatum H+M Ab panel; H farciminosum; Histo; Histopl; Histoplasma farciminosum; Histoplasmos; Histoplasmosis; ID; Infectious Disease; InfectiousDisease; Microbiology; MNSs Blood Group System; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Serum; SR	4180186
1175247	H capsulatum H+M Ab panel Ser	4180186
1175247	荚膜组织胞浆菌 H & M 抗体组套:-:时间点:血清:-	4182948
1175251	Bx; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Point in time; Rad; RADIOLOGY; Random; Thorax; Xiphoid; Xyphoid	4180186
1175251	CT Guided Sternum Bx	4180186
1175251	旨在活组织检查的引导:发现:时间点:胸部>胸骨:文档型:CT	4182948
1175252	Abd; Abdo; Abdomen+; Abdominal; Absc drain+cath place; Absc drainage; CAT scan; Cath; Computed tomography; Computerized tomography; CT scan; Document; Drain; Exudate; Finding; Findings; Guid; Guide; Guided; Imaging; Perinephric space; Perirenal space-R; Point in time; R; Rad; RADIOLOGY; Random; Removal of fluid; RT	4180186
1175252	CT Guided Perirenal sp-R Absc drain+cath	4180186
1175252	旨在脓肿引流+引流导管置入的引导:发现:时间点:腹部>肾周间隙.右侧:文档型:CT	4182948
1175255	Control; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175257	1 month; 1 month (30 days); 30 days; Count/time; Last; month; nRate; Number rate; Number Rate = Count/Time; QNT; Quan; Quant; Quantitative; Survey; SURVEY.NHANES	4180186
1175258	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
1175263	ADMIN; Nominal; Person name; Point in time; Random	4180186
1175263	名称:人员姓名:时间点:工作人员:名义型	4182948
1175265	Public commun target region	4180186
1175265	Location; Nominal; Point in time; Public commun target region; Public Health; PUBLICHEALTH; Random	4180186
1175265	大众传播目标区域:位置:时间点:^事件:名义型	4182948
1175267	Proc dur	4180186
1175267	Durat; Proc dur; QNT; Quan; Quant; Quantitative; SURG	4180186
1175267	操作项目持续时间:时间:操作持续时间:^患者:定量型	4182948
1175268	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; PT; Random; Reeval note; Visit note	4180186
1175268	PT Reeval note	4180186
1175268	重新评估记录:发现:时间点:{环境}:文档型:物理疗法	4182948
1175270	4 weeks; Cogn func; cognition; cognitive status; FCN; Func; Funct; Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; PEDS; Pnl; promise; Survey; SURVEY.PROMIS	4180186
1175272	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; S prime; Screen; Survey; SURVEY.PROMIS	4180186
1175276	Wells PE risk score interp	4180186
1175276	CLIN; CLIN.RISK; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Ordinal; Point in time; Pulm; QL; Qual; Qualitative; Random; Screen; Wells PE risk score interp	4180186
1175281	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175286	Finding; Findings; Last; Ordinal; Othr; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175288	Arm; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; EXT; Extr-R; Finding; Findings; Finger-R; Imaging; MSK; Musculoskeletal; Ortho; Orthopedics; Point in time; R; Rad; Radiology; Random; RT; RUE; UE; UE-R; Up; without contrast	4180186
1175288	CT Finger-R WO contr	4180186
1175288	多层^不采用对比剂:发现:时间点:上肢.右侧>手指:文档型:CT	4182948
1175289	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175291	CDC Emergency Operations Centers; CDC EOC; Centers for Disease Control and Prevention; Pan; Panel; PANEL.SURVEY.CDC; Panl; Pnl; Point in time; Random; Survey; SURVEY.CDC	4180186
1175292	Date EOC SOP issued	4180186
1175292	Date EOC SOP issued; DOC.MISC; MISC; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1175292	应急指挥中心标准操作规程发行日期:日期:时间点:文档:定量型	4182948
1175294	Bx; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Musc; Muscl; Other; Point in time; Rad; RADIOLOGY; Random; Spec; Super Bx; To be specified in another part of the message; Unspecified	4180186
1175294	CT Guided Muscle Super Bx	4180186
1175294	旨在浅表活组织检查的引导:发现:时间点:XXX>肌肉:文档型:CT	4182948
1175295	CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Drain; Drain+CT place; Exudate; Finding; Findings; Guid; Guide; Guided; Imaging; L; LT; Lung; Pl space; Pl space-L; Point in time; Pulmonary; Pulmonology; Rad; Radiology; Random; Removal of fluid; Respiratory; Thorax	4180186
1175295	CT Guided Pl space-L Drain+CT place	4180186
1175295	旨在引流+胸管置入的引导:发现:时间点:胸部>胸膜腔.左侧:文档型:CT	4182948
1175296	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Coccidiodes; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; San Joaquin Valley fever; SerP; SerPl; SerPlas; Serum; Serum or plasma; species; spp; SR; Valley fever	4180186
1175296	Coccidioides IgM SerPl-aCnc	4180186
1175296	球孢子菌属单个未知种 抗体.IgM:任意型浓度:时间点:血清/血浆:定量型	4182948
1175297	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Telemedicine; Visit note	4180186
1175297	Adolescent med Telehealth Note	4180186
1175297	记录:发现:时间点:远程医疗:文档型:青春期医学	4182948
1175298	Abd; Abdo; Abdomen+; Abdominal; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Inj; Jnt; L/sp; L-spine; L-spine facet joint; Lumbar; Lumbo; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord; Zygapophysial Joint	4180186
1175298	CT Guided L-spine facet joint Inj	4180186
1175298	旨在注射的引导:发现:时间点:腹部>脊椎.腰段小面关节:文档型:CT	4182948
1175307	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey; SURVEY.GNHLTH; Tx	4180186
1175309	GABABR Ab Titr CSF CBA IFA	4180186
1175309	Gamma 氨基丁酸 B 受体 抗体:滴定度:时间点:脑脊液:定量型:CBA IFA	4182948
1175309	4-aminobutanoic acid; 4-aminobutyrate; 4-aminobutyric acid; ABS; Aby; Aminobutric; Aminobutyric; Amino-n-butyrate; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); GABA; GABABR; GABABR Ab; Gamma aminobutyric acid; Gamma amino-butyric acid; Gamma amino-n-butyrate; Gamma amino-n-butyric acid; Indirect Fluorescence Antibody; Piperidic acid; Point in time; Random; Rec; Recept; Receptors; Recp; Recptr; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr	4180186
1175312	AMPAR1 Ab Titr CSF CBA IFA	4180186
1175312	Alpha-氨基-3-羟基-5-甲基-4-异噁唑丙酸受体 1 抗体:滴定度:时间点:脑脊液:定量型:CBA IFA	4182948
1175312	ABS; Aby; Alfa; AMPA Receptor; AMPAR1; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); GluA1; GluR1; GluR-A; Hydrox; i; III; Indirect Fluorescence Antibody; Limbic encephalitis; OH; Point in time; Quisqualate Receptor; Random; Rec; Recept; Receptors; Recp; Recptr; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr	4180186
1175314	Antigen; Antigens; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; Lyssavirus; MEIA; Microbiology; Oral fluid; Ordinal; Point in time; PR; QL; Qual; Qualitative; Rabies; RABV; Random; Sal; Screen; SUDS	4180186
1175314	RABV Ag Sal Ql IA	4180186
1175314	狂犬病病毒 抗原:存在情况或阈值:时间点:唾液:序数型:免疫测定法	4182948
1175316	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; Crypt; Crypt sp rRNA gene; Crypto; Cryptococcal; Cryptococcosis; Cryptococcosus; DNA NUCLEIC ACID PROBE; DNA probe; Gen-Probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; rDNA; ribosomal RNA; Screen; SDA; species; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1175316	Crypt sp rRNA gene Bld Ql NAA+probe	4180186
1175316	隐球菌属 rRNA 基因:存在情况或阈值:时间点:全血:序数型:探针法.基因扩增.靶向	4182948
1175319	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175321	Ankle-L; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; EXT; Extr-L; Finding; Findings; Guid; Guide; Guided; Imaging; Inj; L; LE; Leg; LE-L; LLE; Low; Lower extremity joint; LT; MSK; Musculoskeletal; Ortho; Orthopedics; Point in time; Rad; Radiology; Random	4180186
1175321	CT Guided Ankle-L Inj	4180186
1175321	旨在注射的引导:发现:时间点:下肢.左侧>踝关节:文档型:CT	4182948
1175323	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.PROMIS	4180186
1175324	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
1175324	Salicylcarnitine SerPl-sCnc	4180186
1175324	水杨基肉碱:物质的量浓度:时间点:血清/血浆:定量型	4182948
1175326	Cervix; Genital tract; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LM; Micro; Microbiology; Micros; Microscopic; OB; ObGyn; Obstetrics; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; T vaginalis; Tric; Trich; Trichimoniasis; Trichomonad; Trichomonads; Trichomoniasis	4180186
1175326	T vaginalis Cvx Ql Micro	4180186
1175326	阴道毛滴虫:存在情况或阈值:时间点:子宫颈:序数型:显微镜检查.光学	4182948
1175329	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; PM+R; Point in time; Random; Telemedicine; Visit note	4180186
1175329	PM+R Telehealth Note	4180186
1175329	记录:发现:时间点:远程医疗:文档型:物理医学与康复学	4182948
1175330	Develop-behav peds; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Mental health; MentalHealth; notes; OP; Peds; Point in time; Psych; Psychiatry; Random; Visit note	4180186
1175330	Develop-behav peds OP Note	4180186
1175330	记录:发现:时间点:门诊病人:文档型:发育行为儿科学	4182948
1175332	Patient Reported Outcomes Information System; PEDS; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.PROMIS	4180186
1175333	Cardio; Cardiology; Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Heart Disease; Heart function; notes; Point in time; Random; Visit note	4180186
1175333	会诊记录:发现:时间点:{环境}:文档型:心力衰竭	4182948
1175334	Alpha-galactosidase A gene; Blood; Document; Fabry disease; Finding; Findings; full gene sequencing; Full Mut Anl; GALA; galactosidase, alpha; galactosidase, alpha gene; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1175334	Deprecated GLA gene Full Mut Anl Bld/T Seq	4180186
1175336	Vilaz Ur Ql Scn	4180186
1175336	DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn; Viibryd	4180186
1175336	维拉佐酮:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
1175337	Pan; Panel; Panl; Pnl; Point in time; Random; Survey	4180186
1175338	Optometry Res Note	4180186
1175338	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Optometry Res; Point in time; Random; Visit note	4180186
1175338	记录:发现:时间点:{环境}:文档型:视力测定.住院	4182948
1175341	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1175342	Nuc med Attend Note	4180186
1175342	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Nuc med; Nuc med Attend; Nuc Medicine; Point in time; Random; Visit note	4180186
1175342	记录:发现:时间点:{环境}:文档型:核医学.主治	4182948
1175343	CLIN; CLIN.RISK; Point in time; Pulmonary Function Test; QNT; Quan; Quant; Quantitative; Random; Scale; Tot; Totl	4180186
1175343	总评分:评分:时间点:^患者:定量型:PESI 法	4182948
1175345	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; promise; Survey; SURVEY.PROMIS	4180186
1175346	Anaero; Anaerobe; Anaerobe Cult; Bact; C&S; Cult; Cultures; Diaf; DiafP; Dialysate; Dialysis fluid; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Kidney; Microbiology; Nephrology; Nominal; Peritoneal Dialysis fluid; Point in time; Random; Renal	4180186
1175346	Bacteria DiafP Anaerobe Cult	4180186
1175346	细菌 已鉴定的:存在与否或特征标识:时间点:腹膜透析液:名义型:厌氧微生物培养	4182948
1175348	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; HAV; Hep; Hep A; Hepatis; Hepatit; Hepatitis; Hepatitis type A; Hepatology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Liver; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1175348	HAV RNA Stl Ql NAA+probe	4180186
1175348	甲型肝炎病毒 RNA:存在情况或阈值:时间点:大便:序数型:探针法.基因扩增.靶向	4182948
1175351	Count/time; Lung; nRate; Number rate; Number Rate = Count/Time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; RDI; Resp disturbance index; Respiratory; Studies; Study; Sutdies	4180186
1175351	Resp disturbance index nRate	4180186
1175351	呼吸紊乱指数:计数型速率:检查过程持续时间:^患者:定量型	4182948
1175352	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
1175353	Neuro surg Team Conf eval note	4180186
1175353	Conf eval note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Neuro surg Team; Neuro surgery; notes; Point in time; Random; Surg; Visit note	4180186
1175353	会议记录:发现:时间点:{环境}:文档型:神经外科学.团队	4182948
1175356	CDC Emergency Operations Centers; CDC EOC; Centers for Disease Control and Prevention; Pan; Panel; PANEL.SURVEY.CDC; Panl; Pnl; Point in time; Random; Survey; SURVEY.CDC	4180186
1175357	Cancer; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hematology; Hematology and Oncology; Hematology+Oncology; Heme; HemOnc; notes; Oncology; Point in time; Random; Telemedicine; Visit note	4180186
1175357	HemOnc Telehealth Note	4180186
1175357	记录:发现:时间点:远程医疗:文档型:血液学+内科肿瘤学	4182948
1175358	Asp; Bil; Bilat; Both; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; EXT; Extr-Bl; Finding; Findings; Fld; Guid; Guide; Guided; Hip-Bl; Hips; Imaging; LE; LE-Bl; Leg; Low; Lower extremity joint; MSK; Musculoskeletal; Ortho; Orthopedics; PC fluid asp; Perc; Point in time; Rad; Radiology; Random	4180186
1175358	CT Guided Hip-Bl Arthrocentesis	4180186
1175358	旨在经皮穿刺抽吸的引导:发现:时间点:下肢.双侧>髋关节:文档型:CT	4182948
1175359	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; DNA NUCLEIC ACID PROBE; DNA probe; Entero virus; EV; EV-PCR; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1175359	EV RNA Stl Ql NAA+probe	4180186
1175359	肠道病毒 RNA:存在情况或阈值:时间点:大便:序数型:探针法.基因扩增.靶向	4182948
1175361	1 month; 1 month (30 days); 30 days; Count/time; Froz; Frozn; Last; month; nRate; Number rate; Number Rate = Count/Time; Othr; QNT; Quan; Quant; Quantitative; Survey; SURVEY.NHANES	4180186
1175362	4OH-atomoxetine Sal Cfm-mCnc	4180186
1175362	4OH-atomoxetine; Atomoxetine metabolite; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; Strattera metabolite	4180186
1175362	4-羟基托莫西汀:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
1175364	Neut.immature/Neut.total NFr.DF Bld	4180186
1175364	Blood; HEMATOLOGY/CELL COUNTS; Imm; Immat; Neut; Neut.total; Neutr; Neutrophil; Number fraction; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood	4180186
1175364	嗜中性粒细胞.不成熟/嗜中性粒细胞.总计:计数型分数.小数型:时间点:全血:定量型	4182948
1175366	DOC.ONT; Document; Encounter; Endocrine; Endocrinology; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Telemedicine; Visit note	4180186
1175366	记录:发现:时间点:远程医疗:文档型:内分泌学	4182948
1175368	c; CAT scan; Cath; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Drain; Drain+cath place; Exudate; Finding; Findings; Guid; Guide; Guided; Imaging; Pelvic; Point in time; Rad; RADIOLOGY; Random; Removal of fluid; without contrast	4180186
1175368	CT Guided Pelv Drain+cath place--WO cont	4180186
1175368	旨在引流+引流导管置入的引导^不采用对比剂:发现:时间点:盆腔:文档型:CT	4182948
1175371	1 week; Dextro; Finding; Findings; Integument; Ordinal; Past; QL; Qual; Qualitative; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
1175373	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175374	Aerobe; Aerobe Cult; Aerobed; Blood; C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; InternalLabUse; Microbiology; Microorg prel grow; Microorganisms; Ordinal; Org; Organism; Organisms; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood	4180186
1175374	Microorg prel grow Bld Ql Aerobe Cult	4180186
1175374	微生物初步生长情况:存在情况或阈值:时间点:全血:序数型:需氧微生物培养	4182948
1175375	Bil; Bilat; Both; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; EXT; Extr-Bl; Finding; Findings; Guid; Guide; Guided; Imaging; Inj; Kn; Knee-Bl; Knees; LE; LE-Bl; Leg; Low; Lower extremity joint; MSK; Musculoskeletal; Ortho; Orthopedics; Point in time; Rad; RADIOLOGY; Random	4180186
1175375	CT Guided Knee-Bl Inj	4180186
1175375	旨在注射的引导:发现:时间点:下肢.双侧>膝关节:文档型:CT	4182948
1175376	C trach L1 IgM Titr Ser IA	4180186
1175376	沙眼衣原体 L1 型 抗体.IgM:滴定度:时间点:血清:定量型:免疫测定法	4182948
1175376	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C trac; C trach; C trach L1; C tracho; C trachom L1 Ab.IgM; C trachomatis; Chlam; Chlam trac; Chlamid; CT; Dilution factor; Dilution Factor (Titer); EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; LGV; Lymphogranuloma venereum; MEIA; Microbiology; Point in time; Random; Serum; SmQn; SR; SUDS; Titer; Titered; Titre; Trachoma; Ttr	4180186
1175378	Conf eval note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Heart failure Team; Heart function; notes; Point in time; Random; Visit note	4180186
1175378	Heart failure Team Conf eval note	4180186
1175378	会议记录:发现:时间点:{环境}:文档型:心力衰竭.团队	4182948
1175379	Gestation; Gestations; Gravida; Gyn; Gynecology; HEDIS 2019-20 Preg Test Excl; OB; ObGyn; Obstetrics; Pan; Panel; PANEL.HEDIS; Panl; PG test; Pnl; Point in time; Preg test; Pregnancies; Random	4180186
1175379	HEDIS 2019-20 Preg Test Excl	4180186
1175379	HEDIS 2019 取值集合 - 妊娠试验排除组合:-:时间点:^患者:-	4182948
1175381	Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Heart Disease; LDL6; LDL6c; LDLc; LDL-C; Level; Lipid; Low density lipoprotein cholesterol; Low density lipoprotein cholesterols; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1175381	LDL6c SerPl-mCnc	4180186
1175381	胆固醇.LDL 6 之中的:质量浓度:时间点:血清/血浆:定量型	4182948
1175382	C&S; Cult; Cultures; HPIV; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Lung; Microbiology; Nominal; Para; Parainflu; Point in time; Pulmonary; Pulmonology; Random; Respiratory; Spec; Up; Upper resp	4180186
1175382	HPIV Upper resp Cult	4180186
1175382	副流感病毒 已鉴定的:存在与否或特征标识:时间点:呼吸道.上:名义型:微生物特异性培养	4182948
1175383	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175384	Assessment; Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; Initial eval note; notes; Point in time; Random; Visit note	4180186
1175384	Wound care management Initial eval note	4180186
1175384	初步评价记录:发现:时间点:{环境}:文档型:伤口护理管理	4182948
1175386	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bind; IgE RAST; Immune globulin E; Immunoglobulin E; Maltose BP; Maltose-binding protein; MBP; o213; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Ro213; Screen; Serum; SR	4180186
1175386	麦芽糖结合蛋白 抗体.IgE.RAST 类:存在情况或阈值:时间点:血清:序数型	4182948
1175386	Deprecated Maltose BP IgE RAST Ql	4180186
1175387	Anaer cult+Abx neut; Anaero; Anaerobe; Anaerobe Cult; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; C&S; Cult; Cultures; Fl; Fld; FLU; Fluid; ID; Infectious Disease; InfectiousDisease; InternalLabUse; Microbiology; Microorg prel grow; Microorganisms; Ordinal; Org; Organism; Organisms; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
1175387	Microorg prel Fld Ql Anaer cult + neut	4180186
1175387	微生物初步生长情况:存在情况或阈值:时间点:体液:序数型:厌氧培养+抗微生物药物中和剂	4182948
1175388	Benzodiazepines Pnl Ur Cfm	4180186
1175388	Benz; Benzodiaz; Benzodiazepine; Benzodiazepines Pnl; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; UA; UR; Urn	4180186
1175388	苯二氮类组套:-:时间点:尿液:-:毒理学确认试验	4182948
1175394	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175396	Surgery Diag study note	4180186
1175396	Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Study report; Surg; Visit note	4180186
1175396	诊断性检查记录:发现:时间点:{环境}:文档型:外科学	4182948
1175397	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Circo virus; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; PCV; PCV2d; Point in time; Polymerase chain reaction; Pork; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; Swine; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
1175397	PCV2d DNA Ct Spec Qn NAA+probe	4180186
1175397	猪圆环病毒 2d 型 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
1175398	AIDS; Blood; high-throughput sequencing; HIV 1 RNA RT; HIV type 1; HIV type I; HIV1; HTS; Human immunodeficiency virus; i; ID; Infectious Disease; InfectiousDisease; Microbiology; Next generation sequencing; NGS; Nominal; Pl; PlasBld; Plasma; Plsm; Point in time; Random; REV; Ribonucleic acid; RT; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; WB; Whole blood	4180186
1175398	HIV 1 RNA RT SerPlBld-Seq	4180186
1175398	HIV 1 型 RNA 逆转录酶基因:序列:时间点:血清/血浆/全血:名义型:序列测定	4182948
1175399	Aripiprazole metabolite; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; OH-aripiprazole; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
1175399	OH-aripiprazole Ur Cfm-mCnc	4180186
1175399	羟基阿立哌唑:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1175401	Point in time; pressure injury; Pressure ulcer; Pressure Ulcers; PUSH Tool 3.0; PUSH Tool 3.0 total score; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH; Tot; Totl; Ulcer	4180186
1175402	Ejaculate; FERTILITY TESTING; Genitourinary; GU; H/O; Hx; Identity or presence; Nominal; Point in time; Random; Sem; Seminal fluid; Smn; SMPLS; Spec; Treatment hx of specimen; Tx; URO; Urology	4180186
1175402	Treatment hx of specimen Smn	4180186
1175402	标本处理历史:存在与否或特征标识:时间点:精液:名义型	4182948
1175405	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Fld; notes; nursing; Point in time; Random; Visit note	4180186
1175405	液体管理记录:发现:时间点:{环境}:文档型:护士	4182948
1175406	Patient Reported Outcomes Information System; PEDS; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.PROMIS; T prime; T-score	4180186
1175408	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; Crypt; Crypt sp rRNA gene; Crypto; Cryptococcal; Cryptococcosis; Cryptococcosus; DNA NUCLEIC ACID PROBE; DNA probe; Gen-Probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; rDNA; ribosomal RNA; Screen; SDA; species; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1175408	Crypt sp rRNA gene CSF Ql NAA+probe	4180186
1175408	隐球菌属 rRNA 基因:存在情况或阈值:时间点:脑脊液:序数型:探针法.基因扩增.靶向	4182948
1175409	Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; ANTIBIOTIC SUSCEPTIBILITIES; c301; Compx; Hyzyd; INH; Islt; Islt/Spm; Isol; Isoniaz; Isoniazide; M tb; M TB Cmplx; M tuberculosis; Molecular genetics; Mtb; MTB RIF and INH resist Pnl; Myco; Mycobact; Mycobacterium tuberculosum; Nudrazod; Pan; PANEL.ANTIBIOTIC SUSCEPTIBILITIES; Panl; PCR; Pnl; Point in time; Random; Resist; Resistanc; Resistant; Resistent; RIF; Rifadin; Rifampicin; Rimactane; Spec; TB; Tuberculosis	4180186
1175409	MTB RIF and INH resist Pnl Islt/Spm	4180186
1175409	结核分枝杆菌复合菌群利福平与异烟肼耐药组套:-:时间点:分离株/标本:-:分子遗传学类实验室方法	4182948
1175410	N,N'-dimethylarginine SerPl-mCnc	4180186
1175410	ADMA; Asymmetric Dimethylarginine; Chemistry; dimethyl-L-arginine; guanidino-N(1),N(2)-dimethylarginine; Level; Mass concentration; N(G)-dimethylarginine; N(G1),N(G1)-dimethylarginine; N(G1),N(G2)-dimethylarginine; N,N-dimethylarginine; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SDMA; sDMA arginine; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; symmetric dimethylarginine	4180186
1175410	N,N'-二甲基精氨酸:质量浓度:时间点:血清/血浆:定量型	4182948
1175412	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175415	AMPAR2 Ab CSF Ql CBA IFA	4180186
1175415	ABS; Aby; Alfa; AMPA Receptor; AMPAR2; AMPAR2 Ab; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; GluA2; GluR2; GluR-B; Hydrox; II; III; Indirect Fluorescence Antibody; Limbic encephalitis; OH; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
1175415	Alpha-氨基-3-羟基-5-甲基-4-异噁唑丙酸受体 2 抗体:存在情况或阈值:时间点:脑脊液:序数型:CBA IFA	4182948
1175417	Abd; Abdo; Abdomen+; Abdominal; Asp; Bil; Bilat; Both; CAT scan; Computed tomography; Computerized tomography; CT scan; Cyst asp; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Kdny-Bl; Kidney; Kidneys; Nephric; Nephrology; Perc; Point in time; Pyelogram; Rad; RADIOLOGY; Random; Renal	4180186
1175417	CT Guided Kdny-Bl Cyst asp	4180186
1175417	旨在经皮囊肿抽吸的引导:发现:时间点:腹部>肾脏.双侧:文档型:CT	4182948
1175418	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.PROMIS; T prime; T-score	4180186
1175419	1 week; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
1175421	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175423	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175424	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; R; RT; Screen; Survey; SURVEY.PROMIS	4180186
1175425	DOC.ONT; Document; Ear Nose Throat; Encounter; ENT; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Oto; Otolaryngology; Otorhinolaryngology; Point in time; Random; Telemedicine; Visit note	4180186
1175425	记录:发现:时间点:远程医疗:文档型:耳鼻喉科学	4182948
1175427	Abd; Abdo; Abdomen+; Abdominal; Asp; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Fld; Guid; Guide; Guided; Imaging; PC fluid asp; Perc; Peritoneal cavity; Point in time; Rad; RADIOLOGY; Random	4180186
1175427	CT Guided Peritoneal space PC fluid asp	4180186
1175427	旨在经皮穿刺抽吸的引导:发现:时间点:腹部>腹膜腔:文档型:CT	4182948
1175432	Sleep med Telehealth Note	4180186
1175432	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Telemedicine; Visit note	4180186
1175432	记录:发现:时间点:远程医疗:文档型:睡眠医学	4182948
1175433	Lab to provid teleph call date	4180186
1175433	ADMIN; ADMIN.PATIENT; Lab to provid teleph call date; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1175433	实验室为沟通检验结果而致电服务提供方的日期:日期:时间点:^患者:定量型	4182948
1175436	ABS; Aby; AGNA; AGNA-1; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Glial nuc type 1; i; Lambert-Eaton myasthenic syndrome; Nuc; Paraneoplastic Antibody; Paraneoplastic syndrome; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Sox1; Sox1 nuclear antigen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
1175436	Glial nuc type 1 Ab CSF Line blot-aCnc	4180186
1175436	神经胶质细胞核 1 型 抗体:任意型浓度:时间点:脑脊液:定量型:线点印迹法	4182948
1175437	Adrenoleukodystrophies; Adrenoleukodystrophies, X-Linked; Blood; C26:0; C26:0-LPC; Chemistry; DBS; Dried blood spot; Filter paper; FP; Level; LysoPC(26:0); Mass Concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood; X-ALD	4180186
1175437	LysoPC(26:0) DBS-mCnc	4180186
1175437	溶血磷脂酰胆碱(26:0):质量浓度:时间点:全血.斑点:定量型	4182948
1175438	PCA-Tr Ab Titr CSF CBA IFA	4180186
1175438	浦肯雅细胞胞浆 Tr 型 抗体:滴定度:时间点:脑脊液:定量型:CBA IFA	4182948
1175438	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Cytopl; Cytoplas; Dilution factor; Dilution Factor (Titer); Hodgkin's lymphoma; Indirect Fluorescence Antibody; Limbic encephalopathy; Neuro; Neurology; Paraneoplastic cerebellar degeneration; Paraneoplastic neurological syndrome; Paraneoplastic syndrome; PCD; PNS; Point in time; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr	4180186
1175439	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175440	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C parap; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Serum; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1175440	C parap DNA Ser Ql NAA+probe	4180186
1175440	近平滑假丝酵母 DNA:存在情况或阈值:时间点:血清:序数型:探针法.基因扩增.靶向	4182948
1175442	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175443	FCN; Func; Funct; Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
1175444	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; S prime; Screen; Survey; SURVEY.PROMIS	4180186
1175447	Org assigned to task	4180186
1175447	ADMIN; Ident; Identifier; Nominal; Org assigned to task; Point in time; Random	4180186
1175447	被指派任务的组织机构:标识符:时间点:组织机构:名义型	4182948
1175448	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175454	CDC Emergency Operations Centers; CDC EOC; Centers for Disease Control and Prevention; Pan; Panel; PANEL.SURVEY.CDC; Panl; Pnl; Point in time; Random; Survey; SURVEY.CDC	4180186
1175455	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175461	Bx; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Perc; Point in time; Rad; RADIOLOGY; Random; Spec; To be specified in another part of the message; Unspecified	4180186
1175461	CT Guided Soft tiss Bx	4180186
1175461	旨在经皮活组织检查的引导:发现:时间点:XXX>软组织:文档型:CT	4182948
1175462	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; Monilia; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; species; spp; Strand Displacement Amplification; Thrush; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
1175462	Candida DNA Spec Ql NAA+probe	4180186
1175462	假丝酵母属单个未知种 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
1175463	Blood product unit; Blood Product Unit (Pack); C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; InternalLabUse; Microbiology; Microorg prel grow; Microorg prel grow det pnl; Microorganisms; Org; Organism; Organisms; Pan; PANEL.MICROBIOLOGY; Panl; Platelet; Plt; Plts; Pnl; Point in time; Random; Thrb; Thrombocyte; Thrombocytes	4180186
1175463	Microorg prel grow det pnl Plts BPU Cult	4180186
1175463	微生物初步生长情况检测组套:-:时间点:血小板^血液制品单位:-:培养	4182948
1175465	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175466	Glial nuc type 1 Ab CSF Ql IF	4180186
1175466	ABS; Aby; ACIF; AGNA; AGNA-1; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; FA; FANA; Fluorescent antibody; Fluoresent; Glial nuc type 1; i; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Lambert-Eaton myasthenic syndrome; Nuc; Ordinal; Paraneoplastic Antibody; Paraneoplastic syndrome; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Sox1; Sox1 nuclear antigen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF	4180186
1175466	神经胶质细胞核 1 型 抗体:存在情况或阈值:时间点:脑脊液:序数型:免疫荧光法	4182948
1175469	Event-associated cases # in RptPeriod	4180186
1175469	Cnt; Count; Number; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Report period	4180186
1175469	案件:数量(计数):报告期:^事件:定量型	4182948
1175470	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
1175472	CDC Emergency Operations Centers; CDC EOC; Centers for Disease Control and Prevention; Pan; Panel; PANEL.SURVEY.CDC; Panl; Pnl; Point in time; Random; Survey; SURVEY.CDC	4180186
1175473	Genetics; Heredity; Heritable; Inherited; ITPA g.9330C&gt;A; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Nominal; PCR; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Typ	4180186
1175473	ITPA g.9330C>A SerPl	4180186
1175473	ITPA 基因.g.9330C>A:类型:时间点:血清/血浆:名义型:分子遗传学类实验室方法	4182948
1175474	D/T report released; Date and time; Date+time; DOC.MISC; MISC; Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp	4180186
1175474	D/T report released	4180186
1175474	报告发布日期和时间:时间戳:时间点:报告:定量型	4182948
1175476	CAT scan; Cath; Computed tomography; Computerized tomography; CT scan; Document; Drain; Drain+cath place; EXT; Extr-R; Exudate; Finding; Findings; Guid; Guide; Guided; Imaging; LE; Leg; LE-R; Low; Point in time; R; Rad; RADIOLOGY; Random; Removal of fluid; RLE; RT	4180186
1175476	CT Guided LE-R Drain+cath place	4180186
1175476	旨在引流+引流导管置入的引导:发现:时间点:下肢.右侧:文档型:CT	4182948
1175480	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lung; MeV; Microbiology; Msls; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; Rubeola; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Up; Upper resp	4180186
1175480	MeV RNA Upper resp Ql NAA+probe	4180186
1175480	麻疹病毒 RNA:存在情况或阈值:时间点:呼吸道.上:序数型:探针法.基因扩增.靶向	4182948
1175484	4 weeks; Average; Avg; Finding; Findings; Hard to find the right words; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; R; RT; Screen; Survey; SURVEY.PROMIS	4180186
1175486	Sleep med OP Note	4180186
1175486	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Random; Visit note	4180186
1175486	记录:发现:时间点:门诊病人:文档型:睡眠医学	4182948
1175487	CDC Emergency Operations Centers; CDC EOC; Centers for Disease Control and Prevention; Pan; Panel; PANEL.SURVEY.CDC; Panl; Pnl; Point in time; Random; Survey; SURVEY.CDC	4180186
1175489	Status of water supply systems	4180186
1175489	Finding; Findings; Narrative; Point in time; Public Health; PUBLICHEALTH; Random; Report	4180186
1175489	供水系统状态:发现:时间点:^事件:叙述型	4182948
1175491	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175492	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175495	CASPR2 Ab Titr CSF CBA IFA	4180186
1175495	接触蛋白关联蛋白 2 抗体:滴定度:时间点:脑脊液:定量型:CBA IFA	4182948
1175495	ABS; Aby; Antby; Anti; Antibodies; Antibody; Assoc; Autoantibodies; Autoantibody; CASPR2; CASPR2 Ab; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); II; Indirect Fluorescence Antibody; Point in time; PR; Prot; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr	4180186
1175497	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS; T prime	4180186
1175501	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.PROMIS; T prime; T-score	4180186
1175502	CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Guid; Guide; Guided; i; Imaging; Inj; Inj 1 level; Jnt; Levels; Levl; LV; LVL; Misc; Miscellaneous; Other; Point in time; Rad; RADIOLOGY; Random; Spec; Spinal; Spinal Cord; Spine FJ; To be specified in another part of the message; Unspecified; Zygapophysial Joint	4180186
1175502	CT Guided Spine FJ Inj 1 level	4180186
1175502	旨在1级注射的引导:发现:时间点:XXX>脊椎小面关节:文档型:CT	4182948
1175503	5,8,11,14 Eicosatetraenoic acid; AA; Arachidonic acid; Arch acid; Blood; C20:4w6; C20:5w3; Chemistry; Eicosapentaenoic acid; Eicosatetraenoate; EPA; Icosapentaenoate; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; Timnodonate; Timnodonic Acid; WB; Whole blood	4180186
1175503	AA/EPA Bld	4180186
1175503	花生四烯酸/二十碳五烯酸:质量比率:时间点:全血:定量型	4182948
1175506	AA+Linoleate/Fatty acids.C14-C22 MFr Bld	4180186
1175506	5,8,11,14 Eicosatetraenoic acid; AA; AA+Linoleate; Acd; Acid; Arachidonic acid; Arch acid; Blood; C18:2w6; C20:4w6; Chemistry; cis-9, cis-12-octadecadienoate; cis-9, cis-12-octadecadienoic acid; Eicosatetraenoate; Fatty acid; Linoleic acid; Lipid; Mass fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
1175506	花生四烯酸+亚油酸/脂肪酸类.C14-C22:质量分数:时间点:全血:定量型	4182948
1175509	Absc drain+cath place; Absc drainage; CAT scan; Cath; Computed tomography; Computerized tomography; CT scan; Document; Drain; Exudate; Finding; Findings; Guid; Guide; Guided; Imaging; Lung; Lung-R; Point in time; Pulmonary; Pulmonology; R; Rad; RADIOLOGY; Random; Removal of fluid; Respiratory; RT; Thorax	4180186
1175509	CT Guided Lung-R Absc drain+cath place	4180186
1175509	旨在脓肿引流+引流导管置入的引导:发现:时间点:胸部>肺.右侧:文档型:CT	4182948
1175513	Abd; Abdo; Abdomen+; Abdominal; Absc drain+cath place; Absc drainage; CAT scan; Cath; Computed tomography; Computerized tomography; CT scan; Document; Drain; Exudate; Finding; Findings; Guid; Guide; Guided; Imaging; Kidney; Kidney-R; Nephric; Nephrology; Point in time; Pyelogram; R; Rad; Radiology; Random; Removal of fluid; Renal; RT	4180186
1175513	CT Guided Kidney-R Absc drain+cath place	4180186
1175513	旨在脓肿引流+引流导管置入的引导:发现:时间点:腹部>肾脏.右侧:文档型:CT	4182948
1175517	Cnt; Count; Dental; Dentistry; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Teeth+gum	4180186
1175517	Overjet teeth	4180186
1175517	覆盖关系牙齿:数量(计数):时间点:牙齿与牙龈:定量型	4182948
1175518	CLIN; CLIN.RISK; Dis; Diseases; Dz; Point in time; QNT; Quan; Quant; Quantitative; Random; Rel; Rel risk develop disease assessed; Relative ratio	4180186
1175518	Rel risk develop disease assessed	4180186
1175518	已评估的疾病发生相对风险:相对比率:时间点:^患者:定量型	4182948
1175520	DPPX Ab Titr CSF CBA IFA	4180186
1175520	二肽氨基肽酶样蛋白 6 抗体:滴定度:时间点:脑脊液:定量型:CBA IFA	4182948
1175520	ABS; Aby; Amiopep; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); Dipeptidyl peptidase-like protein 6; Dipeptidyl peptidase-like protein 6 Ab; DPPX; DPPX Ab; Indirect Fluorescence Antibody; Point in time; PR; Prot; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr	4180186
1175521	Reg hosp closed	4180186
1175521	Cnt; Count; Number; Point in time; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Random; Reg hosp closed	4180186
1175521	因为事件或意外事件而关闭的区域医院:数量(计数):时间点:^事件:定量型	4182948
1175523	Asp; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Fld; Guid; Guide; Guided; Imaging; Lung; Lung-R; PC fluid asp; Perc; Point in time; Pulmonary; Pulmonology; R; Rad; RADIOLOGY; Random; Respiratory; RT; Thorax	4180186
1175523	CT Guided Lung-R PC fluid asp	4180186
1175523	旨在经皮穿刺抽吸的引导:发现:时间点:胸部>肺.右侧:文档型:CT	4182948
1175524	Abd; Abd.reper; Abdo; Abdomen+; Abdominal; c; CAT scan; Cath; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Drain; Drain+cath place; Exudate; Finding; Findings; Guid; Guide; Guided; Imaging; Point in time; Rad; RADIOLOGY; Random; Removal of fluid; Retroperitoneal; without contrast	4180186
1175524	CT Guided Retroper Drain+cath--WO cont	4180186
1175524	旨在引流+引流导管置入的引导^不采用对比剂:发现:时间点:腹部>腹膜后腔:文档型:CT	4182948
1175525	Blood; CELL MARKERS; Glycosylphosphatidylinositol-linked proteins; Pan; PANEL.CELLMARK; Panl; Paroxysmal nocturnal hemoglobinuria; PLINK; PNH; PNH GPI-Linked WBC + RBC; PNH GPI-Lkd WBC + RBC Ag; PNH GPI-Lkd WBC + RBC Ag Pnl; Pnl; Point in time; Random; WB; Whole blood	4180186
1175525	PNH GPI-Lkd WBC + RBC Ag Pnl Bld	4180186
1175525	阵发性睡眠性血红蛋白尿症 GPI-锚定白细胞与红细胞抗原组套:-:时间点:全血:-	4182948
1175527	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175531	Nominal; Point in time; Public commun doc type; Public Health; Public Health Documents; PUBLICHEALTH; Random; Typ	4180186
1175531	Public commun doc type	4180186
1175531	大众传播文档类型:类型:时间点:文档:名义型	4182948
1175532	ADMIN; Nominal; Point in time; Random	4180186
1175532	电子邮件地址:电子邮件地址:时间点:组织机构:名义型	4182948
1175534	Gram Stn; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Mlk; Nominal; Point in time; Random; St; Stains; Stn	4180186
1175534	Gram Stn Mlk	4180186
1175534	显微镜观察:存在与否或特征标识:时间点:乳:名义型:革兰氏染色法	4182948
1175537	EPA+DPA+DHA/FA.C14-C22 risk Bld Imp	4180186
1175537	Acd; Acid; Blood; C20:5w3; C22:5w3; C22:6w3; Cervonate; Cervonic acid; Chemistry; DHA; Docosahexaenoic acid; Docosapentaenic acid; DPA; Eicosapentaenoic acid; EPA; EPA+DPA+DHA; Fatty acid; Icosapentaenoate; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Lipid; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Timnodonate; Timnodonic Acid; WB; Whole blood	4180186
1175537	二十碳五烯酸+二十二碳五烯酸 w3+二十二碳六烯酸/脂肪酸类.C14-C22 风险:印象:时间点:全血:序数型	4182948
1175542	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; PEDS; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
1175543	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1175543	病程记录:发现:时间点:{环境}:文档型:血栓栓塞	4182948
1175543	Thromboemb Prog note	4180186
1175544	ADMIN; Nominal; Point in time; Random; Typ	4180186
1175544	应急团队成员职位:类型:时间点:工作人员:名义型	4182948
1175546	Countermeasure implementation	4180186
1175546	Finding; Findings; Nominal; Point in time; Public Health; PUBLICHEALTH; Random	4180186
1175546	对策落实工作进展情况:发现:时间点:^事件:名义型	4182948
1175547	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood - (umbilical) cord; Cord (umbilical) blood; Cord bld; Cord blood; DNA NUCLEIC ACID PROBE; DNA probe; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; ZIKV; ZIKV RNA	4180186
1175547	ZIKV RNA BldCo Ql NAA+probe	4180186
1175547	寨卡病毒 RNA:存在情况或阈值:时间点:脐带全血:序数型:探针法.基因扩增.靶向	4182948
1175548	FBPA Ur Ql Scn	4180186
1175548	4 fluorobenzoyl propionic acid; DRUG/TOXICOLOGY; Drugs; FBPA; Haloperidol metabolite; III; Ordinal; Point in time; PR; Propanoic acid; Propioate; Propioic acid; Propionic acid; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
1175548	3-(4-氟苯基)丙酸:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
1175549	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; promise; Survey; SURVEY.PROMIS	4180186
1175550	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; H capsul; H capsulatum; H farciminosum; Histo; Histopl; Histoplasma farciminosum; Histoplasmos; Histoplasmosis; ID; Identity or presence; Imm; Immunodiff; Immunodiffusion; Imun; Imune; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1175550	H capsul Ab SerPl ID	4180186
1175550	荚膜组织胞浆菌 抗体:存在与否或特征标识:时间点:血清/血浆:名义型:免疫扩散法	4182948
1175551	4 weeks; Arterial Stenosis; Finding; Findings; Last; Ordinal; Othr; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175554	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Derm spec; Dermatologic; DNA NUCLEIC ACID PROBE; DNA probe; Epidermis; Har; ID; Infectious Disease; InfectiousDisease; Integument; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; Nails; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Skn; Strand Displacement Amplification; TMA; Transcription mediated amplification; Ungal nail	4180186
1175554	Fungal BT2 gene Derm spec Ql NAA+probe	4180186
1175554	真菌 BT2 基因:存在情况或阈值:时间点:毛发/指或趾甲/皮肤:序数型:探针法.基因扩增.靶向	4182948
1175560	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175561	AIDS; Blood; Deoxyribonucleic acid; high-throughput sequencing; HIV type 1; HIV type I; HIV1; HIV1 proviral DNA; HIV1 proviral DNA IN; HTS; Human immunodeficiency virus; i; ID; Infectious Disease; InfectiousDisease; Microbiology; Next generation sequencing; NGS; Nominal; PBMC; Peripheral blood mononuclear cells; Point in time; Random; WB; Whole blood	4180186
1175561	HIV1 proviral DNA IN Bld MC-Seq	4180186
1175561	HIV 1 型前病毒 DNA 整合酶基因:序列:时间点:全血单个核细胞:名义型:序列测定	4182948
1175566	Bld Bnk+Trans Med Prog note	4180186
1175566	病程记录:发现:时间点:{环境}:文档型:血库与输血医学	4182948
1175566	Bld Bnk+Trans Med; Blood conservation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Tx; Visit note	4180186
1175569	Finding; Findings; III; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175571	Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Heart Disease; III; LDL3; LDL3c; LDLc; LDL-C; Level; Lipid; Low density lipoprotein cholesterol; Low density lipoprotein cholesterols; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
1175571	LDL3c SerPl-sCnc	4180186
1175571	胆固醇.LDL 3 之中的:物质的量浓度:时间点:血清/血浆:定量型	4182948
1175573	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; GBS; Genital vaginal; Gp B Strep; Group B; Group B Strep; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S agalactiae; Screen; SDA; Steptococcus Group B; Strand Displacement Amplification; Strep; Strep B; Strep group B; Strept; Streptococci group B; TMA; Transcription mediated amplification; Vag fld; Vag fluid; Vagina; Vaginal fluid	4180186
1175573	Gp B Strep DNA Vag Ql NAA+probe	4180186
1175573	无乳链球菌 DNA:存在情况或阈值:时间点:阴道:序数型:探针法.基因扩增.靶向	4182948
1175575	4 weeks; Finding; Findings; Job; Last; Occupation; Ordinal; Othr; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175579	Finding; Findings; i; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175582	Ab; CMV; Cytomegalo virus; Cytomgal; HEDIS 2019 CMV Ab; HHV-5; Human Herpesvirus-5; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
1175582	HEDIS 2019 CMV Ab	4180186
1175582	HEDIS 2019 取值集合 - 巨细胞病毒抗体:-:时间点:^患者:-	4182948
1175589	Aer cult+Abx neut; Aerobe; Aerobe Cult; Aerobed; Blood; C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; InternalLabUse; Microbiology; Microorg prel grow; Microorganisms; Ordinal; Org; Organism; Organisms; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood	4180186
1175589	Microorg prel Bld Ql Aer cult + neut	4180186
1175589	微生物初步生长情况:存在情况或阈值:时间点:全血:序数型:需氧培养+抗微生物药物中和剂	4182948
1175590	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175591	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; OP; Outpt Hosp; PM+R; PM+R SW; Point in time; Random; Social work; SW; Visit note	4180186
1175591	PM+R SW Outpt Hosp Note	4180186
1175591	记录:发现:时间点:门诊型医院:文档型:物理医学与康复学.社会工作者	4182948
1175593	c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Guid; Guidance.stereotactic for localization; Guide; Guided; Imaging; Local; Misc; Miscellaneous; Other; Point in time; Rad; RADIOLOGY; Random; Spec; Stereo; Str loc; To be specified in another part of the message; Unspecified; W contr IV; WC	4180186
1175593	CT Guided Str loc--W contr IV	4180186
1175593	旨在为立体定位的引导^采用静脉注射对比剂:发现:时间点:XXX:文档型:CT	4182948
1175595	Chemistry; Identity or presence; M Protein; M Protein isotype; M-band; Monoclonal band; Monoclonal spike; M-protein; M-spike; Nominal; Para protein; Paraprotein; Pl; Plasma; Plsm; Point in time; PR; Prot; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1175595	M Protein isotype SerPl MS.MALDI-TOF	4180186
1175595	蛋白质.单克隆同种型:存在与否或特征标识:时间点:血清/血浆:名义型:MS.MALDI-TOF	4182948
1175596	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175597	7OH-chlorpromazine; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
1175597	7OH-chlorpromazine Ur Ql Scn	4180186
1175597	7-羟基氯丙嗪:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
1175598	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1175598	Psych Procedure note	4180186
1175598	操作记录:发现:时间点:{环境}:文档型:心理学	4182948
1175600	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Aspirate; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; HSV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1175600	HSV DNA Aspirate Ql NAA+probe	4180186
1175600	单纯疱疹病毒 DNA:存在情况或阈值:时间点:吸出物:序数型:探针法.基因扩增.靶向	4182948
1175601	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; R; RT; S prime; Screen; Survey; SURVEY.PROMIS	4180186
1175604	T-cell regulatory subsets Pnl Bld	4180186
1175604	Blood; CELL MARKERS; Pan; PANEL.CELLMARK; Panl; Pnl; Point in time; Random; T cell; T prime; T-cell regulatory subsets Pnl; UCHL-1; WB; Whole blood	4180186
1175604	T-细胞调节亚群组套:-:时间点:全血:-	4182948
1175608	Arm; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; EXT; Extr-L; Finding; Findings; Finger-L; Imaging; L; LT; LUE; MSK; Musculoskeletal; Ortho; Orthopedics; Point in time; Rad; Radiology; Random; UE; UE-L; Up; without contrast	4180186
1175608	CT Finger-L WO contr	4180186
1175608	多层^不采用对比剂:发现:时间点:上肢.左侧>手指:文档型:CT	4182948
1175609	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; Initial eval note; IR; notes; Point in time; Random; Visit note	4180186
1175609	IR Initial eval note	4180186
1175609	初步评价记录:发现:时间点:{环境}:文档型:介入放射医学	4182948
1175610	ARIPiprazole SerPl Ql Scn	4180186
1175610	Abilify; DRUG/TOXICOLOGY; Drugs; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1175610	阿立哌唑:存在情况或阈值:时间点:血清/血浆:序数型:毒理学筛查试验	4182948
1175616	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175617	Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Heart Disease; LDL5; LDL5c; LDLc; LDL-C; Level; Lipid; Low density lipoprotein cholesterol; Low density lipoprotein cholesterols; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
1175617	LDL5c SerPl-sCnc	4180186
1175617	胆固醇.LDL 5 之中的:物质的量浓度:时间点:血清/血浆:定量型	4182948
1175618	5-F ADB-M7; ADB-FUBINACA metabolite; Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; FUD-MDMB metabolite; GCMS; Illicit; Level; Mass concentration; MDMB(N)-BZ-F metabolite; MDMB-FUBINACA metabolite; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Synthetic cannabinoid; UA; UR; Urn	4180186
1175618	5-F ADB-M7 Ur Cfm-mCnc	4180186
1175618	5-氟 ADB-M7:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1175620	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Placent; Placental; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; ZIKV; ZIKV RNA	4180186
1175620	ZIKV RNA Placenta Ql NAA+probe	4180186
1175620	寨卡病毒 RNA:存在情况或阈值:时间点:胎盘:序数型:探针法.基因扩增.靶向	4182948
1175624	Patient Reported Outcomes Information System; PEDS; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.PROMIS	4180186
1175627	Point in time; QNT; Quan; Quant; Quantitative; Random; RAPID-3; Scale; Survey; SURVEY.GNHLTH	4180186
1175633	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C glabrata; C glabrata DNA; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Serum; SR; Strand Displacement Amplification; TMA; Torulopsis glabrata; Transcription mediated amplification	4180186
1175633	C glabrata DNA Ser Ql NAA+probe	4180186
1175633	光滑假丝酵母 DNA:存在情况或阈值:时间点:血清:序数型:探针法.基因扩增.靶向	4182948
1175634	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175635	CDT; CDT Tetrasialo; CDT Trisialo; Chemistry; Glycosylated transferrin; Mass concentration ratio; Mass ratio; MCRto; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Siderophilin; SR; Tf; Trf; TRFRN	4180186
1175635	CDT Trisialo/CDT Tetrasialo SerPl	4180186
1175635	转铁蛋白.碳水化合物缺乏性.三唾液酸/转铁蛋白.碳水化合物缺乏性.四唾液酸:质量比率:时间点:血清/血浆:定量型	4182948
1175636	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Gen-Probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; rDNA; ribosomal RNA; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
1175636	Fungal 18s rRNA gene Spec Ql NAA+probe	4180186
1175636	真菌 18s rRNA 基因:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
1175638	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUAV Subtyp; FLUV; Fowl plague; ID; Identity or presence; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; Random; Respiratory; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1175638	FLUAV Subtyp Lower resp NAA+probe	4180186
1175638	流感病毒 A 型亚型:存在与否或特征标识:时间点:呼吸道.下:名义型:探针法.基因扩增.靶向	4182948
1175639	Global health 0-10 0.5 increments; Ordinal; PGA; Point in time; PtGA; PTGE; QL; Qual; Qualitative; Random; Scale; Screen; Survey; SURVEY.GNHLTH	4180186
1175640	C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Placent; Placental; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; T gondii; Toxo; Toxoplasmosis	4180186
1175640	T gondii Placenta Ql Cult	4180186
1175640	刚地弓形虫:存在情况或阈值:时间点:胎盘:序数型:微生物特异性培养	4182948
1175641	ADB-FUBINACA metabolite; Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; FUD-MDMB metabolite; GCMS; Illicit; Level; Mass concentration; MDMB(N)-BZ-F metabolite; MDMB-FUBINACA metabolite; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Synthetic cannabinoid; UA; UR; Urn	4180186
1175641	MDMB-FUBINACA-M1 Ur Cfm-mCnc	4180186
1175641	MDMB-FUBINACA-M1:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1175643	RBC CD59 complete loss NFr	4180186
1175643	100 235a cells; Blood; CD59 RBC; Cell; CELL MARKERS; Cellularity; Discocytes; Erthrocyte; Erythrocyte; Glycosylphosphatidylinositol-anchored protein; Number fraction; Paroxysmal nocturnal hemoglobinuria; Percent; PLINK; PNH; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; RBCs CD59- comp loss; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; WB; Whole blood	4180186
1175643	红细胞.CD59 完全丧失/100 个细胞.235a:计数型分数:时间点:全血:定量型	4182948
1175644	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175647	Count/time; Lung; nRate; Number rate; Number Rate = Count/Time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Studies; Study; Sutdies	4180186
1175647	Hypopnea index nRate	4180186
1175647	低通气指数:计数型速率:检查过程持续时间:^患者:定量型	4182948
1175651	Finding; Findings; Nominal; Point in time; Random; Response section responsibility; Survey; SURVEY.CDC	4180186
1175652	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175653	Arm; Carpal bone; Carpal bones; Carpal bones and joint; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; EXT; Extr-L; Finding; Findings; Guid; Guide; Guided; Imaging; Inj; L; LT; LUE; Point in time; Rad; RADIOLOGY; Random; UE; UE-L; Up; Upper extremity joint; Wrist-L	4180186
1175653	CT Guided Wrist-L Inj	4180186
1175653	旨在注射的引导:发现:时间点:上肢.左侧>腕部:文档型:CT	4182948
1175655	Dental; Dentistry; Nominal; Point in time; Post inter-arch deviation; Random; Teeth+gum; Typ	4180186
1175655	Post inter-arch deviation Teeth+gum	4180186
1175655	后牙弓间偏差:类型:时间点:牙齿与牙龈:名义型	4182948
1175658	Dental; Dentistry; Finding; Findings; Low; Nominal; Point in time; Random	4180186
1175658	下面部不对称:发现:时间点:面部:名义型	4182948
1175659	4 weeks; Finding; Findings; Job; Last; Occupation; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175660	Addiction; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Desoxyn; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecstasy; Fl; Fld; FLU; Fluid; Illicit; MDMA; Methamphet; Methamphet+MDMA; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn	4180186
1175660	Methamphet+MDMA Fld Ql Scn	4180186
1175660	甲基苯丙胺+亚甲基二氧甲基苯丙胺:存在情况或阈值:时间点:体液:序数型:毒理学筛查试验	4182948
1175661	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175665	9-Hydroxy risperidone; 9-Hydroxy-risperidone; 9-OH-Risperidone; 9OH-risperidone; DRUG/TOXICOLOGY; Drugs; Invega; Ordinal; Paliperidone; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Risperidone metabolite; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1175665	9OH-risperidone SerPl Ql Scn	4180186
1175665	9-羟基利培酮:存在情况或阈值:时间点:血清/血浆:序数型:毒理学筛查试验	4182948
1175666	Cogn func; cognition; cognitive status; FCN; Func; Funct; Patient Reported Outcomes Information System; PEDS; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.PROMIS; T prime; T-score	4180186
1175667	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175669	Aerobe; Aerobe Cult; Aerobed; Bact; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Joint aspirate; Joint fld; Joint flu; Joint fluid; Microbiology; Nominal; Point in time; Random; Rheum; Rheumatology; SF; SNV; Syn; Syn fl; Synov; Synovial fluid	4180186
1175669	Bacteria Snv Aerobe Cult	4180186
1175669	细菌 已鉴定的:存在与否或特征标识:时间点:滑液:名义型:需氧微生物培养	4182948
1175673	MPO IgG & PR3 Ab.IgG Panel Ser	4180186
1175673	III; Immune globulin G; Immunoglobulin G; MPO; MPO - ANCA; MPO IgG & PR3 Ab.IgG Panel; Myeloperoxidase ANCA; Pan; p-ANCA; PANEL.SEROLOGY; Panl; Pnl; Point in time; PR3; PR-3; PR3-ANCA; Proteinase3; PRTN3; Random; Serine protease 3; Serology; Serum; SR; Vasculitis	4180186
1175673	髓过氧化物酶抗体.IgG & 蛋白酶 3 抗体.IgG 组套:-:时间点:血清:-	4182948
1175674	bod; Bodies; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175677	Cath Tip; Catheter tip; Gram Stn; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; St; Stains; Stn	4180186
1175677	Gram Stn Cath Tip	4180186
1175677	显微镜观察:存在与否或特征标识:时间点:尿液管尖端:名义型:革兰氏染色法	4182948
1175678	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175681	Dental; Dentistry; Finding; Findings; Narrative; Orthognathic surg consideration summary; Point in time; Random; Report; Surg	4180186
1175681	Orthognathic surg consideration summary	4180186
1175681	正颌外科手术考虑事项摘要:发现:时间点:^患者:叙述型	4182948
1175682	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175683	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175685	Absorp; c99; Calc; Calculation; CHEMISTRY.CHALLENGE TESTING; L-thyroxine; Mass fraction; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1175685	Levothyroxine absorption MFr SerPl Calc	4180186
1175685	左旋甲状腺素吸收:质量分数:时间点:血清/血浆:定量型:计算法	4182948
1175686	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C pneum; C pneumo; C pneumoniae; Chlamydia; Chlamydia pneumoniae; CPN; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; Twar agent	4180186
1175686	C pneum IgG Ser Ql IA	4180186
1175686	肺炎嗜性衣原体 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
1175688	Addiction; Blood; Dolophin; Dolophine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Metab; Metabolites; Metb; METD; Methadose; MTD; Ordinal; Pl; PlasBld; Plasma; Plsm; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; WB; Whole blood	4180186
1175688	Methadone+metab SerPlBld Ql Scn	4180186
1175688	美沙酮+代谢产物:存在情况或阈值:时间点:血清/血浆/全血:序数型:毒理学筛查试验	4182948
1175690	Emergency response plan Doc	4180186
1175690	DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random	4180186
1175690	紧急响应方案:发现:时间点:^事件:文档型	4182948
1175694	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175695	TriFperazine Ur Ql Scn	4180186
1175695	Calmazine; DRUG/TOXICOLOGY; Drugs; Eskazine; Eskazinyl; Jatroneural; Modalina; Novoflurazine; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Solazine; Stelazine; Terfluzine; Trifluoperaz; TriFperazine; Triftazin; UA; UR; Urn	4180186
1175695	三氟啦嗪:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
1175696	Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; C&S; Cult; Cultures; ID; Identity or presence; Implnt dev; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Myco; Mycobact; Nominal; Point in time; Prostheses; Prosthesis; Prosthetic; Random; Spec; species; spp; Tuberculosis	4180186
1175696	Mycobacterium Implnt dev Cult	4180186
1175696	分枝杆菌属单个未知种 已鉴定的:存在与否或特征标识:时间点:植入装置:名义型:微生物特异性培养	4182948
1175697	Acd; Acid; Blood; C22:5w3; Chemistry; Docosapentaenic acid; DPA; Fatty acid; Lipid; Mass fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
1175697	DPA/Fatty acids.C14-C22 MFr Bld	4180186
1175697	二十二碳五烯酸 w3/脂肪酸类.C14-C22:质量分数:时间点:全血:定量型	4182948
1175699	Acd; Acid fast Stn; Acids; AFB stain; ID; Identity or presence; Implnt dev; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Prostheses; Prosthesis; Prosthetic; Random; St; Stains; Stn	4180186
1175699	Acid fast Stn Implnt dev	4180186
1175699	显微镜观察:存在与否或特征标识:时间点:植入装置:名义型:抗酸染色法	4182948
1175703	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DAU; Drug; DRUG/TOXICOLOGY; Drugs; Drugs of abuse Pnl; Fl; Fld; FLU; Fluid; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random	4180186
1175703	Drugs of abuse Pnl Fld	4180186
1175703	滥用药物组套:-:时间点:体液:-	4182948
1175704	Blood; CDHF12; CDHR16; C-RET; Document; Finding; Findings; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; HSCR1; Inherited; MEN2A; MEN2B; Molecular pathology; MOLPATH; MOLPATH.REARRANGEMENTS; MTC1; Multiple endocrine neoplasia type IIa; Multiple endocrine neoplasia type IIb; Point in time; PTC; Random; Rearr; Rearrangement; ret proto-oncogene; RET51; RET-ELE1; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1175704	RET gene rearrange Bld/T FISH	4180186
1175704	RET 基因重排:发现:时间点:全血/组织:文档型:FISH	4182948
1175705	14-Hydroxydihydromorphinone; Addiction; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fl; Fld; FLU; Fluid; Illicit; Lortab; Numorphan; Numorphone; Opana; Ordinal; OxyContin; Percocet; Percodan; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Vicodin	4180186
1175705	oxyCODONE+oxyMORphone Fld Ql Scn	4180186
1175705	羟考酮+羟吗啡酮:存在情况或阈值:时间点:体液:序数型:毒理学筛查试验	4182948
1175707	Finding; Findings; Levels; Levl; LV; LVL; Ordinal; Point in time; Public Health; PUBLICHEALTH; Ql; Qual; Qualitative; Random; Screen	4180186
1175707	影响程度:发现:时间点:^事件:序数型	4182948
1175708	Actino; C&S; Cult; Cultures; ID; Identity or presence; Implnt dev; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Point in time; Prostheses; Prosthesis; Prosthetic; Random; Spec; species; spp	4180186
1175708	Actinomyces Implnt dev Cult	4180186
1175708	放线菌属单个未知种 已鉴定的:存在与否或特征标识:时间点:植入装置:名义型:微生物特异性培养	4182948
1175710	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175711	Addiction; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fl; Fld; FLU; Fluid; Heroin; Illicit; OP; Opi; Opiate; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn	4180186
1175711	Opiates Fld Ql Scn	4180186
1175711	阿片制剂:存在情况或阈值:时间点:体液:序数型:毒理学筛查试验	4182948
1175712	CDC Emergency Operations Centers; CDC EOC; Centers for Disease Control and Prevention; Pan; Panel; PANEL.SURVEY.CDC; Panl; Pnl; Point in time; Random; Survey; SURVEY.CDC	4180186
1175714	Orthodontic service attach	4180186
1175714	ADMIN; DOC.ADMIN; Document; Finding; Findings; Point in time; Random	4180186
1175714	正畸治疗服务附件:发现:时间点:{环境}:文档型:{角色}	4182948
1175715	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C pneum; C pneumo; C pneumoniae; Chlamydia; Chlamydia pneumoniae; CPN; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; Twar agent	4180186
1175715	C pneum IgM Ser Ql IA	4180186
1175715	肺炎嗜性衣原体 抗体.IgM:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
1175716	EM plan approved date; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.CDC	4180186
1175718	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175719	Alb; CR; Crea; Creat; DL &lt;= 3 mg/L; Left; Levo; MA; Malb; Micro albumin; Microalbumin; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; UA; UCr; UR; URINALYSIS; Urn	4180186
1175719	Microalbumin/Creat Ur DL<=3.0 mg/L-Rto	4180186
1175719	白蛋白/肌酐:比率:时间点:尿液:定量型:检测极限 <= 3.0 mg/L	4182948
1175720	Absc drain+cath place; Absc drainage; CAT scan; Cath; Computed tomography; Computerized tomography; CT scan; Document; Drain; Exudate; Finding; Findings; Guid; Guide; Guided; Imaging; L; LT; Lung; Lung-L; Point in time; Pulmonary; Pulmonology; Rad; RADIOLOGY; Random; Removal of fluid; Respiratory; Thorax	4180186
1175720	CT Guided Lung-L Absc drain+cath place	4180186
1175720	旨在脓肿引流+引流导管置入的引导:发现:时间点:胸部>肺.左侧:文档型:CT	4182948
1175722	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.PROMIS; T prime; T-score	4180186
1175723	1 week; Finding; Findings; Last; No; Num; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.PEG	4180186
1175725	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; promise; Survey; SURVEY.PROMIS	4180186
1175726	HEDIS 2019 Urine Prot Tests; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; PR; Prot; Random	4180186
1175726	HEDIS 2019 Urine Prot Tests	4180186
1175726	HEDIS 2019 取值集合 - 尿液蛋白检验项目:-:时间点:^患者:-	4182948
1175729	Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Heart Disease; III; LDL3; LDL3c; LDLc; LDL-C; Level; Lipid; Low density lipoprotein cholesterol; Low density lipoprotein cholesterols; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1175729	LDL3c SerPl-mCnc	4180186
1175729	胆固醇.LDL 3 之中的:质量浓度:时间点:血清/血浆:定量型	4182948
1175734	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Gen-Probe; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; rDNA; ribosomal RNA; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1175734	Fungal 18s rRNA gene Islt Ql NAA+probe	4180186
1175734	真菌 18s rRNA 基因:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
1175735	ABO + Rh; ABO group and Rh type; ABO+Rh Gp; Blood; BLOOD BANK; D phenotyping; D typing; Hematology; Heme; Nominal; Point in time; Random; Rh phenotyping; Rh typing; Typ; WB; Whole blood	4180186
1175735	ABO + Rh Bld Father	4180186
1175735	ABO与Rh血型:类型:时间点:全血^父亲:名义型	4182948
1175737	Blood; HEMATOLOGY/CELL COUNTS; i; II; NK; NK cyto IL2 30:1 E:T; PBMC; Peripheral blood mononuclear cells; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; RlACnc; WB; Whole blood	4180186
1175737	NK cyto IL2 30:1 E:T/Pos cntrl Bld MC	4180186
1175737	自然杀伤细胞细胞毒性.IL-2 刺激型 效应细胞/靶细胞比 30:1/阳性对照:相对任意型浓度:时间点:全血单个核细胞:定量型	4182948
1175739	CAT scan; Computed tomography; Computerized tomography; CT scan; Document; EXT; Extr-L; Finding; Findings; Guid; Guide; Guided; Imaging; Inj; Kn; Knee-L; L; LE; Leg; LE-L; LLE; Low; Lower extremity joint; LT; MSK; Musculoskeletal; Ortho; Orthopedics; Point in time; Rad; RADIOLOGY; Random	4180186
1175739	CT Guided Knee-L Inj	4180186
1175739	旨在注射的引导:发现:时间点:下肢.左侧>膝关节:文档型:CT	4182948
1175744	D phenotyping; D typing; HEDIS 2019 Rh; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random; Rh phenotyping; Rh typing	4180186
1175744	HEDIS 2019 Rh	4180186
1175744	HEDIS 2019 取值集合 - Rh:-:时间点:^患者:-	4182948
1175747	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.PROMIS	4180186
1175748	Finding; Findings; Last; Ordinal; Othr; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175751	Ident; Identifier; Lead event managing group; Nominal; Painter's colic; PB; Plumbism; Point in time; Random; Survey; SURVEY.CDC	4180186
1175752	Anaero; Anaerobe; Anaerobe Cult; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; C&S; Cult; Cultures; Fl; Fld; FLU; Fluid; ID; Infectious Disease; InfectiousDisease; InternalLabUse; Microbiology; Microorg prel grow; Microorganisms; Ordinal; Org; Organism; Organisms; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
1175752	Microorg prel grow Fld Ql Anaerobe Cult	4180186
1175752	微生物初步生长情况:存在情况或阈值:时间点:体液:序数型:厌氧微生物培养	4182948
1175753	5,8,11,14 Eicosatetraenoic acid; AA; Acd; Acid; Arachidonic acid; Arch acid; Blood; C20:4w6; Chemistry; Eicosatetraenoate; Fatty acid; Lipid; Mass fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
1175753	AA/Fatty acids.C14-C22 MFr Bld	4180186
1175753	花生四烯酸/脂肪酸类.C14-C22:质量分数:时间点:全血:定量型	4182948
1175754	Catalytic Concentration; Chemistry; Erythrocytes; Methyl transferase; Point in time; production of 6-MMP; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; TPMT	4180186
1175754	TPMT RBC production of 6-MMP-cCnc	4180186
1175754	硫嘌呤甲基转移酶:催化浓度:时间点:红细胞:定量型:6-甲基巯基嘌呤生成法	4182948
1175755	Abortus blauw; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blue-eared pig disease; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin M; Immunoglobulin M; Lelystad virus; MEIA; Microbiology; Misc; Miscellaneous; Mystery swine disease; Other; Point in time; Porcine epidemic abortion & respiratory syndrome; Porcine reproductive and respiratory syndrome; Pork; Pos; Pos cntrl; PRRS; PRRS virus Ab.IgM; PRRSV; PRRSV Ab; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Seuchenhafter spatabort der schweine; SIRSV; Spec; SUDS; Swine; Swine infertility and respiratory syndrome; Syndrome dysgenesique et respiratoire porcin; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
1175755	PRRSV IgM/Pos cntrl Spec IA	4180186
1175755	猪繁殖与呼吸综合征病毒 抗体.IgM/阳性对照:相对比率:时间点:XXX:定量型:免疫测定法	4182948
1175756	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Random; Visit note	4180186
1175756	Adolescent med OP Note	4180186
1175756	记录:发现:时间点:门诊病人:文档型:青春期医学	4182948
1175757	AUTS9; Blood; DFNB97; Document; Finding; Findings; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; HGFR; Inherited; MET amp; MET proto-oncogene, receptor tyrosine kinase; Molecular pathology; MOLPATH; Point in time; Random; RCCP2; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1175757	MET amp Bld/T FISH	4180186
1175757	MET 基因扩增:发现:时间点:全血/组织:文档型:FISH	4182948
1175762	Malocclusion severity assess Doc	4180186
1175762	DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random; Teeth+gum	4180186
1175762	错位咬合严重程度评估:发现:时间点:牙齿与牙龈:文档型	4182948
1175764	Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; high-throughput sequencing; HTS; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Misc; Miscellaneous; Myco; Mycobact; Next generation sequencing; NGS; Nominal; Other; Point in time; Random; Spec; species; spp; To be specified in another part of the message; Tuberculosis; Unspecified	4180186
1175764	Mycobacterium Spec Seq	4180186
1175764	分枝杆菌属单个未知种 已鉴定的:存在与否或特征标识:时间点:XXX:名义型:序列测定	4182948
1175766	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; BKV; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log NCNC; Log#; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; UA; UR; Urn; Viral load	4180186
1175766	BKV DNA Ur NAA+probe-Log#	4180186
1175766	BK 病毒 DNA:对数型数量或计数浓度:时间点:尿液:定量型:探针法.基因扩增.靶向	4182948
1175767	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175768	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey; SURVEY.GNHLTH; Tx	4180186
1175769	Ma+Ta Ab CSF Line blot-aCnc	4180186
1175769	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; MA1; MA-1; Ma2; MATA; Paraneoplastic Ag Ma 1; Paraneoplastic syndrome; PNMA1; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
1175769	Ma+Ta 抗体:任意型浓度:时间点:脑脊液:定量型:线点印迹法	4182948
1175774	Arm; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; EXT; Extr-L; Finding; Findings; Guid; Guide; Guided; Imaging; Inj; L; LT; LUE; MSK; Musculoskeletal; Ortho; Orthopedics; Point in time; Rad; RADIOLOGY; Random; Should-L; UE; UE-L; Up; Upper extremity joint	4180186
1175774	CT Guided Should-L Inj	4180186
1175774	旨在注射的引导:发现:时间点:上肢.左侧>肩部:文档型:CT	4182948
1175778	Anesthesia; Anesthesiology Team; Conf eval note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1175778	Anesthesiology Team Conf eval note	4180186
1175778	会议记录:发现:时间点:{环境}:文档型:麻醉学.团队	4182948
1175780	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Implnt dev; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Prostheses; Prosthesis; Prosthetic; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; T whippelii; T whippelli; T whipplei; TMA; Transcription mediated amplification; Tropheryma whippelli; Whipple's disease	4180186
1175780	T whipplei DNA Implnt dev Ql NAA+probe	4180186
1175780	Tropheryma whippelii DNA:存在情况或阈值:时间点:植入装置:序数型:探针法.基因扩增.靶向	4182948
1175781	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
1175781	Norfluvoxamine Ur Cfm-mCnc	4180186
1175781	诺氟伏沙明:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1175785	Ang; Angio; Angiography; Angm; Arm; c; Cardio; Cardiology; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT Angiogram; CT angiography; CT scan; CT venography; CTA; CTV; Document; EXT; Extr-L; Finding; Findings; Heart Disease; Imaging; L; LT; LUE; Point in time; Rad; RADIOLOGY; Random; UE; UE vv; UE vv-L; UE-L; Up; Venogram; Venography; W contr IV; WC	4180186
1175785	CTA UE vv-L W contr IV	4180186
1175785	多层^采用静脉注射对比剂:发现:时间点:上肢.左侧>上肢静脉类:文档型:CT.血管造影术	4182948
1175786	Task description	4180186
1175786	ADMIN; Finding; Findings; Narrative; Point in time; Random; Report	4180186
1175786	任务描述:发现:时间点:^事件:叙述型	4182948
1175787	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; MMP-9; MMP-9 Ab; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
1175787	MMP-9 Ab SerPl IA-aCnc	4180186
1175787	基质金属蛋白酶-9 抗体:任意型浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
1175789	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175794	Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Heart Disease; LDL7; LDL7c; LDLc; LDL-C; Level; Lipid; Low density lipoprotein cholesterol; Low density lipoprotein cholesterols; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
1175794	LDL7c SerPl-sCnc	4180186
1175794	胆固醇.LDL 7 之中的:物质的量浓度:时间点:血清/血浆:定量型	4182948
1175795	Amphiphysin Ab CSF Line blot-aCnc	4180186
1175795	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; breast cancer; Cerebral spinal fluid; Cerebrospinal Fl; Paraneoplastic syndrome; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Stiff Man Syndrome	4180186
1175795	双载蛋白 抗体:任意型浓度:时间点:脑脊液:定量型:线点印迹法	4182948
1175796	Finding; Findings; Last; Ordinal; Othr; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175797	1 week; Activ; Actvty; Finding; Findings; Last; Movements; No; Num; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.PEG	4180186
1175799	AHI; Apnea+hypopnea; Count/time; Ear Nose Throat; ENT; Lung; nRate; Number rate; Number Rate = Count/Time; OAHI; Obstr apnea hypopnea index; Oto; Otolaryngology; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Studies; Study; Sutdies	4180186
1175799	Obstr apnea hypopnea index nRate	4180186
1175799	阻塞性呼吸暂停低通气指数:计数型速率:检查过程持续时间:^患者:定量型	4182948
1175801	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175811	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175813	Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; PsoSat questionnaire; Random; Survey; SURVEY.GNHLTH	4180186
1175815	Drugs of abuse Pnl Tiss	4180186
1175815	DAU; Drug; DRUG/TOXICOLOGY; Drugs; Drugs of abuse Pnl; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; Tissue; Tissue, unspecified	4180186
1175815	滥用药物组套:-:时间点:组织与涂片:-	4182948
1175816	Aerobe; Aerobe Cult; Aerobed; Ascites; Ascitic fluid; Ascitis; Bact; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Peritoneal fluid; Point in time; Prt; Random	4180186
1175816	Bacteria Prt Aerobe Cult	4180186
1175816	细菌 已鉴定的:存在与否或特征标识:时间点:腹膜液:名义型:需氧微生物培养	4182948
1175818	Addiction; B3G; BU; BUP; Bupe; Buprenex; Buprenorphine glucuronide; buprenorphine HCI; Buprex; Butrans; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Finobrin; Gluc; Glucouronide; III; Illicit; Norspan; Ordinal; Point in time; PotentialForAbuse; PR; Prefin; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Suboxone; Subutex; Temgesic; UA; UR; Urn	4180186
1175818	B3G Ur Ql Scn	4180186
1175818	丁丙诺啡-3-葡糖苷酸:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
1175820	CDC Emergency Operations Centers; CDC EOC; Centers for Disease Control and Prevention; Internal communications; Pan; Panel; PANEL.SURVEY.CDC; Panl; Pnl; Point in time; Random; Survey; SURVEY.CDC	4180186
1175821	Finding; Findings; Narrative; Point in time; Random; Report; Survey; SURVEY.CDC	4180186
1175822	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175823	Anabolic steroid; Count/time; Freq anabolic steroids used in past Y; H+P; H+P.HX; Last; Musc; Muscl; nRate; Number rate; Number Rate = Count/Time; Ordinal; P prime; QL; Qual; Qualitative; Screen; Ste; Steriods; Steroid	4180186
1175823	Freq anabolic steroids used in past Y	4180186
1175823	去年为改善肌肉量或力量而使用促同化激素类药物的频率:计数型速率:1年:^患者:序数型	4182948
1175828	Chronic Respiratory Questionnaire Self-Administered, Individualized Format; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH; Tot; Totl	4180186
1175832	Emerg response report Doc	4180186
1175832	DOC.MISC; Document; Emerg response report; Finding; Findings; MISC; Point in time; Random	4180186
1175832	紧急响应报告:发现:时间点:^事件:文档型	4182948
1175836	Molindone Ur Ql Scn	4180186
1175836	DRUG/TOXICOLOGY; Drugs; Moban; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
1175836	吗茚酮:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
1175837	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C trac; C trach; C trach+GC; C trach+GC pnl; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; CT; CT/GC; DNA NUCLEIC ACID PROBE; DNA probe; GC; Gen-Probe; Gono; Gonorrhea; ID; Infectious Disease; InfectiousDisease; LAT; LCR; LGV; Ligase chain reaction; Ligation-activated transcription; Lymphogranuloma venereum; Microbiology; N gonorrhoea; N gonorrhoeae; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; ribosomal RNA; SDA; Strand Displacement Amplification; TMA; Trachoma; Transcription mediated amplification	4180186
1175837	C trach+GC pnl Nph NAA+probe	4180186
1175837	沙眼衣原体与淋病奈瑟菌 rRNA 组套:-:时间点:鼻咽:-:探针法.基因扩增.靶向	4182948
1175838	PCA-Tr Ab CSF Ql CBA IFA	4180186
1175838	浦肯雅细胞胞浆 Tr 型 抗体:存在情况或阈值:时间点:脑脊液:序数型:CBA IFA	4182948
1175838	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Cytopl; Cytoplas; Hodgkin's lymphoma; Indirect Fluorescence Antibody; Limbic encephalopathy; Neuro; Neurology; Ordinal; Paraneoplastic cerebellar degeneration; Paraneoplastic neurological syndrome; Paraneoplastic syndrome; PCD; PNS; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
1175840	7OH-fluphenazine; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
1175840	7OH-fluphenazine Ur Ql Scn	4180186
1175840	7-羟基氟奋乃静:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
1175841	Linoleate/Fatty acids.C14-C22 MFr Bld	4180186
1175841	Acd; Acid; Blood; C18:2w6; Chemistry; cis-9, cis-12-octadecadienoate; cis-9, cis-12-octadecadienoic acid; Fatty acid; Linoleic acid; Lipid; Mass fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
1175841	亚油酸/脂肪酸类.C14-C22:质量分数:时间点:全血:定量型	4182948
1175844	4 weeks; Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; promise; Survey; SURVEY.PROMIS	4180186
1175845	Bil; Bilat; Both; Brain; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Cranial; Cranium; CT scan; Document; Eye socket; Finding; Findings; Head+Orbit-Bl; Imaging; Intracranial; Orbital; Orbit-Bl; Orbits; Point in time; Rad; RADIOLOGY; Random; Skull; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
1175845	CT Head+Orbit-Bl WO+W contr IV	4180186
1175845	多层^不采用 & 采用静脉注射对比剂:发现:时间点:头部 & 头部>眼眶.双侧:文档型:CT	4182948
1175846	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175847	DRUG/TOXICOLOGY; Drugs; Entyvio; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Vedol	4180186
1175847	Vedolizumab Trough SerPl LC/MS/MS-mCnc	4180186
1175847	维多珠单抗^波谷:质量浓度:时间点:血清/血浆:定量型:LC/MS/MS	4182948
1175848	HEDIS 2019-20 Grp A Strep; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
1175848	HEDIS 2019-20 Grp A Strep	4180186
1175848	HEDIS 2019 取值集合 - A 组链球菌试验:-:时间点:^患者:-	4182948
1175849	C&S; Cult; Cultures; hMPV; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Low; Lower resp; Lung; Microbiology; Nominal; Point in time; Pulmonary; Pulmonology; Random; Respiratory; Spec	4180186
1175849	hMPV Lower resp Cult	4180186
1175849	人类偏肺病毒 已鉴定的:存在与否或特征标识:时间点:呼吸道.下:名义型:微生物特异性培养	4182948
1175850	Dental; Dentistry; Finding; Findings; Nominal; Point in time; Random	4180186
1175850	正畸治疗前提条件:发现:时间点:^患者:名义型	4182948
1175852	DOC.MISC; MISC; Point in time; QNT; Quan; Quant; Quantitative; Random; Rnge	4180186
1175852	Date range of report DateRange	4180186
1175852	报告日期范围:日期范围:时间点:报告:定量型	4182948
1175853	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175855	Clin Path; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Laboratory medicine; notes; Path; Point in time; Random; Visit note	4180186
1175855	Clin Path Procedure note	4180186
1175855	操作记录:发现:时间点:{环境}:文档型:临床病理学	4182948
1175856	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.PROMIS	4180186
1175858	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1175858	Ethics Phone Note	4180186
1175858	记录:发现:时间点:电话就医:文档型:伦理学	4182948
1175861	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Peds; Point in time; Random; Visit note	4180186
1175861	Peds OP Note	4180186
1175861	记录:发现:时间点:门诊病人:文档型:儿科学	4182948
1175862	CAT scan; Cath; Computed tomography; Computerized tomography; CT scan; Document; Drain; Drain+cath place; Exudate; Finding; Findings; Guid; Guide; Guided; Imaging; Lung; Lung-R; Point in time; Pulmonary; Pulmonology; R; Rad; RADIOLOGY; Random; Removal of fluid; Respiratory; RT; Thorax	4180186
1175862	CT Guided Lung-R Drain+cath place	4180186
1175862	旨在引流+引流导管置入的引导:发现:时间点:胸部>肺.右侧:文档型:CT	4182948
1175863	Count/time; Lung; nRate; Number rate; Number Rate = Count/Time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; RERA; Resp effort; Resp effort-related arousal; Resp effort-related arousal index; Respiratory; Studies; Study; Sutdies	4180186
1175863	Resp effort-related arousal index nRate	4180186
1175863	呼吸努力相关觉醒指数:计数型速率:检查过程持续时间:^患者:定量型	4182948
1175864	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175866	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175867	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175868	Addiction; Desoxyn; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecstasy; Illicit; MDMA; Methamphet; Methamphet+MDMA; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
1175868	Methamphet+MDMA Ur Ql Scn	4180186
1175868	甲基苯丙胺+亚甲基二氧甲基苯丙胺:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
1175870	BON; Brain; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Cranial; Cranium; CT scan; Document; Finding; Findings; Imaging; Intracranial; Point in time; R; Rad; RADIOLOGY; Random; RT; Skull; Temporal bone-R; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
1175870	CT Temporal bone-R WO+W contr IV	4180186
1175870	多层^不采用 & 采用静脉注射对比剂:发现:时间点:头部>颞骨.右侧:文档型:CT	4182948
1175871	Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1175871	会诊记录:发现:时间点:{环境}:文档型:药物基因组学	4182948
1175874	Control; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175877	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175881	Activ; Actvty; Finding; Findings; Last; Movements; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175883	Abd; Abdo; Abdomen+; Abdominal; c; CAT scan; Cath; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Drain; Drain+cath place; Exudate; Finding; Findings; Guid; Guide; Guided; Imaging; Point in time; Rad; RADIOLOGY; Random; Removal of fluid; W contr IV; WC	4180186
1175883	CT Guided Abd Drain+cath plc--W contr IV	4180186
1175883	旨在引流+引流导管置入的引导^采用静脉注射对比剂:发现:时间点:腹部:文档型:CT	4182948
1175884	120 min; 120 minutes; 120min; 2 hours; Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1175888	Ejaculate; EXS; FERTILITY TESTING; Genitourinary; GU; Number Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Sem; Seminal fluid; Smn; SMPLS; Sperm; Sperm excess residual cytoplasm; URO; Urology	4180186
1175888	Excess residual cytoplasm NFr Smn	4180186
1175888	精子.过多残余胞质/100 个精子:计数型分数:时间点:精液:定量型	4182948
1175892	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Neo peri med; notes; Point in time; Random; Telemedicine; Visit note	4180186
1175892	Neo peri med Telehealth Note	4180186
1175892	记录:发现:时间点:远程医疗:文档型:新生儿围产医学	4182948
1175894	8-iso-prostaglandin F2alpha; Chemistry; CR; Crea; Creat; F2-IsoPs; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
1175894	F2-IsoPs/Creat Ur	4180186
1175894	F2-异前列腺素/肌酐:质量比率:时间点:尿液:定量型	4182948
1175898	Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Heart Disease; LDL4; LDL4c; LDLc; LDL-C; Level; Lipid; Low density lipoprotein cholesterol; Low density lipoprotein cholesterols; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1175898	LDL4c SerPl-mCnc	4180186
1175898	胆固醇.LDL 4 之中的:质量浓度:时间点:血清/血浆:定量型	4182948
1175900	Thyroxine & Thyroxine.free panel SerPl	4180186
1175900	Chemistry; FR; FreeT4; FT4; Levothyroxine; Levo-thyroxine; L-thyroxine; Non-protein bound; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T4; T-4; T4 Free; thyroid hormone; Thyrox; Thyroxin; Thyrx; Total T4; TT4	4180186
1175900	甲状腺素与甲状腺素.游离型 组套:-:时间点:血清/血浆:-	4182948
1175901	Hu3 Ab Titr CSF IF	4180186
1175901	神经元细胞核 3 型 抗体:滴定度:时间点:脑脊液:定量型:免疫荧光法	4182948
1175901	ABS; Aby; ACIF; ANNA 3; ANNA-3; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); FA; FANA; Fluorescent antibody; Fluoresent; Hu; Hu3; IFA; III; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Neuro; Neurology; Neuronal nuclear type III; Nuc; Point in time; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
1175903	Thromboemb Procedure note	4180186
1175903	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1175903	操作记录:发现:时间点:{环境}:文档型:血栓栓塞	4182948
1175905	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.PROMIS	4180186
1175906	Percent of task completed NFr	4180186
1175906	ADMIN; Assignment; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1175906	已完成任务百分比:计数型分数:时间点:^事件:定量型	4182948
1175907	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; FLUB; FLUBV; FLUV; ID; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
1175907	FLUBV RNA Ct Spec Qn NAA+probe	4180186
1175907	流感病毒 B 型 RNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
1175908	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B sp panel; Blood; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lyme; Lyme disease; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; Relapsing fever; SDA; species; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1175908	B sp panel Bld NAA+non-probe	4180186
1175908	疏螺旋体属组套:-:时间点:全血:-:非探针法.基因扩增.靶向	4182948
1175914	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
1175918	4 weeks; Average; Avg; Finding; Findings; Hard to find the right words; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; R; RT; Screen; Survey; SURVEY.PROMIS	4180186
1175921	#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Cnt; Count; Count/volume; CT; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); Other; PCR; Point in time; Polymerase chain reaction; Porcine kobuvirus; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Viral load	4180186
1175921	Aichivirus C RNA # Spec NAA+probe	4180186
1175921	爱知病毒 C 型 RNA:计数型浓度:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
1175922	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175924	CDT + Apo C-III Pnl SerPl	4180186
1175924	APO; Apolipo; Apolipoprot; Apolipoproteins; CDG; CDT; CDT + Apo C-III Pnl; Chemistry; Congenital disorders of glycosylation; Glycosylated transferrin; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Siderophilin; SR; Tf; Trf; TRFRN	4180186
1175924	转铁蛋白.碳水化合物缺乏性 与 载脂蛋白 CIII 组套:-:时间点:血清/血浆:-	4182948
1175928	MA kaolin P Hpase Bld Res TEG	4180186
1175928	最大凝块强度幅度.白陶土诱导型^在添加肝素酶之后:长度:时间点:全血:定量型:血栓弹力描记术.共振	4182948
1175928	add heparinase; Blood; COAGULATION; Hematology; Heme; HKH MA; HKHMA; Length; MA kaolin; MA, HKH; MAK; MAthrombin; Max clot; P Hpase; Point in time; QNT; Quan; Quant; Quantitative; Random; Res TEG; TEG; Thrombelastography; Thrombelastometry; WB; Whole blood	4180186
1175929	ID; Identity or presence; Infectious Disease; InfectiousDisease; Low; Lower resp; Lung; Microbiology; Nominal; Point in time; Pulmonary; Pulmonology; Random; Respiratory; St; Stains; Stn; TBO Stn	4180186
1175929	TBO Stn Lower resp	4180186
1175929	显微镜观察:存在与否或特征标识:时间点:呼吸道.下:名义型:甲苯胺蓝 O 染色法	4182948
1175930	1 hour; 1.0Hr; 1h p levo; 60 min; 60 minutes; 60M; 60min; After; c99; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; Levothyroxine; Levo-thyroxine; L-thyroxine; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T4; T-4; thyroid hormone; Thyrox; Thyroxin; Thyrx; Total T4; TT4	4180186
1175930	T4 1h p levo SerPl-mCnc	4180186
1175930	甲状腺素^在剂量左旋甲状腺素之后1小时:质量浓度:时间点:血清/血浆:定量型	4182948
1175931	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175933	DOC.MISC; Ident; Identifier; MISC; Nominal; Point in time; Random	4180186
1175933	Emergency response plan ID	4180186
1175933	紧急响应方案标识符:标识符:时间点:文档:名义型	4182948
1175934	Finding; Findings; II; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175935	Addiction; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Dolophin; Dolophine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fl; Fld; FLU; Fluid; Illicit; Metab; Metabolites; Metb; METD; Methadose; MTD; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn	4180186
1175935	Methadone+metab Fld Ql Scn	4180186
1175935	美沙酮+代谢产物:存在情况或阈值:时间点:体液:序数型:毒理学筛查试验	4182948
1175936	Adolescent med Consult note	4180186
1175936	Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1175936	会诊记录:发现:时间点:{环境}:文档型:青春期医学	4182948
1175937	Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Level; LysoPC(24:0); Mass Concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
1175937	LysoPC(24:0) DBS-mCnc	4180186
1175937	溶血磷脂酰胆碱(24:0):质量浓度:时间点:全血.斑点:定量型	4182948
1175938	Lymph subset + B-cell phenotype Pnl Bld	4180186
1175938	淋巴细胞亚群与 B-细胞表现型分型组套:-:时间点:全血:-	4182948
1175938	B Cell; B-ALL; B-cell acute lymphoblastic leukemia; BCELLS; Blood; CELL MARKERS; Lymph subset + B-cell phenotype Pnl; Pan; PANEL.CELLMARK; Panl; Pheno; Phenotypic; Pnl; Point in time; Random; WB; Whole blood	4180186
1175942	AMH; Anti Mullerian hormone; Anti- Müllerian hormone; Anti-paramesonephric hormone; APH; Beef; Bovine MIS; EIA; ELFA; ELISA; Enzyme immunoassay; FERTILITY TESTING; IAA; Level; Mass concentration; MEIA; MIF; MIH; MIS; Mullerian inhibiting factor; Mullerian inhibiting hormone; Müllerian-inhibiting factor; Müllerian-inhibiting hormone; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Subs; SUDS; Vet; Veterinary	4180186
1175942	Bovine MIS SerPl IA-mCnc	4180186
1175942	牛小鼠缪勒管抑制物质:质量浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
1175945	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.PROMIS; T prime; T-score	4180186
1175947	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; R; RT; Screen; Survey; SURVEY.PROMIS	4180186
1175950	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Herp splx; Herpes simplex virus type 1; Herpes simplex virus type 1+2; Herpes simplex virus type I+II; HSV; HSV 1+2; HSV1; HSV1+2; i; IAA; ID; II; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
1175950	HSV1+2 IgM Ser Ql IA	4180186
1175950	单纯疱疹病毒 1+2 型 抗体.IgM:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
1175952	Aerobe; Aerobe Cult; Aerobed; Bact; BIFL; Bile fluid; Biliary fluid; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Point in time; Random	4180186
1175952	Bacteria Bifl Aerobe Cult	4180186
1175952	细菌 已鉴定的:存在与否或特征标识:时间点:胆汁:名义型:需氧微生物培养	4182948
1175955	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175957	Arthrogram; Arthrography; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; EXT; Extr-R; Finding; Findings; Imaging; intraarticular; intrasynovial; Jnt; LE; LE joint-R; Leg; LE-R; Low; Point in time; R; Rad; RADIOLOGY; Random; RLE; RT; W contr IS; WC	4180186
1175957	CT LE joint-R W contr IS	4180186
1175957	多层^采用关节内对比剂:发现:时间点:下肢.右侧>下肢关节:文档型:CT	4182948
1175958	Dental; Dentistry; Habits impact orthodontic cond; Nominal; Point in time; Random; Typ	4180186
1175958	Habits impact orthodontic cond	4180186
1175958	影响正畸治疗情况的习惯:类型:时间点:^患者:名义型	4182948
1175959	Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Heart Disease; i; LDL1; LDL1c; LDLc; LDL-C; Level; Lipid; Low density lipoprotein cholesterol; Low density lipoprotein cholesterols; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1175959	LDL1c SerPl-mCnc	4180186
1175959	胆固醇.LDL 1 之中的:质量浓度:时间点:血清/血浆:定量型	4182948
1175960	Finding; Findings; H+P; H+P.PX; Nominal; P prime; Point in time; pressure injury; Pressure ulcer; Pressure Ulcers; Random; Ulcer	4180186
1175962	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; notes; OB; ObGyn; Obstetrics; Point in time; Random; Telemedicine; Visit note	4180186
1175962	记录:发现:时间点:远程医疗:文档型:妇科学	4182948
1175963	Blood; HEMATOLOGY/CELL COUNTS; i; II; NK; NK cyto IL2 15:1 E:T; PBMC; Peripheral blood mononuclear cells; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; RlACnc; WB; Whole blood	4180186
1175963	NK cyto IL2 15:1 E:T/Pos cntrl Bld MC	4180186
1175963	自然杀伤细胞细胞毒性.IL-2 刺激型 效应细胞/靶细胞比 15:1/阳性对照:相对任意型浓度:时间点:全血单个核细胞:定量型	4182948
1175964	Aerobe; Aerobe Cult; Aerobed; Bact; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Low; Lower resp; Lung; Microbiology; Nominal; Point in time; Pulmonary; Pulmonology; Random; Respiratory	4180186
1175964	Bacteria Lower resp Aerobe Cult	4180186
1175964	细菌 已鉴定的:存在与否或特征标识:时间点:呼吸道.下:名义型:需氧微生物培养	4182948
1175967	Consult note; Develop-behav peds; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Mental health; MentalHealth; notes; Peds; Point in time; Psych; Psychiatry; Random; Visit note	4180186
1175967	Develop-behav peds Consult note	4180186
1175967	会诊记录:发现:时间点:{环境}:文档型:发育行为儿科学	4182948
1175968	1 month; 1 month (30 days); 30 days; Count/time; Last; month; nRate; Number rate; Number Rate = Count/Time; QNT; Quan; Quant; Quantitative; Survey; SURVEY.NHANES	4180186
1175971	Addiction; Dolophin; Dolophine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Mec; Metab; Metabolites; Metb; METD; Methadose; MTD; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn	4180186
1175971	Methadone+metab Mec Ql Scn	4180186
1175971	美沙酮+代谢产物:存在情况或阈值:时间点:胎便:序数型:毒理学筛查试验	4182948
1175973	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175976	Desmethylolanzapine; DRUG/TOXICOLOGY; Drugs; Olanzapine metabolite; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
1175976	Norolanzapine Ur Ql Scn	4180186
1175976	去甲基奥氮平:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
1175977	Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.MTLHLTH; Tot; Totl	4180186
1175979	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; Pos; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175980	4 weeks; Cogn func; cognition; cognitive status; FCN; Func; Funct; Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; PEDS; Pnl; promise; Survey; SURVEY.PROMIS	4180186
1175981	Dental; Dentistry; Document; Finding; Findings; Info orthodontic cond; Mouth; Mouth+throat+teeth; Point in time; Random	4180186
1175981	Info orthodontic cond Oral cavity Doc	4180186
1175981	正畸治疗情况补充信息:发现:时间点:口腔:文档型	4182948
1175982	Aerobe; Aerobe Cult; Aerobed; Bact; C&S; Cult; Cultures; Diaf; DiafP; Dialysate; Dialysis fluid; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Kidney; Microbiology; Nephrology; Nominal; Peritoneal Dialysis fluid; Point in time; Random; Renal	4180186
1175982	Bacteria DiafP Aerobe Cult	4180186
1175982	细菌 已鉴定的:存在与否或特征标识:时间点:腹膜透析液:名义型:需氧微生物培养	4182948
1175983	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175984	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; gG; Glycoprot; Glycoproteins; GP; IgG 1; IgG subgroup 1; MOG; MOG Ab; MOG Ab.IgG1; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1175984	MOG IgG1 SerPl Ql FC	4180186
1175984	髓鞘少突胶质细胞糖蛋白 抗体.IgG1:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
1175985	CDC Emergency Operations Centers; CDC EOC; Centers for Disease Control and Prevention; Pan; Panel; PANEL.SURVEY.CDC; Panl; Pnl; Point in time; Random; Started; Survey; SURVEY.CDC	4180186
1175988	People tested Pop	4180186
1175988	Cnt; Count; Number; Point in time; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Random	4180186
1175988	已检测人员:数量(计数):时间点:^人群:定量型	4182948
1175989	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chagas disease; Donr; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; T cruzi; Trypanosomiasis; Trypanosomosis	4180186
1175989	T cruzi IgG SerPl Donr Ql IA.rapid	4180186
1175989	克氏锥虫 抗体.IgG:存在情况或阈值:时间点:血清/血浆^供体:序数型:免疫测定法.快速	4182948
1175990	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Oxycodone metabolite; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
1175990	Noroxymorphone Ur Cfm-mCnc	4180186
1175990	去甲基羟吗啡酮:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1175993	Cnt; Count; Lung; Neuro; Neurology; Number; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Studies; Study; Sutdies	4180186
1175993	Num central hypopnea	4180186
1175993	中枢性低通气:数量(计数):检查过程持续时间:^患者:定量型	4182948
1175994	ADMIN; Nominal; Occupation; Point in time; Random; Typ; Work	4180186
1175994	工作职位:类型:时间点:工作人员:名义型	4182948
1175995	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; Herpes simplex virus type 2; Herpes simplex virus type II; HSV; HSV2; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Up; Upper resp	4180186
1175995	HSV2 DNA Upper resp Ql NAA+probe	4180186
1175995	单纯疱疹病毒 2 型 DNA:存在情况或阈值:时间点:呼吸道.上:序数型:探针法.基因扩增.靶向	4182948
1175999	14-Hydroxydihydromorphinone; Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Lortab; Mec; Numorphan; Numorphone; Opana; Ordinal; OxyContin; Percocet; Percodan; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Vicodin	4180186
1175999	oxyCODONE+oxyMORphone Mec Ql Scn	4180186
1175999	羟考酮+羟吗啡酮:存在情况或阈值:时间点:胎便:序数型:毒理学筛查试验	4182948
1176000	CD24-FLAER- cells/100 CD15 cells NFr Bld	4180186
1176000	100 CD15 cells; 3-FAL; 3-FL; BA-1; Blood; CD15 Cells; CD24 Cells; CD24-FLAER- cells; Cell; CELL MARKERS; Cellularity; Fluor 488-labeled mutant aerolysin; Glycosylphosphatidylinositol-anchored protein; Heat stable antigen; HSA; Lacto-n-neo-fucopentaose III; LeuM1; Leu-M1; Lewis X; Lex; LNFP III; M-1; My1; My-1; Number fraction; Paroxysmal nocturnal hemoglobinuria; Percent; PLINK; PNH; Point in time; QNT; Quan; Quant; Quantitative; Random; SSEA-1; WB; Whole blood; X-hapten	4180186
1176000	细胞.CD24-FLAER-/100 个细胞.CD15:计数型分数:时间点:全血:定量型	4182948
1176001	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Human Calcivirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Norwalk virus; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Regurgitation; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Vom; Vomitus	4180186
1176001	Norovirus RNA Vom Ql NAA+probe	4180186
1176001	诺如病毒 RNA:存在情况或阈值:时间点:呕吐物:序数型:探针法.基因扩增.靶向	4182948
1176004	Abd; Abdo; Abdomen+; Abdominal; Absc drain+cath place; Absc drainage; CAT scan; Cath; Computed tomography; Computerized tomography; CT scan; Document; Drain; Exudate; Finding; Findings; Guid; Guide; Guided; Imaging; Peritoneal cavity; Point in time; Rad; RADIOLOGY; Random; Removal of fluid	4180186
1176004	CT Guided Peritoneal Absc drain+cath plc	4180186
1176004	旨在脓肿引流+引流导管置入的引导:发现:时间点:腹部>腹膜腔:文档型:CT	4182948
1176005	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; species; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1176005	Phlebovirus sp RNA CSF Ql NAA+probe	4180186
1176005	白蛉病毒属单个未知种 RNA:存在情况或阈值:时间点:脑脊液:序数型:探针法.基因扩增.靶向	4182948
1176007	Bact; high-throughput sequencing; HTS; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Next generation sequencing; NGS; Nominal; Point in time; Random	4180186
1176007	Bacterial whole genome Islt-Seq	4180186
1176007	细菌全基因组:序列:时间点:分离株:名义型:序列测定	4182948
1176013	CDC Emergency Operations Centers; CDC EOC; Centers for Disease Control and Prevention; Pan; Panel; PANEL.SURVEY.CDC; Panl; Pnl; Point in time; Random; Survey; SURVEY.CDC	4180186
1176016	Ethics Team Conf eval note	4180186
1176016	Conf eval note; DOC.ONT; Document; Encounter; Ethics Team; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1176016	会议记录:发现:时间点:{环境}:文档型:伦理学.团队	4182948
1176019	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Implnt dev; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Prostheses; Prosthesis; Prosthetic; QBR; QL; Qual; Qualitative; Random; Rochalimaea species; Screen; SDA; species; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1176019	Bartonella DNA Implnt dev Ql NAA+probe	4180186
1176019	巴尔通体属单个未知种 DNA:存在情况或阈值:时间点:植入装置:序数型:探针法.基因扩增.靶向	4182948
1176021	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176023	Incident commander phone #	4180186
1176023	ADMIN; Incident commander phone #; No; Nominal; Num; Phone #; Point in time; Random; Telecommunication number; Telephone number	4180186
1176023	意外事件指挥人员电话号码:电话号码:时间点:工作人员:名义型	4182948
1176025	ED visits RptPeriod	4180186
1176025	Cnt; Count; ED visits; Number; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Report period	4180186
1176025	急诊科就诊:数量(计数):报告期:^事件:定量型	4182948
1176026	CLIN; CLIN.RISK; Fracture Risk Assessment; Lower extremity joint; Point in time; QNT; Quan; Quant; Quantitative; Random; Risk	4180186
1176026	Hip fracture 10Y prob FRAX	4180186
1176027	凝块强度.二磷酸腺苷诱导型:长度分数:时间点:全血:定量型:计算法	4182948
1176027	Adenosine 5'-Pyrophosphate; Adenosine Pyrophosphate; ADO; ADP; ADP % aggregation; ANED; Blood; Calc; Calculation; Clot strength ADP induced; COAGULATION; Hematology; Heme; Length Fraction; Medication stress; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
1176027	Clot strength ADP-ind LenFr Bld Res TEG	4180186
1176029	4 weeks; Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; promise; Survey; SURVEY.PROMIS	4180186
1176030	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; TMA; TMAO; Trimet-amine	4180186
1176030	TMAO SerPl LC/MS/MS-sCnc	4180186
1176030	三甲基胺 N-氧化物:物质的量浓度:时间点:血清/血浆:定量型:LC/MS/MS	4182948
1176033	Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; pressure injury; Pressure ulcer; Pressure Ulcers; PUSH Tool 3.0; Random; Survey; SURVEY.GNHLTH; Ulcer	4180186
1176034	Develop-behav peds; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Mental health; MentalHealth; notes; Peds; Point in time; Psych; Psychiatry; Random; Telemedicine; Visit note	4180186
1176034	Develop-behav peds Telehealth Note	4180186
1176034	记录:发现:时间点:远程医疗:文档型:发育行为儿科学	4182948
1176035	Abd; Abdo; Abdomen+; Abdominal; Asp; CAT scan; Computed tomography; Computerized tomography; CT scan; Cyst asp; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Kidney; Nephric; Nephrology; Perc; Point in time; Pyelogram; Rad; Radiology; Random; Renal	4180186
1176035	CT Guided Kidney Cyst asp	4180186
1176035	旨在经皮囊肿抽吸的引导:发现:时间点:腹部>肾脏:文档型:CT	4182948
1176036	Norclozapine Ur Cfm-mCnc	4180186
1176036	Cfm; Clozapine metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desmethylclozapine; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
1176036	去甲基氯氮平:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1176037	Asp; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; EXT; Extr-R; Finding; Findings; Fld; Guid; Guide; Guided; Hip-R; Imaging; LE; Leg; LE-R; Low; Lower extremity joint; MSK; Musculoskeletal; Ortho; Orthopedics; PC fluid asp; Perc; Point in time; R; Rad; RADIOLOGY; Random; RLE; RT	4180186
1176037	CT Guided Hip-R Arthrocentesis	4180186
1176037	旨在经皮穿刺抽吸的引导:发现:时间点:下肢.右侧>髋关节:文档型:CT	4182948
1176039	Clin Path Prog note	4180186
1176039	病程记录:发现:时间点:{环境}:文档型:临床病理学	4182948
1176039	Clin Path; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Laboratory medicine; notes; Path; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1176040	Bld Bnk+Trans Med Procedure note	4180186
1176040	Bld Bnk+Trans Med; Blood conservation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Tx; Visit note	4180186
1176040	操作记录:发现:时间点:{环境}:文档型:血库与输血医学	4182948
1176041	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C krusei; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Serum; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1176041	C krusei DNA Ser Ql NAA+probe	4180186
1176041	克鲁斯假丝酵母 DNA:存在情况或阈值:时间点:血清:序数型:探针法.基因扩增.靶向	4182948
1176042	Cogn func; cognition; cognitive status; FCN; Func; Funct; Patient Reported Outcomes Information System; PEDS; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.PROMIS	4180186
1176043	Asp; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Fld; Guid; Guide; Guided; Imaging; Lung; PC fluid asp; Perc; Pl space; Pl space-R; Point in time; Pulmonary; Pulmonology; R; Rad; Radiology; Random; Respiratory; RT; Thoracentesis; Thorax; Thorocentesis	4180186
1176043	CT Guided Pl space-R PC fluid asp	4180186
1176043	旨在经皮穿刺抽吸的引导:发现:时间点:胸部>胸膜腔.右侧:文档型:CT	4182948
1176044	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chagas disease; Donr; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; T cruzi; Trypanosomiasis; Trypanosomosis	4180186
1176044	T cruzi IgG SerPl Donr Ql IA	4180186
1176044	克氏锥虫 抗体.IgG:存在情况或阈值:时间点:血清/血浆^供体:序数型:免疫测定法	4182948
1176047	Consult note; Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Telemedicine; Visit note	4180186
1176047	会诊记录:发现:时间点:远程医疗:文档型:缓和照顾	4182948
1176048	#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Circo virus; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; III; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); Other; PCR; PCV; PCV3; PCV3 DNA; Point in time; Polymerase chain reaction; Pork; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; Swine; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary; Viral load	4180186
1176048	PCV3 DNA # Spec NAA+probe	4180186
1176048	猪圆环病毒 3 型 DNA:计数型浓度:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
1176049	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B henselae; Bacillary angiomaosis; Bacillary pelliosis; Cat Scratch Disease; Cat Scratch Fever; CSD; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Implnt dev; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Prostheses; Prosthesis; Prosthetic; QBR; QL; Qual; Qualitative; R henselae; Random; Rochalimaea henselae; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1176049	B henselae DNA Implnt dev Ql NAA+probe	4180186
1176049	汉赛巴尔通体 DNA:存在情况或阈值:时间点:植入装置:序数型:探针法.基因扩增.靶向	4182948
1176052	CAT scan; Cath; Computed tomography; Computerized tomography; CT scan; Document; Drain; Drain+cath place; Exudate; Finding; Findings; Guid; Guide; Guided; Imaging; L; LT; Lung; Lung-L; Point in time; Pulmonary; Pulmonology; Rad; RADIOLOGY; Random; Removal of fluid; Respiratory; Thorax	4180186
1176052	CT Guided Lung-L Drain+cath place	4180186
1176052	旨在引流+引流导管置入的引导:发现:时间点:胸部>肺.左侧:文档型:CT	4182948
1176053	Maltose BP IgE Qn	4180186
1176053	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Bind; Immune globulin E; Immunoglobulin E; Maltose BP; Maltose-binding protein; MBP; o213; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Ro213; Serum; SR	4180186
1176053	麦芽糖结合蛋白 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
1176054	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Genitourinary; GU; notes; Point in time; Random; Telemedicine; URO; Urology; Visit note	4180186
1176054	记录:发现:时间点:远程医疗:文档型:泌尿外科学	4182948
1176056	Cnt; Count; Dental; Dentistry; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Teeth+gum	4180186
1176056	Open-spaced teeth	4180186
1176056	开放间隙牙齿:数量(计数):时间点:牙齿与牙龈:定量型	4182948
1176058	AMPAR2 Ab Titr CSF CBA IFA	4180186
1176058	Alpha-氨基-3-羟基-5-甲基-4-异噁唑丙酸受体 2 抗体:滴定度:时间点:脑脊液:定量型:CBA IFA	4182948
1176058	ABS; Aby; Alfa; AMPA Receptor; AMPAR2; AMPAR2 Ab; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); GluA2; GluR2; GluR-B; Hydrox; II; III; Indirect Fluorescence Antibody; Limbic encephalitis; OH; Point in time; Random; Rec; Recept; Receptors; Recp; Recptr; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr	4180186
1176061	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Telemedicine; Visit note	4180186
1176061	记录:发现:时间点:远程医疗:文档型:风湿病学	4182948
1176064	PCV2 IgG Titr Spec IF	4180186
1176064	猪圆环病毒 2 型 抗体.IgG:滴定度:时间点:XXX:定量型:免疫荧光法	4182948
1176064	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Circo virus; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; II; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Other; PCV; PCV2; PCV2 Ab; PCV2 IgG; Point in time; Pork; Random; SmQn; Spec; Swine; Time Resolved Fluorescence; Titer; Titered; Titre; To be specified in another part of the message; TRF; Ttr; Unspecified; Vet; Veterinary	4180186
1176066	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176067	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176070	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; promise; Survey; SURVEY.PROMIS	4180186
1176072	c; CAT scan; Cath; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Drain; Drain+cath place; Exudate; Finding; Findings; Guid; Guide; Guided; Imaging; Pelvic; Point in time; Rad; RADIOLOGY; Random; Removal of fluid; W contr IV; WC	4180186
1176072	CT Guided Pelv Drain+cath plc--W cont IV	4180186
1176072	旨在引流+引流导管置入的引导^采用静脉注射对比剂:发现:时间点:盆腔:文档型:CT	4182948
1176073	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M hyopneumo; M hyopneumo DNA; M hyopneumoniae; Microbiology; Misc; Miscellaneous; Myco; Mycoplas; Mycoplasm; Mycoplasmosis; Mycoplsm; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; Porcine respiratory mycoplasmosis; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
1176073	M hyopneumo DNA Spec Ql NAA+probe	4180186
1176073	猪肺炎支原体 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
1176082	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176086	ABS; Aby; Ameba; Amebiasis; Amebic; Amoeba; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; E histolyt; E histolytica; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
1176086	E histolyt Ab Ser Ql IA	4180186
1176086	溶组织内阿米巴 抗体:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
1176088	Acanthocyte; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; Spur cells; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
1176088	Acanthocytes UrnS Ql Micro	4180186
1176088	棘红细胞:存在情况或阈值:时间点:尿沉渣:序数型:显微镜检查.光学	4182948
1176089	Abd; Abdo; Abdomen+; Abdominal; Absc drain+cath place; Absc drainage; CAT scan; Cath; Computed tomography; Computerized tomography; CT scan; Document; Drain; Exudate; Finding; Findings; Guid; Guide; Guided; Imaging; L; LT; Perinephric space; Perirenal space-L; Point in time; Rad; RADIOLOGY; Random; Removal of fluid	4180186
1176089	CT Guided Perirenal sp-L Absc drain+cath	4180186
1176089	旨在脓肿引流+引流导管置入的引导:发现:时间点:腹部>肾周间隙.左侧:文档型:CT	4182948
1176090	Cogn func; cognition; cognitive status; FCN; Func; Funct; Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.PROMIS	4180186
1176091	Number fraction; Percent; Point in time; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Random; Reg hosp closed; Reg hosp.total; Tot; Totl	4180186
1176091	Reg hosp closed/Reg hosp.total NFr	4180186
1176091	因为事件或意外事件而关闭的区域医院/区域医院.总计:计数型分数:时间点:^事件:定量型	4182948
1176092	Anaero; Anaerobe; Anaerobe Cult; Bact; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Low; Lower resp; Lung; Microbiology; Nominal; Point in time; Pulmonary; Pulmonology; Random; Respiratory	4180186
1176092	Bacteria Lower resp Anaerobe Cult	4180186
1176092	细菌 已鉴定的:存在与否或特征标识:时间点:呼吸道.下:名义型:厌氧微生物培养	4182948
1176094	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176095	Pseudoephedrine SerPlBld Cfm-mCnc	4180186
1176095	Blood; Cenafed; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Pl; PlasBld; Plasma; Plsm; Point in time; Pseudoephed; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; Sudafed; WB; Whole blood	4180186
1176095	伪麻黄碱:质量浓度:时间点:血清/血浆/全血:定量型:毒理学确认试验	4182948
1176098	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Mat fetal med; notes; Point in time; Random; Visit note	4180186
1176098	操作记录:发现:时间点:{环境}:文档型:母胎医学	4182948
1176098	Mat fetal med Procedure note	4180186
1176100	LysoPC(22:0) DBS-mCnc	4180186
1176100	Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Level; LysoPC(22:0); Mass Concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
1176100	溶血磷脂酰胆碱(22:0):质量浓度:时间点:全血.斑点:定量型	4182948
1176102	Genital vaginal; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LM; Micro; Microbiology; Micros; Microscopic; OB; ObGyn; Obstetrics; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; T vaginalis; Tric; Trich; Trichimoniasis; Trichomonad; Trichomonads; Trichomoniasis; Vag fld; Vag fluid; Vagina; Vaginal fluid	4180186
1176102	T vaginalis Vag Ql Micro	4180186
1176102	阴道毛滴虫:存在情况或阈值:时间点:阴道:序数型:显微镜检查.光学	4182948
1176103	Nuc Medicine Post-op E/M note	4180186
1176103	Assessment; Clinical encounter note; DOC.ONT; Document; E/M note; Encounter; Eval; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Nuc med; Nuc Medicine; Point in time; Post-op E/M note; Post-operative; Random; Visit note	4180186
1176103	术后评价与管理记录:发现:时间点:{环境}:文档型:核医学	4182948
1176104	ANTIBIOTIC SUSCEPTIBILITIES; AST; Baxdela; DLX; Fluoroquinolone; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
1176104	DLX Islt MIC	4180186
1176104	德拉沙星:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
1176105	3 Self-Sustaining Sequence Replication; 3SR SR; Adeno virus; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HAdV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
